,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,1710735,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,59,ACTA2,https://ctdbase.org/detail.go?type=gene&acc=59,,,59.0,ACTA2,9606,Homo sapiens (human),Ascorbic acid promotes the reaction [quartz results in increased expression of ACTA2 mrna],,,PMID:27381660,https://www.ncbi.nlm.nih.gov/pubmed/27381660,27381660,,
1,1710736,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2,A2M,https://ctdbase.org/detail.go?type=gene&acc=2,,,2.0,A2M,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of A2M mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
2,1710737,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,16,AARS1,https://ctdbase.org/detail.go?type=gene&acc=16,,,16.0,AARS1,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of AARS1 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
3,1710804,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,19,ABCA1,https://ctdbase.org/detail.go?type=gene&acc=19,,,19.0,ABCA1,9606,Homo sapiens (human),[tributyltin co-treated with [ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein]] results in increased expression of ABCA1 mrna|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of ABCA1 mrna|diazepinylbenzoic acid inhibits the reaction [[tributyltin co-treated with [ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein]] results in increased expression of ABCA1 mrna]|[tributyltin co-treated with [ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein]] results in increased expression of ABCA1 protein|[bexarotene co-treated with [ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein]] results in increased expression of ABCA1 protein|[lg 100268 co-treated with [ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein]] results in increased expression of ABCA1 mrna|[diazepinylbenzoic acid co-treated with [ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein]] results in decreased expression of ABCA1 mrna|diazepinylbenzoic acid inhibits the reaction [[LG 100268 co-treated with [ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein]] results in increased expression of ABCA1 mrna]|[rosiglitazone co-treated with [ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein]] results in increased expression of ABCA1 protein|[t0901317 co-treated with [ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein]] results in increased expression of ABCA1 mRNA,,,PMID:25932594,https://www.ncbi.nlm.nih.gov/pubmed/25932594,25932594,,
4,1710805,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,19,ABCA1,https://ctdbase.org/detail.go?type=gene&acc=19,,,19.0,ABCA1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of ABCA1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
5,1710806,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,9606,Homo sapiens (human),"Ascorbic acid inhibits the reaction [3',4',7-trihydroxyisoflavone results in decreased expression of ABCB1 mrna]",,,PMID:22914566,https://www.ncbi.nlm.nih.gov/pubmed/22914566,22914566,,
6,1710807,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,18671,ABCB1A,https://ctdbase.org/detail.go?type=gene&acc=18671,,,18671.0,Abcb1a,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with sesame oil] inhibits the reaction [abamectin results in increased expression of ABCB1A mrna]|ascorbic acid inhibits the reaction [abamectin results in increased expression of ABCB1A mrna],,,PMID:31739238,https://www.ncbi.nlm.nih.gov/pubmed/31739238,31739238,,
7,1710808,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4363,ABCC1,https://ctdbase.org/detail.go?type=gene&acc=4363,,,4363.0,ABCC1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ABCC1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
8,1710809,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4363,ABCC1,https://ctdbase.org/detail.go?type=gene&acc=4363,,,4363.0,ABCC1,9606,Homo sapiens (human),"Ascorbic acid inhibits the reaction [3',4',7-trihydroxyisoflavone results in decreased expression of ABCC1 mrna]",,,PMID:22914566,https://www.ncbi.nlm.nih.gov/pubmed/22914566,22914566,,
9,1710810,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1244,ABCC2,https://ctdbase.org/detail.go?type=gene&acc=1244,,,1244.0,ABCC2,9606,Homo sapiens (human),"Ascorbic acid inhibits the reaction [3',4',7-trihydroxyisoflavone results in decreased expression of ABCC2 mrna]",,,PMID:22914566,https://www.ncbi.nlm.nih.gov/pubmed/22914566,22914566,,
10,1710878,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1244,ABCC2,https://ctdbase.org/detail.go?type=gene&acc=1244,,,1244.0,ABCC2,9606,Homo sapiens (human),"Ascorbic acid promotes the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]|ascorbic acid inhibits the reaction [4-hydroxy-2-nonenal inhibits the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]]",,,PMID:19326901,https://www.ncbi.nlm.nih.gov/pubmed/19326901,19326901,,
11,1710879,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1244,ABCC2,https://ctdbase.org/detail.go?type=gene&acc=1244,,,1244.0,ABCC2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [fructose results in decreased expression of ABCC2 mrna]|ascorbic acid inhibits the reaction [fructose results in decreased expression of ABCC2 protein],,,PMID:31005848,https://www.ncbi.nlm.nih.gov/pubmed/31005848,31005848,,
12,1710880,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,176,ACAN,https://ctdbase.org/detail.go?type=gene&acc=176,,,176.0,ACAN,9606,Homo sapiens (human),IL1B protein inhibits the reaction [[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of ACAN mrna]|[tgfb3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of ACAN mrna|resveratrol inhibits the reaction [IL1B protein inhibits the reaction [[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of ACAN mrna]],,,PMID:26526931,https://www.ncbi.nlm.nih.gov/pubmed/26526931,26526931,,
13,1710881,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1636,ACE,https://ctdbase.org/detail.go?type=gene&acc=1636,,,1636.0,ACE,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [epigallocatechin gallate results in decreased activity of ACE protein],,,PMID:28544013,https://www.ncbi.nlm.nih.gov/pubmed/28544013,28544013,,
14,1710882,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,59272,ACE2,https://ctdbase.org/detail.go?type=gene&acc=59272,,,59272.0,ACE2,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of ACE2 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
15,1710883,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [glucose results in decreased activity of ACHE protein],,,PMID:26163454,https://www.ncbi.nlm.nih.gov/pubmed/26163454,26163454,,
16,1710884,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,10090,Mus musculus (house mouse),Ascorbic acid results in decreased activity of ACHE protein,,,PMID:16822217,https://www.ncbi.nlm.nih.gov/pubmed/16822217,16822217,,
17,1710885,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,10090,Mus musculus (house mouse),[resveratrol co-treated with ascorbic acid co-treated with thioctic acid co-treated with vitamin E] results in increased activity of ACHE protein|hexachlorocyclohexane inhibits the reaction [[resveratrol co-treated with ascorbic acid co-treated with thioctic acid co-treated with vitamin E] results in increased activity of ACHE protein],,,PMID:20663516,https://www.ncbi.nlm.nih.gov/pubmed/20663516,20663516,,
18,1710886,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chlorodiphenyl (54% chlorine) results in decreased activity of ACHE protein],,,PMID:16248992,https://www.ncbi.nlm.nih.gov/pubmed/16248992,16248992,,
19,1710901,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [scopolamine results in decreased activity of ACHE protein],,,PMID:11814146,https://www.ncbi.nlm.nih.gov/pubmed/11814146,11814146,,
20,1710902,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [sodium benzoate results in increased activity of ACHE protein],,,PMID:35187746,https://www.ncbi.nlm.nih.gov/pubmed/35187746,35187746,,
21,1710903,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased activity of ACHE protein,,,PMID:19703495,https://www.ncbi.nlm.nih.gov/pubmed/19703495,19703495,,
22,1710904,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,10116,Rattus norvegicus (Norway rat),[dexamethasone co-treated with ascorbic acid] results in increased expression of and results in increased activity of ACHE protein|[dexamethasone co-treated with ascorbic acid] results in increased expression of ACHE mRNA,,,PMID:27019979,https://www.ncbi.nlm.nih.gov/pubmed/27019979,27019979,,
23,1710905,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,10116,Rattus norvegicus (Norway rat),[zinc co-treated with vitamin E co-treated with ascorbic acid] inhibits the reaction [sodium arsenite results in increased activity of ACHE protein],,,PMID:23619517,https://www.ncbi.nlm.nih.gov/pubmed/23619517,23619517,,
24,1710906,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2182,ACSL4,https://ctdbase.org/detail.go?type=gene&acc=2182,,,2182.0,ACSL4,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of ACSL4 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
25,1710907,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,51703,ACSL5,https://ctdbase.org/detail.go?type=gene&acc=51703,,,51703.0,ACSL5,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of ACSL5 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
26,1710908,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,59,ACTA2,https://ctdbase.org/detail.go?type=gene&acc=59,,,59.0,ACTA2,10141,Cavia porcellus (domestic guinea pig),Ascorbic acid inhibits the reaction [ethanol results in increased expression of ACTA2 protein],,,PMID:24239723,https://www.ncbi.nlm.nih.gov/pubmed/24239723,24239723,,
27,1710909,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,59,ACTA2,https://ctdbase.org/detail.go?type=gene&acc=59,,,59.0,ACTA2,9606,Homo sapiens (human),[ascorbic acid co-treated with TGFB1 protein] results in increased expression of ACTA2 protein|[ascorbic acid co-treated with TGFB1 protein] results in increased expression of ACTA2 mRNA,,,PMID:18607632,https://www.ncbi.nlm.nih.gov/pubmed/18607632,18607632,,
28,1710910,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,59,ACTA2,https://ctdbase.org/detail.go?type=gene&acc=59,,,59.0,ACTA2,9606,Homo sapiens (human),[mercaptoethanol co-treated with ascorbic acid] results in increased expression of ACTA2 protein,,,PMID:17053324,https://www.ncbi.nlm.nih.gov/pubmed/17053324,17053324,,
29,1711658,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,59,ACTA2,https://ctdbase.org/detail.go?type=gene&acc=59,,,59.0,ACTA2,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with ferrous sulfate] results in increased expression of ACTA2 protein,,,PMID:7593635,https://www.ncbi.nlm.nih.gov/pubmed/7593635,7593635,,
30,1711659,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,88,ACTN2,https://ctdbase.org/detail.go?type=gene&acc=88,,,88.0,ACTN2,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ACTN2 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
31,1711660,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,112,ADCY6,https://ctdbase.org/detail.go?type=gene&acc=112,,,112.0,ADCY6,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of ADCY6 mRNA,,,PMID:17303424,https://www.ncbi.nlm.nih.gov/pubmed/17303424,17303424,,
32,1711664,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,22859,ADGRL1,https://ctdbase.org/detail.go?type=gene&acc=22859,,,22859.0,ADGRL1,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of ADGRL1 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
33,1711665,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,174,AFP,https://ctdbase.org/detail.go?type=gene&acc=174,,,174.0,AFP,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of AFP mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
34,1711666,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,174,AFP,https://ctdbase.org/detail.go?type=gene&acc=174,,,174.0,AFP,8022,Oncorhynchus mykiss (rainbow trout),[vitamin A co-treated with cholecalciferol co-treated with vitamin E co-treated with ascorbic acid] inhibits the reaction [[cyhalothrin co-treated with chlorantranilipole] results in increased expression of AFP protein],,,PMID:36813254,https://www.ncbi.nlm.nih.gov/pubmed/36813254,36813254,,
35,1711725,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,27161,AGO2,https://ctdbase.org/detail.go?type=gene&acc=27161,,,27161.0,AGO2,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of AGO2 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
36,1711726,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,183,AGT,https://ctdbase.org/detail.go?type=gene&acc=183,,,183.0,AGT,9606,Homo sapiens (human),Losartan inhibits the reaction [[AGT protein modified form co-treated with ascorbic acid co-treated with copper sulfate] results in increased chemical synthesis of [pyruvamide binds to AGT protein modified form]]|[ascorbic acid co-treated with copper sulfate] promotes the reaction [AGT protein modified form results in increased chemical synthesis of [4-hydroxy-2-nonenal binds to AGT protein modified form]]|[ascorbic acid co-treated with copper sulfate] promotes the reaction [AGT protein modified form results in increased chemical synthesis of [pyruvamide binds to AGT protein modified form]]|losartan inhibits the reaction [[AGT protein modified form co-treated with ascorbic acid co-treated with copper sulfate] results in increased chemical synthesis of [4-hydroxy-2-nonenal binds to AGT protein modified form]],,,PMID:31144504,https://www.ncbi.nlm.nih.gov/pubmed/31144504,31144504,,
37,1711727,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,183,AGT,https://ctdbase.org/detail.go?type=gene&acc=183,,,183.0,AGT,9606,Homo sapiens (human),Ascorbic acid promotes the reaction [linoleic acid hydroperoxide results in increased lipidation of AGT protein modified form],,,PMID:26111765,https://www.ncbi.nlm.nih.gov/pubmed/26111765,26111765,,
38,1711728,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,183,AGT,https://ctdbase.org/detail.go?type=gene&acc=183,,,183.0,AGT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [AGT protein modified form results in decreased hydroxylation of HIF1A protein]|ascorbic acid inhibits the reaction [AGT protein modified form results in increased expression of TIMP1 protein],,,PMID:20881940,https://www.ncbi.nlm.nih.gov/pubmed/20881940,20881940,,
39,1711729,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,205,AK4,https://ctdbase.org/detail.go?type=gene&acc=205,,,205.0,AK4,10090,Mus musculus (house mouse),Ascorbic acid results in decreased expression of AK4 mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
40,1711730,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10327,AKR1A1,https://ctdbase.org/detail.go?type=gene&acc=10327,,,10327.0,AKR1A1,10090,Mus musculus (house mouse),AKR1A1 gene mutant form promotes the reaction [diethylnitrosamine results in decreased abundance of ascorbic acid]|[akr1a1 gene mutant form results in increased susceptibility to diethylnitrosamine] which results in decreased abundance of ascorbic acid|akr1a1 gene mutant form results in decreased abundance of ascorbic acid,,,PMID:32805337,https://www.ncbi.nlm.nih.gov/pubmed/32805337,32805337,,
41,1711731,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,231,AKR1B1,https://ctdbase.org/detail.go?type=gene&acc=231,,,231.0,AKR1B1,9606,Homo sapiens (human),Ascorbic acid results in increased reduction of AKR1B1 protein modified form,,,PMID:19061876,https://www.ncbi.nlm.nih.gov/pubmed/19061876,19061876,,
42,1711732,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,57016,AKR1B10,https://ctdbase.org/detail.go?type=gene&acc=57016,,,57016.0,AKR1B10,9606,Homo sapiens (human),Ascorbic acid results in increased expression of AKR1B10 mRNA,,,PMID:26198647,https://www.ncbi.nlm.nih.gov/pubmed/26198647,26198647,,
43,1711733,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1646,AKR1C2,https://ctdbase.org/detail.go?type=gene&acc=1646,,,1646.0,AKR1C2,9606,Homo sapiens (human),Ascorbic acid results in increased expression of AKR1C2 mRNA,,,PMID:26198647,https://www.ncbi.nlm.nih.gov/pubmed/26198647,26198647,,
44,1711789,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with vitamin E] inhibits the reaction [diethylhexyl phthalate results in decreased phosphorylation of AKT1 protein],,,PMID:21911000,https://www.ncbi.nlm.nih.gov/pubmed/21911000,21911000,,
45,1711790,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in decreased phosphorylation of AKT1 protein],,,PMID:21262251,https://www.ncbi.nlm.nih.gov/pubmed/21262251,21262251,,
46,1711791,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,208,AKT2,https://ctdbase.org/detail.go?type=gene&acc=208,,,208.0,AKT2,9606,Homo sapiens (human),Ascorbic acid affects the expression of AKT2 mRNA,,,PMID:30597948,https://www.ncbi.nlm.nih.gov/pubmed/30597948,30597948,,
47,1711792,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,211,ALAS1,https://ctdbase.org/detail.go?type=gene&acc=211,,,211.0,ALAS1,10090,Mus musculus (house mouse),"Ascorbic acid inhibits the reaction [griseofulvin results in increased activity of ALAS1 protein]|[ascorbic acid co-treated with 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid] inhibits the reaction [griseofulvin results in increased activity of ALAS1 protein]",,,PMID:24523661,https://www.ncbi.nlm.nih.gov/pubmed/24523661,24523661,,
48,1711793,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,9913,Bos taurus (cattle),[linoleic acid co-treated with ferrous sulfate co-treated with ascorbic acid] affects the metabolism of ALB protein|[arachidonic acid co-treated with ferrous sulfate co-treated with ascorbic acid] affects the metabolism of ALB protein|[docosahexaenoic acids co-treated with ferrous sulfate co-treated with ascorbic acid] affects the metabolism of ALB protein,,,PMID:16582421,https://www.ncbi.nlm.nih.gov/pubmed/16582421,16582421,,
49,1711794,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,9913,Bos taurus (cattle),Ascorbic acid inhibits the reaction [ANFT binds to ALB protein],,,PMID:2121382,https://www.ncbi.nlm.nih.gov/pubmed/2121382,2121382,,
50,1711795,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,9913,Bos taurus (cattle),Ascorbic acid results in increased glycation of ALB protein,,,PMID:26163454,https://www.ncbi.nlm.nih.gov/pubmed/26163454,26163454,,
51,1711796,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,9913,Bos taurus (cattle),[copper co-treated with ascorbic acid co-treated with ALB protein] promotes the reaction [glyoxal binds to imidazolone],,,PMID:17390397,https://www.ncbi.nlm.nih.gov/pubmed/17390397,17390397,,
52,1711797,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of ALB mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
53,1711798,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,217,ALDH2,https://ctdbase.org/detail.go?type=gene&acc=217,,,217.0,ALDH2,10090,Mus musculus (house mouse),ALDH2 protein affects the reaction [ascorbic acid deficiency results in decreased susceptibility to nitroglycerin],,,PMID:23194305,https://www.ncbi.nlm.nih.gov/pubmed/23194305,23194305,,
54,1711817,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,226,ALDOA,https://ctdbase.org/detail.go?type=gene&acc=226,,,226.0,ALDOA,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ALDOA mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
55,1711818,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,246,ALOX15,https://ctdbase.org/detail.go?type=gene&acc=246,,,246.0,ALOX15,9986,Oryctolagus cuniculus (rabbit),Ascorbic acid affects the activity of ALOX15 protein,,,PMID:10995031,https://www.ncbi.nlm.nih.gov/pubmed/10995031,10995031,,
56,1711819,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,246,ALOX15,https://ctdbase.org/detail.go?type=gene&acc=246,,,246.0,ALOX15,9986,Oryctolagus cuniculus (rabbit),Ascorbic acid inhibits the reaction [ALOX15 protein results in increased abundance of cholesteryl ester hydroperoxide]|ascorbic acid inhibits the reaction [ALOX15 protein results in increased degradation of alpha-tocopherol],,,PMID:9448720,https://www.ncbi.nlm.nih.gov/pubmed/9448720,9448720,,
57,1711820,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,248,ALPI,https://ctdbase.org/detail.go?type=gene&acc=248,,,248.0,ALPI,9913,Bos taurus (cattle),Ascorbic acid inhibits the reaction [perhydroxyl radical results in decreased activity of ALPI protein]|ascorbic acid inhibits the reaction [reactive oxygen species results in decreased activity of ALPI protein],,,PMID:17705259,https://www.ncbi.nlm.nih.gov/pubmed/17705259,17705259,,
58,1711821,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,248,ALPI,https://ctdbase.org/detail.go?type=gene&acc=248,,,248.0,ALPI,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of ALPI mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
59,1711822,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,249,ALPL,https://ctdbase.org/detail.go?type=gene&acc=249,,,249.0,ALPL,9606,Homo sapiens (human),EZH2 protein inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of ALPL mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of ALPL mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
60,1711823,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,249,ALPL,https://ctdbase.org/detail.go?type=gene&acc=249,,,249.0,ALPL,9606,Homo sapiens (human),Ascorbic acid results in increased expression of ALPL mRNA,,,PMID:28105418,https://www.ncbi.nlm.nih.gov/pubmed/28105418,28105418,,
61,1711824,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,249,ALPL,https://ctdbase.org/detail.go?type=gene&acc=249,,,249.0,ALPL,10090,Mus musculus (house mouse),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of ALPL mrna]|[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of ALPL mRNA",,,PMID:26492236,https://www.ncbi.nlm.nih.gov/pubmed/26492236,26492236,,
62,1711825,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,249,ALPL,https://ctdbase.org/detail.go?type=gene&acc=249,,,249.0,ALPL,9823,Sus scrofa (pig),"[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of ALPL mrna|2,2-bis(4-glycidyloxyphenyl)propane promotes the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of ALPL mrna]",,,PMID:30481989,https://www.ncbi.nlm.nih.gov/pubmed/30481989,30481989,,
63,1711896,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,269,AMHR2,https://ctdbase.org/detail.go?type=gene&acc=269,,,269.0,AMHR2,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of AMHR2 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
64,1711897,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,290,ANPEP,https://ctdbase.org/detail.go?type=gene&acc=290,,,290.0,ANPEP,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of ANPEP mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
65,1711898,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,301,ANXA1,https://ctdbase.org/detail.go?type=gene&acc=301,,,301.0,ANXA1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of ANXA1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
66,1711899,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,301,ANXA1,https://ctdbase.org/detail.go?type=gene&acc=301,,,301.0,ANXA1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of ANXA1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
67,1711900,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,301,ANXA1,https://ctdbase.org/detail.go?type=gene&acc=301,,,301.0,ANXA1,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of ANXA1 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
68,1711901,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,308,ANXA5,https://ctdbase.org/detail.go?type=gene&acc=308,,,308.0,ANXA5,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of ANXA5 protein,,,PMID:19224539,https://www.ncbi.nlm.nih.gov/pubmed/19224539,19224539,,
69,1711902,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,308,ANXA5,https://ctdbase.org/detail.go?type=gene&acc=308,,,308.0,ANXA5,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of ANXA5 mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
70,1711903,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,308,ANXA5,https://ctdbase.org/detail.go?type=gene&acc=308,,,308.0,ANXA5,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of ANXA5 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
71,1711904,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,335,APOA1,https://ctdbase.org/detail.go?type=gene&acc=335,,,335.0,APOA1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of APOA1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
72,1711905,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,335,APOA1,https://ctdbase.org/detail.go?type=gene&acc=335,,,335.0,APOA1,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of APOA1 mrna|ascorbic acid results in decreased activity of APOA1 promoter|ascorbic acid results in decreased expression of APOA1 protein,,,PMID:16423621,https://www.ncbi.nlm.nih.gov/pubmed/16423621,16423621,,
73,1711976,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,338,APOB,https://ctdbase.org/detail.go?type=gene&acc=338,,,338.0,APOB,9606,Homo sapiens (human),Ascorbic acid promotes the reaction [quercetin inhibits the reaction [copper results in increased oxidation of APOB protein]]|ascorbic acid promotes the reaction [flavonoids inhibits the reaction [copper results in increased oxidation of APOB protein]],,,PMID:17475462,https://www.ncbi.nlm.nih.gov/pubmed/17475462,17475462,,
74,1711977,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,338,APOB,https://ctdbase.org/detail.go?type=gene&acc=338,,,338.0,APOB,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of APOB mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
75,1711978,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,348,APOE,https://ctdbase.org/detail.go?type=gene&acc=348,,,348.0,APOE,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of APOE mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
76,1711979,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,55937,APOM,https://ctdbase.org/detail.go?type=gene&acc=55937,,,55937.0,APOM,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of APOM mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
77,1711980,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,351,APP,https://ctdbase.org/detail.go?type=gene&acc=351,,,351.0,APP,9606,Homo sapiens (human),APP protein inhibits the reaction [copper results in increased oxidation of ascorbic acid]|[app protein modified form binds to copper] which results in increased oxidation of ascorbic acid,,,PMID:24276282,https://www.ncbi.nlm.nih.gov/pubmed/24276282,24276282,,
78,1711981,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,351,APP,https://ctdbase.org/detail.go?type=gene&acc=351,,,351.0,APP,9606,Homo sapiens (human),Copper promotes the reaction [APP protein modified form results in increased oxidation of ascorbic acid]|[app protein modified form inhibits the reaction [[copper co-treated with ascorbic acid] results in increased oxidation of phosphatidylcholine hydroperoxide]] which results in increased chemical synthesis of 4-hydroxy-2-nonenal|trientine inhibits the reaction [[[[APP protein modified form binds to copper] which co-treated with ascorbic acid] results in increased oxidation of phosphatidylcholine hydroperoxide] which results in increased chemical synthesis of 4-hydroxy-2-nonenal]|trientine inhibits the reaction [[[[APP protein modified form binds to copper] which co-treated with ascorbic acid] results in increased oxidation of phosphatidylcholines] which results in increased chemical synthesis of phosphatidylcholine hydroperoxide]|[[[app protein modified form binds to copper] which co-treated with ascorbic acid] results in increased oxidation of phosphatidylcholine hydroperoxide] which results in increased chemical synthesis of 4-hydroxy-2-nonenal|[[[app protein modified form binds to copper] which co-treated with ascorbic acid] results in increased oxidation of phosphatidylcholines] which results in increased chemical synthesis of phosphatidylcholine hydroperoxide|app protein modified form inhibits the reaction [[copper co-treated with ascorbic acid] results in increased oxidation of phosphatidylcholine hydroperoxide]|app protein modified form results in increased oxidation of ascorbic acid|[[app protein modified form binds to copper] which co-treated with ascorbic acid] results in increased oxidation of phosphatidylcholines|deferoxamine inhibits the reaction [[[[APP protein modified form binds to copper] which co-treated with ascorbic acid] results in increased oxidation of phosphatidylcholine hydroperoxide] which results in increased chemical synthesis of 4-hydroxy-2-nonenal]|edetic acid inhibits the reaction [[[[APP protein modified form binds to copper] which co-treated with ascorbic acid] results in increased oxidation of phosphatidylcholines] which results in increased chemical synthesis of phosphatidylcholine hydroperoxide]|penicillamine inhibits the reaction [[[[APP protein modified form binds to copper] which co-treated with ascorbic acid] results in increased oxidation of phosphatidylcholines] which results in increased chemical synthesis of phosphatidylcholine hydroperoxide]|edetic acid inhibits the reaction [[[[APP protein modified form binds to copper] which co-treated with ascorbic acid] results in increased oxidation of phosphatidylcholine hydroperoxide] which results in increased chemical synthesis of 4-hydroxy-2-nonenal]|[[app protein modified form binds to copper] which co-treated with ascorbic acid] results in increased oxidation of phosphatidylcholine hydroperoxide,,,PMID:17964426,https://www.ncbi.nlm.nih.gov/pubmed/17964426,17964426,,
79,1712050,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,351,APP,https://ctdbase.org/detail.go?type=gene&acc=351,,,351.0,APP,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [APP protein modified form results in decreased abundance of ascorbic acid]|app protein modified form results in decreased abundance of ascorbic acid,,,PMID:25654502,https://www.ncbi.nlm.nih.gov/pubmed/25654502,25654502,,
80,1712051,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,351,APP,https://ctdbase.org/detail.go?type=gene&acc=351,,,351.0,APP,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [APP protein modified form results in increased abundance of reactive oxygen species],,,PMID:15030205,https://www.ncbi.nlm.nih.gov/pubmed/15030205,15030205,,
81,1712052,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,351,APP,https://ctdbase.org/detail.go?type=gene&acc=351,,,351.0,APP,9606,Homo sapiens (human),Ascorbic acid affects the reaction [[APP protein modified form binds to copper] which results in increased chemical synthesis of hydrogen peroxide],,,PMID:12192006,https://www.ncbi.nlm.nih.gov/pubmed/12192006,12192006,,
82,1712053,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,351,APP,https://ctdbase.org/detail.go?type=gene&acc=351,,,351.0,APP,9606,Homo sapiens (human),Ascorbic acid results in increased reduction of [copper binds to APP protein modified form],,,PMID:17636872,https://www.ncbi.nlm.nih.gov/pubmed/17636872,17636872,,
83,1712054,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,351,APP,https://ctdbase.org/detail.go?type=gene&acc=351,,,351.0,APP,9606,Homo sapiens (human),[[copper binds to APP protein modified form] which co-treated with oxygen] results in increased oxidation of ascorbic acid,,,PMID:20302320,https://www.ncbi.nlm.nih.gov/pubmed/20302320,20302320,,
84,1712055,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,360,AQP3,https://ctdbase.org/detail.go?type=gene&acc=360,,,360.0,AQP3,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of AQP3 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
85,1712056,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,396,ARHGDIA,https://ctdbase.org/detail.go?type=gene&acc=396,,,396.0,ARHGDIA,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of ARHGDIA mRNA,,,PMID:22139585,https://www.ncbi.nlm.nih.gov/pubmed/22139585,22139585,,
86,1712057,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,397,ARHGDIB,https://ctdbase.org/detail.go?type=gene&acc=397,,,397.0,ARHGDIB,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of ARHGDIB mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
87,1712058,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,397,ARHGDIB,https://ctdbase.org/detail.go?type=gene&acc=397,,,397.0,ARHGDIB,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of ARHGDIB protein,,,PMID:22139585,https://www.ncbi.nlm.nih.gov/pubmed/22139585,22139585,,
88,1712059,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10092,ARPC5,https://ctdbase.org/detail.go?type=gene&acc=10092,,,10092.0,ARPC5,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of ARPC5 mrna|ascorbic acid results in increased expression of ARPC5 protein,,,PMID:22139585,https://www.ncbi.nlm.nih.gov/pubmed/22139585,22139585,,
89,1712158,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,429,ASCL1,https://ctdbase.org/detail.go?type=gene&acc=429,,,429.0,ASCL1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ASCL1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
90,1712159,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,440,ASNS,https://ctdbase.org/detail.go?type=gene&acc=440,,,440.0,ASNS,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of ASNS mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
91,1712160,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,29028,ATAD2,https://ctdbase.org/detail.go?type=gene&acc=29028,,,29028.0,ATAD2,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in decreased expression of ATAD2 mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
92,1712161,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,54454,ATAD2B,https://ctdbase.org/detail.go?type=gene&acc=54454,,,54454.0,ATAD2B,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of ATAD2B mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
93,1712162,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,467,ATF3,https://ctdbase.org/detail.go?type=gene&acc=467,,,467.0,ATF3,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of ATF3 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
94,1712163,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,472,ATM,https://ctdbase.org/detail.go?type=gene&acc=472,,,472.0,ATM,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [potassium chromate(vi) results in increased expression of ATM protein modified form],,,PMID:25977998,https://www.ncbi.nlm.nih.gov/pubmed/25977998,25977998,,
95,1712164,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,472,ATM,https://ctdbase.org/detail.go?type=gene&acc=472,,,472.0,ATM,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of ATM mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
96,1712165,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,506,ATP5F1B,https://ctdbase.org/detail.go?type=gene&acc=506,,,506.0,ATP5F1B,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of ATP5F1B protein,,,PMID:22139585,https://www.ncbi.nlm.nih.gov/pubmed/22139585,22139585,,
97,1712166,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,523,ATP6V1A,https://ctdbase.org/detail.go?type=gene&acc=523,,,523.0,ATP6V1A,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of ATP6V1A mRNA,,,PMID:22139585,https://www.ncbi.nlm.nih.gov/pubmed/22139585,22139585,,
98,1712167,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9212,AURKB,https://ctdbase.org/detail.go?type=gene&acc=9212,,,9212.0,AURKB,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of AURKB mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
99,1712232,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,26053,AUTS2,https://ctdbase.org/detail.go?type=gene&acc=26053,,,26053.0,AUTS2,9606,Homo sapiens (human),Ascorbic acid results in increased expression of AUTS2 mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
100,1712233,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,567,B2M,https://ctdbase.org/detail.go?type=gene&acc=567,,,567.0,B2M,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of B2M mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
101,1712234,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,571,BACH1,https://ctdbase.org/detail.go?type=gene&acc=571,,,571.0,BACH1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [hydrogen peroxide results in decreased expression of BACH1 protein],,,PMID:28285367,https://www.ncbi.nlm.nih.gov/pubmed/28285367,28285367,,
102,1712235,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,572,BAD,https://ctdbase.org/detail.go?type=gene&acc=572,,,572.0,BAD,9606,Homo sapiens (human),[juglone co-treated with ascorbic acid] results in increased expression of BAD protein,,,PMID:29992683,https://www.ncbi.nlm.nih.gov/pubmed/29992683,29992683,,
103,1712236,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,572,BAD,https://ctdbase.org/detail.go?type=gene&acc=572,,,572.0,BAD,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in decreased phosphorylation of BAD protein]|ascorbic acid inhibits the reaction [potassium dichromate affects the localization of BAD protein]|ascorbic acid inhibits the reaction [potassium dichromate results in increased expression of BAD protein],,,PMID:21262251,https://www.ncbi.nlm.nih.gov/pubmed/21262251,21262251,,
104,1712237,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,578,BAK1,https://ctdbase.org/detail.go?type=gene&acc=578,,,578.0,BAK1,9606,Homo sapiens (human),[arsenic trioxide co-treated with ascorbic acid co-treated with disulfiram] results in decreased expression of BAK1 protein,,,PMID:24126434,https://www.ncbi.nlm.nih.gov/pubmed/24126434,24126434,,
105,1712238,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606,Homo sapiens (human),[arsenic trioxide co-treated with ascorbic acid co-treated with disulfiram] results in increased expression of BAX protein,,,PMID:24126434,https://www.ncbi.nlm.nih.gov/pubmed/24126434,24126434,,
106,1712239,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [deoxynivalenol results in increased expression of BAX protein],,,PMID:17166419,https://www.ncbi.nlm.nih.gov/pubmed/17166419,17166419,,
107,1712240,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [silicon dioxide results in increased expression of BAX mrna]|ascorbic acid inhibits the reaction [silicon dioxide results in increased expression of BAX protein],,,PMID:22245848,https://www.ncbi.nlm.nih.gov/pubmed/22245848,22245848,,
108,1712241,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606,Homo sapiens (human),[juglone co-treated with ascorbic acid] results in increased expression of BAX protein,,,PMID:29992683,https://www.ncbi.nlm.nih.gov/pubmed/29992683,29992683,,
109,1712340,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [glycidamide results in increased expression of BAX mrna],,,PMID:32632975,https://www.ncbi.nlm.nih.gov/pubmed/32632975,32632975,,
110,1712341,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9669,Mustela putorius furo (domestic ferret),[beta carotene co-treated with alpha-tocopherol co-treated with ascorbic acid] inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BAX protein],,,PMID:16401635,https://www.ncbi.nlm.nih.gov/pubmed/16401635,16401635,,
111,1712342,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [humic substances results in increased expression of BAX protein],,,PMID:18683188,https://www.ncbi.nlm.nih.gov/pubmed/18683188,18683188,,
112,1712343,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [lead acetate results in increased expression of BAX protein],,,PMID:17959157,https://www.ncbi.nlm.nih.gov/pubmed/17959157,17959157,,
113,1712344,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate affects the localization of BAX protein]|ascorbic acid inhibits the reaction [potassium dichromate results in increased expression of BAX protein],,,PMID:21262251,https://www.ncbi.nlm.nih.gov/pubmed/21262251,21262251,,
114,1712345,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [streptozocin results in increased expression of BAX protein],,,PMID:18758938,https://www.ncbi.nlm.nih.gov/pubmed/18758938,18758938,,
115,1712346,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,27113,BBC3,https://ctdbase.org/detail.go?type=gene&acc=27113,,,27113.0,BBC3,9606,Homo sapiens (human),Benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[ascorbic acid co-treated with zinc acetate co-treated with motexafin gadolinium] results in decreased expression of BBC3 protein]|[ascorbic acid co-treated with zinc acetate co-treated with motexafin gadolinium] results in decreased expression of BBC3 protein,,,PMID:20530418,https://www.ncbi.nlm.nih.gov/pubmed/20530418,20530418,,
116,1712347,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,590,BCHE,https://ctdbase.org/detail.go?type=gene&acc=590,,,590.0,BCHE,10090,Mus musculus (house mouse),Hexachlorocyclohexane inhibits the reaction [[resveratrol co-treated with ascorbic acid co-treated with thioctic acid co-treated with vitamin E] results in increased activity of BCHE protein]|[resveratrol co-treated with ascorbic acid co-treated with thioctic acid co-treated with vitamin E] results in increased activity of BCHE protein,,,PMID:20663516,https://www.ncbi.nlm.nih.gov/pubmed/20663516,20663516,,
117,1712348,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606,Homo sapiens (human),[arsenic trioxide co-treated with ascorbic acid co-treated with disulfiram] results in decreased expression of BCL2 protein,,,PMID:24126434,https://www.ncbi.nlm.nih.gov/pubmed/24126434,24126434,,
118,1712392,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606,Homo sapiens (human),[ascorbic acid co-treated with quartz] results in increased expression of BCL2 mRNA,,,PMID:27381660,https://www.ncbi.nlm.nih.gov/pubmed/27381660,27381660,,
119,1712393,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 protein],,,PMID:17166419,https://www.ncbi.nlm.nih.gov/pubmed/17166419,17166419,,
120,1712394,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [silicon dioxide results in decreased expression of BCL2 mrna]|ascorbic acid inhibits the reaction [silicon dioxide results in decreased expression of BCL2 protein],,,PMID:22245848,https://www.ncbi.nlm.nih.gov/pubmed/22245848,22245848,,
121,1712395,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of BCL2 mRNA,,,PMID:21919647,https://www.ncbi.nlm.nih.gov/pubmed/21919647,21919647,,
122,1712396,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606,Homo sapiens (human),BCL2 protein results in increased abundance of ascorbic acid,,,PMID:15449323,https://www.ncbi.nlm.nih.gov/pubmed/15449323,15449323,,
123,1712397,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [glycidamide results in decreased expression of BCL2 mrna],,,PMID:32632975,https://www.ncbi.nlm.nih.gov/pubmed/32632975,32632975,,
124,1712398,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,8022,Oncorhynchus mykiss (rainbow trout),[vitamin A co-treated with cholecalciferol co-treated with vitamin E co-treated with ascorbic acid] inhibits the reaction [[cyhalothrin co-treated with chlorantranilipole] results in increased expression of BCL2 protein],,,PMID:36813254,https://www.ncbi.nlm.nih.gov/pubmed/36813254,36813254,,
125,1712399,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10116,Rattus norvegicus (Norway rat),[alpha-tocopherol co-treated with ascorbic acid] inhibits the reaction [arsenic trioxide results in decreased expression of BCL2 mrna],,,PMID:29297235,https://www.ncbi.nlm.nih.gov/pubmed/29297235,29297235,,
126,1712400,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [humic substances results in decreased expression of BCL2 protein],,,PMID:18683188,https://www.ncbi.nlm.nih.gov/pubmed/18683188,18683188,,
127,1712401,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in decreased expression of BCL2 protein],,,PMID:21262251,https://www.ncbi.nlm.nih.gov/pubmed/21262251,21262251,,
128,1712466,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [streptozocin results in decreased expression of BCL2 protein],,,PMID:18758938,https://www.ncbi.nlm.nih.gov/pubmed/18758938,18758938,,
129,1712467,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10116,Rattus norvegicus (Norway rat),Ascorbic acid promotes the reaction [lead acetate results in increased expression of BCL2 protein],,,PMID:17959157,https://www.ncbi.nlm.nih.gov/pubmed/17959157,17959157,,
130,1712468,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,598,BCL2L1,https://ctdbase.org/detail.go?type=gene&acc=598,,,598.0,BCL2L1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in decreased expression of BCL2L1 protein],,,PMID:21262251,https://www.ncbi.nlm.nih.gov/pubmed/21262251,21262251,,
131,1712469,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,598,BCL2L1,https://ctdbase.org/detail.go?type=gene&acc=598,,,598.0,BCL2L1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [streptozocin results in decreased expression of BCL2L1 protein],,,PMID:18758938,https://www.ncbi.nlm.nih.gov/pubmed/18758938,18758938,,
132,1712470,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,598,BCL2L1,https://ctdbase.org/detail.go?type=gene&acc=598,,,598.0,BCL2L1,9823,Sus scrofa (pig),[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of BCL2L1 mRNA,,,PMID:30481989,https://www.ncbi.nlm.nih.gov/pubmed/30481989,30481989,,
133,1712471,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,79370,BCL2L14,https://ctdbase.org/detail.go?type=gene&acc=79370,,,79370.0,BCL2L14,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of BCL2L14 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
134,1712472,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,599,BCL2L2,https://ctdbase.org/detail.go?type=gene&acc=599,,,599.0,BCL2L2,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of BCL2L2 mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
135,1712473,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,53630,BCO1,https://ctdbase.org/detail.go?type=gene&acc=53630,,,53630.0,BCO1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [oxidants inhibits the reaction [BCO1 protein results in increased oxidation of beta carotene]],,,PMID:9526112,https://www.ncbi.nlm.nih.gov/pubmed/9526112,9526112,,
136,1712474,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,632,BGLAP,https://ctdbase.org/detail.go?type=gene&acc=632,,,632.0,BGLAP,10090,Mus musculus (house mouse),4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [[[dexamethasone co-treated with beta-glycerophosphoric acid co-treated with ascorbic acid] co-treated with fasudil] results in increased expression of BGLAP mrna]|4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [[[dexamethasone co-treated with beta-glycerophosphoric acid co-treated with ascorbic acid] co-treated with fasudil] results in increased expression of BGLAP protein]|[[dexamethasone co-treated with beta-glycerophosphoric acid co-treated with ascorbic acid] co-treated with fasudil] results in increased expression of BGLAP protein|[[dexamethasone co-treated with beta-glycerophosphoric acid co-treated with ascorbic acid] co-treated with fasudil] results in increased expression of BGLAP mRNA,,,PMID:31935364,https://www.ncbi.nlm.nih.gov/pubmed/31935364,31935364,,
137,1712528,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,632,BGLAP,https://ctdbase.org/detail.go?type=gene&acc=632,,,632.0,BGLAP,10090,Mus musculus (house mouse),"Triphenyltin hydroxide inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna]|rosiglitazone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna]|quinoxyfen inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna]|pioglitazone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna]|tretinoin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna]|d,d-T80-prallethrin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna|allethrins inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna]",,,PMID:32473317,https://www.ncbi.nlm.nih.gov/pubmed/32473317,32473317,,
138,1712529,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,632,BGLAP,https://ctdbase.org/detail.go?type=gene&acc=632,,,632.0,BGLAP,10090,Mus musculus (house mouse),"[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of BGLAP protein|[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of BGLAP mrna|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of BGLAP protein]|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of BGLAP mrna]",,,PMID:26492236,https://www.ncbi.nlm.nih.gov/pubmed/26492236,26492236,,
139,1712530,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,627,BDNF,https://ctdbase.org/detail.go?type=gene&acc=627,,,627.0,BDNF,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of TUBB3 protein|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of S100B mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of FOXM1 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GRIA2 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of LEF1 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of E2F2 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of RBFOX3 protein|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of HOXB1 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of SYN protein|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of RBFOX3 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of HES3 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of SYN mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of FZD10 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of SLC17A6 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GFAP mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of SLC17A7 protein|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GRIN1 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of TERT mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of S100B protein|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of MAP2 protein|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of DLG4 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GABRA2 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of INHBE mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GRIN2A mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of SCN2A mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of CNTN1 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of GLI1 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GRIN2B mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
140,1712590,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,627,BDNF,https://ctdbase.org/detail.go?type=gene&acc=627,,,627.0,BDNF,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of BDNF mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
141,1712591,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,632,BGLAP,https://ctdbase.org/detail.go?type=gene&acc=632,,,632.0,BGLAP,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna|rosiglitazone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna]|bexarotene inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna]|tributyltin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna],,,PMID:25932594,https://www.ncbi.nlm.nih.gov/pubmed/25932594,25932594,,
142,1712592,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,632,BGLAP,https://ctdbase.org/detail.go?type=gene&acc=632,,,632.0,BGLAP,9606,Homo sapiens (human),[ascorbic acid co-treated with dexamethasone] results in increased expression of BGLAP mRNA,,,PMID:12510807,https://www.ncbi.nlm.nih.gov/pubmed/12510807,12510807,,
143,1712593,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,632,BGLAP,https://ctdbase.org/detail.go?type=gene&acc=632,,,632.0,BGLAP,9606,Homo sapiens (human),[cholecalciferol co-treated with beta-glycerophosphoric acid co-treated with ascorbic acid] results in increased expression of BGLAP protein,,,PMID:17692823,https://www.ncbi.nlm.nih.gov/pubmed/17692823,17692823,,
144,1712594,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [norepinephrine results in increased activity of CASP3 protein],,,PMID:15158148,https://www.ncbi.nlm.nih.gov/pubmed/15158148,15158148,,
145,1712595,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,632,BGLAP,https://ctdbase.org/detail.go?type=gene&acc=632,,,632.0,BGLAP,10116,Rattus norvegicus (Norway rat),Hydrogen peroxide affects the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] affects the expression of BGLAP mrna]|[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] affects the expression of BGLAP mrna|quercetin affects the reaction [hydrogen peroxide affects the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] affects the expression of BGLAP mrna]],,,PMID:27028516,https://www.ncbi.nlm.nih.gov/pubmed/27028516,27028516,,
146,1712596,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,632,BGLAP,https://ctdbase.org/detail.go?type=gene&acc=632,,,632.0,BGLAP,9606,Homo sapiens (human),[ascorbic acid co-treated with IL11 protein] results in increased expression of BGLAP mRNA,,,PMID:17956465,https://www.ncbi.nlm.nih.gov/pubmed/17956465,17956465,,
147,1712597,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,632,BGLAP,https://ctdbase.org/detail.go?type=gene&acc=632,,,632.0,BGLAP,9606,Homo sapiens (human),Ascorbic acid results in increased expression of BGLAP mRNA,,,PMID:17274723,https://www.ncbi.nlm.nih.gov/pubmed/17274723,17274723,,
148,1712598,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,12095,BGLAP3,https://ctdbase.org/detail.go?type=gene&acc=12095,,,12095.0,Bglap3,9606,Homo sapiens (human),[ascorbic acid co-treated with copper] affects the cleavage of BGLAP3 protein|bglap3 protein binds to ascorbic acid,,,PMID:11396734,https://www.ncbi.nlm.nih.gov/pubmed/11396734,11396734,,
149,1712649,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,637,BID,https://ctdbase.org/detail.go?type=gene&acc=637,,,637.0,BID,9606,Homo sapiens (human),[juglone co-treated with ascorbic acid] affects the expression of BID protein,,,PMID:29992683,https://www.ncbi.nlm.nih.gov/pubmed/29992683,29992683,,
150,1712650,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,330,BIRC3,https://ctdbase.org/detail.go?type=gene&acc=330,,,330.0,BIRC3,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of BIRC3 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
151,1712651,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,332,BIRC5,https://ctdbase.org/detail.go?type=gene&acc=332,,,332.0,BIRC5,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of BIRC5 mRNA,,,PMID:21919647,https://www.ncbi.nlm.nih.gov/pubmed/21919647,21919647,,
152,1712652,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,649,BMP1,https://ctdbase.org/detail.go?type=gene&acc=649,,,649.0,BMP1,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of BMP1 mRNA,,,PMID:15994055,https://www.ncbi.nlm.nih.gov/pubmed/15994055,15994055,,
153,1712653,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,650,BMP2,https://ctdbase.org/detail.go?type=gene&acc=650,,,650.0,BMP2,10090,Mus musculus (house mouse),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of BMP2 mrna]|[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of BMP2 protein|[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of BMP2 mrna|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of BMP2 protein]",,,PMID:26492236,https://www.ncbi.nlm.nih.gov/pubmed/26492236,26492236,,
154,1712654,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,650,BMP2,https://ctdbase.org/detail.go?type=gene&acc=650,,,650.0,BMP2,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of BMP2 mRNA,,,PMID:15994055,https://www.ncbi.nlm.nih.gov/pubmed/15994055,15994055,,
155,1712655,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,650,BMP2,https://ctdbase.org/detail.go?type=gene&acc=650,,,650.0,BMP2,10116,Rattus norvegicus (Norway rat),Ginsenoside rg3 inhibits the reaction [dexamethasone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of BMP2 protein]]|[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of BMP2 protein|dexamethasone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of BMP2 protein]|nog protein inhibits the reaction [ginsenoside rg3 inhibits the reaction [dexamethasone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of BMP2 protein]]],,,PMID:27387537,https://www.ncbi.nlm.nih.gov/pubmed/27387537,27387537,,
156,1712656,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,651,BMP3,https://ctdbase.org/detail.go?type=gene&acc=651,,,651.0,BMP3,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of BMP3 mRNA,,,PMID:15994055,https://www.ncbi.nlm.nih.gov/pubmed/15994055,15994055,,
157,1712657,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,652,BMP4,https://ctdbase.org/detail.go?type=gene&acc=652,,,652.0,BMP4,13489,Dicentrarchus labrax (European seabass),Ascorbic acid affects the expression of BMP4 mRNA,,,PMID:21281732,https://www.ncbi.nlm.nih.gov/pubmed/21281732,21281732,,
158,1712733,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,652,BMP4,https://ctdbase.org/detail.go?type=gene&acc=652,,,652.0,BMP4,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of TF mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of STMN2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HOXB3 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SOX1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of EGLN3 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of NR2F2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GCLM mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FABP1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HOXA2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FGB mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of EBF3 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of ZFAND2A mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of DCC mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of OTX2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of CDH10 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FLRT3 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of FOXD3 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of IL1R1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of SERPINA1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GPX2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FGF7 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GSTO1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ECSCR mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GRIA2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of TFAP2A mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of DCX mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ABCC1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of SLCO2B1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SRXN1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of CRYAB mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of AMHR2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ELAVL4 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of SCN2A mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of AFP mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of MYL4 mrna|[[ascorbic acid co-treated with ch,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
159,1712734,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,653,BMP5,https://ctdbase.org/detail.go?type=gene&acc=653,,,653.0,BMP5,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of BMP5 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
160,1712735,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,655,BMP7,https://ctdbase.org/detail.go?type=gene&acc=655,,,655.0,BMP7,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of BMP7 mRNA,,,PMID:15994055,https://www.ncbi.nlm.nih.gov/pubmed/15994055,15994055,,
161,1712736,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,657,BMPR1A,https://ctdbase.org/detail.go?type=gene&acc=657,,,657.0,BMPR1A,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of BMPR1A protein|ginsenoside rg3 inhibits the reaction [dexamethasone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of BMPR1A protein]]|nog protein inhibits the reaction [ginsenoside rg3 inhibits the reaction [dexamethasone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of BMPR1A protein]]]|dexamethasone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of BMPR1A protein],,,PMID:27387537,https://www.ncbi.nlm.nih.gov/pubmed/27387537,27387537,,
162,1712737,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,658,BMPR1B,https://ctdbase.org/detail.go?type=gene&acc=658,,,658.0,BMPR1B,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of BMPR1B mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
163,1712738,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,699,BUB1,https://ctdbase.org/detail.go?type=gene&acc=699,,,699.0,BUB1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of BUB1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
164,1712739,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,28970,C11ORF54,https://ctdbase.org/detail.go?type=gene&acc=28970,,,28970.0,C11orf54,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of C11ORF54 mrna|[arsenic trioxide co-treated with ascorbic acid] results in decreased expression of C11ORF54 mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
165,1712740,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,718,C3,https://ctdbase.org/detail.go?type=gene&acc=718,,,718.0,C3,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of C3 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
166,1712741,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,727,C5,https://ctdbase.org/detail.go?type=gene&acc=727,,,727.0,C5,9606,Homo sapiens (human),"Ascorbic acid inhibits the reaction [asbestos, crocidolite results in increased cleavage of C5 protein]|ascorbic acid inhibits the reaction [asbestos, serpentine results in increased cleavage of C5 protein]",,,PMID:10777245,https://www.ncbi.nlm.nih.gov/pubmed/10777245,10777245,,
167,1712797,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,768,CA9,https://ctdbase.org/detail.go?type=gene&acc=768,,,768.0,CA9,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [nickel sulfate results in increased expression of CA9 protein],,,PMID:16288478,https://www.ncbi.nlm.nih.gov/pubmed/16288478,16288478,,
168,1712798,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8912,CACNA1H,https://ctdbase.org/detail.go?type=gene&acc=8912,,,8912.0,CACNA1H,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [vincristine results in increased expression of CACNA1H mrna]|ascorbic acid results in decreased activity of CACNA1H protein|ascorbic acid inhibits the reaction [vincristine results in increased expression of CACNA1H protein],,,PMID:34286406,https://www.ncbi.nlm.nih.gov/pubmed/34286406,34286406,,
169,1712799,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,794,CALB2,https://ctdbase.org/detail.go?type=gene&acc=794,,,794.0,CALB2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [[lead acetate results in increased abundance of lead] which results in decreased expression of CALB2 protein],,,PMID:31708536,https://www.ncbi.nlm.nih.gov/pubmed/31708536,31708536,,
170,1712800,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,12349,CAR2,https://ctdbase.org/detail.go?type=gene&acc=12349,,,12349.0,Car2,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of CAR2 mrna|[ascorbic acid co-treated with TNFSF11 protein] results in decreased expression of CAR2 mRNA,,,PMID:15730627,https://www.ncbi.nlm.nih.gov/pubmed/15730627,15730627,,
171,1712801,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,12349,CAR2,https://ctdbase.org/detail.go?type=gene&acc=12349,,,12349.0,Car2,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [TNFSF11 protein results in increased expression of CAR2 mrna]|ascorbic acid inhibits the reaction [TNFSF11 protein results in increased expression of CAR2 protein],,,PMID:15952411,https://www.ncbi.nlm.nih.gov/pubmed/15952411,15952411,,
172,1712802,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,835,CASP2,https://ctdbase.org/detail.go?type=gene&acc=835,,,835.0,CASP2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [norepinephrine results in increased activity of CASP2 protein],,,PMID:15158148,https://www.ncbi.nlm.nih.gov/pubmed/15158148,15158148,,
173,1712803,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10140,Cavia (guinea pigs),[ascorbic acid co-treated with ethanol] results in decreased activity of CASP3 protein,,,PMID:22149461,https://www.ncbi.nlm.nih.gov/pubmed/22149461,22149461,,
174,1712804,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),CAT protein inhibits the reaction [[ascorbic acid co-treated with eosine I bluish] results in increased activity of CASP3 protein]|[ascorbic acid co-treated with eosine I bluish] results in increased activity of CASP3 protein,,,PMID:24488945,https://www.ncbi.nlm.nih.gov/pubmed/24488945,24488945,,
175,1712805,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),[ascorbic acid co-treated with ferrous sulfate] results in increased expression of CASP3 mrna|[hyaluronic acid co-treated with chondroitin sulfates] inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased activity of CASP3 protein]|[hyaluronic acid co-treated with chondroitin sulfates] inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of CASP3 mrna]|[ascorbic acid co-treated with ferrous sulfate] results in increased activity of CASP3 protein,,,PMID:17879260,https://www.ncbi.nlm.nih.gov/pubmed/17879260,17879260,,
176,1712882,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [arsenic trioxide results in increased activity of CASP3 protein],,,PMID:20356860,https://www.ncbi.nlm.nih.gov/pubmed/20356860,20356860,,
177,1712883,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [rotenone results in increased activity of CASP3 protein]|ascorbic acid inhibits the reaction [[chromium hexavalent ion co-treated with antimycin A] results in increased activity of CASP3 protein]|ascorbic acid inhibits the reaction [[chromium hexavalent ion co-treated with rotenone] results in increased activity of CASP3 protein]|ascorbic acid inhibits the reaction [antimycin A results in increased activity of CASP3 protein]|ascorbic acid inhibits the reaction [chromium hexavalent ion results in increased activity of CASP3 protein],,,PMID:24732427,https://www.ncbi.nlm.nih.gov/pubmed/24732427,24732427,,
178,1712884,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [deoxynivalenol results in increased expression of CASP3 protein],,,PMID:17166419,https://www.ncbi.nlm.nih.gov/pubmed/17166419,17166419,,
179,1712885,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [fenretinide results in increased activity of CASP3 protein],,,PMID:16124896|PMID:16407847,https://www.ncbi.nlm.nih.gov/pubmed/16124896|https://www.ncbi.nlm.nih.gov/pubmed/16407847,16124896|16407847,,
180,1712886,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [hydroxyethyl methacrylate results in increased activity of CASP3 protein]|ascorbic acid inhibits the reaction [triethylene glycol dimethacrylate results in increased activity of CASP3 protein],,,PMID:33248029,https://www.ncbi.nlm.nih.gov/pubmed/33248029,33248029,,
181,1712887,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [oleanolic acid results in increased cleavage of CASP3 protein],,,PMID:22678527,https://www.ncbi.nlm.nih.gov/pubmed/22678527,22678527,,
182,1712888,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [paraquat results in increased activity of CASP3 protein],,,PMID:33592258,https://www.ncbi.nlm.nih.gov/pubmed/33592258,33592258,,
183,1712889,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [reactive oxygen species results in increased activity of CASP3 protein],,,PMID:16124896,https://www.ncbi.nlm.nih.gov/pubmed/16124896,16124896,,
184,1712890,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [silicon dioxide results in decreased expression of CASP3 mrna]|ascorbic acid inhibits the reaction [silicon dioxide results in increased activity of CASP3 protein],,,PMID:22245848,https://www.ncbi.nlm.nih.gov/pubmed/22245848,22245848,,
185,1712957,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [TNFSF10 protein results in increased activity of CASP3 protein],,,PMID:23711929,https://www.ncbi.nlm.nih.gov/pubmed/23711929,23711929,,
186,1712958,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Ascorbic acid promotes the reaction [arsenic trioxide results in increased activity of CASP3 protein],,,PMID:12750841,https://www.ncbi.nlm.nih.gov/pubmed/12750841,12750841,,
187,1712959,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Ascorbic acid promotes the reaction [arsenic trioxide results in increased cleavage of and results in increased activity of CASP3 protein],,,PMID:16867262,https://www.ncbi.nlm.nih.gov/pubmed/16867262,16867262,,
188,1712960,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Ascorbic acid promotes the reaction [chromium hexavalent ion results in increased cleavage of CASP3 protein],,,PMID:17301063,https://www.ncbi.nlm.nih.gov/pubmed/17301063,17301063,,
189,1712961,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Ascorbic acid results in decreased activity of CASP3 protein,,,PMID:17618090,https://www.ncbi.nlm.nih.gov/pubmed/17618090,17618090,,
190,1712962,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Ascorbic acid results in increased expression of CASP3 mRNA,,,PMID:30597948,https://www.ncbi.nlm.nih.gov/pubmed/30597948,30597948,,
191,1712963,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),[juglone co-treated with ascorbic acid] results in decreased expression of CASP3 protein,,,PMID:29992683,https://www.ncbi.nlm.nih.gov/pubmed/29992683,29992683,,
192,1712964,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [glycidamide results in increased expression of CASP3 mrna],,,PMID:32632975,https://www.ncbi.nlm.nih.gov/pubmed/32632975,32632975,,
193,1712965,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [abamectin results in increased expression of CASP3 protein]|[ascorbic acid co-treated with sesame oil] inhibits the reaction [abamectin results in increased expression of CASP3 protein],,,PMID:31739238,https://www.ncbi.nlm.nih.gov/pubmed/31739238,31739238,,
194,1712966,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [arsenic results in increased activity of CASP3 protein],,,PMID:24295472,https://www.ncbi.nlm.nih.gov/pubmed/24295472,24295472,,
195,1713011,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in increased cleavage of CASP3 protein],,,PMID:21262251,https://www.ncbi.nlm.nih.gov/pubmed/21262251,21262251,,
196,1713012,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [sodium benzoate results in increased expression of CASP3 protein],,,PMID:35187746,https://www.ncbi.nlm.nih.gov/pubmed/35187746,35187746,,
197,1713013,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein],,,PMID:21873648,https://www.ncbi.nlm.nih.gov/pubmed/21873648,21873648,,
198,1713014,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [streptozocin results in increased activity of CASP3 protein],,,PMID:18758938,https://www.ncbi.nlm.nih.gov/pubmed/18758938,18758938,,
199,1713015,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116,Rattus norvegicus (Norway rat),[vitamin E co-treated with ascorbic acid] inhibits the reaction [dichlorvos results in increased activity of CASP3 protein],,,PMID:16973328,https://www.ncbi.nlm.nih.gov/pubmed/16973328,16973328,,
200,1713016,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9823,Sus scrofa (pig),[troglitazone co-treated with beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of CASP3 mRNA,,,PMID:30481989,https://www.ncbi.nlm.nih.gov/pubmed/30481989,30481989,,
201,1713017,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,837,CASP4,https://ctdbase.org/detail.go?type=gene&acc=837,,,837.0,CASP4,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [[kojic acid co-treated with diethylnitrosamine] results in increased expression of CASP4 mrna],,,PMID:18544905,https://www.ncbi.nlm.nih.gov/pubmed/18544905,18544905,,
202,1713018,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,839,CASP6,https://ctdbase.org/detail.go?type=gene&acc=839,,,839.0,CASP6,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [norepinephrine results in increased activity of CASP6 protein],,,PMID:15158148,https://www.ncbi.nlm.nih.gov/pubmed/15158148,15158148,,
203,1713019,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,840,CASP7,https://ctdbase.org/detail.go?type=gene&acc=840,,,840.0,CASP7,9606,Homo sapiens (human),[ascorbic acid co-treated with ferrous sulfate] results in increased expression of CASP7 mrna|[hyaluronic acid co-treated with chondroitin sulfates] inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of CASP7 mrna]|[hyaluronic acid co-treated with chondroitin sulfates] inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased activity of CASP7 protein]|[ascorbic acid co-treated with ferrous sulfate] results in increased activity of CASP7 protein,,,PMID:17879260,https://www.ncbi.nlm.nih.gov/pubmed/17879260,17879260,,
204,1713071,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,840,CASP7,https://ctdbase.org/detail.go?type=gene&acc=840,,,840.0,CASP7,9606,Homo sapiens (human),Ascorbic acid promotes the reaction [chromium hexavalent ion results in increased cleavage of CASP7 protein],,,PMID:17301063,https://www.ncbi.nlm.nih.gov/pubmed/17301063,17301063,,
205,1713072,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841.0,CASP8,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [TNFSF10 protein results in increased activity of CASP8 protein],,,PMID:23711929,https://www.ncbi.nlm.nih.gov/pubmed/23711929,23711929,,
206,1713073,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841.0,CASP8,9606,Homo sapiens (human),Ascorbic acid results in increased expression of CASP8 mRNA,,,PMID:30597948,https://www.ncbi.nlm.nih.gov/pubmed/30597948,30597948,,
207,1713074,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841.0,CASP8,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with INS1 protein] results in increased expression of CASP8 mRNA,,,PMID:20400526,https://www.ncbi.nlm.nih.gov/pubmed/20400526,20400526,,
208,1713075,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841.0,CASP8,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with kojic acid co-treated with diethylnitrosamine] results in decreased expression of CASP8 mRNA,,,PMID:18544905,https://www.ncbi.nlm.nih.gov/pubmed/18544905,18544905,,
209,1713076,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [TNFSF10 protein results in increased activity of CASP9 protein],,,PMID:23711929,https://www.ncbi.nlm.nih.gov/pubmed/23711929,23711929,,
210,1713077,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [norepinephrine results in increased activity of CASP9 protein],,,PMID:15158148,https://www.ncbi.nlm.nih.gov/pubmed/15158148,15158148,,
211,1713078,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,10116,Rattus norvegicus (Norway rat),[vitamin E co-treated with ascorbic acid] inhibits the reaction [dichlorvos results in increased activity of CASP9 protein],,,PMID:16973328,https://www.ncbi.nlm.nih.gov/pubmed/16973328,16973328,,
212,1713079,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,831,CAST,https://ctdbase.org/detail.go?type=gene&acc=831,,,831.0,CAST,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of CAST mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
213,1713080,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9925,Capra hircus (goat),Ascorbic acid inhibits the reaction [cypermethrin results in decreased activity of CAT protein],,,PMID:29975445,https://www.ncbi.nlm.nih.gov/pubmed/29975445,29975445,,
214,1713155,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10029,Cricetulus griseus (Chinese hamster),"Ascorbic acid inhibits the reaction [3,5-dimethylaminophenol results in decreased activity of CAT protein]",,,PMID:25178734,https://www.ncbi.nlm.nih.gov/pubmed/25178734,25178734,,
215,1713156,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606,Homo sapiens (human),Ascorbic acid affects the expression of CAT protein,,,PMID:10772068,https://www.ncbi.nlm.nih.gov/pubmed/10772068,10772068,,
216,1713157,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606,Homo sapiens (human),"[ascorbic acid co-treated with vitamin E] inhibits the reaction [air pollutants, occupational affects the expression of CAT protein]",,,PMID:20535553,https://www.ncbi.nlm.nih.gov/pubmed/20535553,20535553,,
217,1713158,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [malathion results in increased activity of CAT protein]|[ascorbic acid co-treated with vitamin E] inhibits the reaction [malathion results in increased activity of CAT protein],,,PMID:18655177,https://www.ncbi.nlm.nih.gov/pubmed/18655177,18655177,,
218,1713159,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606,Homo sapiens (human),[ascorbic acid co-treated with vitamin E] results in increased expression of CAT mRNA,,,PMID:22207723,https://www.ncbi.nlm.nih.gov/pubmed/22207723,22207723,,
219,1713160,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [dimethoate results in increased activity of CAT protein],,,PMID:20077558,https://www.ncbi.nlm.nih.gov/pubmed/20077558,20077558,,
220,1713161,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [triethylene glycol dimethacrylate results in increased degradation of CAT mrna]|ascorbic acid inhibits the reaction [hydroxyethyl methacrylate results in increased degradation of CAT mrna],,,PMID:33248029,https://www.ncbi.nlm.nih.gov/pubmed/33248029,33248029,,
221,1713162,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606,Homo sapiens (human),Ascorbic acid results in increased activity of CAT protein|ascorbic acid inhibits the reaction [[lead acetate results in increased abundance of lead] which results in decreased activity of CAT protein]|ascorbic acid inhibits the reaction [[lead acetate results in increased abundance of lead] which results in decreased expression of CAT mrna],,,PMID:31610155,https://www.ncbi.nlm.nih.gov/pubmed/31610155,31610155,,
222,1713163,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606,Homo sapiens (human),Ascorbic acid results in increased expression of CAT mRNA,,,PMID:31576639|PMID:32913121|PMID:33248029,https://www.ncbi.nlm.nih.gov/pubmed/31576639|https://www.ncbi.nlm.nih.gov/pubmed/32913121|https://www.ncbi.nlm.nih.gov/pubmed/33248029,31576639|32913121|33248029,,
223,1713164,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606,Homo sapiens (human),CAT protein inhibits the reaction [[ascorbic acid co-treated with eosine I bluish] results in increased activity of CASP3 protein]|cat protein inhibits the reaction [[ascorbic acid co-treated with eosine I bluish] results in increased phosphorylation of MAPK9 protein]|cat protein inhibits the reaction [[ascorbic acid co-treated with eosine I bluish] results in increased phosphorylation of MAPK8 protein],,,PMID:24488945,https://www.ncbi.nlm.nih.gov/pubmed/24488945,24488945,,
224,1713261,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606,Homo sapiens (human),CAT protein inhibits the reaction [copper promotes the reaction [ascorbic acid results in decreased activity of PON1 protein]],,,PMID:15104111,https://www.ncbi.nlm.nih.gov/pubmed/15104111,15104111,,
225,1713262,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606,Homo sapiens (human),CAT protein results in decreased susceptibility to [arsenic trioxide co-treated with ascorbic acid],,,PMID:20171736,https://www.ncbi.nlm.nih.gov/pubmed/20171736,20171736,,
226,1713263,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606,Homo sapiens (human),CAT protein results in decreased susceptibility to ascorbic acid,,,PMID:14698046,https://www.ncbi.nlm.nih.gov/pubmed/14698046,14698046,,
227,1713264,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606,Homo sapiens (human),CAT results in decreased susceptibility to [vitamin K 3 co-treated with ascorbic acid],,,PMID:21689642,https://www.ncbi.nlm.nih.gov/pubmed/21689642,21689642,,
228,1713265,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606,Homo sapiens (human),[juglone co-treated with ascorbic acid] results in decreased activity of CAT protein,,,PMID:29992683,https://www.ncbi.nlm.nih.gov/pubmed/29992683,29992683,,
229,1713266,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090,Mus musculus (house mouse),[ascorbic acid co-treated with CAT protein] inhibits the reaction [zinc deficiency results in increased expression of TFRC protein]|[ascorbic acid co-treated with CAT protein] inhibits the reaction [zinc deficiency results in increased expression of IREB2 protein],,,PMID:18073202,https://www.ncbi.nlm.nih.gov/pubmed/18073202,18073202,,
230,1713267,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [arsenic trioxide results in decreased activity of CAT protein],,,PMID:18715643,https://www.ncbi.nlm.nih.gov/pubmed/18715643,18715643,,
231,1713268,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [cadmium chloride results in decreased activity of CAT protein],,,PMID:18548748,https://www.ncbi.nlm.nih.gov/pubmed/18548748,18548748,,
232,1713269,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [fipronil results in decreased activity of CAT protein],,,PMID:25721553,https://www.ncbi.nlm.nih.gov/pubmed/25721553,25721553,,
233,1713270,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090,Mus musculus (house mouse),Ascorbic acid results in increased activity of CAT protein,,,PMID:29572072,https://www.ncbi.nlm.nih.gov/pubmed/29572072,29572072,,
234,1713345,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of CAT mRNA,,,PMID:32913121,https://www.ncbi.nlm.nih.gov/pubmed/32913121,32913121,,
235,1713346,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of CAT protein,,,PMID:17512118,https://www.ncbi.nlm.nih.gov/pubmed/17512118,17512118,,
236,1713347,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),[zinc co-treated with vitamin E co-treated with ascorbic acid co-treated with sodium arsenite] results in increased activity of CAT protein,,,PMID:23619517,https://www.ncbi.nlm.nih.gov/pubmed/23619517,23619517,,
237,1713348,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [1-hydroxyethyl radical results in decreased activity of CAT protein],,,PMID:10600175,https://www.ncbi.nlm.nih.gov/pubmed/10600175,10600175,,
238,1713349,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090,Mus musculus (house mouse),CAT protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TLR4 mrna]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of CD44 mrna]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TLR2 protein]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of MMP13 protein]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of NOS2 protein]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of CD44 protein]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of NOS2 mrna]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TLR2 mrna]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TLR4 protein]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TNF mrna]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TNF protein]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased degradation of hyaluronic acid]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of IL1B mrna]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased activity of [NFKB1 protein binds to RELA protein]]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of IL1B protein]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of MMP13 mrna],,,PMID:23692848,https://www.ncbi.nlm.nih.gov/pubmed/23692848,23692848,,
239,1713350,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090,Mus musculus (house mouse),CAT protein inhibits the reaction [ascorbic acid promotes the reaction [quartz results in increased secretion of TNF protein]],,,PMID:19298665,https://www.ncbi.nlm.nih.gov/pubmed/19298665,19298665,,
240,1713351,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with beta carotene co-treated with alpha-tocopherol co-treated with sodium selenite] inhibits the reaction [galactosamine results in increased activity of CAT protein],,,PMID:31022331,https://www.ncbi.nlm.nih.gov/pubmed/31022331,31022331,,
241,1713411,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with lead] results in increased expression of CAT protein,,,PMID:22056337,https://www.ncbi.nlm.nih.gov/pubmed/22056337,22056337,,
242,1713412,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [abamectin results in increased activity of CAT protein]|[ascorbic acid co-treated with sesame oil] inhibits the reaction [abamectin results in increased activity of CAT protein],,,PMID:31739238,https://www.ncbi.nlm.nih.gov/pubmed/31739238,31739238,,
243,1713413,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with sodium arsenite] results in increased activity of CAT protein,,,PMID:12540038,https://www.ncbi.nlm.nih.gov/pubmed/12540038,12540038,,
244,1713414,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [arsenic results in decreased activity of CAT protein],,,PMID:24295472,https://www.ncbi.nlm.nih.gov/pubmed/24295472,24295472,,
245,1713415,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [bisphenol A results in decreased activity of CAT protein],,,PMID:12767684,https://www.ncbi.nlm.nih.gov/pubmed/12767684,12767684,,
246,1713416,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [cadmium results in decreased activity of CAT protein],,,PMID:22008531,https://www.ncbi.nlm.nih.gov/pubmed/22008531,22008531,,
247,1713417,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [carbon tetrachloride results in decreased activity of CAT protein],,,PMID:30676168,https://www.ncbi.nlm.nih.gov/pubmed/30676168,30676168,,
248,1713418,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chlorodiphenyl (54% chlorine) results in decreased activity of CAT protein],,,PMID:16248992|PMID:16298753,https://www.ncbi.nlm.nih.gov/pubmed/16248992|https://www.ncbi.nlm.nih.gov/pubmed/16298753,16248992|16298753,,
249,1713419,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased activity of CAT protein],,,PMID:17822687,https://www.ncbi.nlm.nih.gov/pubmed/17822687,17822687,,
250,1713420,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [cisplatin results in decreased activity of CAT protein],,,PMID:21310208,https://www.ncbi.nlm.nih.gov/pubmed/21310208,21310208,,
251,1713508,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [cyclosporine results in decreased activity of CAT protein],,,PMID:19391111,https://www.ncbi.nlm.nih.gov/pubmed/19391111,19391111,,
252,1713509,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [food additives affects the activity of CAT protein],,,PMID:16758767,https://www.ncbi.nlm.nih.gov/pubmed/16758767,16758767,,
253,1713510,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [indomethacin results in increased activity of CAT protein],,,PMID:18726076,https://www.ncbi.nlm.nih.gov/pubmed/18726076,18726076,,
254,1713511,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in decreased activity of CAT protein],,,PMID:17822687|PMID:23470461,https://www.ncbi.nlm.nih.gov/pubmed/17822687|https://www.ncbi.nlm.nih.gov/pubmed/23470461,17822687|23470461,,
255,1713512,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in decreased expression of CAT mrna],,,PMID:23470461,https://www.ncbi.nlm.nih.gov/pubmed/23470461,23470461,,
256,1713513,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [sodium arsenite results in decreased activity of CAT protein],,,PMID:20028703|PMID:20122981|PMID:23194016,https://www.ncbi.nlm.nih.gov/pubmed/20028703|https://www.ncbi.nlm.nih.gov/pubmed/20122981|https://www.ncbi.nlm.nih.gov/pubmed/23194016,20028703|20122981|23194016,,
257,1713514,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [sodium arsenite results in decreased expression of CAT protein],,,PMID:19429265,https://www.ncbi.nlm.nih.gov/pubmed/19429265,19429265,,
258,1713515,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [sodium arsenite results in increased activity of CAT protein],,,PMID:20876158,https://www.ncbi.nlm.nih.gov/pubmed/20876158,20876158,,
259,1713516,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [sodium benzoate results in decreased activity of CAT protein],,,PMID:35187746,https://www.ncbi.nlm.nih.gov/pubmed/35187746,35187746,,
260,1713517,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [sodium fluoride results in decreased activity of CAT protein],,,PMID:34089294,https://www.ncbi.nlm.nih.gov/pubmed/34089294,34089294,,
261,1713604,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased activity of CAT protein,,,PMID:31005848,https://www.ncbi.nlm.nih.gov/pubmed/31005848,31005848,,
262,1713605,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased activity of CAT protein,,,PMID:18096215|PMID:22008531,https://www.ncbi.nlm.nih.gov/pubmed/18096215|https://www.ncbi.nlm.nih.gov/pubmed/22008531,18096215|22008531,,
263,1713606,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,857,CAV1,https://ctdbase.org/detail.go?type=gene&acc=857,,,857.0,CAV1,9606,Homo sapiens (human),"Ascorbic acid inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased phosphorylation of CAV1 protein]",,,PMID:35349355,https://www.ncbi.nlm.nih.gov/pubmed/35349355,35349355,,
264,1713607,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,875,CBS,https://ctdbase.org/detail.go?type=gene&acc=875,,,875.0,CBS,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of CBS mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
265,1713608,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9606,Homo sapiens (human),Ascorbic acid deficiency affects the expression of CCL2 mrna|ascorbic acid affects the expression of CCL2 mRNA,,,PMID:19932582,https://www.ncbi.nlm.nih.gov/pubmed/19932582,19932582,,
266,1713609,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,10090,Mus musculus (house mouse),Ascorbic acid results in decreased expression of CCL2 mRNA,,,PMID:21796779,https://www.ncbi.nlm.nih.gov/pubmed/21796779,21796779,,
267,1713610,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,18829,CCL21A,https://ctdbase.org/detail.go?type=gene&acc=18829,,,18829.0,Ccl21a,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of CCL21A mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
268,1713611,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6348,CCL3,https://ctdbase.org/detail.go?type=gene&acc=6348,,,6348.0,CCL3,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of CCL3 mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
269,1713612,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8900,CCNA1,https://ctdbase.org/detail.go?type=gene&acc=8900,,,8900.0,CCNA1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of CCNA1 protein],,,PMID:21621607,https://www.ncbi.nlm.nih.gov/pubmed/21621607,21621607,,
270,1713613,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,891,CCNB1,https://ctdbase.org/detail.go?type=gene&acc=891,,,891.0,CCNB1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of CCNB1 protein],,,PMID:21621607,https://www.ncbi.nlm.nih.gov/pubmed/21621607,21621607,,
271,1713669,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,892,CCNC,https://ctdbase.org/detail.go?type=gene&acc=892,,,892.0,CCNC,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of CCNC mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
272,1713670,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of CCND1 mRNA,,,PMID:21919647,https://www.ncbi.nlm.nih.gov/pubmed/21919647,21919647,,
273,1713671,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [phenylhydrazine results in decreased expression of CCND1 mrna],,,PMID:30140404,https://www.ncbi.nlm.nih.gov/pubmed/30140404,30140404,,
274,1713672,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of CCND1 mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
275,1713673,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of CCND1 protein],,,PMID:21621607,https://www.ncbi.nlm.nih.gov/pubmed/21621607,21621607,,
276,1713674,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,894,CCND2,https://ctdbase.org/detail.go?type=gene&acc=894,,,894.0,CCND2,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of CCND2 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
277,1713675,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,894,CCND2,https://ctdbase.org/detail.go?type=gene&acc=894,,,894.0,CCND2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of CCND2 protein],,,PMID:21621607,https://www.ncbi.nlm.nih.gov/pubmed/21621607,21621607,,
278,1713676,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,896,CCND3,https://ctdbase.org/detail.go?type=gene&acc=896,,,896.0,CCND3,9606,Homo sapiens (human),Ascorbic acid promotes the reaction [juglone results in decreased expression of CCND3 protein],,,PMID:29992683,https://www.ncbi.nlm.nih.gov/pubmed/29992683,29992683,,
279,1713677,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,896,CCND3,https://ctdbase.org/detail.go?type=gene&acc=896,,,896.0,CCND3,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of CCND3 protein],,,PMID:21621607,https://www.ncbi.nlm.nih.gov/pubmed/21621607,21621607,,
280,1713678,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9134,CCNE2,https://ctdbase.org/detail.go?type=gene&acc=9134,,,9134.0,CCNE2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of CCNE2 protein],,,PMID:21621607,https://www.ncbi.nlm.nih.gov/pubmed/21621607,21621607,,
281,1713717,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,900,CCNG1,https://ctdbase.org/detail.go?type=gene&acc=900,,,900.0,CCNG1,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of CCNG1 mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
282,1713718,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,900,CCNG1,https://ctdbase.org/detail.go?type=gene&acc=900,,,900.0,CCNG1,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with kojic acid co-treated with diethylnitrosamine] results in increased expression of CCNG1 mRNA,,,PMID:18544905,https://www.ncbi.nlm.nih.gov/pubmed/18544905,18544905,,
283,1713719,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,929,CD14,https://ctdbase.org/detail.go?type=gene&acc=929,,,929.0,CD14,10141,Cavia porcellus (domestic guinea pig),Ascorbic acid inhibits the reaction [ethanol results in increased expression of CD14 mrna],,,PMID:24239723,https://www.ncbi.nlm.nih.gov/pubmed/24239723,24239723,,
284,1713720,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,100133941,CD24,https://ctdbase.org/detail.go?type=gene&acc=100133941,,,100133941.0,CD24,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of CD24 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
285,1713721,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,947,CD34,https://ctdbase.org/detail.go?type=gene&acc=947,,,947.0,CD34,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in decreased expression of CD34 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
286,1713722,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,958,CD40,https://ctdbase.org/detail.go?type=gene&acc=958,,,958.0,CD40,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in decreased expression of CD40 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
287,1713723,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,960,CD44,https://ctdbase.org/detail.go?type=gene&acc=960,,,960.0,CD44,10090,Mus musculus (house mouse),"CAT protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of CD44 mrna]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of CD44 protein]|[ascorbic acid co-treated with ferrous sulfate] results in increased expression of CD44 mrna|mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of CD44 mrna]|[ascorbic acid co-treated with ferrous sulfate] results in increased expression of CD44 protein|mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of CD44 protein]",,,PMID:23692848,https://www.ncbi.nlm.nih.gov/pubmed/23692848,23692848,,
288,1713724,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,962,CD48,https://ctdbase.org/detail.go?type=gene&acc=962,,,962.0,CD48,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of CD48 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
289,1713725,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,969,CD69,https://ctdbase.org/detail.go?type=gene&acc=969,,,969.0,CD69,10090,Mus musculus (house mouse),Ascorbic acid deficiency results in decreased expression of CD69 protein,,,PMID:22306178,https://www.ncbi.nlm.nih.gov/pubmed/22306178,22306178,,
290,1713779,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3732,CD82,https://ctdbase.org/detail.go?type=gene&acc=3732,,,3732.0,CD82,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of CD82 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
291,1713780,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,991,CDC20,https://ctdbase.org/detail.go?type=gene&acc=991,,,991.0,CDC20,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of CDC20 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
292,1713781,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,990,CDC6,https://ctdbase.org/detail.go?type=gene&acc=990,,,990.0,CDC6,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of CDC6 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
293,1713782,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,999,CDH1,https://ctdbase.org/detail.go?type=gene&acc=999,,,999.0,CDH1,8022,Oncorhynchus mykiss (rainbow trout),[vitamin A co-treated with cholecalciferol co-treated with vitamin E co-treated with ascorbic acid] inhibits the reaction [[cyhalothrin co-treated with chlorantranilipole] results in decreased expression of CDH1 protein],,,PMID:36813254,https://www.ncbi.nlm.nih.gov/pubmed/36813254,36813254,,
294,1713783,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1008,CDH10,https://ctdbase.org/detail.go?type=gene&acc=1008,,,1008.0,CDH10,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of CDH10 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
295,1713784,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1012,CDH13,https://ctdbase.org/detail.go?type=gene&acc=1012,,,1012.0,CDH13,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of CDH13 mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
296,1713785,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1000,CDH2,https://ctdbase.org/detail.go?type=gene&acc=1000,,,1000.0,CDH2,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate affects the localization of CDH2 protein],,,PMID:29940330,https://www.ncbi.nlm.nih.gov/pubmed/29940330,29940330,,
297,1713786,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,64405,CDH22,https://ctdbase.org/detail.go?type=gene&acc=64405,,,64405.0,CDH22,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of CDH22 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
298,1713787,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,983,CDK1,https://ctdbase.org/detail.go?type=gene&acc=983,,,983.0,CDK1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of CDK1 protein],,,PMID:21621607,https://www.ncbi.nlm.nih.gov/pubmed/21621607,21621607,,
299,1713788,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,728642,CDK11A,https://ctdbase.org/detail.go?type=gene&acc=728642,,,728642.0,CDK11A,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in increased expression of CDK11A mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
300,1713844,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1017,CDK2,https://ctdbase.org/detail.go?type=gene&acc=1017,,,1017.0,CDK2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of CDK2 protein],,,PMID:21621607,https://www.ncbi.nlm.nih.gov/pubmed/21621607,21621607,,
301,1713845,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1019,CDK4,https://ctdbase.org/detail.go?type=gene&acc=1019,,,1019.0,CDK4,9606,Homo sapiens (human),[juglone co-treated with ascorbic acid] results in decreased expression of CDK4 protein,,,PMID:29992683,https://www.ncbi.nlm.nih.gov/pubmed/29992683,29992683,,
302,1713846,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1019,CDK4,https://ctdbase.org/detail.go?type=gene&acc=1019,,,1019.0,CDK4,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of CDK4 protein],,,PMID:21621607,https://www.ncbi.nlm.nih.gov/pubmed/21621607,21621607,,
303,1713847,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1021,CDK6,https://ctdbase.org/detail.go?type=gene&acc=1021,,,1021.0,CDK6,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of CDK6 protein],,,PMID:21621607,https://www.ncbi.nlm.nih.gov/pubmed/21621607,21621607,,
304,1713848,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606,Homo sapiens (human),[ascorbic acid co-treated with zinc acetate co-treated with motexafin gadolinium] results in decreased expression of CDKN1A mrna|nutlin 3 inhibits the reaction [[ascorbic acid co-treated with zinc acetate co-treated with motexafin gadolinium] results in decreased expression of CDKN1A mrna],,,PMID:20530418,https://www.ncbi.nlm.nih.gov/pubmed/20530418,20530418,,
305,1713849,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [potassium bromate results in increased expression of CDKN1A protein],,,PMID:20067818,https://www.ncbi.nlm.nih.gov/pubmed/20067818,20067818,,
306,1713850,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of CDKN1A mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
307,1713851,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of CDKN1A mrna|[ins1 protein co-treated with ascorbic acid] results in increased expression of CDKN1A mRNA,,,PMID:20400526,https://www.ncbi.nlm.nih.gov/pubmed/20400526,20400526,,
308,1713852,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1027,CDKN1B,https://ctdbase.org/detail.go?type=gene&acc=1027,,,1027.0,CDKN1B,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with kojic acid co-treated with diethylnitrosamine] results in decreased expression of CDKN1B mRNA,,,PMID:18544905,https://www.ncbi.nlm.nih.gov/pubmed/18544905,18544905,,
309,1713853,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1029,CDKN2A,https://ctdbase.org/detail.go?type=gene&acc=1029,,,1029.0,CDKN2A,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in increased expression of CDKN2A protein],,,PMID:21621607,https://www.ncbi.nlm.nih.gov/pubmed/21621607,21621607,,
310,1713935,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4680,CEACAM6,https://ctdbase.org/detail.go?type=gene&acc=4680,,,4680.0,CEACAM6,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of CEACAM6 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
311,1713936,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1050,CEBPA,https://ctdbase.org/detail.go?type=gene&acc=1050,,,1050.0,CEBPA,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of CEBPA mRNA,,,PMID:25932594,https://www.ncbi.nlm.nih.gov/pubmed/25932594,25932594,,
312,1713937,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1050,CEBPA,https://ctdbase.org/detail.go?type=gene&acc=1050,,,1050.0,CEBPA,10090,Mus musculus (house mouse),[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of CEBPA protein,,,PMID:14505802,https://www.ncbi.nlm.nih.gov/pubmed/14505802,14505802,,
313,1713938,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1050,CEBPA,https://ctdbase.org/detail.go?type=gene&acc=1050,,,1050.0,CEBPA,9823,Sus scrofa (pig),Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of CEBPA mrna]|[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of CEBPA mRNA,,,PMID:30481989,https://www.ncbi.nlm.nih.gov/pubmed/30481989,30481989,,
314,1713939,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1051,CEBPB,https://ctdbase.org/detail.go?type=gene&acc=1051,,,1051.0,CEBPB,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of CEBPB mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
315,1713940,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,629,CFB,https://ctdbase.org/detail.go?type=gene&acc=629,,,629.0,CFB,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of CFB mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
316,1713941,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1080,CFTR,https://ctdbase.org/detail.go?type=gene&acc=1080,,,1080.0,CFTR,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [vehicle emissions results in decreased activity of CFTR protein],,,PMID:34601066,https://www.ncbi.nlm.nih.gov/pubmed/34601066,34601066,,
317,1713942,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1080,CFTR,https://ctdbase.org/detail.go?type=gene&acc=1080,,,1080.0,CFTR,9606,Homo sapiens (human),Ascorbic acid promotes the reaction [CFTR protein results in increased secretion of chlorides],,,PMID:14993613,https://www.ncbi.nlm.nih.gov/pubmed/14993613,14993613,,
318,1713943,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1080,CFTR,https://ctdbase.org/detail.go?type=gene&acc=1080,,,1080.0,CFTR,9606,Homo sapiens (human),Ascorbic acid results in increased activity of CFTR protein,,,PMID:14993613|PMID:32374624,https://www.ncbi.nlm.nih.gov/pubmed/14993613|https://www.ncbi.nlm.nih.gov/pubmed/32374624,14993613|32374624,,
319,1713944,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1080,CFTR,https://ctdbase.org/detail.go?type=gene&acc=1080,,,1080.0,CFTR,9606,Homo sapiens (human),[bicarbonates co-treated with glutathione co-treated with ascorbic acid] results in increased activity of CFTR protein,,,PMID:32374624,https://www.ncbi.nlm.nih.gov/pubmed/32374624,32374624,,
320,1714048,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8208,CHAF1B,https://ctdbase.org/detail.go?type=gene&acc=8208,,,8208.0,CHAF1B,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in decreased expression of CHAF1B mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
321,1714049,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1103,CHAT,https://ctdbase.org/detail.go?type=gene&acc=1103,,,1103.0,CHAT,10116,Rattus norvegicus (Norway rat),Tobacco smoke pollution inhibits the reaction [[ascorbic acid co-treated with alpha-tocopherol co-treated with acetylcysteine] results in increased expression of CHAT protein]|[ascorbic acid co-treated with alpha-tocopherol co-treated with acetylcysteine] results in increased expression of CHAT protein,,,PMID:25891525,https://www.ncbi.nlm.nih.gov/pubmed/25891525,25891525,,
322,1714050,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,11200,CHEK2,https://ctdbase.org/detail.go?type=gene&acc=11200,,,11200.0,CHEK2,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in increased phosphorylation of CHEK2 protein],,,PMID:31388677,https://www.ncbi.nlm.nih.gov/pubmed/31388677,31388677,,
323,1714051,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,11200,CHEK2,https://ctdbase.org/detail.go?type=gene&acc=11200,,,11200.0,CHEK2,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [potassium chromate(vi) results in increased phosphorylation of CHEK2 protein]|ascorbic acid inhibits the reaction [potassium chromate(vi) results in increased expression of CHEK2 protein modified form],,,PMID:25977998,https://www.ncbi.nlm.nih.gov/pubmed/25977998,25977998,,
324,1714052,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,11200,CHEK2,https://ctdbase.org/detail.go?type=gene&acc=11200,,,11200.0,CHEK2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [[kojic acid co-treated with diethylnitrosamine] results in increased expression of CHEK2 mrna],,,PMID:18544905,https://www.ncbi.nlm.nih.gov/pubmed/18544905,18544905,,
325,1714053,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,63924,CIDEC,https://ctdbase.org/detail.go?type=gene&acc=63924,,,63924.0,CIDEC,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of CIDEC mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
326,1714054,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,11113,CIT,https://ctdbase.org/detail.go?type=gene&acc=11113,,,11113.0,CIT,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of CIT mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
327,1714055,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4435,CITED1,https://ctdbase.org/detail.go?type=gene&acc=4435,,,4435.0,CITED1,10090,Mus musculus (house mouse),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of CITED1 mrna|cadmium sulfate inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of CITED1 mrna],,,PMID:28189605,https://www.ncbi.nlm.nih.gov/pubmed/28189605,28189605,,
328,1714056,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9076,CLDN1,https://ctdbase.org/detail.go?type=gene&acc=9076,,,9076.0,CLDN1,10141,Cavia porcellus (domestic guinea pig),Ascorbic acid inhibits the reaction [ethanol results in decreased expression of CLDN1 mrna],,,PMID:24239723,https://www.ncbi.nlm.nih.gov/pubmed/24239723,24239723,,
329,1714118,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1191,CLU,https://ctdbase.org/detail.go?type=gene&acc=1191,,,1191.0,CLU,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of CLU mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
330,1714119,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,80790,CMIP,https://ctdbase.org/detail.go?type=gene&acc=80790,,,80790.0,CMIP,9606,Homo sapiens (human),Ascorbic acid results in increased expression of CMIP mrna|[arsenic trioxide co-treated with ascorbic acid] results in increased expression of CMIP mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
331,1714120,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1264,CNN1,https://ctdbase.org/detail.go?type=gene&acc=1264,,,1264.0,CNN1,9606,Homo sapiens (human),[ascorbic acid co-treated with TGFB1 protein] results in increased expression of CNN1 protein|[ascorbic acid co-treated with TGFB1 protein] results in increased expression of CNN1 mRNA,,,PMID:18607632,https://www.ncbi.nlm.nih.gov/pubmed/18607632,18607632,,
332,1714121,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1264,CNN1,https://ctdbase.org/detail.go?type=gene&acc=1264,,,1264.0,CNN1,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of CNN1 protein,,,PMID:14639096,https://www.ncbi.nlm.nih.gov/pubmed/14639096,14639096,,
333,1714122,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1268,CNR1,https://ctdbase.org/detail.go?type=gene&acc=1268,,,1268.0,CNR1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [hydrogen peroxide results in increased expression of CNR1 protein],,,PMID:28285367,https://www.ncbi.nlm.nih.gov/pubmed/28285367,28285367,,
334,1714123,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1269,CNR2,https://ctdbase.org/detail.go?type=gene&acc=1269,,,1269.0,CNR2,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [hydrogen peroxide results in increased expression of CNR2 protein],,,PMID:28285367,https://www.ncbi.nlm.nih.gov/pubmed/28285367,28285367,,
335,1714124,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1270,CNTF,https://ctdbase.org/detail.go?type=gene&acc=1270,,,1270.0,CNTF,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [mercuric chloride inhibits the reaction [CNTF protein results in increased phosphorylation of STAT1 protein]]|ascorbic acid inhibits the reaction [mercuric chloride inhibits the reaction [CNTF protein results in increased phosphorylation of STAT3 protein]],,,PMID:16896058,https://www.ncbi.nlm.nih.gov/pubmed/16896058,16896058,,
336,1714125,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1272,CNTN1,https://ctdbase.org/detail.go?type=gene&acc=1272,,,1272.0,CNTN1,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of CNTN1 mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
337,1714126,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8506,CNTNAP1,https://ctdbase.org/detail.go?type=gene&acc=8506,,,8506.0,CNTNAP1,9606,Homo sapiens (human),[arsenic trioxide co-treated with ascorbic acid] results in increased expression of CNTNAP1 mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
338,1714127,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1300,COL10A1,https://ctdbase.org/detail.go?type=gene&acc=1300,,,1300.0,COL10A1,10090,Mus musculus (house mouse),U 0126 inhibits the reaction [ascorbic acid results in increased expression of COL10A1 mrna]|ascorbic acid results in increased expression of COL10A1 mRNA,,,PMID:20530736,https://www.ncbi.nlm.nih.gov/pubmed/20530736,20530736,,
339,1714184,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1301,COL11A1,https://ctdbase.org/detail.go?type=gene&acc=1301,,,1301.0,COL11A1,9606,Homo sapiens (human),Ascorbic acid results in increased expression of COL11A1 mRNA,,,PMID:17518733,https://www.ncbi.nlm.nih.gov/pubmed/17518733,17518733,,
340,1714185,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1277,COL1A1,https://ctdbase.org/detail.go?type=gene&acc=1277,,,1277.0,COL1A1,10140,Cavia (guinea pigs),[ascorbic acid co-treated with ethanol] results in decreased expression of COL1A1 mRNA,,,PMID:22149461,https://www.ncbi.nlm.nih.gov/pubmed/22149461,22149461,,
341,1714186,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1277,COL1A1,https://ctdbase.org/detail.go?type=gene&acc=1277,,,1277.0,COL1A1,10141,Cavia porcellus (domestic guinea pig),Ascorbic acid inhibits the reaction [ethanol results in increased expression of COL1A1 protein],,,PMID:24239723,https://www.ncbi.nlm.nih.gov/pubmed/24239723,24239723,,
342,1714187,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1277,COL1A1,https://ctdbase.org/detail.go?type=gene&acc=1277,,,1277.0,COL1A1,9606,Homo sapiens (human),Ascorbic acid results in increased expression of COL1A1 mRNA,,,PMID:12510807|PMID:28105418,https://www.ncbi.nlm.nih.gov/pubmed/12510807|https://www.ncbi.nlm.nih.gov/pubmed/28105418,12510807|28105418,,
343,1714188,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1277,COL1A1,https://ctdbase.org/detail.go?type=gene&acc=1277,,,1277.0,COL1A1,10090,Mus musculus (house mouse),[[dexamethasone co-treated with beta-glycerophosphoric acid co-treated with ascorbic acid] co-treated with fasudil] results in increased expression of COL1A1 mrna|4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [[[dexamethasone co-treated with beta-glycerophosphoric acid co-treated with ascorbic acid] co-treated with fasudil] results in increased expression of COL1A1 mrna],,,PMID:31935364,https://www.ncbi.nlm.nih.gov/pubmed/31935364,31935364,,
344,1714189,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1277,COL1A1,https://ctdbase.org/detail.go?type=gene&acc=1277,,,1277.0,COL1A1,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of COL1A1 mRNA,,,PMID:14566779,https://www.ncbi.nlm.nih.gov/pubmed/14566779,14566779,,
345,1714190,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1277,COL1A1,https://ctdbase.org/detail.go?type=gene&acc=1277,,,1277.0,COL1A1,9823,Sus scrofa (pig),"2,2-bis(4-glycidyloxyphenyl)propane promotes the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of COL1A1 mrna]|[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of COL1A1 mRNA",,,PMID:30481989,https://www.ncbi.nlm.nih.gov/pubmed/30481989,30481989,,
346,1714191,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1278,COL1A2,https://ctdbase.org/detail.go?type=gene&acc=1278,,,1278.0,COL1A2,9606,Homo sapiens (human),[arsenic trioxide co-treated with ascorbic acid] results in increased expression of COL1A2 mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
347,1714192,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1278,COL1A2,https://ctdbase.org/detail.go?type=gene&acc=1278,,,1278.0,COL1A2,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of COL1A2 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
348,1714193,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1280,COL2A1,https://ctdbase.org/detail.go?type=gene&acc=1280,,,1280.0,COL2A1,9606,Homo sapiens (human),[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of COL2A1 mrna|resveratrol inhibits the reaction [IL1B protein inhibits the reaction [[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of COL2A1 mrna]]|il1b protein inhibits the reaction [[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of COL2A1 mrna],,,PMID:26526931,https://www.ncbi.nlm.nih.gov/pubmed/26526931,26526931,,
349,1714270,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1280,COL2A1,https://ctdbase.org/detail.go?type=gene&acc=1280,,,1280.0,COL2A1,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of COL2A1 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
350,1714271,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1556,CYP2B7P,https://ctdbase.org/detail.go?type=gene&acc=1556,,,1556.0,CYP2B7P,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of CYP2B7P mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
351,1714272,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1281,COL3A1,https://ctdbase.org/detail.go?type=gene&acc=1281,,,1281.0,COL3A1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of COL3A1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
352,1714273,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1356,CP,https://ctdbase.org/detail.go?type=gene&acc=1356,,,1356.0,CP,9606,Homo sapiens (human),Copper affects the reaction [CP mRNA affects the reaction [[ascorbic acid co-treated with zinc] results in increased degradation of heparitin sulfate]]|cp mRNA affects the reaction [[ascorbic acid co-treated with zinc] results in increased degradation of heparitin sulfate],,,PMID:14707133,https://www.ncbi.nlm.nih.gov/pubmed/14707133,14707133,,
353,1714274,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1380,CR2,https://ctdbase.org/detail.go?type=gene&acc=1380,,,1380.0,CR2,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in decreased expression of CR2 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
354,1714275,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1397,CRIP2,https://ctdbase.org/detail.go?type=gene&acc=1397,,,1397.0,CRIP2,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of CRIP2 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
355,1714276,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1401,CRP,https://ctdbase.org/detail.go?type=gene&acc=1401,,,1401.0,CRP,9606,Homo sapiens (human),[vitamin E co-treated with ascorbic acid co-treated with folic acid co-treated with riboflavin co-treated with vitamin B 6 co-treated with vitamin B 12] results in decreased expression of CRP protein|[vitamin E co-treated with ascorbic acid] results in decreased expression of CRP protein,,,PMID:16517955,https://www.ncbi.nlm.nih.gov/pubmed/16517955,16517955,,
356,1714277,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1410,CRYAB,https://ctdbase.org/detail.go?type=gene&acc=1410,,,1410.0,CRYAB,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of CRYAB mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
357,1714278,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1410,CRYAB,https://ctdbase.org/detail.go?type=gene&acc=1410,,,1410.0,CRYAB,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of CRYAB mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
358,1714336,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1431,CS,https://ctdbase.org/detail.go?type=gene&acc=1431,,,1431.0,CS,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [FMR1 5' UTR mutant form results in decreased activity of CS protein],,,PMID:27385396,https://www.ncbi.nlm.nih.gov/pubmed/27385396,27385396,,
359,1714337,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10675,CSPG5,https://ctdbase.org/detail.go?type=gene&acc=10675,,,10675.0,CSPG5,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of CSPG5 mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
360,1714338,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1465,CSRP1,https://ctdbase.org/detail.go?type=gene&acc=1465,,,1465.0,CSRP1,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of CSRP1 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
361,1714339,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1474,CST6,https://ctdbase.org/detail.go?type=gene&acc=1474,,,1474.0,CST6,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of CST6 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
362,1714340,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate affects the localization of CTNNB1 protein]|[ascorbic acid co-treated with vitamin E] inhibits the reaction [diethylhexyl phthalate results in increased expression of and affects the localization of CTNNB1 protein],,,PMID:29940330,https://www.ncbi.nlm.nih.gov/pubmed/29940330,29940330,,
363,1714341,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,9823,Sus scrofa (pig),"Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of CTNNB1 mrna]|2,2-bis(4-glycidyloxyphenyl)propane promotes the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of CTNNB1 mrna]|[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of CTNNB1 mRNA",,,PMID:30481989,https://www.ncbi.nlm.nih.gov/pubmed/30481989,30481989,,
364,1714342,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,56474,CTPS2,https://ctdbase.org/detail.go?type=gene&acc=56474,,,56474.0,CTPS2,9606,Homo sapiens (human),[arsenic trioxide co-treated with ascorbic acid] results in decreased expression of CTPS2 mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
365,1714343,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1509,CTSD,https://ctdbase.org/detail.go?type=gene&acc=1509,,,1509.0,CTSD,10116,Rattus norvegicus (Norway rat),[ferulic acid co-treated with ascorbic acid] inhibits the reaction [isoproterenol results in increased activity of CTSD protein],,,PMID:17045618,https://www.ncbi.nlm.nih.gov/pubmed/17045618,17045618,,
366,1714344,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1513,CTSK,https://ctdbase.org/detail.go?type=gene&acc=1513,,,1513.0,CTSK,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of CTSK mRNA,,,PMID:15730627,https://www.ncbi.nlm.nih.gov/pubmed/15730627,15730627,,
367,1714345,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1519,CTSO,https://ctdbase.org/detail.go?type=gene&acc=1519,,,1519.0,CTSO,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of CTSO mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
368,1714455,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2919,CXCL1,https://ctdbase.org/detail.go?type=gene&acc=2919,,,2919.0,CXCL1,10116,Rattus norvegicus (Norway rat),Ascorbic acid deficiency results in increased expression of CXCL1 mrna|ascorbic acid deficiency results in increased expression of CXCL1 protein,,,PMID:16637227,https://www.ncbi.nlm.nih.gov/pubmed/16637227,16637227,,
369,1714456,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3627,CXCL10,https://ctdbase.org/detail.go?type=gene&acc=3627,,,3627.0,CXCL10,9606,Homo sapiens (human),Ascorbic acid deficiency results in increased expression of CXCL10 mrna|ascorbic acid results in decreased expression of CXCL10 mRNA,,,PMID:19932582,https://www.ncbi.nlm.nih.gov/pubmed/19932582,19932582,,
370,1714457,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6372,CXCL6,https://ctdbase.org/detail.go?type=gene&acc=6372,,,6372.0,CXCL6,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of CXCL6 mrna|ascorbic acid deficiency results in increased expression of CXCL6 mRNA,,,PMID:19932582,https://www.ncbi.nlm.nih.gov/pubmed/19932582,19932582,,
371,1714458,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606,Homo sapiens (human),Ascorbic acid deficiency affects the expression of CXCL8 mrna|ascorbic acid affects the expression of CXCL8 mRNA,,,PMID:19932582,https://www.ncbi.nlm.nih.gov/pubmed/19932582,19932582,,
372,1714459,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606,Homo sapiens (human),Ascorbic acid affects the reaction [homocysteine results in increased secretion of CXCL8 protein]|ascorbic acid affects the reaction [homocysteine thiolactone results in increased secretion of CXCL8 protein],,,PMID:16715183,https://www.ncbi.nlm.nih.gov/pubmed/16715183,16715183,,
373,1714460,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606,Homo sapiens (human),[ascorbic acid co-treated with alpha-tocopherol co-treated with ferulic acid] inhibits the reaction [[ozone co-treated with oxygen] results in increased expression of CXCL8 mrna],,,PMID:26270818,https://www.ncbi.nlm.nih.gov/pubmed/26270818,26270818,,
374,1714461,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606,Homo sapiens (human),[ascorbic acid co-treated with lycopene co-treated with alpha-tocopherol] inhibits the reaction [TNF protein results in increased expression of CXCL8 mrna]|ascorbic acid inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of CXCL8 protein]|[ascorbic acid co-treated with lycopene co-treated with alpha-tocopherol] inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of CXCL8 protein]|ascorbic acid inhibits the reaction [TNF protein results in increased expression of CXCL8 mrna],,,PMID:25551565,https://www.ncbi.nlm.nih.gov/pubmed/25551565,25551565,,
375,1714462,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4283,CXCL9,https://ctdbase.org/detail.go?type=gene&acc=4283,,,4283.0,CXCL9,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in increased expression of CXCL9 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
376,1714463,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,643,CXCR5,https://ctdbase.org/detail.go?type=gene&acc=643,,,643.0,CXCR5,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in increased expression of CXCR5 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
377,1714519,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1528,CYB5A,https://ctdbase.org/detail.go?type=gene&acc=1528,,,1528.0,CYB5A,10140,Cavia (guinea pigs),[ascorbic acid deficiency co-treated with buthionine sulfoximine] results in decreased expression of CYB5A mrna|[ascorbic acid deficiency co-treated with buthionine sulfoximine] results in decreased expression of CYB5A protein,,,PMID:20221587,https://www.ncbi.nlm.nih.gov/pubmed/20221587,20221587,,
378,1714520,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1535,CYBA,https://ctdbase.org/detail.go?type=gene&acc=1535,,,1535.0,CYBA,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [hydrogen peroxide results in increased expression of CYBA protein]|ascorbic acid inhibits the reaction [hydrogen peroxide results in increased expression of CYBA mrna],,,PMID:25305479,https://www.ncbi.nlm.nih.gov/pubmed/25305479,25305479,,
379,1714521,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1536,CYBB,https://ctdbase.org/detail.go?type=gene&acc=1536,,,1536.0,CYBB,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of CYBB protein,,,PMID:21570463,https://www.ncbi.nlm.nih.gov/pubmed/21570463,21570463,,
380,1714522,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,79901,CYBRD1,https://ctdbase.org/detail.go?type=gene&acc=79901,,,79901.0,CYBRD1,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of CYBRD1 protein|ascorbic acid results in increased expression of CYBRD1 protein,,,PMID:18815723,https://www.ncbi.nlm.nih.gov/pubmed/18815723,18815723,,
381,1714523,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,54205,CYCS,https://ctdbase.org/detail.go?type=gene&acc=54205,,,54205.0,CYCS,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [TNFSF10 protein affects the localization of CYCS protein],,,PMID:23711929,https://www.ncbi.nlm.nih.gov/pubmed/23711929,23711929,,
382,1714524,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1583,CYP11A1,https://ctdbase.org/detail.go?type=gene&acc=1583,,,1583.0,CYP11A1,9606,Homo sapiens (human),Ascorbic acid results in increased expression of CYP11A1 mRNA,,,PMID:17901237,https://www.ncbi.nlm.nih.gov/pubmed/17901237,17901237,,
383,1714525,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1583,CYP11A1,https://ctdbase.org/detail.go?type=gene&acc=1583,,,1583.0,CYP11A1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [cadmium results in decreased expression of CYP11A1 mrna],,,PMID:15223132,https://www.ncbi.nlm.nih.gov/pubmed/15223132,15223132,,
384,1714526,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1583,CYP11A1,https://ctdbase.org/detail.go?type=gene&acc=1583,,,1583.0,CYP11A1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chlorodiphenyl (54% chlorine) results in decreased activity of CYP11A1 protein],,,PMID:16298753,https://www.ncbi.nlm.nih.gov/pubmed/16298753,16298753,,
385,1714527,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1583,CYP11A1,https://ctdbase.org/detail.go?type=gene&acc=1583,,,1583.0,CYP11A1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chlorodiphenyl (54% chlorine) results in decreased expression of CYP11A1 mrna],,,PMID:17280759,https://www.ncbi.nlm.nih.gov/pubmed/17280759,17280759,,
386,1714528,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1588,CYP19A1,https://ctdbase.org/detail.go?type=gene&acc=1588,,,1588.0,CYP19A1,9606,Homo sapiens (human),Ascorbic acid results in increased expression of CYP19A1 mRNA,,,PMID:17901237,https://www.ncbi.nlm.nih.gov/pubmed/17901237,17901237,,
387,1714563,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1588,CYP19A1,https://ctdbase.org/detail.go?type=gene&acc=1588,,,1588.0,CYP19A1,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in decreased expression of CYP19A1 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
388,1714564,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]|ascorbic acid inhibits the reaction [tetrachlorodibenzodioxin results in increased expression of CYP1A1 protein]|ascorbic acid inhibits the reaction [tetrachlorodibenzodioxin results in increased expression of CYP1A1 mrna],,,PMID:19268519,https://www.ncbi.nlm.nih.gov/pubmed/19268519,19268519,,
389,1714565,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606,Homo sapiens (human),Ascorbic acid results in decreased activity of CYP1A1 protein,,,PMID:17512695,https://www.ncbi.nlm.nih.gov/pubmed/17512695,17512695,,
390,1714566,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of CYP1A1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
391,1714567,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,10090,Mus musculus (house mouse),Ascorbic acid affects the reaction [beta-naphthoflavone results in increased expression of CYP1A1 mrna]|ascorbic acid affects the reaction [andrographolide affects the reaction [beta-naphthoflavone results in increased expression of CYP1A1 mrna]],,,PMID:21094198,https://www.ncbi.nlm.nih.gov/pubmed/21094198,21094198,,
392,1714568,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in increased expression of CYP1A1 mrna]|ascorbic acid inhibits the reaction [sodium arsenite results in increased expression of CYP1A1 mrna],,,PMID:16517059,https://www.ncbi.nlm.nih.gov/pubmed/16517059,16517059,,
393,1714569,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1544,CYP1A2,https://ctdbase.org/detail.go?type=gene&acc=1544,,,1544.0,CYP1A2,10116,Rattus norvegicus (Norway rat),Ascorbic acid deficiency results in increased expression of CYP1A2 protein|ascorbic acid deficiency results in increased expression of CYP1A2 mRNA,,,PMID:8269614,https://www.ncbi.nlm.nih.gov/pubmed/8269614,8269614,,
394,1714570,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1591,CYP24A1,https://ctdbase.org/detail.go?type=gene&acc=1591,,,1591.0,CYP24A1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of CYP24A1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
395,1714571,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,56603,CYP26B1,https://ctdbase.org/detail.go?type=gene&acc=56603,,,56603.0,CYP26B1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of CYP26B1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
396,1714628,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,13087,CYP2A5,https://ctdbase.org/detail.go?type=gene&acc=13087,,,13087.0,Cyp2a5,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [ethanol results in increased expression of and results in increased activity of CYP2A5 protein],,,PMID:22552773,https://www.ncbi.nlm.nih.gov/pubmed/22552773,22552773,,
397,1714629,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,13087,CYP2A5,https://ctdbase.org/detail.go?type=gene&acc=13087,,,13087.0,Cyp2a5,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of CYP2A5 mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
398,1714630,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1548,CYP2A6,https://ctdbase.org/detail.go?type=gene&acc=1548,,,1548.0,CYP2A6,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [ethanol results in increased expression of CYP2A6 protein]|ascorbic acid inhibits the reaction [ethanol results in increased expression of CYP2A6 mrna],,,PMID:22530035,https://www.ncbi.nlm.nih.gov/pubmed/22530035,22530035,,
399,1714631,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1548,CYP2A6,https://ctdbase.org/detail.go?type=gene&acc=1548,,,1548.0,CYP2A6,9606,Homo sapiens (human),Ascorbic acid results in decreased activity of CYP2A6 protein,,,PMID:17512695,https://www.ncbi.nlm.nih.gov/pubmed/17512695,17512695,,
400,1714632,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,13088,CYP2B10,https://ctdbase.org/detail.go?type=gene&acc=13088,,,13088.0,Cyp2b10,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of CYP2B10 mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
401,1714633,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,361523,CYP2B2,https://ctdbase.org/detail.go?type=gene&acc=361523,,,361523.0,Cyp2b2,10116,Rattus norvegicus (Norway rat),Ascorbic acid deficiency results in decreased expression of CYP2B2 protein,,,PMID:8269614,https://www.ncbi.nlm.nih.gov/pubmed/8269614,8269614,,
402,1714634,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,13094,CYP2B9,https://ctdbase.org/detail.go?type=gene&acc=13094,,,13094.0,Cyp2b9,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of CYP2B9 mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
403,1714635,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1571,CYP2E1,https://ctdbase.org/detail.go?type=gene&acc=1571,,,1571.0,CYP2E1,10140,Cavia (guinea pigs),[ascorbic acid co-treated with ethanol] results in decreased expression of CYP2E1 mRNA,,,PMID:22149461,https://www.ncbi.nlm.nih.gov/pubmed/22149461,22149461,,
404,1714636,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1571,CYP2E1,https://ctdbase.org/detail.go?type=gene&acc=1571,,,1571.0,CYP2E1,9606,Homo sapiens (human),Ascorbic acid results in decreased activity of CYP2E1 protein,,,PMID:17512695,https://www.ncbi.nlm.nih.gov/pubmed/17512695,17512695,,
405,1714637,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1571,CYP2E1,https://ctdbase.org/detail.go?type=gene&acc=1571,,,1571.0,CYP2E1,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with sesame oil] inhibits the reaction [abamectin results in increased expression of CYP2E1 protein]|ascorbic acid inhibits the reaction [abamectin results in increased expression of CYP2E1 protein],,,PMID:31739238,https://www.ncbi.nlm.nih.gov/pubmed/31739238,31739238,,
406,1714692,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1571,CYP2E1,https://ctdbase.org/detail.go?type=gene&acc=1571,,,1571.0,CYP2E1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [ethylene chlorohydrin results in increased expression of CYP2E1 mrna]|ascorbic acid inhibits the reaction [ethylene chlorohydrin results in increased expression of CYP2E1 protein],,,PMID:31585129,https://www.ncbi.nlm.nih.gov/pubmed/31585129,31585129,,
407,1714693,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1577,CYP3A5,https://ctdbase.org/detail.go?type=gene&acc=1577,,,1577.0,CYP3A5,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of CYP3A5 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
408,1714694,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,13117,CYP4A10,https://ctdbase.org/detail.go?type=gene&acc=13117,,,13117.0,Cyp4a10,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of CYP4A10 mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
409,1714695,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1581,CYP7A1,https://ctdbase.org/detail.go?type=gene&acc=1581,,,1581.0,CYP7A1,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with ascorbic acid] results in increased expression of CYP7A1 mrna|[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of CYP7A1 mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
410,1714696,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1601,DAB2,https://ctdbase.org/detail.go?type=gene&acc=1601,,,1601.0,DAB2,10090,Mus musculus (house mouse),Ascorbic acid results in decreased expression of DAB2 mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
411,1714697,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1610,DAO,https://ctdbase.org/detail.go?type=gene&acc=1610,,,1610.0,DAO,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [diquat results in increased activity of DAO protein],,,PMID:33475796,https://www.ncbi.nlm.nih.gov/pubmed/33475796,33475796,,
412,1714698,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1630,DCC,https://ctdbase.org/detail.go?type=gene&acc=1630,,,1630.0,DCC,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of DCC mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
413,1714699,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9201,DCLK1,https://ctdbase.org/detail.go?type=gene&acc=9201,,,9201.0,DCLK1,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of DCLK1 mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
414,1714700,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1634,DCN,https://ctdbase.org/detail.go?type=gene&acc=1634,,,1634.0,DCN,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of DCN mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
415,1714827,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1641,DCX,https://ctdbase.org/detail.go?type=gene&acc=1641,,,1641.0,DCX,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of DCX mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
416,1714828,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1649,DDIT3,https://ctdbase.org/detail.go?type=gene&acc=1649,,,1649.0,DDIT3,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with kojic acid co-treated with diethylnitrosamine] results in decreased expression of DDIT3 mRNA,,,PMID:18544905,https://www.ncbi.nlm.nih.gov/pubmed/18544905,18544905,,
417,1714829,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10170,DHRS9,https://ctdbase.org/detail.go?type=gene&acc=10170,,,10170.0,DHRS9,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of DHRS9 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
418,1714830,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,22943,DKK1,https://ctdbase.org/detail.go?type=gene&acc=22943,,,22943.0,DKK1,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of DKK1 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
419,1714831,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,27123,DKK2,https://ctdbase.org/detail.go?type=gene&acc=27123,,,27123.0,DKK2,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [benzo(a)pyrene results in increased methylation of DKK2 promoter]|ascorbic acid inhibits the reaction [benzo(a)pyrene results in decreased expression of DKK2 mrna],,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
420,1714832,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1738,DLD,https://ctdbase.org/detail.go?type=gene&acc=1738,,,1738.0,DLD,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [cadmium chloride results in decreased activity of and results in increased phosphorylation of DLD protein],,,PMID:29158198,https://www.ncbi.nlm.nih.gov/pubmed/29158198,29158198,,
421,1714833,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1742,DLG4,https://ctdbase.org/detail.go?type=gene&acc=1742,,,1742.0,DLG4,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of DLG4 mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
422,1714834,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1742,DLG4,https://ctdbase.org/detail.go?type=gene&acc=1742,,,1742.0,DLG4,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [corticosterone results in decreased expression of DLG4 protein],,,PMID:33872575,https://www.ncbi.nlm.nih.gov/pubmed/33872575,33872575,,
423,1714835,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9787,DLGAP5,https://ctdbase.org/detail.go?type=gene&acc=9787,,,9787.0,DLGAP5,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of DLGAP5 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
424,1714922,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1758,DMP1,https://ctdbase.org/detail.go?type=gene&acc=1758,,,1758.0,DMP1,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of DMP1 mrna|rosiglitazone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of DMP1 mrna]|tributyltin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of DMP1 mrna]|bexarotene inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of DMP1 mrna],,,PMID:25932594,https://www.ncbi.nlm.nih.gov/pubmed/25932594,25932594,,
425,1714923,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3337,DNAJB1,https://ctdbase.org/detail.go?type=gene&acc=3337,,,3337.0,DNAJB1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of DNAJB1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
426,1714924,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,54431,DNAJC10,https://ctdbase.org/detail.go?type=gene&acc=54431,,,54431.0,DNAJC10,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [fenretinide results in increased expression of DNAJC10 mrna],,,PMID:17353921,https://www.ncbi.nlm.nih.gov/pubmed/17353921,17353921,,
427,1714925,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1773,DNASE1,https://ctdbase.org/detail.go?type=gene&acc=1773,,,1773.0,DNASE1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of DNASE1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
428,1714926,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8193,DPF1,https://ctdbase.org/detail.go?type=gene&acc=8193,,,8193.0,DPF1,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in decreased expression of DPF1 mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
429,1714927,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1803,DPP4,https://ctdbase.org/detail.go?type=gene&acc=1803,,,1803.0,DPP4,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of DPP4 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
430,1714928,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,151871,DPPA2,https://ctdbase.org/detail.go?type=gene&acc=151871,,,151871.0,DPPA2,10090,Mus musculus (house mouse),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in decreased expression of DPPA2 mRNA,,,PMID:28189605,https://www.ncbi.nlm.nih.gov/pubmed/28189605,28189605,,
431,1714929,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,434423,DPPA5A,https://ctdbase.org/detail.go?type=gene&acc=434423,,,434423.0,Dppa5a,10090,Mus musculus (house mouse),Ascorbic acid results in decreased expression of DPPA5A mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
432,1714930,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1848,DUSP6,https://ctdbase.org/detail.go?type=gene&acc=1848,,,1848.0,DUSP6,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of DUSP6 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
433,1715015,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1870,E2F2,https://ctdbase.org/detail.go?type=gene&acc=1870,,,1870.0,E2F2,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of E2F2 mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
434,1715016,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,253738,EBF3,https://ctdbase.org/detail.go?type=gene&acc=253738,,,253738.0,EBF3,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of EBF3 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
435,1715017,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,641700,ECSCR,https://ctdbase.org/detail.go?type=gene&acc=641700,,,641700.0,ECSCR,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ECSCR mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
436,1715018,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1906,EDN1,https://ctdbase.org/detail.go?type=gene&acc=1906,,,1906.0,EDN1,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in increased expression of EDN1 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
437,1715019,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1908,EDN3,https://ctdbase.org/detail.go?type=gene&acc=1908,,,1908.0,EDN3,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in decreased expression of EDN3 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
438,1715020,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1910,EDNRB,https://ctdbase.org/detail.go?type=gene&acc=1910,,,1910.0,EDNRB,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of EDNRB mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
439,1715021,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of EGFR mRNA,,,PMID:21919647,https://www.ncbi.nlm.nih.gov/pubmed/21919647,21919647,,
440,1715022,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,54583,EGLN1,https://ctdbase.org/detail.go?type=gene&acc=54583,,,54583.0,EGLN1,10090,Mus musculus (house mouse),EGLN1 mRNA affects the reaction [ascorbic acid results in increased expression of SP7 protein],,,PMID:21467157,https://www.ncbi.nlm.nih.gov/pubmed/21467157,21467157,,
441,1715023,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,112399,EGLN3,https://ctdbase.org/detail.go?type=gene&acc=112399,,,112399.0,EGLN3,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of EGLN3 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
442,1715024,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,112399,EGLN3,https://ctdbase.org/detail.go?type=gene&acc=112399,,,112399.0,EGLN3,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of EGLN3 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
443,1715175,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8894,EIF2S2,https://ctdbase.org/detail.go?type=gene&acc=8894,,,8894.0,EIF2S2,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of EIF2S2 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
444,1715176,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8661,EIF3A,https://ctdbase.org/detail.go?type=gene&acc=8661,,,8661.0,EIF3A,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of EIF3A mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
445,1715177,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8663,EIF3C,https://ctdbase.org/detail.go?type=gene&acc=8663,,,8663.0,EIF3C,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of EIF3C mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
446,1715178,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8668,EIF3I,https://ctdbase.org/detail.go?type=gene&acc=8668,,,8668.0,EIF3I,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of EIF3I mRNA,,,PMID:22139585,https://www.ncbi.nlm.nih.gov/pubmed/22139585,22139585,,
447,1715179,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1973,EIF4A1,https://ctdbase.org/detail.go?type=gene&acc=1973,,,1973.0,EIF4A1,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of EIF4A1 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
448,1715180,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,286512,EIF4A2P4,https://ctdbase.org/detail.go?type=gene&acc=286512,,,286512.0,EIF4A2P4,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of EIF4A2P4 mrna|[arsenic trioxide co-treated with ascorbic acid] results in decreased expression of EIF4A2P4 mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
449,1715181,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1995,ELAVL3,https://ctdbase.org/detail.go?type=gene&acc=1995,,,1995.0,ELAVL3,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ELAVL3 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
450,1715182,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1996,ELAVL4,https://ctdbase.org/detail.go?type=gene&acc=1996,,,1996.0,ELAVL4,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ELAVL4 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
451,1715183,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,54859,ELP6,https://ctdbase.org/detail.go?type=gene&acc=54859,,,54859.0,ELP6,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of ELP6 mrna|[arsenic trioxide co-treated with ascorbic acid] results in decreased expression of ELP6 mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
452,1715184,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2012,EMP1,https://ctdbase.org/detail.go?type=gene&acc=2012,,,2012.0,EMP1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of EMP1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
453,1775037,54670067,Therapeutic Target Database (TTD),Ascorbic Acid,D07AHW,Vitamin C,https://idrblab.net/ttd/data/drug/details/D07AHW,T08378,Solute carrier family 23 member 2 (SLC23A2),https://idrblab.net/ttd/data/target/details/T08378,Q9UGH3,Solute carrier family 23 member 2,9962.0,SLC23A2,9606,Homo sapiens (human),Modulator,,,,,,,
454,1775038,54670067,Therapeutic Target Database (TTD),Ascorbic Acid,D07AHW,Vitamin C,https://idrblab.net/ttd/data/drug/details/D07AHW,T37382,Solute carrier family 23 member 1 (SLC23A1),https://idrblab.net/ttd/data/target/details/T37382,Q9UHI7,Solute carrier family 23 member 1,9963.0,SLC23A1,9606,Homo sapiens (human),Modulator,,,,,,,
455,2009589,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2014,EMP3,https://ctdbase.org/detail.go?type=gene&acc=2014,,,2014.0,EMP3,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of EMP3 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
456,2009590,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2018,EMX2,https://ctdbase.org/detail.go?type=gene&acc=2018,,,2018.0,EMX2,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of EMX2 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
457,2009591,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2019,EN1,https://ctdbase.org/detail.go?type=gene&acc=2019,,,2019.0,EN1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [benzo(a)pyrene results in increased methylation of EN1 promoter]|ascorbic acid inhibits the reaction [benzo(a)pyrene results in decreased expression of EN1 mrna],,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
458,2009592,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2034,EPAS1,https://ctdbase.org/detail.go?type=gene&acc=2034,,,2034.0,EPAS1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [nickel sulfate results in increased expression of EPAS1 protein],,,PMID:16288478,https://www.ncbi.nlm.nih.gov/pubmed/16288478,16288478,,
459,2009593,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2052,EPHX1,https://ctdbase.org/detail.go?type=gene&acc=2052,,,2052.0,EPHX1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of EPHX1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
460,2009594,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2053,EPHX2,https://ctdbase.org/detail.go?type=gene&acc=2053,,,2053.0,EPHX2,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of EPHX2 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
461,2009595,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2058,EPRS1,https://ctdbase.org/detail.go?type=gene&acc=2058,,,2058.0,EPRS1,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of EPRS1 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
462,2009596,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2068,ERCC2,https://ctdbase.org/detail.go?type=gene&acc=2068,,,2068.0,ERCC2,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of ERCC2 mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
463,2009597,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2072,ERCC4,https://ctdbase.org/detail.go?type=gene&acc=2072,,,2072.0,ERCC4,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of ERCC4 mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
464,2009598,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2073,ERCC5,https://ctdbase.org/detail.go?type=gene&acc=2073,,,2073.0,ERCC5,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of ERCC5 mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
465,2009599,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of ESR1 mrna],,,PMID:18602937,https://www.ncbi.nlm.nih.gov/pubmed/18602937,18602937,,
466,2009600,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of ESR2 mrna],,,PMID:18602937,https://www.ncbi.nlm.nih.gov/pubmed/18602937,18602937,,
467,2009601,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,790952,ESRG,https://ctdbase.org/detail.go?type=gene&acc=790952,,,790952.0,ESRG,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ESRG mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
468,2009602,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2145,EZH1,https://ctdbase.org/detail.go?type=gene&acc=2145,,,2145.0,EZH1,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of EZH1 mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
469,2009603,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2146,EZH2,https://ctdbase.org/detail.go?type=gene&acc=2146,,,2146.0,EZH2,9606,Homo sapiens (human),EZH2 protein inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of ALPL mrna]|ezh2 protein inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of TNFRSF11B mrna]|ezh2 protein inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of SATB2 mrna]|ezh2 protein inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of RUNX2 mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in decreased expression of EZH2 protein|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in decreased expression of EZH2 mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
470,2009604,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2152,F3,https://ctdbase.org/detail.go?type=gene&acc=2152,,,2152.0,F3,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [norepinephrine results in increased expression of F3 mrna],,,PMID:23114885,https://www.ncbi.nlm.nih.gov/pubmed/23114885,23114885,,
471,2009605,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2168,FABP1,https://ctdbase.org/detail.go?type=gene&acc=2168,,,2168.0,FABP1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FABP1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
472,2009606,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2167,FABP4,https://ctdbase.org/detail.go?type=gene&acc=2167,,,2167.0,FABP4,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of FABP4 mRNA,,,PMID:25932594,https://www.ncbi.nlm.nih.gov/pubmed/25932594,25932594,,
473,2009607,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2167,FABP4,https://ctdbase.org/detail.go?type=gene&acc=2167,,,2167.0,FABP4,10090,Mus musculus (house mouse),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS1 protein co-treated with firemaster 550] results in increased expression of FABP4 mrna|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS1 protein co-treated with triphenyl phosphate] results in increased expression of FABP4 mRNA,,,PMID:25062436,https://www.ncbi.nlm.nih.gov/pubmed/25062436,25062436,,
474,2009608,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2167,FABP4,https://ctdbase.org/detail.go?type=gene&acc=2167,,,2167.0,FABP4,10090,Mus musculus (house mouse),"Triphenyltin hydroxide promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of FABP4 mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of FABP4 mrna|tetrabromobisphenol A promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of FABP4 mrna]|rosiglitazone promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of FABP4 mrna]|pioglitazone promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of FABP4 mrna]|d,d-T80-prallethrin promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of FABP4 mrna]",,,PMID:32473317,https://www.ncbi.nlm.nih.gov/pubmed/32473317,32473317,,
475,2009609,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2167,FABP4,https://ctdbase.org/detail.go?type=gene&acc=2167,,,2167.0,FABP4,9823,Sus scrofa (pig),"Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of FABP4 mrna]|2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of FABP4 mrna]|[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of FABP4 mRNA",,,PMID:30481989,https://www.ncbi.nlm.nih.gov/pubmed/30481989,30481989,,
476,2009610,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2172,FABP6,https://ctdbase.org/detail.go?type=gene&acc=2172,,,2172.0,FABP6,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of FABP6 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
477,2009611,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2184,FAH,https://ctdbase.org/detail.go?type=gene&acc=2184,,,2184.0,FAH,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of FAH mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
478,2009612,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,55120,FANCL,https://ctdbase.org/detail.go?type=gene&acc=55120,,,55120.0,FANCL,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in decreased expression of FANCL mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
479,2009613,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2195,FAT1,https://ctdbase.org/detail.go?type=gene&acc=2195,,,2195.0,FAT1,9606,Homo sapiens (human),[arsenic trioxide co-treated with ascorbic acid] results in increased expression of FAT1 mrna|ascorbic acid results in increased expression of FAT1 mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
480,2009614,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2192,FBLN1,https://ctdbase.org/detail.go?type=gene&acc=2192,,,2192.0,FBLN1,9606,Homo sapiens (human),[arsenic trioxide co-treated with ascorbic acid] results in increased expression of FBLN1 mrna|ascorbic acid results in increased expression of FBLN1 mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
481,2009615,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2203,FBP1,https://ctdbase.org/detail.go?type=gene&acc=2203,,,2203.0,FBP1,10090,Mus musculus (house mouse),Ascorbic acid affects the expression of FBP1 protein,,,PMID:19224539,https://www.ncbi.nlm.nih.gov/pubmed/19224539,19224539,,
482,2009616,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,114907,FBXO32,https://ctdbase.org/detail.go?type=gene&acc=114907,,,114907.0,FBXO32,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FBXO32 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
483,2009617,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2232,FDXR,https://ctdbase.org/detail.go?type=gene&acc=2232,,,2232.0,FDXR,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of FDXR mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
484,2009618,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2244,FGB,https://ctdbase.org/detail.go?type=gene&acc=2244,,,2244.0,FGB,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FGB mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
485,2009619,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2246,FGF1,https://ctdbase.org/detail.go?type=gene&acc=2246,,,2246.0,FGF1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of TF mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of STMN2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HOXB3 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SOX1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of EGLN3 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of NR2F2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GCLM mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FABP1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HOXA2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FGB mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of EBF3 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of ZFAND2A mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of DCC mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of OTX2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of CDH10 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FLRT3 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of FOXD3 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of IL1R1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of SERPINA1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GPX2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FGF7 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GSTO1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ECSCR mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GRIA2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of TFAP2A mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of DCX mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ABCC1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of SLCO2B1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SRXN1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of CRYAB mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of AMHR2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ELAVL4 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of SCN2A mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of AFP mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of MYL4 mrna|[[ascorbic acid co-treated with ch,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
486,2009620,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2247,FGF2,https://ctdbase.org/detail.go?type=gene&acc=2247,,,2247.0,FGF2,9031,Gallus gallus (chicken),Ascorbic acid promotes the reaction [alliin results in decreased activity of FGF2 protein],,,PMID:16351512,https://www.ncbi.nlm.nih.gov/pubmed/16351512,16351512,,
487,2009624,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2252,FGF7,https://ctdbase.org/detail.go?type=gene&acc=2252,,,2252.0,FGF7,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FGF7 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
488,2009625,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2266,FGG,https://ctdbase.org/detail.go?type=gene&acc=2266,,,2266.0,FGG,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FGG mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
489,2009626,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,23767,FLRT3,https://ctdbase.org/detail.go?type=gene&acc=23767,,,23767.0,FLRT3,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FLRT3 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
490,2009627,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2321,FLT1,https://ctdbase.org/detail.go?type=gene&acc=2321,,,2321.0,FLT1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of FLT1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
491,2009628,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2321,FLT1,https://ctdbase.org/detail.go?type=gene&acc=2321,,,2321.0,FLT1,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of FLT1 mRNA,,,PMID:21919647,https://www.ncbi.nlm.nih.gov/pubmed/21919647,21919647,,
492,2009629,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2326,FMO1,https://ctdbase.org/detail.go?type=gene&acc=2326,,,2326.0,FMO1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of FMO1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
493,2009630,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2330,FMO5,https://ctdbase.org/detail.go?type=gene&acc=2330,,,2330.0,FMO5,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of FMO5 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
494,2009631,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2332,FMR1,https://ctdbase.org/detail.go?type=gene&acc=2332,,,2332.0,FMR1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [FMR1 5' UTR mutant form results in decreased activity of CS protein],,,PMID:27385396,https://www.ncbi.nlm.nih.gov/pubmed/27385396,27385396,,
495,2009632,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2335,FN1,https://ctdbase.org/detail.go?type=gene&acc=2335,,,2335.0,FN1,9606,Homo sapiens (human),[ascorbic acid co-treated with quartz] results in increased expression of FN1 mRNA,,,PMID:27381660,https://www.ncbi.nlm.nih.gov/pubmed/27381660,27381660,,
496,2009633,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2335,FN1,https://ctdbase.org/detail.go?type=gene&acc=2335,,,2335.0,FN1,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in increased expression of FN1 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
497,2009634,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,79672,FN3KRP,https://ctdbase.org/detail.go?type=gene&acc=79672,,,79672.0,FN3KRP,9606,Homo sapiens (human),Ascorbic acid results in increased expression of FN3KRP mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
498,2009635,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2353,FOS,https://ctdbase.org/detail.go?type=gene&acc=2353,,,2353.0,FOS,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of FOS mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
499,2009636,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3170,FOXA2,https://ctdbase.org/detail.go?type=gene&acc=3170,,,3170.0,FOXA2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [nitrofen results in decreased expression of FOXA2 protein],,,PMID:16863852,https://www.ncbi.nlm.nih.gov/pubmed/16863852,16863852,,
500,2009637,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,27022,FOXD3,https://ctdbase.org/detail.go?type=gene&acc=27022,,,27022.0,FOXD3,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of FOXD3 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
501,2009638,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2290,FOXG1,https://ctdbase.org/detail.go?type=gene&acc=2290,,,2290.0,FOXG1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of FOXG1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
502,2009639,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2302,FOXJ1,https://ctdbase.org/detail.go?type=gene&acc=2302,,,2302.0,FOXJ1,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in increased expression of FOXJ1 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
503,2009640,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2302,FOXJ1,https://ctdbase.org/detail.go?type=gene&acc=2302,,,2302.0,FOXJ1,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of FOXJ1 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
504,2009641,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2305,FOXM1,https://ctdbase.org/detail.go?type=gene&acc=2305,,,2305.0,FOXM1,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of FOXM1 mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
505,2009642,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2309,FOXO3,https://ctdbase.org/detail.go?type=gene&acc=2309,,,2309.0,FOXO3,9606,Homo sapiens (human),Ascorbic acid results in increased expression of and results in decreased phosphorylation of FOXO3 protein|ascorbic acid affects the localization of FOXO3 protein|foxo3 protein affects the reaction [ascorbic acid results in increased expression of LDLR protein]|foxo3 protein affects the reaction [ascorbic acid results in decreased expression of PCSK9 protein]|ascorbic acid results in increased expression of FOXO3 mRNA,,,PMID:32913121,https://www.ncbi.nlm.nih.gov/pubmed/32913121,32913121,,
506,2009643,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2488,FSHB,https://ctdbase.org/detail.go?type=gene&acc=2488,,,2488.0,FSHB,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chlorodiphenyl (54% chlorine) results in decreased expression of FSHB protein],,,PMID:16248992|PMID:17280759,https://www.ncbi.nlm.nih.gov/pubmed/16248992|https://www.ncbi.nlm.nih.gov/pubmed/17280759,16248992|17280759,,
507,2009644,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2488,FSHB,https://ctdbase.org/detail.go?type=gene&acc=2488,,,2488.0,FSHB,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in increased expression of FSHB protein],,,PMID:18602937,https://www.ncbi.nlm.nih.gov/pubmed/18602937,18602937,,
508,2009645,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2488,FSHB,https://ctdbase.org/detail.go?type=gene&acc=2488,,,2488.0,FSHB,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in increased expression of FSHB protein],,,PMID:23470461,https://www.ncbi.nlm.nih.gov/pubmed/23470461,23470461,,
509,2009646,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2492,FSHR,https://ctdbase.org/detail.go?type=gene&acc=2492,,,2492.0,FSHR,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of FSHR mrna],,,PMID:18602937,https://www.ncbi.nlm.nih.gov/pubmed/18602937,18602937,,
510,2009647,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2492,FSHR,https://ctdbase.org/detail.go?type=gene&acc=2492,,,2492.0,FSHR,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in decreased expression of FSHR protein]|ascorbic acid inhibits the reaction [potassium dichromate results in decreased expression of FSHR mrna],,,PMID:23470461,https://www.ncbi.nlm.nih.gov/pubmed/23470461,23470461,,
511,2009648,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2495,FTH1,https://ctdbase.org/detail.go?type=gene&acc=2495,,,2495.0,FTH1,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of FTH1 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
512,2009649,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2512,FTL,https://ctdbase.org/detail.go?type=gene&acc=2512,,,2512.0,FTL,10090,Mus musculus (house mouse),Ascorbic acid affects the expression of FTL protein,,,PMID:19224539,https://www.ncbi.nlm.nih.gov/pubmed/19224539,19224539,,
513,2009650,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2534,FYN,https://ctdbase.org/detail.go?type=gene&acc=2534,,,2534.0,FYN,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [potassium dichromate results in increased phosphorylation of FYN protein]|ascorbic acid inhibits the reaction [bis(2-hydroxy-2-ethylbutanoato)oxochromate(v) results in increased phosphorylation of FYN protein],,,PMID:14572611,https://www.ncbi.nlm.nih.gov/pubmed/14572611,14572611,,
514,2009651,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,11211,FZD10,https://ctdbase.org/detail.go?type=gene&acc=11211,,,11211.0,FZD10,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of FZD10 mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
515,2009652,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2535,FZD2,https://ctdbase.org/detail.go?type=gene&acc=2535,,,2535.0,FZD2,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of FZD2 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
516,2009653,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,50486,G0S2,https://ctdbase.org/detail.go?type=gene&acc=50486,,,50486.0,G0S2,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of G0S2 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
517,2009654,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2539,G6PD,https://ctdbase.org/detail.go?type=gene&acc=2539,,,2539.0,G6PD,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [cadmium chloride results in decreased activity of G6PD protein],,,PMID:18548748,https://www.ncbi.nlm.nih.gov/pubmed/18548748,18548748,,
518,2009655,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,11337,GABARAP,https://ctdbase.org/detail.go?type=gene&acc=11337,,,11337.0,GABARAP,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of GABARAP mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
519,2009656,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2555,GABRA2,https://ctdbase.org/detail.go?type=gene&acc=2555,,,2555.0,GABRA2,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GABRA2 mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
520,2009657,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1647,GADD45A,https://ctdbase.org/detail.go?type=gene&acc=1647,,,1647.0,GADD45A,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GADD45A mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
521,2009658,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4616,GADD45B,https://ctdbase.org/detail.go?type=gene&acc=4616,,,4616.0,GADD45B,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with kojic acid co-treated with diethylnitrosamine] results in decreased expression of GADD45B mRNA,,,PMID:18544905,https://www.ncbi.nlm.nih.gov/pubmed/18544905,18544905,,
522,2009659,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2580,GAK,https://ctdbase.org/detail.go?type=gene&acc=2580,,,2580.0,GAK,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in decreased expression of GAK mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
523,2009660,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,51083,GAL,https://ctdbase.org/detail.go?type=gene&acc=51083,,,51083.0,GAL,10116,Rattus norvegicus (Norway rat),[ferulic acid co-treated with ascorbic acid] inhibits the reaction [isoproterenol results in increased activity of GAL protein],,,PMID:17045618,https://www.ncbi.nlm.nih.gov/pubmed/17045618,17045618,,
524,2009661,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2592,GALT,https://ctdbase.org/detail.go?type=gene&acc=2592,,,2592.0,GALT,7227,Drosophila melanogaster (fruit fly),Ascorbic acid inhibits the reaction [GALT gene mutant form results in increased susceptibility to galactose],,,PMID:22773758,https://www.ncbi.nlm.nih.gov/pubmed/22773758,22773758,,
525,2009662,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2593,GAMT,https://ctdbase.org/detail.go?type=gene&acc=2593,,,2593.0,GAMT,10090,Mus musculus (house mouse),Ascorbic acid affects the expression of GAMT protein,,,PMID:19224539,https://www.ncbi.nlm.nih.gov/pubmed/19224539,19224539,,
526,2009663,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2597,GAPDH,https://ctdbase.org/detail.go?type=gene&acc=2597,,,2597.0,GAPDH,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of GAPDH protein,,,PMID:22139585,https://www.ncbi.nlm.nih.gov/pubmed/22139585,22139585,,
527,2009664,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2597,GAPDH,https://ctdbase.org/detail.go?type=gene&acc=2597,,,2597.0,GAPDH,9986,Oryctolagus cuniculus (rabbit),"Ascorbic acid affects the reaction [3,4-dihydroxyphenylacetaldehyde binds to and affects the metabolism of GAPDH protein]",,,PMID:19537779,https://www.ncbi.nlm.nih.gov/pubmed/19537779,19537779,,
528,2009665,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2617,GARS1,https://ctdbase.org/detail.go?type=gene&acc=2617,,,2617.0,GARS1,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of GARS1 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
529,2009666,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8522,GAS7,https://ctdbase.org/detail.go?type=gene&acc=8522,,,8522.0,GAS7,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of GAS7 mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
530,2009667,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2623,GATA1,https://ctdbase.org/detail.go?type=gene&acc=2623,,,2623.0,GATA1,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in increased expression of GATA1 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
531,2009668,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2626,GATA4,https://ctdbase.org/detail.go?type=gene&acc=2626,,,2626.0,GATA4,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of GATA4 mRNA,,,PMID:12668514,https://www.ncbi.nlm.nih.gov/pubmed/12668514,12668514,,
532,2009669,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2627,GATA6,https://ctdbase.org/detail.go?type=gene&acc=2627,,,2627.0,GATA6,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GATA6 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
533,2009670,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2634,GBP2,https://ctdbase.org/detail.go?type=gene&acc=2634,,,2634.0,GBP2,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of GBP2 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
534,2009671,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2643,GCH1,https://ctdbase.org/detail.go?type=gene&acc=2643,,,2643.0,GCH1,9913,Bos taurus (cattle),Ascorbic acid inhibits the reaction [[4-hydroxy-2-nonenal results in decreased activity of GCH1 protein] which results in decreased chemical synthesis of sapropterin]|ascorbic acid inhibits the reaction [4-hydroxy-2-nonenal results in increased degradation of GCH1 protein],,,PMID:17872449,https://www.ncbi.nlm.nih.gov/pubmed/17872449,17872449,,
535,2009672,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2729,GCLC,https://ctdbase.org/detail.go?type=gene&acc=2729,,,2729.0,GCLC,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [ethylene chlorohydrin results in increased expression of GCLC mrna]|ascorbic acid inhibits the reaction [ethylene chlorohydrin results in increased expression of GCLC protein],,,PMID:31585129,https://www.ncbi.nlm.nih.gov/pubmed/31585129,31585129,,
536,2009673,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,9606,Homo sapiens (human),[ascorbic acid co-treated with GSR protein] affects the metabolism of glucose,,,PMID:1901343,https://www.ncbi.nlm.nih.gov/pubmed/1901343,1901343,,
537,2009674,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2729,GCLC,https://ctdbase.org/detail.go?type=gene&acc=2729,,,2729.0,GCLC,10116,Rattus norvegicus (Norway rat),[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] affects the expression of GCLC mrna|quercetin affects the reaction [hydrogen peroxide affects the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] affects the expression of GCLC mrna]]|hydrogen peroxide affects the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] affects the expression of GCLC mrna],,,PMID:27028516,https://www.ncbi.nlm.nih.gov/pubmed/27028516,27028516,,
538,2009675,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2730,GCLM,https://ctdbase.org/detail.go?type=gene&acc=2730,,,2730.0,GCLM,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GCLM mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
539,2009676,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2662,GDF10,https://ctdbase.org/detail.go?type=gene&acc=2662,,,2662.0,GDF10,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of GDF10 mRNA,,,PMID:15994055,https://www.ncbi.nlm.nih.gov/pubmed/15994055,15994055,,
540,2009677,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2745,GLRX,https://ctdbase.org/detail.go?type=gene&acc=2745,,,2745.0,GLRX,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in decreased expression of GLRX mrna],,,PMID:23470461,https://www.ncbi.nlm.nih.gov/pubmed/23470461,23470461,,
541,2009678,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2744,GLS,https://ctdbase.org/detail.go?type=gene&acc=2744,,,2744.0,GLS,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of GLS mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
542,2009679,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2668,GDNF,https://ctdbase.org/detail.go?type=gene&acc=2668,,,2668.0,GDNF,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of TUBB3 protein|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of S100B mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of FOXM1 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GRIA2 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of LEF1 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of E2F2 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of RBFOX3 protein|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of HOXB1 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of SYN protein|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of RBFOX3 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of HES3 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of SYN mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of FZD10 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of SLC17A6 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GFAP mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of SLC17A7 protein|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GRIN1 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of TERT mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of S100B protein|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of MAP2 protein|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of DLG4 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GABRA2 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of INHBE mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GRIN2A mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of SCN2A mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of CNTN1 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of GLI1 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GRIN2B mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
543,2009680,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2670,GFAP,https://ctdbase.org/detail.go?type=gene&acc=2670,,,2670.0,GFAP,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GFAP mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
544,2009681,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2670,GFAP,https://ctdbase.org/detail.go?type=gene&acc=2670,,,2670.0,GFAP,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [vincristine results in increased expression of GFAP protein],,,PMID:34286406,https://www.ncbi.nlm.nih.gov/pubmed/34286406,34286406,,
545,2009682,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2670,GFAP,https://ctdbase.org/detail.go?type=gene&acc=2670,,,2670.0,GFAP,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of GFAP protein,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
546,2009683,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2674,GFRA1,https://ctdbase.org/detail.go?type=gene&acc=2674,,,2674.0,GFRA1,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in increased expression of GFRA1 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
547,2009684,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2678,GGT1,https://ctdbase.org/detail.go?type=gene&acc=2678,,,2678.0,GGT1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chlorodiphenyl (54% chlorine) results in decreased activity of GGT1 protein],,,PMID:16298753,https://www.ncbi.nlm.nih.gov/pubmed/16298753,16298753,,
548,2009685,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2688,GH1,https://ctdbase.org/detail.go?type=gene&acc=2688,,,2688.0,GH1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of GH1 protein],,,PMID:18602937,https://www.ncbi.nlm.nih.gov/pubmed/18602937,18602937,,
549,2009686,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2697,GJA1,https://ctdbase.org/detail.go?type=gene&acc=2697,,,2697.0,GJA1,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [vincristine results in increased expression of GJA1 protein]|ascorbic acid inhibits the reaction [vincristine results in increased expression of GJA1 mrna],,,PMID:34286406,https://www.ncbi.nlm.nih.gov/pubmed/34286406,34286406,,
550,2009687,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2697,GJA1,https://ctdbase.org/detail.go?type=gene&acc=2697,,,2697.0,GJA1,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of GJA1 protein]|[ascorbic acid co-treated with vitamin E] inhibits the reaction [diethylhexyl phthalate results in decreased expression of GJA1 protein],,,PMID:29940330,https://www.ncbi.nlm.nih.gov/pubmed/29940330,29940330,,
551,2009688,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2717,GLA,https://ctdbase.org/detail.go?type=gene&acc=2717,,,2717.0,GLA,13489,Dicentrarchus labrax (European seabass),Ascorbic acid results in decreased expression of GLA mRNA,,,PMID:21281732,https://www.ncbi.nlm.nih.gov/pubmed/21281732,21281732,,
552,2009689,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2735,GLI1,https://ctdbase.org/detail.go?type=gene&acc=2735,,,2735.0,GLI1,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of GLI1 mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
553,2009690,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2739,GLO1,https://ctdbase.org/detail.go?type=gene&acc=2739,,,2739.0,GLO1,10090,Mus musculus (house mouse),Ascorbic acid affects the expression of GLO1 protein,,,PMID:19224539,https://www.ncbi.nlm.nih.gov/pubmed/19224539,19224539,,
554,2009691,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2785,GNG3,https://ctdbase.org/detail.go?type=gene&acc=2785,,,2785.0,GNG3,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of GNG3 mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
555,2009692,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2786,GNG4,https://ctdbase.org/detail.go?type=gene&acc=2786,,,2786.0,GNG4,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of GNG4 mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
556,2009693,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2805,GOT1,https://ctdbase.org/detail.go?type=gene&acc=2805,,,2805.0,GOT1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [carbon tetrachloride results in increased expression of GOT1 protein],,,PMID:30676168,https://www.ncbi.nlm.nih.gov/pubmed/30676168,30676168,,
557,2009694,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,84803,GPAT3,https://ctdbase.org/detail.go?type=gene&acc=84803,,,84803.0,GPAT3,9606,Homo sapiens (human),Ascorbic acid results in increased expression of GPAT3 mRNA,,,PMID:26198647,https://www.ncbi.nlm.nih.gov/pubmed/26198647,26198647,,
558,2009695,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2817,GPC1,https://ctdbase.org/detail.go?type=gene&acc=2817,,,2817.0,GPC1,9606,Homo sapiens (human),Ascorbic acid results in increased expression of GPC1 mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
559,2009696,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2817,GPC1,https://ctdbase.org/detail.go?type=gene&acc=2817,,,2817.0,GPC1,10090,Mus musculus (house mouse),Zinc promotes the reaction [[ascorbic acid co-treated with nitric oxide] results in increased degradation of GPC1 protein modified form]|[ascorbic acid co-treated with nitric oxide] results in increased degradation of GPC1 protein modified form,,,PMID:15677459,https://www.ncbi.nlm.nih.gov/pubmed/15677459,15677459,,
560,2009697,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2817,GPC1,https://ctdbase.org/detail.go?type=gene&acc=2817,,,2817.0,GPC1,10090,Mus musculus (house mouse),Ascorbic acid results in increased degradation of GPC1 protein,,,PMID:21642435,https://www.ncbi.nlm.nih.gov/pubmed/21642435,21642435,,
561,2009698,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [hydrogen peroxide results in increased activity of GSR protein],,,PMID:28285367,https://www.ncbi.nlm.nih.gov/pubmed/28285367,28285367,,
562,2009699,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2719,GPC3,https://ctdbase.org/detail.go?type=gene&acc=2719,,,2719.0,GPC3,10090,Mus musculus (house mouse),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of GPC3 mrna|cadmium sulfate inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of GPC3 mrna],,,PMID:28189605,https://www.ncbi.nlm.nih.gov/pubmed/28189605,28189605,,
563,2009700,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2819,GPD1,https://ctdbase.org/detail.go?type=gene&acc=2819,,,2819.0,GPD1,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with INS1 protein] results in decreased expression of GPD1 mRNA,,,PMID:20400526,https://www.ncbi.nlm.nih.gov/pubmed/20400526,20400526,,
564,2009701,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,11321,GPN1,https://ctdbase.org/detail.go?type=gene&acc=11321,,,11321.0,GPN1,9606,Homo sapiens (human),[arsenic trioxide co-treated with ascorbic acid] results in decreased expression of GPN1 mrna|ascorbic acid results in decreased expression of GPN1 mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
565,2009702,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1880,GPR183,https://ctdbase.org/detail.go?type=gene&acc=1880,,,1880.0,GPR183,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GPR183 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
566,2009703,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9290,GPR55,https://ctdbase.org/detail.go?type=gene&acc=9290,,,9290.0,GPR55,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [hydrogen peroxide results in increased expression of GPR55 protein],,,PMID:28285367,https://www.ncbi.nlm.nih.gov/pubmed/28285367,28285367,,
567,2009704,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [diquat results in increased expression of GPT protein],,,PMID:33475796,https://www.ncbi.nlm.nih.gov/pubmed/33475796,33475796,,
568,2009705,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,8022,Oncorhynchus mykiss (rainbow trout),[vitamin A co-treated with cholecalciferol co-treated with vitamin E co-treated with ascorbic acid] inhibits the reaction [[cyhalothrin co-treated with chlorantranilipole] results in increased activity of GPT protein],,,PMID:36813254,https://www.ncbi.nlm.nih.gov/pubmed/36813254,36813254,,
569,2009706,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [carbon tetrachloride results in increased expression of GPT protein],,,PMID:30676168,https://www.ncbi.nlm.nih.gov/pubmed/30676168,30676168,,
570,2009707,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [cyclosporine results in increased activity of GPT protein],,,PMID:19391111,https://www.ncbi.nlm.nih.gov/pubmed/19391111,19391111,,
571,2009708,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [food additives results in increased activity of GPT protein],,,PMID:16758767,https://www.ncbi.nlm.nih.gov/pubmed/16758767,16758767,,
572,2009709,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2876,GPX1,https://ctdbase.org/detail.go?type=gene&acc=2876,,,2876.0,GPX1,10029,Cricetulus griseus (Chinese hamster),"Ascorbic acid results in increased activity of GPX1 protein|ascorbic acid inhibits the reaction [3,5-dimethylaminophenol results in decreased activity of GPX1 protein]",,,PMID:25178734,https://www.ncbi.nlm.nih.gov/pubmed/25178734,25178734,,
573,2009710,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2876,GPX1,https://ctdbase.org/detail.go?type=gene&acc=2876,,,2876.0,GPX1,9606,Homo sapiens (human),[ascorbic acid co-treated with vitamin E] results in increased expression of GPX1 mRNA,,,PMID:22207723,https://www.ncbi.nlm.nih.gov/pubmed/22207723,22207723,,
574,2009711,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2876,GPX1,https://ctdbase.org/detail.go?type=gene&acc=2876,,,2876.0,GPX1,9606,Homo sapiens (human),[ascorbic acid co-treated with zinc acetate co-treated with motexafin gadolinium] results in decreased expression of GPX1 mrna|nutlin 3 inhibits the reaction [[ascorbic acid co-treated with zinc acetate co-treated with motexafin gadolinium] results in decreased expression of GPX1 mrna],,,PMID:20530418,https://www.ncbi.nlm.nih.gov/pubmed/20530418,20530418,,
575,2009712,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2876,GPX1,https://ctdbase.org/detail.go?type=gene&acc=2876,,,2876.0,GPX1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [[lead acetate results in increased abundance of lead] which results in decreased expression of GPX1 mrna],,,PMID:31610155,https://www.ncbi.nlm.nih.gov/pubmed/31610155,31610155,,
576,2009713,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2876,GPX1,https://ctdbase.org/detail.go?type=gene&acc=2876,,,2876.0,GPX1,9606,Homo sapiens (human),Ascorbic acid results in increased expression of GPX1 mRNA,,,PMID:31576639,https://www.ncbi.nlm.nih.gov/pubmed/31576639,31576639,,
577,2009714,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2876,GPX1,https://ctdbase.org/detail.go?type=gene&acc=2876,,,2876.0,GPX1,9606,Homo sapiens (human),[vitamin A co-treated with ascorbic acid co-treated with vitamin E] results in increased expression of GPX1 protein,,,PMID:17179735,https://www.ncbi.nlm.nih.gov/pubmed/17179735,17179735,,
578,2009715,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2876,GPX1,https://ctdbase.org/detail.go?type=gene&acc=2876,,,2876.0,GPX1,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with vitamin E] inhibits the reaction [diethylhexyl phthalate results in increased expression of GPX1 protein],,,PMID:29663635,https://www.ncbi.nlm.nih.gov/pubmed/29663635,29663635,,
579,2009716,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2876,GPX1,https://ctdbase.org/detail.go?type=gene&acc=2876,,,2876.0,GPX1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [carbon tetrachloride results in decreased activity of GPX1 protein],,,PMID:30676168,https://www.ncbi.nlm.nih.gov/pubmed/30676168,30676168,,
580,2009717,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2876,GPX1,https://ctdbase.org/detail.go?type=gene&acc=2876,,,2876.0,GPX1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chlorodiphenyl (54% chlorine) results in decreased activity of GPX1 protein],,,PMID:16248992|PMID:16298753,https://www.ncbi.nlm.nih.gov/pubmed/16248992|https://www.ncbi.nlm.nih.gov/pubmed/16298753,16248992|16298753,,
581,2009718,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2876,GPX1,https://ctdbase.org/detail.go?type=gene&acc=2876,,,2876.0,GPX1,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of GPX1 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
582,2009719,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2877,GPX2,https://ctdbase.org/detail.go?type=gene&acc=2877,,,2877.0,GPX2,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GPX2 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
583,2009720,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2877,GPX2,https://ctdbase.org/detail.go?type=gene&acc=2877,,,2877.0,GPX2,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of GPX2 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
584,2009721,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2877,GPX2,https://ctdbase.org/detail.go?type=gene&acc=2877,,,2877.0,GPX2,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in increased expression of GPX2 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
585,2009722,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2879,GPX4,https://ctdbase.org/detail.go?type=gene&acc=2879,,,2879.0,GPX4,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of GPX4 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
586,2009723,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2890,GRIA1,https://ctdbase.org/detail.go?type=gene&acc=2890,,,2890.0,GRIA1,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of GRIA1 protein,,,PMID:33872575,https://www.ncbi.nlm.nih.gov/pubmed/33872575,33872575,,
587,2009724,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2891,GRIA2,https://ctdbase.org/detail.go?type=gene&acc=2891,,,2891.0,GRIA2,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GRIA2 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
588,2009725,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2891,GRIA2,https://ctdbase.org/detail.go?type=gene&acc=2891,,,2891.0,GRIA2,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GRIA2 mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
589,2009726,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2892,GRIA3,https://ctdbase.org/detail.go?type=gene&acc=2892,,,2892.0,GRIA3,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GRIA3 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
590,2009727,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2902,GRIN1,https://ctdbase.org/detail.go?type=gene&acc=2902,,,2902.0,GRIN1,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GRIN1 mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
591,2009728,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2903,GRIN2A,https://ctdbase.org/detail.go?type=gene&acc=2903,,,2903.0,GRIN2A,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GRIN2A mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
592,2009729,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2904,GRIN2B,https://ctdbase.org/detail.go?type=gene&acc=2904,,,2904.0,GRIN2B,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GRIN2B mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
593,2009730,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2896,GRN,https://ctdbase.org/detail.go?type=gene&acc=2896,,,2896.0,GRN,9606,Homo sapiens (human),[arsenic trioxide co-treated with ascorbic acid] results in increased expression of GRN mrna|ascorbic acid results in increased expression of GRN mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
594,2009731,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [excitatory amino acid agonists results in increased phosphorylation of GSK3B protein],,,PMID:24675465,https://www.ncbi.nlm.nih.gov/pubmed/24675465,24675465,,
595,2009732,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of GSK3B mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
596,2009733,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,9922,Capra,Ascorbic acid inhibits the reaction [methoxychlor results in decreased activity of GSR protein],,,PMID:11753474,https://www.ncbi.nlm.nih.gov/pubmed/11753474,11753474,,
597,2009734,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10029,Cricetulus griseus (Chinese hamster),"Ascorbic acid inhibits the reaction [3,5-dimethylaminophenol results in decreased activity of GSR protein]",,,PMID:25178734,https://www.ncbi.nlm.nih.gov/pubmed/25178734,25178734,,
598,2009735,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,9606,Homo sapiens (human),[juglone co-treated with ascorbic acid] results in decreased activity of GSR protein,,,PMID:29992683,https://www.ncbi.nlm.nih.gov/pubmed/29992683,29992683,,
599,2009736,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [arsenic trioxide results in decreased activity of GSR protein],,,PMID:18715643,https://www.ncbi.nlm.nih.gov/pubmed/18715643,18715643,,
600,2009737,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [cadmium chloride results in decreased activity of GSR protein],,,PMID:18548748,https://www.ncbi.nlm.nih.gov/pubmed/18548748,18548748,,
601,2009738,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of GSR mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
602,2009739,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [bisphenol A results in decreased activity of GSR protein],,,PMID:12767684,https://www.ncbi.nlm.nih.gov/pubmed/12767684,12767684,,
603,2009740,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chlorodiphenyl (54% chlorine) results in decreased activity of GSR protein],,,PMID:16248992|PMID:16298753,https://www.ncbi.nlm.nih.gov/pubmed/16248992|https://www.ncbi.nlm.nih.gov/pubmed/16298753,16248992|16298753,,
604,2009741,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [cyclosporine results in decreased activity of GSR protein],,,PMID:19391111,https://www.ncbi.nlm.nih.gov/pubmed/19391111,19391111,,
605,2009742,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [[lead acetate results in increased abundance of lead] which results in decreased activity of GSR protein],,,PMID:32407874,https://www.ncbi.nlm.nih.gov/pubmed/32407874,32407874,,
606,2009743,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in decreased expression of GSR mrna]|ascorbic acid inhibits the reaction [potassium dichromate results in decreased activity of GSR protein],,,PMID:23470461,https://www.ncbi.nlm.nih.gov/pubmed/23470461,23470461,,
607,2009744,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [sodium arsenite results in decreased activity of GSR protein],,,PMID:23194016,https://www.ncbi.nlm.nih.gov/pubmed/23194016,23194016,,
608,2009745,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [sodium arsenite results in decreased expression of GSR protein],,,PMID:19429265,https://www.ncbi.nlm.nih.gov/pubmed/19429265,19429265,,
609,2009746,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2938,GSTA1,https://ctdbase.org/detail.go?type=gene&acc=2938,,,2938.0,GSTA1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GSTA1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
610,2009747,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2938,GSTA1,https://ctdbase.org/detail.go?type=gene&acc=2938,,,2938.0,GSTA1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of GSTA1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
611,2009748,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2938,GSTA1,https://ctdbase.org/detail.go?type=gene&acc=2938,,,2938.0,GSTA1,10090,Mus musculus (house mouse),Ascorbic acid promotes the reaction [sodium arsenite results in increased expression of GSTA1 mrna],,,PMID:16517059,https://www.ncbi.nlm.nih.gov/pubmed/16517059,16517059,,
612,2009749,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2939,GSTA2,https://ctdbase.org/detail.go?type=gene&acc=2939,,,2939.0,GSTA2,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GSTA2 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
613,2009750,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2941,GSTA4,https://ctdbase.org/detail.go?type=gene&acc=2941,,,2941.0,GSTA4,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in decreased expression of GSTA4 mrna],,,PMID:23470461,https://www.ncbi.nlm.nih.gov/pubmed/23470461,23470461,,
614,2009751,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2944,GSTM1,https://ctdbase.org/detail.go?type=gene&acc=2944,,,2944.0,GSTM1,9606,Homo sapiens (human),GSTM1 affects the susceptibility to ascorbic acid deficiency,,,PMID:19710200,https://www.ncbi.nlm.nih.gov/pubmed/19710200,19710200,,
615,2009752,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2944,GSTM1,https://ctdbase.org/detail.go?type=gene&acc=2944,,,2944.0,GSTM1,9606,Homo sapiens (human),"GSTM1 gene polymorphism affects the susceptibility to [ascorbic acid co-treated with tocotrienol, alpha]",,,PMID:15668500,https://www.ncbi.nlm.nih.gov/pubmed/15668500,15668500,,
616,2009753,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2944,GSTM1,https://ctdbase.org/detail.go?type=gene&acc=2944,,,2944.0,GSTM1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in decreased expression of GSTM1 mrna]|ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of GSTM1 mrna],,,PMID:23470461,https://www.ncbi.nlm.nih.gov/pubmed/23470461,23470461,,
617,2009754,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2946,GSTM2,https://ctdbase.org/detail.go?type=gene&acc=2946,,,2946.0,GSTM2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in decreased expression of GSTM2 mrna],,,PMID:23470461,https://www.ncbi.nlm.nih.gov/pubmed/23470461,23470461,,
618,2009755,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2946,GSTM2,https://ctdbase.org/detail.go?type=gene&acc=2946,,,2946.0,GSTM2,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of GSTM2 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
619,2009756,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9446,GSTO1,https://ctdbase.org/detail.go?type=gene&acc=9446,,,9446.0,GSTO1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GSTO1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
620,2009757,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9446,GSTO1,https://ctdbase.org/detail.go?type=gene&acc=9446,,,9446.0,GSTO1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [[lead acetate results in increased abundance of lead] which results in decreased expression of GSTO1 mrna]|ascorbic acid results in increased expression of GSTO1 mRNA,,,PMID:31610155,https://www.ncbi.nlm.nih.gov/pubmed/31610155,31610155,,
621,2009758,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2950,GSTP1,https://ctdbase.org/detail.go?type=gene&acc=2950,,,2950.0,GSTP1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of GSTP1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
622,2009759,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2950,GSTP1,https://ctdbase.org/detail.go?type=gene&acc=2950,,,2950.0,GSTP1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [sodium arsenite results in increased methylation of GSTP1 promoter]|ascorbic acid inhibits the reaction [sodium arsenite results in decreased expression of GSTP1 protein],,,PMID:33388378,https://www.ncbi.nlm.nih.gov/pubmed/33388378,33388378,,
623,2009760,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2952,GSTT1,https://ctdbase.org/detail.go?type=gene&acc=2952,,,2952.0,GSTT1,9606,Homo sapiens (human),GSTT1 affects the susceptibility to ascorbic acid deficiency,,,PMID:19710200,https://www.ncbi.nlm.nih.gov/pubmed/19710200,19710200,,
624,2009761,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2965,GTF2H1,https://ctdbase.org/detail.go?type=gene&acc=2965,,,2965.0,GTF2H1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of GTF2H1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
625,2009762,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2982,GUCY1A1,https://ctdbase.org/detail.go?type=gene&acc=2982,,,2982.0,GUCY1A1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GUCY1A1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
626,2009763,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2983,GUCY1B1,https://ctdbase.org/detail.go?type=gene&acc=2983,,,2983.0,GUCY1B1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [lead acetate results in decreased expression of GUCY1B1 protein],,,PMID:11729227,https://www.ncbi.nlm.nih.gov/pubmed/11729227,11729227,,
627,2009764,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2983,GUCY1B1,https://ctdbase.org/detail.go?type=gene&acc=2983,,,2983.0,GUCY1B1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [lead results in decreased expression of GUCY1B1 protein],,,PMID:12761246,https://www.ncbi.nlm.nih.gov/pubmed/12761246,12761246,,
628,2009765,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,268756,GULO,https://ctdbase.org/detail.go?type=gene&acc=268756,,,268756.0,Gulo,10090,Mus musculus (house mouse),Ascorbic acid affects the reaction [GULO protein affects the expression of LDLR protein]|ascorbic acid affects the reaction [GULO protein affects the expression of PCSK9 protein],,,PMID:32913121,https://www.ncbi.nlm.nih.gov/pubmed/32913121,32913121,,
629,2009766,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,268756,GULO,https://ctdbase.org/detail.go?type=gene&acc=268756,,,268756.0,Gulo,10090,Mus musculus (house mouse),Ascorbic acid deficiency affects the reaction [GULO affects the susceptibility to nickel subsulfide],,,PMID:21878346,https://www.ncbi.nlm.nih.gov/pubmed/21878346,21878346,,
630,2009767,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,268756,GULO,https://ctdbase.org/detail.go?type=gene&acc=268756,,,268756.0,Gulo,10090,Mus musculus (house mouse),[gulonolactone co-treated with GULO protein] results in increased abundance of ascorbic acid,,,PMID:16737683,https://www.ncbi.nlm.nih.gov/pubmed/16737683,16737683,,
631,2009768,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,268756,GULO,https://ctdbase.org/detail.go?type=gene&acc=268756,,,268756.0,Gulo,10090,Mus musculus (house mouse),GULO protein affects the chemical synthesis of ascorbic acid,,,PMID:22306178,https://www.ncbi.nlm.nih.gov/pubmed/22306178,22306178,,
632,2009769,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,268756,GULO,https://ctdbase.org/detail.go?type=gene&acc=268756,,,268756.0,Gulo,10116,Rattus norvegicus (Norway rat),GULO protein results in increased chemical synthesis of ascorbic acid,,,PMID:30606963,https://www.ncbi.nlm.nih.gov/pubmed/30606963,30606963,,
633,2009770,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3082,HGF,https://ctdbase.org/detail.go?type=gene&acc=3082,,,3082.0,HGF,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of TF mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of STMN2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HOXB3 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SOX1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of EGLN3 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of NR2F2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GCLM mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FABP1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HOXA2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FGB mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of EBF3 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of ZFAND2A mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of DCC mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of OTX2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of CDH10 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FLRT3 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of FOXD3 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of IL1R1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of SERPINA1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GPX2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FGF7 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GSTO1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ECSCR mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GRIA2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of TFAP2A mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of DCX mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ABCC1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of SLCO2B1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SRXN1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of CRYAB mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of AMHR2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ELAVL4 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of SCN2A mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of AFP mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of MYL4 mrna|[[ascorbic acid co-treated with ch,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
634,2009771,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2990,GUSB,https://ctdbase.org/detail.go?type=gene&acc=2990,,,2990.0,GUSB,10116,Rattus norvegicus (Norway rat),[ferulic acid co-treated with ascorbic acid] inhibits the reaction [isoproterenol results in increased activity of GUSB protein],,,PMID:17045618,https://www.ncbi.nlm.nih.gov/pubmed/17045618,17045618,,
635,2009772,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3002,GZMB,https://ctdbase.org/detail.go?type=gene&acc=3002,,,3002.0,GZMB,10090,Mus musculus (house mouse),Ascorbic acid deficiency results in decreased expression of GZMB mRNA,,,PMID:22306178,https://www.ncbi.nlm.nih.gov/pubmed/22306178,22306178,,
636,2009773,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3014,H2AX,https://ctdbase.org/detail.go?type=gene&acc=3014,,,3014.0,H2AX,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in decreased expression of H2AX mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
637,2009774,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3014,H2AX,https://ctdbase.org/detail.go?type=gene&acc=3014,,,3014.0,H2AX,9606,Homo sapiens (human),[ascorbic acid results in increased reduction of vitamin K 3] which results in increased phosphorylation of H2AX protein,,,PMID:19482829,https://www.ncbi.nlm.nih.gov/pubmed/19482829,19482829,,
638,2009775,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8342,H2BC14,https://ctdbase.org/detail.go?type=gene&acc=8342,,,8342.0,H2BC14,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of H2BC14 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
639,2009776,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3017,H2BC5,https://ctdbase.org/detail.go?type=gene&acc=3017,,,3017.0,H2BC5,9606,Homo sapiens (human),[arsenic trioxide co-treated with ascorbic acid] results in decreased expression of H2BC5 mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
640,2009777,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3030,HADHA,https://ctdbase.org/detail.go?type=gene&acc=3030,,,3030.0,HADHA,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of HADHA mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
641,2009778,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9464,HAND2,https://ctdbase.org/detail.go?type=gene&acc=9464,,,9464.0,HAND2,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HAND2 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
642,2009779,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9464,HAND2,https://ctdbase.org/detail.go?type=gene&acc=9464,,,9464.0,HAND2,10090,Mus musculus (house mouse),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of HAND2 mrna|cadmium sulfate inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of HAND2 mrna],,,PMID:28189605,https://www.ncbi.nlm.nih.gov/pubmed/28189605,28189605,,
643,2009780,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,26762,HAVCR1,https://ctdbase.org/detail.go?type=gene&acc=26762,,,26762.0,HAVCR1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HAVCR1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
644,2009781,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3054,HCFC1,https://ctdbase.org/detail.go?type=gene&acc=3054,,,3054.0,HCFC1,9606,Homo sapiens (human),[arsenic trioxide co-treated with ascorbic acid] results in increased expression of HCFC1 mrna|ascorbic acid results in increased expression of HCFC1 mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
645,2009782,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3070,HELLS,https://ctdbase.org/detail.go?type=gene&acc=3070,,,3070.0,HELLS,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in decreased expression of HELLS mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
646,2009783,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9843,HEPH,https://ctdbase.org/detail.go?type=gene&acc=9843,,,9843.0,HEPH,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of HEPH mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
647,2009784,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9709,HERPUD1,https://ctdbase.org/detail.go?type=gene&acc=9709,,,9709.0,HERPUD1,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of HERPUD1 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
648,2009785,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3280,HES1,https://ctdbase.org/detail.go?type=gene&acc=3280,,,3280.0,HES1,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with vitamin E] inhibits the reaction [diethylhexyl phthalate results in decreased expression of HES1 protein],,,PMID:29663635,https://www.ncbi.nlm.nih.gov/pubmed/29663635,29663635,,
649,2009786,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,390992,HES3,https://ctdbase.org/detail.go?type=gene&acc=390992,,,390992.0,HES3,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of HES3 mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
650,2009787,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,388585,HES5,https://ctdbase.org/detail.go?type=gene&acc=388585,,,388585.0,HES5,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of HES5 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
651,2009788,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in increased stability of HIF1A protein]|ascorbic acid inhibits the reaction [nickel sulfate results in increased stability of HIF1A protein]|ascorbic acid inhibits the reaction [potassium chromate(vi) results in increased stability of HIF1A protein],,,PMID:17382205,https://www.ncbi.nlm.nih.gov/pubmed/17382205,17382205,,
652,2009789,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [cupric chloride results in increased stability of HIF1A protein]|ascorbic acid inhibits the reaction [sodium arsenite results in decreased hydroxylation of HIF1A protein]|ascorbic acid inhibits the reaction [cupric chloride results in decreased hydroxylation of HIF1A protein]|ascorbic acid results in increased degradation of HIF1A protein|ascorbic acid inhibits the reaction [vanadates results in decreased hydroxylation of HIF1A protein]|ascorbic acid inhibits the reaction [nickel sulfate results in decreased hydroxylation of HIF1A protein]|ascorbic acid inhibits the reaction [vanadates results in increased stability of HIF1A protein]|ascorbic acid inhibits the reaction [manganese chloride results in decreased hydroxylation of HIF1A protein]|ascorbic acid inhibits the reaction [manganese chloride results in increased stability of HIF1A protein],,,PMID:19074761,https://www.ncbi.nlm.nih.gov/pubmed/19074761,19074761,,
653,2009790,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [nickel sulfate results in increased expression of HIF1A protein],,,PMID:16288478,https://www.ncbi.nlm.nih.gov/pubmed/16288478,16288478,,
654,2009791,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [quercetin results in increased expression of HIF1A protein],,,PMID:17364964,https://www.ncbi.nlm.nih.gov/pubmed/17364964,17364964,,
655,2009792,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [sodium arsenite results in increased expression of HIF1A protein],,,PMID:24188932,https://www.ncbi.nlm.nih.gov/pubmed/24188932,24188932,,
656,2009793,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [sodium arsenite results in increased stability of HIF1A protein],,,PMID:19074761|PMID:24188932,https://www.ncbi.nlm.nih.gov/pubmed/19074761|https://www.ncbi.nlm.nih.gov/pubmed/24188932,19074761|24188932,,
657,2009794,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,9606,Homo sapiens (human),[benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with ketoglutaric acids co-treated with ascorbic acid co-treated with ferrous chloride] promotes the reaction [VHL protein binds to HIF1A protein]|manganese chloride inhibits the reaction [[benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with ketoglutaric acids co-treated with ascorbic acid co-treated with ferrous chloride] promotes the reaction [VHL protein binds to HIF1A protein]],,,PMID:19263519,https://www.ncbi.nlm.nih.gov/pubmed/19263519,19263519,,
658,2009795,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [AGT protein modified form results in decreased hydroxylation of HIF1A protein]|ascorbic acid inhibits the reaction [hydrogen peroxide results in decreased hydroxylation of HIF1A protein],,,PMID:20881940,https://www.ncbi.nlm.nih.gov/pubmed/20881940,20881940,,
659,2009796,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3098,HK1,https://ctdbase.org/detail.go?type=gene&acc=3098,,,3098.0,HK1,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in increased expression of HK1 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
660,2009797,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3141,HLCS,https://ctdbase.org/detail.go?type=gene&acc=3141,,,3141.0,HLCS,9606,Homo sapiens (human),Ascorbic acid results in decreased activity of HLCS protein,,,PMID:26303405,https://www.ncbi.nlm.nih.gov/pubmed/26303405,26303405,,
661,2009798,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3146,HMGB1,https://ctdbase.org/detail.go?type=gene&acc=3146,,,3146.0,HMGB1,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in decreased expression of HMGB1 mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
662,2009799,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3148,HMGB2,https://ctdbase.org/detail.go?type=gene&acc=3148,,,3148.0,HMGB2,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in decreased expression of HMGB2 mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
663,2009800,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156.0,HMGCR,10140,Cavia (guinea pigs),[ascorbic acid co-treated with ammonium metavanadate] affects the activity of HMGCR protein,,,PMID:1669016,https://www.ncbi.nlm.nih.gov/pubmed/1669016,1669016,,
664,2009801,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156.0,HMGCR,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of HMGCR mRNA,,,PMID:32913121,https://www.ncbi.nlm.nih.gov/pubmed/32913121,32913121,,
665,2009802,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3157,HMGCS1,https://ctdbase.org/detail.go?type=gene&acc=3157,,,3157.0,HMGCS1,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of HMGCS1 mRNA,,,PMID:32913121,https://www.ncbi.nlm.nih.gov/pubmed/32913121,32913121,,
666,2009803,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3488,IGFBP5,https://ctdbase.org/detail.go?type=gene&acc=3488,,,3488.0,IGFBP5,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in decreased expression of IGFBP5 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
667,2009804,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3158,HMGCS2,https://ctdbase.org/detail.go?type=gene&acc=3158,,,3158.0,HMGCS2,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HMGCS2 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
668,2009805,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606,Homo sapiens (human),"Ascorbic acid inhibits the reaction [benzo(a)pyrene-7,8-dione results in increased expression of HMOX1 protein]",,,PMID:22053912,https://www.ncbi.nlm.nih.gov/pubmed/22053912,22053912,,
669,2009806,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [HMOX1 protein results in increased expression of SOD2 mrna],,,PMID:10942521,https://www.ncbi.nlm.nih.gov/pubmed/10942521,10942521,,
670,2009807,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [hydrogen peroxide results in increased expression of HMOX1 protein],,,PMID:28285367,https://www.ncbi.nlm.nih.gov/pubmed/28285367,28285367,,
671,2009808,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [resveratrol results in increased expression of HMOX1 protein]|ascorbic acid inhibits the reaction [resveratrol results in increased expression of HMOX1 mrna],,,PMID:21199573,https://www.ncbi.nlm.nih.gov/pubmed/21199573,21199573,,
672,2009809,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [[vehicle emissions results in increased abundance of particulate matter] which results in increased expression of HMOX1 mrna],,,PMID:32525552,https://www.ncbi.nlm.nih.gov/pubmed/32525552,32525552,,
673,2009810,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606,Homo sapiens (human),Ascorbic acid promotes the reaction [[lead acetate results in increased abundance of lead] which results in increased expression of HMOX1 mrna],,,PMID:31610155,https://www.ncbi.nlm.nih.gov/pubmed/31610155,31610155,,
674,2009811,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606,Homo sapiens (human),Ascorbic acid results in increased expression of HMOX1 mRNA,,,PMID:33248029|PMID:8743975,https://www.ncbi.nlm.nih.gov/pubmed/33248029|https://www.ncbi.nlm.nih.gov/pubmed/8743975,33248029|8743975,,
675,2009812,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606,Homo sapiens (human),[buthionine sulfoximine co-treated with ascorbic acid] promotes the reaction [copper sulfate results in increased expression of HMOX1 mrna],,,PMID:19683516,https://www.ncbi.nlm.nih.gov/pubmed/19683516,19683516,,
676,2009813,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in increased expression of HMOX1 mrna]|ascorbic acid inhibits the reaction [cadmium results in increased expression of HMOX1 mrna]|ascorbic acid inhibits the reaction [cadmium chloride results in increased expression of HMOX1 mrna]|ascorbic acid promotes the reaction [sodium arsenite results in increased expression of HMOX1 mrna],,,PMID:16517059,https://www.ncbi.nlm.nih.gov/pubmed/16517059,16517059,,
677,2009814,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [diquat results in decreased expression of HMOX1 protein],,,PMID:33475796,https://www.ncbi.nlm.nih.gov/pubmed/33475796,33475796,,
678,2009815,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [nelfinavir results in increased expression of HMOX1],,,PMID:15577407,https://www.ncbi.nlm.nih.gov/pubmed/15577407,15577407,,
679,2009816,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of HMOX1 protein,,,PMID:16171798,https://www.ncbi.nlm.nih.gov/pubmed/16171798,16171798,,
680,2009817,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with vitamin E] inhibits the reaction [diethylhexyl phthalate results in increased expression of HMOX1 protein],,,PMID:29663635|PMID:29940330,https://www.ncbi.nlm.nih.gov/pubmed/29663635|https://www.ncbi.nlm.nih.gov/pubmed/29940330,29663635|29940330,,
681,2009818,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [ethylene chlorohydrin results in increased expression of HMOX1 protein]|ascorbic acid inhibits the reaction [ethylene chlorohydrin results in increased expression of HMOX1 mrna],,,PMID:31585129,https://www.ncbi.nlm.nih.gov/pubmed/31585129,31585129,,
682,2009819,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10116,Rattus norvegicus (Norway rat),Methamphetamine promotes the reaction [ascorbic acid results in increased expression of HMOX1 protein]|sb 203580 inhibits the reaction [ascorbic acid results in increased expression of HMOX1 protein]|ascorbic acid results in increased expression of HMOX1 mrna|methamphetamine promotes the reaction [ascorbic acid results in increased expression of HMOX1 mrna],,,PMID:23022510,https://www.ncbi.nlm.nih.gov/pubmed/23022510,23022510,,
683,2009820,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4133,MAP2,https://ctdbase.org/detail.go?type=gene&acc=4133,,,4133.0,MAP2,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of MAP2 protein,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
684,2009821,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of HMOX1 protein,,,PMID:22008531|PMID:23022510,https://www.ncbi.nlm.nih.gov/pubmed/22008531|https://www.ncbi.nlm.nih.gov/pubmed/23022510,22008531|23022510,,
685,2009822,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10116,Rattus norvegicus (Norway rat),Quercetin affects the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] affects the expression of HMOX1 mrna]|hydrogen peroxide affects the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] affects the expression of HMOX1 mrna]|[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] affects the expression of HMOX1 protein|hydrogen peroxide affects the reaction [quercetin affects the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] affects the expression of HMOX1 protein]]|hydrogen peroxide affects the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] affects the expression of HMOX1 protein]|quercetin affects the reaction [hydrogen peroxide affects the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] affects the expression of HMOX1 protein]]|quercetin affects the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] affects the expression of HMOX1 protein]|[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] affects the expression of HMOX1 mrna|hydrogen peroxide affects the reaction [quercetin affects the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] affects the expression of HMOX1 mrna]],,,PMID:27028516,https://www.ncbi.nlm.nih.gov/pubmed/27028516,27028516,,
686,2009823,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,388275,HNRNPA1P7,https://ctdbase.org/detail.go?type=gene&acc=388275,,,388275.0,HNRNPA1P7,9606,Homo sapiens (human),[arsenic trioxide co-treated with ascorbic acid] results in decreased expression of HNRNPA1P7 mrna|ascorbic acid results in decreased expression of HNRNPA1P7 mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
687,2009824,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3199,HOXA2,https://ctdbase.org/detail.go?type=gene&acc=3199,,,3199.0,HOXA2,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HOXA2 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
688,2009825,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3199,HOXA2,https://ctdbase.org/detail.go?type=gene&acc=3199,,,3199.0,HOXA2,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [valproic acid results in decreased expression of HOXA2 mrna],,,PMID:19655241,https://www.ncbi.nlm.nih.gov/pubmed/19655241,19655241,,
689,2009826,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3211,HOXB1,https://ctdbase.org/detail.go?type=gene&acc=3211,,,3211.0,HOXB1,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of HOXB1 mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
690,2009827,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3213,HOXB3,https://ctdbase.org/detail.go?type=gene&acc=3213,,,3213.0,HOXB3,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HOXB3 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
691,2009828,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3233,HOXD4,https://ctdbase.org/detail.go?type=gene&acc=3233,,,3233.0,HOXD4,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HOXD4 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
692,2009829,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3234,HOXD8,https://ctdbase.org/detail.go?type=gene&acc=3234,,,3234.0,HOXD8,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HOXD8 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
693,2009830,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3240,HP,https://ctdbase.org/detail.go?type=gene&acc=3240,,,3240.0,HP,9606,Homo sapiens (human),Ascorbic acid affects the activity of HP protein polymorphism|ascorbic acid inhibits the reaction [alpha-tocopherol affects the activity of HP protein polymorphism],,,PMID:19769483,https://www.ncbi.nlm.nih.gov/pubmed/19769483,19769483,,
694,2009831,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3240,HP,https://ctdbase.org/detail.go?type=gene&acc=3240,,,3240.0,HP,9606,Homo sapiens (human),HP gene polymorphism affects the susceptibility to ascorbic acid deficiency,,,PMID:20926521,https://www.ncbi.nlm.nih.gov/pubmed/20926521,20926521,,
695,2009832,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3251,HPRT1,https://ctdbase.org/detail.go?type=gene&acc=3251,,,3251.0,HPRT1,10029,Cricetulus griseus (Chinese hamster),"Ascorbic acid inhibits the reaction [3,5-dimethylaminophenol results in increased mutagenesis of HPRT1 gene]",,,PMID:25178734,https://www.ncbi.nlm.nih.gov/pubmed/25178734,25178734,,
696,2009833,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3251,HPRT1,https://ctdbase.org/detail.go?type=gene&acc=3251,,,3251.0,HPRT1,10029,Cricetulus griseus (Chinese hamster),[ascorbic acid results in increased susceptibility to chromium hexavalent ion] which results in increased mutagenesis of HPRT1 gene,,,PMID:17169990,https://www.ncbi.nlm.nih.gov/pubmed/17169990,17169990,,
697,2009834,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4316,MMP7,https://ctdbase.org/detail.go?type=gene&acc=4316,,,4316.0,MMP7,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of MMP7 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
698,2009835,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3251,HPRT1,https://ctdbase.org/detail.go?type=gene&acc=3251,,,3251.0,HPRT1,10116,Rattus norvegicus (Norway rat),"Ascorbic acid inhibits the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased mutagenesis of HPRT1 gene]",,,PMID:12467141,https://www.ncbi.nlm.nih.gov/pubmed/12467141,12467141,,
699,2009836,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3292,HSD17B1,https://ctdbase.org/detail.go?type=gene&acc=3292,,,3292.0,HSD17B1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of HSD17B1 mrna],,,PMID:18602937,https://www.ncbi.nlm.nih.gov/pubmed/18602937,18602937,,
700,2009837,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3294,HSD17B2,https://ctdbase.org/detail.go?type=gene&acc=3294,,,3294.0,HSD17B2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of HSD17B2 mrna],,,PMID:18602937,https://www.ncbi.nlm.nih.gov/pubmed/18602937,18602937,,
701,2009838,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3293,HSD17B3,https://ctdbase.org/detail.go?type=gene&acc=3293,,,3293.0,HSD17B3,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chlorodiphenyl (54% chlorine) results in decreased expression of HSD17B3 mrna],,,PMID:17280759,https://www.ncbi.nlm.nih.gov/pubmed/17280759,17280759,,
702,2009839,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3283,HSD3B1,https://ctdbase.org/detail.go?type=gene&acc=3283,,,3283.0,HSD3B1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HSD3B1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
703,2009840,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3283,HSD3B1,https://ctdbase.org/detail.go?type=gene&acc=3283,,,3283.0,HSD3B1,9606,Homo sapiens (human),Ascorbic acid results in increased expression of HSD3B1 mRNA,,,PMID:17901237,https://www.ncbi.nlm.nih.gov/pubmed/17901237,17901237,,
704,2009841,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3283,HSD3B1,https://ctdbase.org/detail.go?type=gene&acc=3283,,,3283.0,HSD3B1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chlorodiphenyl (54% chlorine) results in decreased expression of HSD3B1 mrna],,,PMID:17280759,https://www.ncbi.nlm.nih.gov/pubmed/17280759,17280759,,
705,2009842,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3326,HSP90AB1,https://ctdbase.org/detail.go?type=gene&acc=3326,,,3326.0,HSP90AB1,10090,Mus musculus (house mouse),Ascorbic acid affects the expression of HSP90AB1 protein,,,PMID:19224539,https://www.ncbi.nlm.nih.gov/pubmed/19224539,19224539,,
706,2009843,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3303,HSPA1A,https://ctdbase.org/detail.go?type=gene&acc=3303,,,3303.0,HSPA1A,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of HSPA1A mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
707,2009844,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3309,HSPA5,https://ctdbase.org/detail.go?type=gene&acc=3309,,,3309.0,HSPA5,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [fenretinide results in increased expression of HSPA5 protein],,,PMID:17353921,https://www.ncbi.nlm.nih.gov/pubmed/17353921,17353921,,
708,2009845,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3309,HSPA5,https://ctdbase.org/detail.go?type=gene&acc=3309,,,3309.0,HSPA5,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of HSPA5 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
709,2009846,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3313,HSPA9,https://ctdbase.org/detail.go?type=gene&acc=3313,,,3313.0,HSPA9,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of HSPA9 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
710,2009847,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3315,HSPB1,https://ctdbase.org/detail.go?type=gene&acc=3315,,,3315.0,HSPB1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of HSPB1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
711,2009848,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3315,HSPB1,https://ctdbase.org/detail.go?type=gene&acc=3315,,,3315.0,HSPB1,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of HSPB1 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
712,2009849,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3336,HSPE1,https://ctdbase.org/detail.go?type=gene&acc=3336,,,3336.0,HSPE1,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of HSPE1 mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
713,2009850,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3347,HTN3,https://ctdbase.org/detail.go?type=gene&acc=3347,,,3347.0,HTN3,9606,Homo sapiens (human),[HTN3 protein modified form co-treated with copper co-treated with ascorbic acid] results in increased abundance of hydrogen peroxide,,,PMID:18975018,https://www.ncbi.nlm.nih.gov/pubmed/18975018,18975018,,
714,2009851,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3375,IAPP,https://ctdbase.org/detail.go?type=gene&acc=3375,,,3375.0,IAPP,10116,Rattus norvegicus (Norway rat),IAPP protein promotes the reaction [[copper co-treated with ascorbic acid] results in increased abundance of hydroxyl radical]|iapp protein promotes the reaction [[copper co-treated with ascorbic acid] results in increased abundance of hydrogen peroxide],,,PMID:23793354,https://www.ncbi.nlm.nih.gov/pubmed/23793354,23793354,,
715,2009852,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3376,IARS1,https://ctdbase.org/detail.go?type=gene&acc=3376,,,3376.0,IARS1,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of IARS1 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
716,2009853,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3381,IBSP,https://ctdbase.org/detail.go?type=gene&acc=3381,,,3381.0,IBSP,9606,Homo sapiens (human),Ascorbic acid results in increased expression of IBSP mRNA,,,PMID:28105418,https://www.ncbi.nlm.nih.gov/pubmed/28105418,28105418,,
717,2009854,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3381,IBSP,https://ctdbase.org/detail.go?type=gene&acc=3381,,,3381.0,IBSP,10090,Mus musculus (house mouse),"[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of IBSP mrna|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of IBSP mrna]",,,PMID:26492236,https://www.ncbi.nlm.nih.gov/pubmed/26492236,26492236,,
718,2009855,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3381,IBSP,https://ctdbase.org/detail.go?type=gene&acc=3381,,,3381.0,IBSP,10116,Rattus norvegicus (Norway rat),Quercetin affects the reaction [hydrogen peroxide affects the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] affects the expression of IBSP mrna]]|hydrogen peroxide affects the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] affects the expression of IBSP mrna]|[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] affects the expression of IBSP mRNA,,,PMID:27028516,https://www.ncbi.nlm.nih.gov/pubmed/27028516,27028516,,
719,2009856,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3381,IBSP,https://ctdbase.org/detail.go?type=gene&acc=3381,,,3381.0,IBSP,9606,Homo sapiens (human),[ascorbic acid co-treated with IL11 protein] results in increased expression of IBSP mRNA,,,PMID:17956465,https://www.ncbi.nlm.nih.gov/pubmed/17956465,17956465,,
720,2009857,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,9606,Homo sapiens (human),[ascorbic acid co-treated with lycopene co-treated with alpha-tocopherol] inhibits the reaction [TNF protein results in increased expression of ICAM1 mrna],,,PMID:25551565,https://www.ncbi.nlm.nih.gov/pubmed/25551565,25551565,,
721,2009858,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,9606,Homo sapiens (human),"Ascorbic acid inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of ICAM1 protein]",,,PMID:35349355,https://www.ncbi.nlm.nih.gov/pubmed/35349355,35349355,,
722,2009859,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [hydrogen peroxide results in increased expression of ICAM1 protein]|ascorbic acid inhibits the reaction [hydrogen peroxide results in increased expression of ICAM1 mrna],,,PMID:25305479,https://www.ncbi.nlm.nih.gov/pubmed/25305479,25305479,,
723,2009860,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [norepinephrine results in increased expression of ICAM1 mrna],,,PMID:23114885,https://www.ncbi.nlm.nih.gov/pubmed/23114885,23114885,,
724,2009861,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [TNF protein results in increased expression of ICAM1 protein],,,PMID:12723939,https://www.ncbi.nlm.nih.gov/pubmed/12723939,12723939,,
725,2009862,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8870,IER3,https://ctdbase.org/detail.go?type=gene&acc=8870,,,8870.0,IER3,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of IER3 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
726,2009863,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3429,IFI27,https://ctdbase.org/detail.go?type=gene&acc=3429,,,3429.0,IFI27,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of IFI27 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
727,2009864,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458.0,IFNG,10090,Mus musculus (house mouse),Ascorbic acid results in decreased expression of IFNG protein,,,PMID:14624943,https://www.ncbi.nlm.nih.gov/pubmed/14624943,14624943,,
728,2009865,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458.0,IFNG,10090,Mus musculus (house mouse),IFNG protein promotes the reaction [ascorbic acid promotes the reaction [quartz results in increased secretion of TNF protein]],,,PMID:19298665,https://www.ncbi.nlm.nih.gov/pubmed/19298665,19298665,,
729,2009866,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458.0,IFNG,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [formaldehyde results in increased expression of IFNG mrna],,,PMID:27020608,https://www.ncbi.nlm.nih.gov/pubmed/27020608,27020608,,
730,2009867,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3479,IGF1,https://ctdbase.org/detail.go?type=gene&acc=3479,,,3479.0,IGF1,13489,Dicentrarchus labrax (European seabass),Ascorbic acid affects the expression of IGF1 mRNA,,,PMID:21281732,https://www.ncbi.nlm.nih.gov/pubmed/21281732,21281732,,
731,2009868,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3479,IGF1,https://ctdbase.org/detail.go?type=gene&acc=3479,,,3479.0,IGF1,9823,Sus scrofa (pig),Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of IGF1 mrna]|[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of IGF1 mRNA,,,PMID:30481989,https://www.ncbi.nlm.nih.gov/pubmed/30481989,30481989,,
732,2009869,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3480,IGF1R,https://ctdbase.org/detail.go?type=gene&acc=3480,,,3480.0,IGF1R,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of IGF1R protein,,,PMID:20530736,https://www.ncbi.nlm.nih.gov/pubmed/20530736,20530736,,
733,2009870,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3480,IGF1R,https://ctdbase.org/detail.go?type=gene&acc=3480,,,3480.0,IGF1R,9823,Sus scrofa (pig),[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of IGF1R mrna|troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of IGF1R mrna],,,PMID:30481989,https://www.ncbi.nlm.nih.gov/pubmed/30481989,30481989,,
734,2009871,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3488,IGFBP5,https://ctdbase.org/detail.go?type=gene&acc=3488,,,3488.0,IGFBP5,10116,Rattus norvegicus (Norway rat),[alpha-tocopherol co-treated with beta carotene co-treated with ascorbic acid co-treated with zinc co-treated with sodium selenite] results in decreased expression of IGFBP5 mRNA,,,PMID:23859036,https://www.ncbi.nlm.nih.gov/pubmed/23859036,23859036,,
735,2009872,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3490,IGFBP7,https://ctdbase.org/detail.go?type=gene&acc=3490,,,3490.0,IGFBP7,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of IGFBP7 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
736,2009873,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,714473,IGHV3,https://ctdbase.org/detail.go?type=gene&acc=714473,,,714473.0,,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of IGHV3 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
737,2009874,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3549,IHH,https://ctdbase.org/detail.go?type=gene&acc=3549,,,3549.0,IHH,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of IHH mRNA,,,PMID:20530736,https://www.ncbi.nlm.nih.gov/pubmed/20530736,20530736,,
738,2009875,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3551,IKBKB,https://ctdbase.org/detail.go?type=gene&acc=3551,,,3551.0,IKBKB,10141,Cavia porcellus (domestic guinea pig),Ascorbic acid inhibits the reaction [ethanol results in increased activity of IKBKB protein],,,PMID:24239723,https://www.ncbi.nlm.nih.gov/pubmed/24239723,24239723,,
739,2009876,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10320,IKZF1,https://ctdbase.org/detail.go?type=gene&acc=10320,,,10320.0,IKZF1,9606,Homo sapiens (human),"2-dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole inhibits the reaction [ascorbic acid results in decreased activity of IKZF1 protein]|ascorbic acid results in decreased activity of IKZF1 protein|5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole-3',5'-monophosphorothioate inhibits the reaction [ascorbic acid results in decreased activity of IKZF1 protein]",,,PMID:17664058,https://www.ncbi.nlm.nih.gov/pubmed/17664058,17664058,,
740,2009877,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3586,IL10,https://ctdbase.org/detail.go?type=gene&acc=3586,,,3586.0,IL10,9606,Homo sapiens (human),Ascorbic acid promotes the reaction [TNF protein results in increased expression of and results in increased secretion of IL10 protein]|[ascorbic acid co-treated with lycopene co-treated with alpha-tocopherol] promotes the reaction [TNF protein results in increased expression of and results in increased secretion of IL10 protein],,,PMID:25551565,https://www.ncbi.nlm.nih.gov/pubmed/25551565,25551565,,
741,2009878,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3586,IL10,https://ctdbase.org/detail.go?type=gene&acc=3586,,,3586.0,IL10,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [formaldehyde promotes the reaction [lipopolysaccharides results in increased expression of IL10 mrna]],,,PMID:27020608,https://www.ncbi.nlm.nih.gov/pubmed/27020608,27020608,,
742,2009879,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3589,IL11,https://ctdbase.org/detail.go?type=gene&acc=3589,,,3589.0,IL11,9606,Homo sapiens (human),[ascorbic acid co-treated with IL11 protein] results in increased expression of IBSP mrna|[ascorbic acid co-treated with IL11 protein] results in increased expression of RUNX2 mrna|[ascorbic acid co-treated with IL11 protein] results in increased expression of BGLAP mRNA,,,PMID:17956465,https://www.ncbi.nlm.nih.gov/pubmed/17956465,17956465,,
743,2009880,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606,Homo sapiens (human),"Ascorbic acid inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of IL1B protein]",,,PMID:35349355,https://www.ncbi.nlm.nih.gov/pubmed/35349355,35349355,,
744,2009881,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606,Homo sapiens (human),Ascorbic acid promotes the reaction [aspirin inhibits the reaction [IL1B results in increased chemical synthesis of dinoprostone]]|ascorbic acid promotes the reaction [aspirin inhibits the reaction [IL1B results in increased chemical synthesis of 8-epi-prostaglandin f2alpha]]|ascorbic acid inhibits the reaction [IL1B results in increased chemical synthesis of 8-epi-prostaglandin f2alpha]|ascorbic acid inhibits the reaction [IL1B results in increased chemical synthesis of dinoprostone],,,PMID:16529823,https://www.ncbi.nlm.nih.gov/pubmed/16529823,16529823,,
745,2009882,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9669,Mustela putorius furo (domestic ferret),[beta carotene co-treated with alpha-tocopherol co-treated with ascorbic acid] inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of MAPK3 protein],,,PMID:16401635,https://www.ncbi.nlm.nih.gov/pubmed/16401635,16401635,,
746,2009883,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [lead acetate results in increased expression of IL6 protein],,,PMID:22728154,https://www.ncbi.nlm.nih.gov/pubmed/22728154,22728154,,
747,2009884,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [sodium fluoride results in increased expression of IL6 protein],,,PMID:34089294,https://www.ncbi.nlm.nih.gov/pubmed/34089294,34089294,,
748,2009885,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606,Homo sapiens (human),[ascorbic acid co-treated with vitamin E] results in decreased expression of IL6,,,PMID:22207723,https://www.ncbi.nlm.nih.gov/pubmed/22207723,22207723,,
749,2009886,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3624,INHBA,https://ctdbase.org/detail.go?type=gene&acc=3624,,,3624.0,INHBA,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of TF mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of STMN2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HOXB3 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SOX1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of EGLN3 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of NR2F2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GCLM mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FABP1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HOXA2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FGB mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of EBF3 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of ZFAND2A mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of DCC mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of OTX2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of CDH10 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FLRT3 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of FOXD3 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of IL1R1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of SERPINA1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GPX2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FGF7 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GSTO1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ECSCR mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GRIA2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of TFAP2A mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of DCX mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ABCC1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of SLCO2B1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SRXN1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of CRYAB mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of AMHR2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ELAVL4 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of SCN2A mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of AFP mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of MYL4 mrna|[[ascorbic acid co-treated with ch,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
750,2009887,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606,Homo sapiens (human),Resveratrol inhibits the reaction [IL1B protein inhibits the reaction [[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of ACAN mrna]]|il1b protein inhibits the reaction [[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of COL2A1 mrna]|il1b protein inhibits the reaction [[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of ACAN mrna]|resveratrol inhibits the reaction [IL1B protein inhibits the reaction [[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of SOX9 mrna]]|il1b protein inhibits the reaction [[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of SOX9 mrna]|il1b protein results in decreased susceptibility to [TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone]|il1b protein inhibits the reaction [[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in decreased expression of MMP13 mrna]|resveratrol inhibits the reaction [IL1B protein inhibits the reaction [[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of COL2A1 mrna]],,,PMID:26526931,https://www.ncbi.nlm.nih.gov/pubmed/26526931,26526931,,
751,2009888,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10090,Mus musculus (house mouse),"Mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of IL1B mrna]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of IL1B mrna]|[ascorbic acid co-treated with ferrous sulfate] results in increased expression of IL1B protein|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of IL1B protein]|mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of IL1B protein]|[ascorbic acid co-treated with ferrous sulfate] results in increased expression of IL1B mRNA",,,PMID:23692848,https://www.ncbi.nlm.nih.gov/pubmed/23692848,23692848,,
752,2009889,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [silicon dioxide analog promotes the reaction [lipopolysaccharides results in increased expression of IL1B protein]],,,PMID:24685903,https://www.ncbi.nlm.nih.gov/pubmed/24685903,24685903,,
753,2009890,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [streptozocin results in increased expression of IL1B protein],,,PMID:28259689,https://www.ncbi.nlm.nih.gov/pubmed/28259689,28259689,,
754,2009891,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116,Rattus norvegicus (Norway rat),"Ascorbic acid deficiency promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL1B protein]|ascorbic acid inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL1B protein]",,,PMID:30606963,https://www.ncbi.nlm.nih.gov/pubmed/30606963,30606963,,
755,2009892,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [lead acetate results in increased expression of IL1B protein],,,PMID:22728154,https://www.ncbi.nlm.nih.gov/pubmed/22728154,22728154,,
756,2009893,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [lipopolysaccharides results in increased expression of IL1B mrna],,,PMID:15612528,https://www.ncbi.nlm.nih.gov/pubmed/15612528,15612528,,
757,2009894,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [sodium fluoride results in increased expression of IL1B protein],,,PMID:34089294,https://www.ncbi.nlm.nih.gov/pubmed/34089294,34089294,,
758,2009895,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3554,IL1R1,https://ctdbase.org/detail.go?type=gene&acc=3554,,,3554.0,IL1R1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of IL1R1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
759,2009896,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3565,IL4,https://ctdbase.org/detail.go?type=gene&acc=3565,,,3565.0,IL4,10090,Mus musculus (house mouse),Ascorbic acid results in decreased expression of IL4 protein,,,PMID:14624943,https://www.ncbi.nlm.nih.gov/pubmed/14624943,14624943,,
760,2009897,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10141,Cavia porcellus (domestic guinea pig),Ascorbic acid inhibits the reaction [ethanol results in increased expression of IL6 protein],,,PMID:24239723,https://www.ncbi.nlm.nih.gov/pubmed/24239723,24239723,,
761,2009898,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606,Homo sapiens (human),[acetylcysteine co-treated with ascorbic acid] inhibits the reaction [vehicle emissions results in increased expression of IL6 mrna],,,PMID:32810504,https://www.ncbi.nlm.nih.gov/pubmed/32810504,32810504,,
762,2009899,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606,Homo sapiens (human),"Ascorbic acid inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of IL6 protein]",,,PMID:35349355,https://www.ncbi.nlm.nih.gov/pubmed/35349355,35349355,,
763,2009900,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [formaldehyde inhibits the reaction [lipopolysaccharides results in increased expression of IL6 mrna]],,,PMID:27020608,https://www.ncbi.nlm.nih.gov/pubmed/27020608,27020608,,
764,2009901,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,83729,INHBE,https://ctdbase.org/detail.go?type=gene&acc=83729,,,83729.0,INHBE,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of INHBE mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
765,2009902,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [ethylene chlorohydrin results in increased phosphorylation of MAPK3 protein],,,PMID:31585129,https://www.ncbi.nlm.nih.gov/pubmed/31585129,31585129,,
766,2009903,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [lead acetate results in increased phosphorylation of MAPK3 protein],,,PMID:22728154,https://www.ncbi.nlm.nih.gov/pubmed/22728154,22728154,,
767,2009904,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate affects the localization of MAPK3 protein modified form],,,PMID:21262251,https://www.ncbi.nlm.nih.gov/pubmed/21262251,21262251,,
768,2009905,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599.0,MAPK8,9606,Homo sapiens (human),CAT protein inhibits the reaction [[ascorbic acid co-treated with eosine I bluish] results in increased phosphorylation of MAPK8 protein]|[ascorbic acid co-treated with eosine I bluish] results in increased phosphorylation of MAPK8 protein,,,PMID:24488945,https://www.ncbi.nlm.nih.gov/pubmed/24488945,24488945,,
769,2009906,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599.0,MAPK8,9669,Mustela putorius furo (domestic ferret),[beta carotene co-treated with alpha-tocopherol co-treated with ascorbic acid] inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of MAPK8 protein],,,PMID:16401635,https://www.ncbi.nlm.nih.gov/pubmed/16401635,16401635,,
770,2009907,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5601,MAPK9,https://ctdbase.org/detail.go?type=gene&acc=5601,,,5601.0,MAPK9,9606,Homo sapiens (human),CAT protein inhibits the reaction [[ascorbic acid co-treated with eosine I bluish] results in increased phosphorylation of MAPK9 protein]|[ascorbic acid co-treated with eosine I bluish] results in increased phosphorylation of MAPK9 protein,,,PMID:24488945,https://www.ncbi.nlm.nih.gov/pubmed/24488945,24488945,,
771,2009908,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333.0,Ins1,10116,Rattus norvegicus (Norway rat),[INS1 protein co-treated with ascorbic acid] results in increased expression of CDKN1A mrna|[ascorbic acid co-treated with INS1 protein] results in increased expression of CASP8 mrna|ascorbic acid inhibits the reaction [INS1 protein results in increased secretion of LEP protein]|[ascorbic acid co-treated with INS1 protein] results in decreased expression of GPD1 mrna|[ascorbic acid co-treated with INS1 protein] results in increased expression of NAMPT mRNA,,,PMID:20400526,https://www.ncbi.nlm.nih.gov/pubmed/20400526,20400526,,
772,2009909,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333.0,Ins1,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with vitamin E] inhibits the reaction [diethylhexyl phthalate results in decreased expression of INS1 protein],,,PMID:21911000,https://www.ncbi.nlm.nih.gov/pubmed/21911000,21911000,,
773,2009910,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333.0,Ins1,10116,Rattus norvegicus (Norway rat),[lutein co-treated with ascorbic acid] results in decreased expression of INS1 protein,,,PMID:12949374,https://www.ncbi.nlm.nih.gov/pubmed/12949374,12949374,,
774,2009911,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3643,INSR,https://ctdbase.org/detail.go?type=gene&acc=3643,,,3643.0,INSR,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with vitamin E] inhibits the reaction [diethylhexyl phthalate results in increased expression of INSR mrna],,,PMID:21911000,https://www.ncbi.nlm.nih.gov/pubmed/21911000,21911000,,
775,2009912,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3658,IREB2,https://ctdbase.org/detail.go?type=gene&acc=3658,,,3658.0,IREB2,10090,Mus musculus (house mouse),[ascorbic acid co-treated with CAT protein] inhibits the reaction [zinc deficiency results in increased expression of IREB2 protein],,,PMID:18073202,https://www.ncbi.nlm.nih.gov/pubmed/18073202,18073202,,
776,2009913,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3667,IRS1,https://ctdbase.org/detail.go?type=gene&acc=3667,,,3667.0,IRS1,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with vitamin E] inhibits the reaction [diethylhexyl phthalate results in decreased expression of IRS1 protein]|[ascorbic acid co-treated with vitamin E] inhibits the reaction [diethylhexyl phthalate results in decreased phosphorylation of IRS1 protein],,,PMID:21911000,https://www.ncbi.nlm.nih.gov/pubmed/21911000,21911000,,
777,2009914,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3670,ISL1,https://ctdbase.org/detail.go?type=gene&acc=3670,,,3670.0,ISL1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of ISL1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
778,2009915,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3670,ISL1,https://ctdbase.org/detail.go?type=gene&acc=3670,,,3670.0,ISL1,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of ISL1 mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
779,2009916,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,182,JAG1,https://ctdbase.org/detail.go?type=gene&acc=182,,,182.0,JAG1,10090,Mus musculus (house mouse),Ascorbic acid results in decreased expression of JAG1 mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
780,2009917,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3745,KCNB1,https://ctdbase.org/detail.go?type=gene&acc=3745,,,3745.0,KCNB1,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in increased expression of KCNB1 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
781,2009918,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3630,INS,https://ctdbase.org/detail.go?type=gene&acc=3630,,,3630.0,INS,9606,Homo sapiens (human),Rosiglitazone promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SREBF1 mrna]|tributyltin promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of NR1H3 mrna]|[tributyltin co-treated with [ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein]] results in increased expression of ABCA1 protein|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna|tributyltin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of DMP1 mrna]|bexarotene inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]|[tributyltin co-treated with [ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein]] results in increased expression of ABCA1 mrna|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PLIN1 mrna|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of NR1H3 mrna|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of DMP1 mrna|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna|bexarotene promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of NR1H3 mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of FABP4 mrna|rosiglitazone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]|bexarotene inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of DMP1 mrna]|rosiglitazone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna]|bexarotene inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PPARG mrna|diazepinylbenzoic acid inhibits the reaction [[tributyltin co-treated with [ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein]] results in increased expression of ABCA1 mrna]|rosiglitazone promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of NR1H3 mrna]|tributyltin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna]|tributyltin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of CEBPA mrna|[lg 100268 co-treated with [ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein]] results in increased expression of ABCA1 mrna|diazepinylbenzoic acid inhibits the reaction [[LG 100268 co-treated with [ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein]] results in increased expression of ABCA1 mrna]|[rosiglitazone co-treated with [ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein]] results in increased expression of ABCA1 protein|[t0901317 co-treated with [ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein]] results in increased expression of ABCA1 mrna|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of ABCA1 mrna|rosiglitazone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of DMP1 mrna]|tributyltin promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SREBF1 mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SREBF1 mrna|[bexarotene co-treated with [ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein]] results in increased expression of ABCA1 protein|bexarotene promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SREBF1 mrna]|[diazepinylbenzoic acid co-treated with [ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein]] results in decreased expression of ABCA1 mRNA,,,PMID:25932594,https://www.ncbi.nlm.nih.gov/pubmed/25932594,25932594,,
782,2009919,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3630,INS,https://ctdbase.org/detail.go?type=gene&acc=3630,,,3630.0,INS,9606,Homo sapiens (human),Trientine inhibits the reaction [[copper co-treated with ascorbic acid] results in increased oxidation of and affects the folding of INS protein]|[copper co-treated with ascorbic acid] results in increased oxidation of and affects the folding of INS protein,,,PMID:23403016,https://www.ncbi.nlm.nih.gov/pubmed/23403016,23403016,,
783,2009920,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599.0,MAPK8,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [plant extracts results in increased phosphorylation of MAPK8 protein],,,PMID:20206247,https://www.ncbi.nlm.nih.gov/pubmed/20206247,20206247,,
784,2009921,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3630,INS,https://ctdbase.org/detail.go?type=gene&acc=3630,,,3630.0,INS,10090,Mus musculus (house mouse),"Triphenyltin hydroxide inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna]|tetrabromobisphenol A promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PLIN1 mrna]|rosiglitazone promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PLIN1 mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of RUNX2 mrna|tretinoin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PLIN1 mrna]|tretinoin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PPARG mrna]|triphenyltin hydroxide promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of FABP4 mrna]|triphenyltin hydroxide inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PLIN1 mrna|d,d-T80-prallethrin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]|pioglitazone promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PLIN1 mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna|allethrins inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of FABP4 mrna|rosiglitazone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]|rosiglitazone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PPARG mrna|tretinoin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]|d,d-T80-prallethrin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna]|pioglitazone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]|triphenyltin hydroxide promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PLIN1 mrna]|tetrabromobisphenol A promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of FABP4 mrna]|pioglitazone promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of FABP4 mrna]|d,d-T80-prallethrin promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of FABP4 mrna]|rosiglitazone promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PPARG mrna]|quinoxyfen inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna]|pioglitazone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna]|tretinoin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna]|rosiglitazone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of RUNX2 mrna]|tetrabromobisphenol A inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]|quinoxyfen inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]|rosiglitazone promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of FABP4 mrna]|allethrins inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]",,,PMID:32473317,https://www.ncbi.nlm.nih.gov/pubmed/32473317,32473317,,
785,2009922,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333.0,Ins1,10090,Mus musculus (house mouse),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS1 protein co-treated with triphenyl phosphate] results in decreased expression of SP7 mrna|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS1 protein co-treated with firemaster 550] results in increased expression of FABP4 mrna|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS1 protein co-treated with triphenyl phosphate] results in increased expression of FABP4 mrna|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS1 protein co-treated with firemaster 550] results in decreased expression of SP7 mRNA,,,PMID:25062436,https://www.ncbi.nlm.nih.gov/pubmed/25062436,25062436,,
786,2009923,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,55818,KDM3A,https://ctdbase.org/detail.go?type=gene&acc=55818,,,55818.0,KDM3A,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [nickel chloride results in increased expression of KDM3A mrna]|ascorbic acid inhibits the reaction [nickel chloride results in increased expression of KDM3A protein],,,PMID:22318714,https://www.ncbi.nlm.nih.gov/pubmed/22318714,22318714,,
787,2009924,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3791,KDR,https://ctdbase.org/detail.go?type=gene&acc=3791,,,3791.0,KDR,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of KDR mRNA,,,PMID:21919647,https://www.ncbi.nlm.nih.gov/pubmed/21919647,21919647,,
788,2009925,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9817,KEAP1,https://ctdbase.org/detail.go?type=gene&acc=9817,,,9817.0,KEAP1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of KEAP1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
789,2009926,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9817,KEAP1,https://ctdbase.org/detail.go?type=gene&acc=9817,,,9817.0,KEAP1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [hydrogen peroxide results in decreased expression of KEAP1 protein],,,PMID:28285367,https://www.ncbi.nlm.nih.gov/pubmed/28285367,28285367,,
790,2009927,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9817,KEAP1,https://ctdbase.org/detail.go?type=gene&acc=9817,,,9817.0,KEAP1,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of KEAP1 protein|ascorbic acid inhibits the reaction [[lead acetate results in increased abundance of lead] which results in increased expression of KEAP1 protein],,,PMID:31610155,https://www.ncbi.nlm.nih.gov/pubmed/31610155,31610155,,
791,2009928,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,57498,KIDINS220,https://ctdbase.org/detail.go?type=gene&acc=57498,,,57498.0,KIDINS220,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of KIDINS220 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
792,2009929,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,23095,KIF1B,https://ctdbase.org/detail.go?type=gene&acc=23095,,,23095.0,KIF1B,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of KIF1B mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
793,2009930,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10749,KIF1C,https://ctdbase.org/detail.go?type=gene&acc=10749,,,10749.0,KIF1C,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of KIF1C mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
794,2009931,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9493,KIF23,https://ctdbase.org/detail.go?type=gene&acc=9493,,,9493.0,KIF23,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of KIF23 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
795,2009932,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,22914,KLRK1,https://ctdbase.org/detail.go?type=gene&acc=22914,,,22914.0,KLRK1,10090,Mus musculus (house mouse),Ascorbic acid deficiency results in decreased expression of KLRK1 protein,,,PMID:22306178,https://www.ncbi.nlm.nih.gov/pubmed/22306178,22306178,,
796,2009933,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3853,KRT6A,https://ctdbase.org/detail.go?type=gene&acc=3853,,,3853.0,KRT6A,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of KRT6A mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
797,2009934,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3929,LBP,https://ctdbase.org/detail.go?type=gene&acc=3929,,,3929.0,LBP,10141,Cavia porcellus (domestic guinea pig),Ascorbic acid inhibits the reaction [ethanol results in increased expression of LBP mrna],,,PMID:24239723,https://www.ncbi.nlm.nih.gov/pubmed/24239723,24239723,,
798,2009935,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3932,LCK,https://ctdbase.org/detail.go?type=gene&acc=3932,,,3932.0,LCK,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of LCK mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
799,2009936,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3932,LCK,https://ctdbase.org/detail.go?type=gene&acc=3932,,,3932.0,LCK,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [bis(2-hydroxy-2-ethylbutanoato)oxochromate(v) results in increased phosphorylation of LCK protein]|ascorbic acid inhibits the reaction [potassium dichromate results in increased phosphorylation of LCK protein],,,PMID:14572611,https://www.ncbi.nlm.nih.gov/pubmed/14572611,14572611,,
800,2009937,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3939,LDHA,https://ctdbase.org/detail.go?type=gene&acc=3939,,,3939.0,LDHA,9606,Homo sapiens (human),[ascorbic acid co-treated with alpha-tocopherol co-treated with ferulic acid] inhibits the reaction [[ozone co-treated with oxygen] results in increased secretion of LDHA protein],,,PMID:26270818,https://www.ncbi.nlm.nih.gov/pubmed/26270818,26270818,,
801,2009938,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3949,LDLR,https://ctdbase.org/detail.go?type=gene&acc=3949,,,3949.0,LDLR,9606,Homo sapiens (human),Ascorbic acid affects the reaction [GULO protein affects the expression of LDLR protein]|ascorbic acid results in increased expression of LDLR protein|foxo3 protein affects the reaction [ascorbic acid results in increased expression of LDLR protein]|ascorbic acid inhibits the reaction [dactinomycin results in decreased expression of LDLR mrna]|ascorbic acid results in increased expression of LDLR mrna|srebf2 protein affects the reaction [ascorbic acid results in increased expression of LDLR mrna]|srebf2 protein affects the reaction [ascorbic acid results in increased expression of LDLR protein],,,PMID:32913121,https://www.ncbi.nlm.nih.gov/pubmed/32913121,32913121,,
802,2009939,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,51176,LEF1,https://ctdbase.org/detail.go?type=gene&acc=51176,,,51176.0,LEF1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of LEF1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
803,2009940,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,51176,LEF1,https://ctdbase.org/detail.go?type=gene&acc=51176,,,51176.0,LEF1,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of LEF1 mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
804,2009941,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3952,LEP,https://ctdbase.org/detail.go?type=gene&acc=3952,,,3952.0,LEP,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [INS1 protein results in increased secretion of LEP protein]|ascorbic acid results in decreased secretion of LEP protein,,,PMID:20400526,https://www.ncbi.nlm.nih.gov/pubmed/20400526,20400526,,
805,2009942,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3956,LGALS1,https://ctdbase.org/detail.go?type=gene&acc=3956,,,3956.0,LGALS1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of LGALS1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
806,2009943,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3958,LGALS3,https://ctdbase.org/detail.go?type=gene&acc=3958,,,3958.0,LGALS3,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of LGALS3 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
807,2009944,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3972,LHB,https://ctdbase.org/detail.go?type=gene&acc=3972,,,3972.0,LHB,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chlorodiphenyl (54% chlorine) results in decreased expression of LHB protein],,,PMID:16248992|PMID:16298753|PMID:17280759,https://www.ncbi.nlm.nih.gov/pubmed/16248992|https://www.ncbi.nlm.nih.gov/pubmed/16298753|https://www.ncbi.nlm.nih.gov/pubmed/17280759,16248992|16298753|17280759,,
808,2009945,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3973,LHCGR,https://ctdbase.org/detail.go?type=gene&acc=3973,,,3973.0,LHCGR,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of LHCGR mrna],,,PMID:18602937,https://www.ncbi.nlm.nih.gov/pubmed/18602937,18602937,,
809,2009946,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4017,LOXL2,https://ctdbase.org/detail.go?type=gene&acc=4017,,,4017.0,LOXL2,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of LOXL2 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
810,2009947,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9170,LPAR2,https://ctdbase.org/detail.go?type=gene&acc=9170,,,9170.0,LPAR2,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [benzo(a)pyrene results in decreased methylation of LPAR2 promoter]|ascorbic acid inhibits the reaction [benzo(a)pyrene results in increased expression of LPAR2 mrna],,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
811,2009948,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4060,LUM,https://ctdbase.org/detail.go?type=gene&acc=4060,,,4060.0,LUM,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of LUM mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
812,2009949,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,56925,LXN,https://ctdbase.org/detail.go?type=gene&acc=56925,,,56925.0,LXN,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of LXN protein|ascorbic acid results in increased expression of LXN mRNA,,,PMID:22139585,https://www.ncbi.nlm.nih.gov/pubmed/22139585,22139585,,
813,2009950,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4067,LYN,https://ctdbase.org/detail.go?type=gene&acc=4067,,,4067.0,LYN,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [bis(2-hydroxy-2-ethylbutanoato)oxochromate(v) results in increased phosphorylation of LYN protein]|ascorbic acid inhibits the reaction [potassium dichromate results in increased phosphorylation of LYN protein],,,PMID:14572611,https://www.ncbi.nlm.nih.gov/pubmed/14572611,14572611,,
814,2009951,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,23764,MAFF,https://ctdbase.org/detail.go?type=gene&acc=23764,,,23764.0,MAFF,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of MAFF mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
815,2009952,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4097,MAFG,https://ctdbase.org/detail.go?type=gene&acc=4097,,,4097.0,MAFG,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of MAFG mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
816,2009953,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9863,MAGI2,https://ctdbase.org/detail.go?type=gene&acc=9863,,,9863.0,MAGI2,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of MAGI2 mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
817,2009954,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10892,MALT1,https://ctdbase.org/detail.go?type=gene&acc=10892,,,10892.0,MALT1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of MALT1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
818,2009955,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4133,MAP2,https://ctdbase.org/detail.go?type=gene&acc=4133,,,4133.0,MAP2,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of MAP2 protein,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
819,2009956,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5606,MAP2K3,https://ctdbase.org/detail.go?type=gene&acc=5606,,,5606.0,MAP2K3,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [fenretinide results in increased phosphorylation of MAP2K3 protein],,,PMID:16407847,https://www.ncbi.nlm.nih.gov/pubmed/16407847,16407847,,
820,2009957,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5608,MAP2K6,https://ctdbase.org/detail.go?type=gene&acc=5608,,,5608.0,MAP2K6,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [fenretinide results in increased phosphorylation of MAP2K6 protein],,,PMID:16407847,https://www.ncbi.nlm.nih.gov/pubmed/16407847,16407847,,
821,2009958,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4217,MAP3K5,https://ctdbase.org/detail.go?type=gene&acc=4217,,,4217.0,MAP3K5,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [plant extracts results in increased phosphorylation of MAP3K5 protein],,,PMID:20206247,https://www.ncbi.nlm.nih.gov/pubmed/20206247,20206247,,
822,2009959,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9606,Homo sapiens (human),[juglone co-treated with ascorbic acid] results in decreased phosphorylation of MAPK1 protein,,,PMID:29992683,https://www.ncbi.nlm.nih.gov/pubmed/29992683,29992683,,
823,2009960,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10090,Mus musculus (house mouse),Ascorbic acid results in increased phosphorylation of MAPK1 protein|u 0126 inhibits the reaction [ascorbic acid results in increased phosphorylation of MAPK1 protein],,,PMID:20530736,https://www.ncbi.nlm.nih.gov/pubmed/20530736,20530736,,
824,2009961,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9669,Mustela putorius furo (domestic ferret),[beta carotene co-treated with alpha-tocopherol co-treated with ascorbic acid] inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of MAPK1 protein],,,PMID:16401635,https://www.ncbi.nlm.nih.gov/pubmed/16401635,16401635,,
825,2009962,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [ethylene chlorohydrin results in increased phosphorylation of MAPK1 protein],,,PMID:31585129,https://www.ncbi.nlm.nih.gov/pubmed/31585129,31585129,,
826,2009963,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [lead acetate results in increased phosphorylation of MAPK1 protein],,,PMID:22728154,https://www.ncbi.nlm.nih.gov/pubmed/22728154,22728154,,
827,2009964,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate affects the localization of MAPK1 protein modified form],,,PMID:21262251,https://www.ncbi.nlm.nih.gov/pubmed/21262251,21262251,,
828,2009965,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1432,MAPK14,https://ctdbase.org/detail.go?type=gene&acc=1432,,,1432.0,MAPK14,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [fenretinide results in increased phosphorylation of MAPK14 protein],,,PMID:16407847,https://www.ncbi.nlm.nih.gov/pubmed/16407847,16407847,,
829,2009966,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606,Homo sapiens (human),[juglone co-treated with ascorbic acid] results in decreased phosphorylation of MAPK3 protein,,,PMID:29992683,https://www.ncbi.nlm.nih.gov/pubmed/29992683,29992683,,
830,2009967,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10090,Mus musculus (house mouse),U 0126 inhibits the reaction [ascorbic acid results in increased phosphorylation of MAPK3 protein]|ascorbic acid results in increased phosphorylation of MAPK3 protein,,,PMID:20530736,https://www.ncbi.nlm.nih.gov/pubmed/20530736,20530736,,
831,2009968,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5601,MAPK9,https://ctdbase.org/detail.go?type=gene&acc=5601,,,5601.0,MAPK9,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [plant extracts results in increased phosphorylation of MAPK9 protein],,,PMID:20206247,https://www.ncbi.nlm.nih.gov/pubmed/20206247,20206247,,
832,2009969,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4137,MAPT,https://ctdbase.org/detail.go?type=gene&acc=4137,,,4137.0,MAPT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [cyanoginosin LR results in increased phosphorylation of MAPT protein],,,PMID:24142891,https://www.ncbi.nlm.nih.gov/pubmed/24142891,24142891,,
833,2009970,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4173,MCM4,https://ctdbase.org/detail.go?type=gene&acc=4173,,,4173.0,MCM4,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of MCM4 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
834,2009971,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4192,MDK,https://ctdbase.org/detail.go?type=gene&acc=4192,,,4192.0,MDK,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of MDK mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
835,2009972,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4193,MDM2,https://ctdbase.org/detail.go?type=gene&acc=4193,,,4193.0,MDM2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in decreased expression of MDM2 protein],,,PMID:21262251,https://www.ncbi.nlm.nih.gov/pubmed/21262251,21262251,,
836,2009973,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4224,MEP1A,https://ctdbase.org/detail.go?type=gene&acc=4224,,,4224.0,MEP1A,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of MEP1A mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
837,2009974,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4233,MET,https://ctdbase.org/detail.go?type=gene&acc=4233,,,4233.0,MET,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of MET mRNA,,,PMID:21919647,https://www.ncbi.nlm.nih.gov/pubmed/21919647,21919647,,
838,2009975,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4255,MGMT,https://ctdbase.org/detail.go?type=gene&acc=4255,,,4255.0,MGMT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [[kojic acid co-treated with diethylnitrosamine] results in increased expression of MGMT mrna],,,PMID:18544905,https://www.ncbi.nlm.nih.gov/pubmed/18544905,18544905,,
839,2009976,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4257,MGST1,https://ctdbase.org/detail.go?type=gene&acc=4257,,,4257.0,MGST1,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of MGST1 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
840,2009977,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,407050,MIR93,https://ctdbase.org/detail.go?type=gene&acc=407050,,,407050.0,MIR93,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [estradiol results in increased expression of MIR93 mrna],,,PMID:23492819,https://www.ncbi.nlm.nih.gov/pubmed/23492819,23492819,,
841,2009978,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4288,MKI67,https://ctdbase.org/detail.go?type=gene&acc=4288,,,4288.0,MKI67,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of MKI67 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
842,2009979,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4288,MKI67,https://ctdbase.org/detail.go?type=gene&acc=4288,,,4288.0,MKI67,8022,Oncorhynchus mykiss (rainbow trout),[vitamin A co-treated with cholecalciferol co-treated with vitamin E co-treated with ascorbic acid] inhibits the reaction [[cyhalothrin co-treated with chlorantranilipole] results in increased expression of MKI67 protein],,,PMID:36813254,https://www.ncbi.nlm.nih.gov/pubmed/36813254,36813254,,
843,2009980,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4288,MKI67,https://ctdbase.org/detail.go?type=gene&acc=4288,,,4288.0,MKI67,10116,Rattus norvegicus (Norway rat),[alpha-tocopherol co-treated with beta carotene co-treated with ascorbic acid co-treated with zinc co-treated with sodium selenite] results in decreased expression of MKI67 mRNA,,,PMID:23859036,https://www.ncbi.nlm.nih.gov/pubmed/23859036,23859036,,
844,2009981,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4292,MLH1,https://ctdbase.org/detail.go?type=gene&acc=4292,,,4292.0,MLH1,9606,Homo sapiens (human),Ascorbic acid promotes the reaction [MLH1 gene mutant form results in decreased susceptibility to chromium hexavalent ion],,,PMID:15831465,https://www.ncbi.nlm.nih.gov/pubmed/15831465,15831465,,
845,2009982,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4292,MLH1,https://ctdbase.org/detail.go?type=gene&acc=4292,,,4292.0,MLH1,9606,Homo sapiens (human),MLH1 protein promotes the reaction [ascorbic acid results in increased susceptibility to chromium hexavalent ion],,,PMID:17301063,https://www.ncbi.nlm.nih.gov/pubmed/17301063,17301063,,
846,2009983,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4292,MLH1,https://ctdbase.org/detail.go?type=gene&acc=4292,,,4292.0,MLH1,9606,Homo sapiens (human),MLH1 protein results in increased susceptibility to [chromium hexavalent ion co-treated with ascorbic acid],,,PMID:17169990,https://www.ncbi.nlm.nih.gov/pubmed/17169990,17169990,,
847,2009984,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,90523,MLIP,https://ctdbase.org/detail.go?type=gene&acc=90523,,,90523.0,MLIP,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of MLIP mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
848,2009985,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4312,MMP1,https://ctdbase.org/detail.go?type=gene&acc=4312,,,4312.0,MMP1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of MMP1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
849,2009986,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4312,MMP1,https://ctdbase.org/detail.go?type=gene&acc=4312,,,4312.0,MMP1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [tobacco smoke pollution results in increased expression of MMP1 mrna],,,PMID:10836612,https://www.ncbi.nlm.nih.gov/pubmed/10836612,10836612,,
850,2009987,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4322,MMP13,https://ctdbase.org/detail.go?type=gene&acc=4322,,,4322.0,MMP13,9606,Homo sapiens (human),IL1B protein inhibits the reaction [[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in decreased expression of MMP13 mrna]|[tgfb3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in decreased expression of MMP13 mRNA,,,PMID:26526931,https://www.ncbi.nlm.nih.gov/pubmed/26526931,26526931,,
851,2009988,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4322,MMP13,https://ctdbase.org/detail.go?type=gene&acc=4322,,,4322.0,MMP13,10090,Mus musculus (house mouse),"CAT protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of MMP13 protein]|mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of MMP13 protein]|[ascorbic acid co-treated with ferrous sulfate] results in increased expression of MMP13 mrna|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of MMP13 mrna]|mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of MMP13 mrna]",,,PMID:23692848,https://www.ncbi.nlm.nih.gov/pubmed/23692848,23692848,,
852,2009989,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4313,MMP2,https://ctdbase.org/detail.go?type=gene&acc=4313,,,4313.0,MMP2,9606,Homo sapiens (human),[juglone co-treated with ascorbic acid] affects the expression of MMP2 mRNA,,,PMID:29992683,https://www.ncbi.nlm.nih.gov/pubmed/29992683,29992683,,
853,2009990,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4313,MMP2,https://ctdbase.org/detail.go?type=gene&acc=4313,,,4313.0,MMP2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [cyclosporine results in increased expression of MMP2 protein],,,PMID:19391111,https://www.ncbi.nlm.nih.gov/pubmed/19391111,19391111,,
854,2009991,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318.0,MMP9,9606,Homo sapiens (human),[juglone co-treated with ascorbic acid] results in decreased expression of MMP9 mRNA,,,PMID:29992683,https://www.ncbi.nlm.nih.gov/pubmed/29992683,29992683,,
855,2009992,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4353,MPO,https://ctdbase.org/detail.go?type=gene&acc=4353,,,4353.0,MPO,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [[MPO protein co-treated with hydrogen peroxide] results in increased oxidation of fenoterol]|ascorbic acid inhibits the reaction [[MPO protein co-treated with hydrogen peroxide] results in increased oxidation of albuterol],,,PMID:19462961,https://www.ncbi.nlm.nih.gov/pubmed/19462961,19462961,,
856,2009993,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4353,MPO,https://ctdbase.org/detail.go?type=gene&acc=4353,,,4353.0,MPO,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with beta carotene co-treated with alpha-tocopherol co-treated with sodium selenite] inhibits the reaction [galactosamine results in increased activity of MPO protein],,,PMID:31022331,https://www.ncbi.nlm.nih.gov/pubmed/31022331,31022331,,
857,2009994,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4353,MPO,https://ctdbase.org/detail.go?type=gene&acc=4353,,,4353.0,MPO,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [formaldehyde inhibits the reaction [lipopolysaccharides results in increased expression of MPO protein]],,,PMID:27020608,https://www.ncbi.nlm.nih.gov/pubmed/27020608,27020608,,
858,2009995,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4353,MPO,https://ctdbase.org/detail.go?type=gene&acc=4353,,,4353.0,MPO,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [indomethacin results in increased activity of MPO protein],,,PMID:18726076,https://www.ncbi.nlm.nih.gov/pubmed/18726076,18726076,,
859,2009996,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4353,MPO,https://ctdbase.org/detail.go?type=gene&acc=4353,,,4353.0,MPO,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [MPO results in increased chemical synthesis of troglitazone analog],,,PMID:15039298,https://www.ncbi.nlm.nih.gov/pubmed/15039298,15039298,,
860,2009997,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9019,MPZL1,https://ctdbase.org/detail.go?type=gene&acc=9019,,,9019.0,MPZL1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of MPZL1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
861,2009998,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4436,MSH2,https://ctdbase.org/detail.go?type=gene&acc=4436,,,4436.0,MSH2,9606,Homo sapiens (human),MSH2 protein promotes the reaction [ascorbic acid results in increased susceptibility to chromium hexavalent ion],,,PMID:17301063,https://www.ncbi.nlm.nih.gov/pubmed/17301063,17301063,,
862,2009999,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4436,MSH2,https://ctdbase.org/detail.go?type=gene&acc=4436,,,4436.0,MSH2,9606,Homo sapiens (human),MSH2 protein results in increased susceptibility to [chromium hexavalent ion co-treated with ascorbic acid],,,PMID:17169990,https://www.ncbi.nlm.nih.gov/pubmed/17169990,17169990,,
863,2010000,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4485,MST1,https://ctdbase.org/detail.go?type=gene&acc=4485,,,4485.0,MST1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of MST1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
864,2010001,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,11223,MST1L,https://ctdbase.org/detail.go?type=gene&acc=11223,,,11223.0,MST1L,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of MST1L mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
865,2010002,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4488,MSX2,https://ctdbase.org/detail.go?type=gene&acc=4488,,,4488.0,MSX2,10090,Mus musculus (house mouse),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of MSX2 mrna|cadmium sulfate inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of MSX2 mrna],,,PMID:28189605,https://www.ncbi.nlm.nih.gov/pubmed/28189605,28189605,,
866,2010003,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4489,MT1A,https://ctdbase.org/detail.go?type=gene&acc=4489,,,4489.0,MT1A,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of MT1A mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
867,2010004,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4504,MT3,https://ctdbase.org/detail.go?type=gene&acc=4504,,,4504.0,MT3,9606,Homo sapiens (human),[[MT3 protein binds to zinc] which co-treated with ascorbic acid] inhibits the reaction [copper results in increased chemical synthesis of hydroxyl radical],,,PMID:17389590,https://www.ncbi.nlm.nih.gov/pubmed/17389590,17389590,,
868,2010005,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4504,MT3,https://ctdbase.org/detail.go?type=gene&acc=4504,,,4504.0,MT3,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of MT3 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
869,2010006,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10797,MTHFD2,https://ctdbase.org/detail.go?type=gene&acc=10797,,,10797.0,MTHFD2,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of MTHFD2 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
870,2010007,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4602,MYB,https://ctdbase.org/detail.go?type=gene&acc=4602,,,4602.0,MYB,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with ferrous sulfate] results in increased expression of MYB protein,,,PMID:7593635,https://www.ncbi.nlm.nih.gov/pubmed/7593635,7593635,,
871,2010008,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4605,MYBL2,https://ctdbase.org/detail.go?type=gene&acc=4605,,,4605.0,MYBL2,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of MYBL2 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
872,2010009,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4609,MYC,https://ctdbase.org/detail.go?type=gene&acc=4609,,,4609.0,MYC,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [phenylhydrazine results in decreased expression of MYC mrna],,,PMID:30140404,https://www.ncbi.nlm.nih.gov/pubmed/30140404,30140404,,
873,2010010,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4629,MYH11,https://ctdbase.org/detail.go?type=gene&acc=4629,,,4629.0,MYH11,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of MYH11 protein,,,PMID:14639096,https://www.ncbi.nlm.nih.gov/pubmed/14639096,14639096,,
874,2010011,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4624,MYH6,https://ctdbase.org/detail.go?type=gene&acc=4624,,,4624.0,MYH6,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of MYH6 mRNA,,,PMID:12668514,https://www.ncbi.nlm.nih.gov/pubmed/12668514,12668514,,
875,2010012,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4625,MYH7,https://ctdbase.org/detail.go?type=gene&acc=4625,,,4625.0,MYH7,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of MYH7 mRNA,,,PMID:12668514|PMID:21570463,https://www.ncbi.nlm.nih.gov/pubmed/12668514|https://www.ncbi.nlm.nih.gov/pubmed/21570463,12668514|21570463,,
876,2010013,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4633,MYL2,https://ctdbase.org/detail.go?type=gene&acc=4633,,,4633.0,MYL2,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of MYL2 mRNA,,,PMID:21570463,https://www.ncbi.nlm.nih.gov/pubmed/21570463,21570463,,
877,2010014,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4635,MYL4,https://ctdbase.org/detail.go?type=gene&acc=4635,,,4635.0,MYL4,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of MYL4 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
878,2010015,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4640,MYO1A,https://ctdbase.org/detail.go?type=gene&acc=4640,,,4640.0,MYO1A,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of MYO1A mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
879,2010016,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4643,MYO1E,https://ctdbase.org/detail.go?type=gene&acc=4643,,,4643.0,MYO1E,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of MYO1E mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
880,2010017,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10135,NAMPT,https://ctdbase.org/detail.go?type=gene&acc=10135,,,10135.0,NAMPT,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with INS1 protein] results in increased expression of NAMPT mRNA,,,PMID:20400526,https://www.ncbi.nlm.nih.gov/pubmed/20400526,20400526,,
881,2010018,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4677,NARS1,https://ctdbase.org/detail.go?type=gene&acc=4677,,,4677.0,NARS1,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of NARS1 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
882,2010019,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,83988,NCALD,https://ctdbase.org/detail.go?type=gene&acc=83988,,,83988.0,NCALD,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of NCALD mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
883,2010020,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10397,NDRG1,https://ctdbase.org/detail.go?type=gene&acc=10397,,,10397.0,NDRG1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [nickel sulfate results in increased expression of NDRG1 protein],,,PMID:16288478,https://www.ncbi.nlm.nih.gov/pubmed/16288478,16288478,,
884,2010021,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,57447,NDRG2,https://ctdbase.org/detail.go?type=gene&acc=57447,,,57447.0,NDRG2,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of NDRG2 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
885,2010022,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10763,NES,https://ctdbase.org/detail.go?type=gene&acc=10763,,,10763.0,NES,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of NES protein,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
886,2010023,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4779,NFE2L1,https://ctdbase.org/detail.go?type=gene&acc=4779,,,4779.0,NFE2L1,9606,Homo sapiens (human),Ascorbic acid results in increased expression of NFE2L1 protein|ascorbic acid results in increased expression of NFE2L1 mRNA,,,PMID:25130429,https://www.ncbi.nlm.nih.gov/pubmed/25130429,25130429,,
887,2010024,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,9606,Homo sapiens (human),[ascorbic acid co-treated with alpha-tocopherol co-treated with ferulic acid] promotes the reaction [[ozone co-treated with oxygen] results in increased localization of NFE2L2 protein],,,PMID:26270818,https://www.ncbi.nlm.nih.gov/pubmed/26270818,26270818,,
888,2010025,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [estradiol results in decreased expression of NFE2L2 protein]|ascorbic acid inhibits the reaction [estradiol results in decreased expression of NFE2L2 mrna],,,PMID:23492819|PMID:25130429,https://www.ncbi.nlm.nih.gov/pubmed/23492819|https://www.ncbi.nlm.nih.gov/pubmed/25130429,23492819|25130429,,
889,2010026,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [hydrogen peroxide results in increased phosphorylation of NFE2L2 protein],,,PMID:28285367,https://www.ncbi.nlm.nih.gov/pubmed/28285367,28285367,,
890,2010027,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [resveratrol results in increased activity of NFE2L2 promoter],,,PMID:21199573,https://www.ncbi.nlm.nih.gov/pubmed/21199573,21199573,,
891,2010028,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,9606,Homo sapiens (human),Ascorbic acid results in increased expression of NFE2L2 protein|[lead acetate results in increased abundance of lead] inhibits the reaction [ascorbic acid results in increased expression of NFE2L2 protein]|ascorbic acid results in increased expression of NFE2L2 mrna|ascorbic acid promotes the reaction [[lead acetate results in increased abundance of lead] which results in increased expression of NFE2L2 mrna],,,PMID:31610155,https://www.ncbi.nlm.nih.gov/pubmed/31610155,31610155,,
892,2010029,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [diquat results in decreased expression of NFE2L2 protein],,,PMID:33475796,https://www.ncbi.nlm.nih.gov/pubmed/33475796,33475796,,
893,2010030,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [estradiol inhibits the reaction [NFE2L2 protein binds to SOD3 promoter]]|ascorbic acid affects the localization of NFE2L2 protein|ascorbic acid inhibits the reaction [estradiol affects the localization of NFE2L2 protein],,,PMID:23027624,https://www.ncbi.nlm.nih.gov/pubmed/23027624,23027624,,
894,2010031,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with vitamin E] inhibits the reaction [diethylhexyl phthalate results in increased expression of NFE2L2 protein],,,PMID:29663635|PMID:29940330,https://www.ncbi.nlm.nih.gov/pubmed/29663635|https://www.ncbi.nlm.nih.gov/pubmed/29940330,29663635|29940330,,
895,2010032,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [arsenic trioxide results in decreased expression of NFE2L2 mrna],,,PMID:29297235,https://www.ncbi.nlm.nih.gov/pubmed/29297235,29297235,,
896,2010033,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [estradiol results in decreased expression of NFE2L2 protein]|ascorbic acid inhibits the reaction [estradiol results in decreased expression of NFE2L2 mrna],,,PMID:23492819,https://www.ncbi.nlm.nih.gov/pubmed/23492819,23492819,,
897,2010034,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [ethylene chlorohydrin results in increased expression of NFE2L2 protein]|ascorbic acid inhibits the reaction [ethylene chlorohydrin results in increased expression of NFE2L2 mrna],,,PMID:31585129,https://www.ncbi.nlm.nih.gov/pubmed/31585129,31585129,,
898,2010035,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10116,Rattus norvegicus (Norway rat),Ascorbic acid promotes the reaction [cadmium results in increased expression of NFE2L2 protein],,,PMID:22008531,https://www.ncbi.nlm.nih.gov/pubmed/22008531,22008531,,
899,2010036,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of NFE2L2 protein,,,PMID:22008531|PMID:23027624,https://www.ncbi.nlm.nih.gov/pubmed/22008531|https://www.ncbi.nlm.nih.gov/pubmed/23027624,22008531|23027624,,
900,2010037,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9603,NFE2L3,https://ctdbase.org/detail.go?type=gene&acc=9603,,,9603.0,NFE2L3,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of NFE2L3 protein|ascorbic acid results in decreased expression of NFE2L3 mRNA,,,PMID:25130429,https://www.ncbi.nlm.nih.gov/pubmed/25130429,25130429,,
901,2010038,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4781,NFIB,https://ctdbase.org/detail.go?type=gene&acc=4781,,,4781.0,NFIB,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of NFIB mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
902,2010039,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4790,NFKB1,https://ctdbase.org/detail.go?type=gene&acc=4790,,,4790.0,NFKB1,9606,Homo sapiens (human),[hyaluronic acid co-treated with chondroitin sulfates] inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased activity of NFKB1 protein]|[ascorbic acid co-treated with ferrous sulfate] results in increased activity of NFKB1 protein,,,PMID:17879260,https://www.ncbi.nlm.nih.gov/pubmed/17879260,17879260,,
903,2010040,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4790,NFKB1,https://ctdbase.org/detail.go?type=gene&acc=4790,,,4790.0,NFKB1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [norepinephrine affects the localization of NFKB1 protein],,,PMID:23114885,https://www.ncbi.nlm.nih.gov/pubmed/23114885,23114885,,
904,2010041,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4790,NFKB1,https://ctdbase.org/detail.go?type=gene&acc=4790,,,4790.0,NFKB1,10090,Mus musculus (house mouse),"[ascorbic acid co-treated with ferrous sulfate] results in increased activity of [NFKB1 protein binds to RELA protein]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased activity of [NFKB1 protein binds to RELA protein]]|mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased activity of [NFKB1 protein binds to RELA protein]]",,,PMID:23692848,https://www.ncbi.nlm.nih.gov/pubmed/23692848,23692848,,
905,2010042,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,10141,Cavia porcellus (domestic guinea pig),Ascorbic acid inhibits the reaction [ethanol results in increased expression of NFKBIA protein modified form],,,PMID:24239723,https://www.ncbi.nlm.nih.gov/pubmed/24239723,24239723,,
906,2010043,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,9606,Homo sapiens (human),[hyaluronic acid co-treated with chondroitin sulfates] inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in decreased expression of NFKBIA protein]|[ascorbic acid co-treated with ferrous sulfate] results in decreased expression of NFKBIA protein,,,PMID:17879260,https://www.ncbi.nlm.nih.gov/pubmed/17879260,17879260,,
907,2010044,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,9606,Homo sapiens (human),[ascorbic acid co-treated with lycopene co-treated with alpha-tocopherol] inhibits the reaction [TNF protein results in increased expression of NFKBIA mrna]|ascorbic acid inhibits the reaction [TNF protein results in increased expression of NFKBIA mrna],,,PMID:25551565,https://www.ncbi.nlm.nih.gov/pubmed/25551565,25551565,,
908,2010045,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [hydrogen peroxide results in increased degradation of NFKBIA protein],,,PMID:25305479,https://www.ncbi.nlm.nih.gov/pubmed/25305479,25305479,,
909,2010046,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4800,NFYA,https://ctdbase.org/detail.go?type=gene&acc=4800,,,4800.0,NFYA,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in decreased expression of NFYA mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
910,2010047,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4814,NINJ1,https://ctdbase.org/detail.go?type=gene&acc=4814,,,4814.0,NINJ1,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in decreased expression of NINJ1 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
911,2010048,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7080,NKX2-1,https://ctdbase.org/detail.go?type=gene&acc=7080,,,7080.0,NKX2-1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [nitrofen results in decreased expression of NKX2-1 protein]|ascorbic acid inhibits the reaction [nitrofen results in decreased expression of NKX2-1 mrna],,,PMID:15083329,https://www.ncbi.nlm.nih.gov/pubmed/15083329,15083329,,
912,2010049,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7080,NKX2-1,https://ctdbase.org/detail.go?type=gene&acc=7080,,,7080.0,NKX2-1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [nitrofen results in decreased expression of NKX2-1 protein],,,PMID:16863852,https://www.ncbi.nlm.nih.gov/pubmed/16863852,16863852,,
913,2010050,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1482,NKX2-5,https://ctdbase.org/detail.go?type=gene&acc=1482,,,1482.0,NKX2-5,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of NKX2-5 mRNA,,,PMID:12668514,https://www.ncbi.nlm.nih.gov/pubmed/12668514,12668514,,
914,2010051,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4830,NME1,https://ctdbase.org/detail.go?type=gene&acc=4830,,,4830.0,NME1,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in decreased expression of NME1 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
915,2010052,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4826,NNAT,https://ctdbase.org/detail.go?type=gene&acc=4826,,,4826.0,NNAT,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of NNAT mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
916,2010053,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9241,NOG,https://ctdbase.org/detail.go?type=gene&acc=9241,,,9241.0,NOG,10116,Rattus norvegicus (Norway rat),NOG protein inhibits the reaction [ginsenoside rg3 inhibits the reaction [dexamethasone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of RUNX2 protein]]]|nog protein inhibits the reaction [ginsenoside rg3 inhibits the reaction [dexamethasone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of BMPR1A protein]]]|nog protein inhibits the reaction [ginsenoside rg3 inhibits the reaction [dexamethasone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of BMP2 protein]]],,,PMID:27387537,https://www.ncbi.nlm.nih.gov/pubmed/27387537,27387537,,
917,2010054,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [aspirin results in increased expression of NOS2 protein],,,PMID:17218764,https://www.ncbi.nlm.nih.gov/pubmed/17218764,17218764,,
918,2010055,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,9606,Homo sapiens (human),Ascorbic acid results in increased activity of NOS2 protein,,,PMID:20179380,https://www.ncbi.nlm.nih.gov/pubmed/20179380,20179380,,
919,2010056,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10090,Mus musculus (house mouse),"Mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of NOS2 mrna]|[ascorbic acid co-treated with ferrous sulfate] results in increased expression of NOS2 protein|mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of NOS2 protein]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of NOS2 protein]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of NOS2 mrna]|[ascorbic acid co-treated with ferrous sulfate] results in increased expression of NOS2 mRNA",,,PMID:23692848,https://www.ncbi.nlm.nih.gov/pubmed/23692848,23692848,,
920,2010057,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,9986,Oryctolagus cuniculus (rabbit),[trimetazidine co-treated with acetylcysteine co-treated with ascorbic acid co-treated with insulin] inhibits the reaction [aluminum phosphide results in increased expression of NOS2 protein],,,PMID:34665895,https://www.ncbi.nlm.nih.gov/pubmed/34665895,34665895,,
921,2010058,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with formaldehyde] results in decreased expression of NOS2 mRNA,,,PMID:27020608,https://www.ncbi.nlm.nih.gov/pubmed/27020608,27020608,,
922,2010059,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with vitamin E co-treated with beta carotene co-treated with copper] inhibits the reaction [streptozocin results in increased expression of NOS2 mrna],,,PMID:18779489,https://www.ncbi.nlm.nih.gov/pubmed/18779489,18779489,,
923,2010060,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [cyclosporine results in increased expression of NOS2 protein],,,PMID:19391111,https://www.ncbi.nlm.nih.gov/pubmed/19391111,19391111,,
924,2010061,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10116,Rattus norvegicus (Norway rat),"Ascorbic acid inhibits the reaction [lipopolysaccharides results in increased expression of NOS2 protein]|ascorbic acid inhibits the reaction [endotoxin, escherichia coli results in increased expression of NOS2 protein]",,,PMID:17637181,https://www.ncbi.nlm.nih.gov/pubmed/17637181,17637181,,
925,2010062,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [isoproterenol results in increased expression of NOS2 protein],,,PMID:19466570,https://www.ncbi.nlm.nih.gov/pubmed/19466570,19466570,,
926,2010063,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [lipopolysaccharides results in increased expression of NOS2 mrna],,,PMID:15612528,https://www.ncbi.nlm.nih.gov/pubmed/15612528,15612528,,
927,2010064,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [nickel sulfate results in increased activity of NOS2 protein],,,PMID:23463385,https://www.ncbi.nlm.nih.gov/pubmed/23463385,23463385,,
928,2010065,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of NOS2,,,PMID:19494560,https://www.ncbi.nlm.nih.gov/pubmed/19494560,19494560,,
929,2010066,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4846,NOS3,https://ctdbase.org/detail.go?type=gene&acc=4846,,,4846.0,NOS3,9606,Homo sapiens (human),Ascorbic acid results in increased activity of NOS3 protein,,,PMID:11243424,https://www.ncbi.nlm.nih.gov/pubmed/11243424,11243424,,
930,2010067,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4846,NOS3,https://ctdbase.org/detail.go?type=gene&acc=4846,,,4846.0,NOS3,9606,Homo sapiens (human),[isosorbide dinitrate co-treated with ascorbic acid] affects the expression of NOS3 mRNA,,,PMID:15719745,https://www.ncbi.nlm.nih.gov/pubmed/15719745,15719745,,
931,2010068,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4846,NOS3,https://ctdbase.org/detail.go?type=gene&acc=4846,,,4846.0,NOS3,10090,Mus musculus (house mouse),Ascorbic acid results in increased phosphorylation of NOS3 protein,,,PMID:21570463,https://www.ncbi.nlm.nih.gov/pubmed/21570463,21570463,,
932,2010069,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4846,NOS3,https://ctdbase.org/detail.go?type=gene&acc=4846,,,4846.0,NOS3,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [formaldehyde results in decreased expression of NOS3 mrna],,,PMID:27020608,https://www.ncbi.nlm.nih.gov/pubmed/27020608,27020608,,
933,2010070,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4846,NOS3,https://ctdbase.org/detail.go?type=gene&acc=4846,,,4846.0,NOS3,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [lead acetate results in increased expression of NOS3 protein],,,PMID:11729227,https://www.ncbi.nlm.nih.gov/pubmed/11729227,11729227,,
934,2010071,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4846,NOS3,https://ctdbase.org/detail.go?type=gene&acc=4846,,,4846.0,NOS3,10116,Rattus norvegicus (Norway rat),[vitamin E co-treated with ascorbic acid] inhibits the reaction [dexamethasone results in decreased expression of NOS3 protein],,,PMID:20068362,https://www.ncbi.nlm.nih.gov/pubmed/20068362,20068362,,
935,2010072,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,27035,NOX1,https://ctdbase.org/detail.go?type=gene&acc=27035,,,27035.0,NOX1,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of NOX1 protein,,,PMID:21570463,https://www.ncbi.nlm.nih.gov/pubmed/21570463,21570463,,
936,2010073,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,50507,NOX4,https://ctdbase.org/detail.go?type=gene&acc=50507,,,50507.0,NOX4,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [hydrogen peroxide results in increased expression of NOX4 protein]|ascorbic acid inhibits the reaction [hydrogen peroxide results in increased expression of NOX4 mrna],,,PMID:25305479,https://www.ncbi.nlm.nih.gov/pubmed/25305479,25305479,,
937,2010074,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,50507,NOX4,https://ctdbase.org/detail.go?type=gene&acc=50507,,,50507.0,NOX4,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of NOX4 protein|ascorbic acid results in increased expression of NOX4 mRNA,,,PMID:21570463,https://www.ncbi.nlm.nih.gov/pubmed/21570463,21570463,,
938,2010075,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4869,NPM1,https://ctdbase.org/detail.go?type=gene&acc=4869,,,4869.0,NPM1,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of NPM1 mRNA,,,PMID:22139585,https://www.ncbi.nlm.nih.gov/pubmed/22139585,22139585,,
939,2010076,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of NQO1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
940,2010077,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [estradiol results in decreased expression of NQO1 mrna]|ascorbic acid inhibits the reaction [estradiol results in decreased expression of NQO1 protein],,,PMID:25130429,https://www.ncbi.nlm.nih.gov/pubmed/25130429,25130429,,
941,2010078,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [[lead acetate results in increased abundance of lead] which results in decreased expression of NQO1 mrna],,,PMID:31610155,https://www.ncbi.nlm.nih.gov/pubmed/31610155,31610155,,
942,2010079,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [[vehicle emissions results in increased abundance of particulate matter] which results in increased expression of NQO1 mrna],,,PMID:32525552,https://www.ncbi.nlm.nih.gov/pubmed/32525552,32525552,,
943,2010080,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [diquat results in decreased expression of NQO1 protein],,,PMID:33475796,https://www.ncbi.nlm.nih.gov/pubmed/33475796,33475796,,
944,2010081,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,10090,Mus musculus (house mouse),Ascorbic acid promotes the reaction [sodium arsenite results in increased expression of NQO1 mrna],,,PMID:16517059,https://www.ncbi.nlm.nih.gov/pubmed/16517059,16517059,,
945,2010082,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with vitamin E] inhibits the reaction [diethylhexyl phthalate results in increased expression of NQO1 protein],,,PMID:29663635,https://www.ncbi.nlm.nih.gov/pubmed/29663635,29663635,,
946,2010083,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of NQO1 protein|ascorbic acid promotes the reaction [cadmium results in increased expression of NQO1 protein],,,PMID:22008531,https://www.ncbi.nlm.nih.gov/pubmed/22008531,22008531,,
947,2010084,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10062,NR1H3,https://ctdbase.org/detail.go?type=gene&acc=10062,,,10062.0,NR1H3,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of NR1H3 mrna|bexarotene promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of NR1H3 mrna]|rosiglitazone promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of NR1H3 mrna]|tributyltin promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of NR1H3 mrna],,,PMID:25932594,https://www.ncbi.nlm.nih.gov/pubmed/25932594,25932594,,
948,2010085,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7025,NR2F1,https://ctdbase.org/detail.go?type=gene&acc=7025,,,7025.0,NR2F1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of NR2F1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
949,2010086,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7026,NR2F2,https://ctdbase.org/detail.go?type=gene&acc=7026,,,7026.0,NR2F2,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of NR2F2 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
950,2010087,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2908,NR3C1,https://ctdbase.org/detail.go?type=gene&acc=2908,,,2908.0,NR3C1,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in increased expression of NR3C1 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
951,2010088,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8013,NR4A3,https://ctdbase.org/detail.go?type=gene&acc=8013,,,8013.0,NR4A3,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in increased expression of NR4A3 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
952,2010089,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2516,NR5A1,https://ctdbase.org/detail.go?type=gene&acc=2516,,,2516.0,NR5A1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of NR5A1 mrna],,,PMID:18602937,https://www.ncbi.nlm.nih.gov/pubmed/18602937,18602937,,
953,2010090,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9315,NREP,https://ctdbase.org/detail.go?type=gene&acc=9315,,,9315.0,NREP,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of NREP mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
954,2010091,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9378,NRXN1,https://ctdbase.org/detail.go?type=gene&acc=9378,,,9378.0,NRXN1,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of NRXN1 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
955,2010092,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7468,NSD2,https://ctdbase.org/detail.go?type=gene&acc=7468,,,7468.0,NSD2,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in decreased expression of NSD2 mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
956,2010093,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4915,NTRK2,https://ctdbase.org/detail.go?type=gene&acc=4915,,,4915.0,NTRK2,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of NTRK2 mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
957,2010094,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,100506658,OCLN,https://ctdbase.org/detail.go?type=gene&acc=100506658,,,100506658.0,OCLN,10141,Cavia porcellus (domestic guinea pig),Ascorbic acid inhibits the reaction [ethanol results in decreased expression of OCLN mrna],,,PMID:24239723,https://www.ncbi.nlm.nih.gov/pubmed/24239723,24239723,,
958,2010095,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,100506658,OCLN,https://ctdbase.org/detail.go?type=gene&acc=100506658,,,100506658.0,OCLN,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate affects the localization of OCLN protein],,,PMID:29940330,https://www.ncbi.nlm.nih.gov/pubmed/29940330,29940330,,
959,2010096,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4967,OGDH,https://ctdbase.org/detail.go?type=gene&acc=4967,,,4967.0,OGDH,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [arsenic results in decreased activity of OGDH protein],,,PMID:24295472,https://www.ncbi.nlm.nih.gov/pubmed/24295472,24295472,,
960,2010097,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4967,OGDH,https://ctdbase.org/detail.go?type=gene&acc=4967,,,4967.0,OGDH,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [sodium arsenite results in decreased activity of OGDH protein],,,PMID:12915223,https://www.ncbi.nlm.nih.gov/pubmed/12915223,12915223,,
961,2010098,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,55239,OGFOD1,https://ctdbase.org/detail.go?type=gene&acc=55239,,,55239.0,OGFOD1,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of OGFOD1 mrna|[arsenic trioxide co-treated with ascorbic acid] results in decreased expression of OGFOD1 mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
962,2010099,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4968,OGG1,https://ctdbase.org/detail.go?type=gene&acc=4968,,,4968.0,OGG1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [sodium arsenite results in decreased expression of OGG1 protein]|ascorbic acid inhibits the reaction [sodium arsenite results in increased methylation of OGG1 promoter],,,PMID:33388378,https://www.ncbi.nlm.nih.gov/pubmed/33388378,33388378,,
963,2010100,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10215,OLIG2,https://ctdbase.org/detail.go?type=gene&acc=10215,,,10215.0,OLIG2,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of OLIG2 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
964,2010101,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4973,OLR1,https://ctdbase.org/detail.go?type=gene&acc=4973,,,4973.0,OLR1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of OLR1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
965,2010102,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10956,OS9,https://ctdbase.org/detail.go?type=gene&acc=10956,,,10956.0,OS9,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in decreased expression of OS9 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
966,2010103,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5015,OTX2,https://ctdbase.org/detail.go?type=gene&acc=5015,,,5015.0,OTX2,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of OTX2 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
967,2010104,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8974,P4HA2,https://ctdbase.org/detail.go?type=gene&acc=8974,,,8974.0,P4HA2,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of P4HA2 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
968,2010105,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,54681,P4HTM,https://ctdbase.org/detail.go?type=gene&acc=54681,,,54681.0,P4HTM,9606,Homo sapiens (human),[ketoglutaric acids co-treated with ascorbic acid co-treated with ferrous chloride] results in increased activity of P4HTM protein,,,PMID:19263519,https://www.ncbi.nlm.nih.gov/pubmed/19263519,19263519,,
969,2010106,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5066,PAM,https://ctdbase.org/detail.go?type=gene&acc=5066,,,5066.0,PAM,10029,Cricetulus griseus (Chinese hamster),Ascorbic acid results in decreased activity of PAM protein,,,PMID:16704972,https://www.ncbi.nlm.nih.gov/pubmed/16704972,16704972,,
970,2010107,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9061,PAPSS1,https://ctdbase.org/detail.go?type=gene&acc=9061,,,9061.0,PAPSS1,9606,Homo sapiens (human),[arsenic trioxide co-treated with ascorbic acid] results in decreased expression of PAPSS1 mrna|ascorbic acid results in decreased expression of PAPSS1 mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
971,2010108,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [fenretinide results in increased cleavage of PARP1 protein],,,PMID:16407847,https://www.ncbi.nlm.nih.gov/pubmed/16407847,16407847,,
972,2010109,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [oleanolic acid results in increased cleavage of PARP1 protein],,,PMID:22678527,https://www.ncbi.nlm.nih.gov/pubmed/22678527,22678527,,
973,2010110,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606,Homo sapiens (human),Ascorbic acid promotes the reaction [chromium hexavalent ion results in increased cleavage of PARP1 protein],,,PMID:17301063,https://www.ncbi.nlm.nih.gov/pubmed/17301063,17301063,,
974,2010111,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606,Homo sapiens (human),[juglone co-treated with ascorbic acid] results in increased degradation of PARP1 protein,,,PMID:29992683,https://www.ncbi.nlm.nih.gov/pubmed/29992683,29992683,,
975,2010112,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,10090,Mus musculus (house mouse),"[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of PARP1 mrna|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of PARP1 mrna]",,,PMID:26492236,https://www.ncbi.nlm.nih.gov/pubmed/26492236,26492236,,
976,2010113,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [cadmium results in increased cleavage of PARP1 protein],,,PMID:19433269,https://www.ncbi.nlm.nih.gov/pubmed/19433269,19433269,,
977,2010114,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in increased cleavage of PARP1 protein],,,PMID:21262251,https://www.ncbi.nlm.nih.gov/pubmed/21262251,21262251,,
978,2010115,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,67307,PBLD2,https://ctdbase.org/detail.go?type=gene&acc=67307,,,67307.0,Pbld2,10090,Mus musculus (house mouse),Ascorbic acid affects the expression of PBLD2 protein,,,PMID:19224539,https://www.ncbi.nlm.nih.gov/pubmed/19224539,19224539,,
979,2010116,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,26025,PCDHGA12,https://ctdbase.org/detail.go?type=gene&acc=26025,,,26025.0,PCDHGA12,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of PCDHGA12 mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
980,2010117,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5106,PCK2,https://ctdbase.org/detail.go?type=gene&acc=5106,,,5106.0,PCK2,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of PCK2 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
981,2010118,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5111,PCNA,https://ctdbase.org/detail.go?type=gene&acc=5111,,,5111.0,PCNA,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of PCNA protein,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
982,2010119,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5111,PCNA,https://ctdbase.org/detail.go?type=gene&acc=5111,,,5111.0,PCNA,9669,Mustela putorius furo (domestic ferret),[beta carotene co-treated with alpha-tocopherol co-treated with ascorbic acid] inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of PCNA protein],,,PMID:16401635,https://www.ncbi.nlm.nih.gov/pubmed/16401635,16401635,,
983,2010120,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5111,PCNA,https://ctdbase.org/detail.go?type=gene&acc=5111,,,5111.0,PCNA,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with kojic acid co-treated with diethylnitrosamine] results in increased expression of PCNA protein,,,PMID:18544905,https://www.ncbi.nlm.nih.gov/pubmed/18544905,18544905,,
984,2010121,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5111,PCNA,https://ctdbase.org/detail.go?type=gene&acc=5111,,,5111.0,PCNA,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of PCNA protein],,,PMID:21621607,https://www.ncbi.nlm.nih.gov/pubmed/21621607,21621607,,
985,2010122,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5121,PCP4,https://ctdbase.org/detail.go?type=gene&acc=5121,,,5121.0,PCP4,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of PCP4 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
986,2010123,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,255738,PCSK9,https://ctdbase.org/detail.go?type=gene&acc=255738,,,255738.0,PCSK9,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of PCSK9 mrna|foxo3 protein affects the reaction [ascorbic acid results in decreased expression of PCSK9 protein]|ascorbic acid results in decreased expression of and results in decreased secretion of PCSK9 protein|ascorbic acid affects the reaction [GULO protein affects the expression of PCSK9 protein]|ascorbic acid results in decreased expression of PCSK9 protein,,,PMID:32913121,https://www.ncbi.nlm.nih.gov/pubmed/32913121,32913121,,
987,2010124,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5136,PDE1A,https://ctdbase.org/detail.go?type=gene&acc=5136,,,5136.0,PDE1A,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of PDE1A mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
988,2010125,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5159,PDGFRB,https://ctdbase.org/detail.go?type=gene&acc=5159,,,5159.0,PDGFRB,10116,Rattus norvegicus (Norway rat),[alpha-tocopherol co-treated with beta carotene co-treated with ascorbic acid co-treated with zinc co-treated with sodium selenite] results in decreased expression of PDGFRB protein|[alpha-tocopherol co-treated with beta carotene co-treated with ascorbic acid co-treated with zinc co-treated with sodium selenite] results in decreased expression of PDGFRB mRNA,,,PMID:23859036,https://www.ncbi.nlm.nih.gov/pubmed/23859036,23859036,,
989,2010126,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,64714,PDIA2,https://ctdbase.org/detail.go?type=gene&acc=64714,,,64714.0,PDIA2,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of PDIA2 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
990,2010127,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2923,PDIA3,https://ctdbase.org/detail.go?type=gene&acc=2923,,,2923.0,PDIA3,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [fenretinide results in increased expression of PDIA3 mrna]|ascorbic acid inhibits the reaction [fenretinide results in increased expression of PDIA3 protein],,,PMID:17353921,https://www.ncbi.nlm.nih.gov/pubmed/17353921,17353921,,
991,2010128,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5037,PEBP1,https://ctdbase.org/detail.go?type=gene&acc=5037,,,5037.0,PEBP1,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of PEBP1 mrna|ascorbic acid results in increased expression of PEBP1 protein,,,PMID:19224539,https://www.ncbi.nlm.nih.gov/pubmed/19224539,19224539,,
992,2010129,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5184,PEPD,https://ctdbase.org/detail.go?type=gene&acc=5184,,,5184.0,PEPD,9606,Homo sapiens (human),Ascorbic acid results in increased activity of PEPD protein,,,PMID:28285367,https://www.ncbi.nlm.nih.gov/pubmed/28285367,28285367,,
993,2010130,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5198,PFAS,https://ctdbase.org/detail.go?type=gene&acc=5198,,,5198.0,PFAS,9606,Homo sapiens (human),[arsenic trioxide co-treated with ascorbic acid] results in increased expression of PFAS mrna|ascorbic acid results in increased expression of PFAS mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
994,2010131,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5207,PFKFB1,https://ctdbase.org/detail.go?type=gene&acc=5207,,,5207.0,PFKFB1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [iodoacetamide affects the activity of PFKFB1 protein],,,PMID:6092364,https://www.ncbi.nlm.nih.gov/pubmed/6092364,6092364,,
995,2010132,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5253,PHF2,https://ctdbase.org/detail.go?type=gene&acc=5253,,,5253.0,PHF2,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of PHF2 mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
996,2010133,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,26227,PHGDH,https://ctdbase.org/detail.go?type=gene&acc=26227,,,26227.0,PHGDH,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of PHGDH mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
997,2010134,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,22822,PHLDA1,https://ctdbase.org/detail.go?type=gene&acc=22822,,,22822.0,PHLDA1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of PHLDA1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
998,2010135,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7262,PHLDA2,https://ctdbase.org/detail.go?type=gene&acc=7262,,,7262.0,PHLDA2,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of PHLDA2 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
999,2010136,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5295,PIK3R1,https://ctdbase.org/detail.go?type=gene&acc=5295,,,5295.0,PIK3R1,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of PIK3R1 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1000,2010137,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5315,PKM,https://ctdbase.org/detail.go?type=gene&acc=5315,,,5315.0,PKM,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of PKM mRNA,,,PMID:22139585,https://www.ncbi.nlm.nih.gov/pubmed/22139585,22139585,,
1001,2010138,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,11145,PLAAT3,https://ctdbase.org/detail.go?type=gene&acc=11145,,,11145.0,PLAAT3,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of PLAAT3 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1002,2010139,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5327,PLAT,https://ctdbase.org/detail.go?type=gene&acc=5327,,,5327.0,PLAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid promotes the reaction [vitamin E results in increased activity of PLAT protein]|[ascorbic acid co-treated with vitamin E] inhibits the reaction [endosulfan results in increased activity of PLAT protein],,,PMID:21804306,https://www.ncbi.nlm.nih.gov/pubmed/21804306,21804306,,
1003,2010140,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5340,PLG,https://ctdbase.org/detail.go?type=gene&acc=5340,,,5340.0,PLG,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [arsenic promotes the reaction [humic substances results in decreased activity of PLG protein]]|ascorbic acid inhibits the reaction [humic substances results in decreased activity of PLG protein],,,PMID:11419606,https://www.ncbi.nlm.nih.gov/pubmed/11419606,11419606,,
1004,2010141,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5346,PLIN1,https://ctdbase.org/detail.go?type=gene&acc=5346,,,5346.0,PLIN1,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PLIN1 mRNA,,,PMID:25932594,https://www.ncbi.nlm.nih.gov/pubmed/25932594,25932594,,
1005,2010142,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5346,PLIN1,https://ctdbase.org/detail.go?type=gene&acc=5346,,,5346.0,PLIN1,10090,Mus musculus (house mouse),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PLIN1 mrna|rosiglitazone promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PLIN1 mrna]|tretinoin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PLIN1 mrna]|tetrabromobisphenol A promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PLIN1 mrna]|triphenyltin hydroxide promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PLIN1 mrna]|pioglitazone promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PLIN1 mrna],,,PMID:32473317,https://www.ncbi.nlm.nih.gov/pubmed/32473317,32473317,,
1006,2010143,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5347,PLK1,https://ctdbase.org/detail.go?type=gene&acc=5347,,,5347.0,PLK1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of PLK1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1007,2010144,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10769,PLK2,https://ctdbase.org/detail.go?type=gene&acc=10769,,,10769.0,PLK2,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of PLK2 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1008,2010145,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5350,PLN,https://ctdbase.org/detail.go?type=gene&acc=5350,,,5350.0,PLN,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of PLN mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1009,2010146,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5358,PLS3,https://ctdbase.org/detail.go?type=gene&acc=5358,,,5358.0,PLS3,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of PLS3 protein|ascorbic acid results in increased expression of PLS3 mRNA,,,PMID:22139585,https://www.ncbi.nlm.nih.gov/pubmed/22139585,22139585,,
1010,2010147,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5366,PMAIP1,https://ctdbase.org/detail.go?type=gene&acc=5366,,,5366.0,PMAIP1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [fenretinide results in increased expression of PMAIP1 mrna],,,PMID:17216584,https://www.ncbi.nlm.nih.gov/pubmed/17216584,17216584,,
1011,2010148,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5376,PMP22,https://ctdbase.org/detail.go?type=gene&acc=5376,,,5376.0,PMP22,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of PMP22 mRNA,,,PMID:15034573|PMID:17303424,https://www.ncbi.nlm.nih.gov/pubmed/15034573|https://www.ncbi.nlm.nih.gov/pubmed/17303424,15034573|17303424,,
1012,2010149,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5376,PMP22,https://ctdbase.org/detail.go?type=gene&acc=5376,,,5376.0,PMP22,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [bucladesine results in increased activity of PMP22 promoter],,,PMID:15034573,https://www.ncbi.nlm.nih.gov/pubmed/15034573,15034573,,
1013,2010150,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4860,PNP,https://ctdbase.org/detail.go?type=gene&acc=4860,,,4860.0,PNP,10090,Mus musculus (house mouse),Ascorbic acid affects the expression of PNP protein,,,PMID:19224539,https://www.ncbi.nlm.nih.gov/pubmed/19224539,19224539,,
1014,2010151,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5444,PON1,https://ctdbase.org/detail.go?type=gene&acc=5444,,,5444.0,PON1,9606,Homo sapiens (human),"Oleic acid inhibits the reaction [[ascorbic acid co-treated with copper sulfate] results in decreased activity of PON1 protein]|erucic acid inhibits the reaction [[ascorbic acid co-treated with copper sulfate] results in decreased activity of PON1 protein]|1,2-dioleoyl-sn-glycero-3-phosphoglycerol inhibits the reaction [[ascorbic acid co-treated with copper sulfate] results in decreased activity of PON1 protein]|palmitoleic acid inhibits the reaction [[ascorbic acid co-treated with copper sulfate] results in decreased activity of PON1 protein]|1,2-oleoylphosphatidylcholine inhibits the reaction [[ascorbic acid co-treated with copper sulfate] results in decreased activity of PON1 protein]",,,PMID:12871208,https://www.ncbi.nlm.nih.gov/pubmed/12871208,12871208,,
1015,2010152,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5444,PON1,https://ctdbase.org/detail.go?type=gene&acc=5444,,,5444.0,PON1,9606,Homo sapiens (human),"Ascorbic acid results in decreased activity of PON1 protein|sulfhydryl compounds inhibits the reaction [copper promotes the reaction [ascorbic acid results in decreased activity of PON1 protein]]|oleic acid inhibits the reaction [copper promotes the reaction [ascorbic acid results in decreased activity of PON1 protein]]|copper promotes the reaction [ascorbic acid results in decreased activity of PON1 protein]|cat protein inhibits the reaction [copper promotes the reaction [ascorbic acid results in decreased activity of PON1 protein]]|1,2-dioleoyl-sn-glycero-3-phosphoglycerol inhibits the reaction [copper promotes the reaction [ascorbic acid results in decreased activity of PON1 protein]]|hypochlorous acid promotes the reaction [copper promotes the reaction [ascorbic acid results in decreased activity of PON1 protein]]|1,2-dipalmitoylphosphatidylglycerol inhibits the reaction [copper promotes the reaction [ascorbic acid results in decreased activity of PON1 protein]]",,,PMID:15104111,https://www.ncbi.nlm.nih.gov/pubmed/15104111,15104111,,
1016,2010153,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5444,PON1,https://ctdbase.org/detail.go?type=gene&acc=5444,,,5444.0,PON1,9606,Homo sapiens (human),[ascorbic acid co-treated with ferrous sulfate] inhibits the reaction [PON1 protein results in increased hydrolysis of paraoxon]|[ascorbic acid co-treated with copper sulfate] inhibits the reaction [PON1 protein results in increased hydrolysis of paraoxon]|[ascorbic acid co-treated with ferrous sulfate] inhibits the reaction [PON1 protein results in increased hydrolysis of phenylacetic acid]|[ascorbic acid co-treated with copper sulfate] inhibits the reaction [PON1 protein results in increased hydrolysis of phenylacetic acid],,,PMID:15375178,https://www.ncbi.nlm.nih.gov/pubmed/15375178,15375178,,
1017,2010154,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5444,PON1,https://ctdbase.org/detail.go?type=gene&acc=5444,,,5444.0,PON1,9606,Homo sapiens (human),[ascorbic acid co-treated with ferrous sulfate] results in decreased activity of PON1 protein|[ascorbic acid co-treated with copper sulfate] results in decreased activity of PON1 protein,,,PMID:12871208|PMID:15375178,https://www.ncbi.nlm.nih.gov/pubmed/12871208|https://www.ncbi.nlm.nih.gov/pubmed/15375178,12871208|15375178,,
1018,2010155,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5444,PON1,https://ctdbase.org/detail.go?type=gene&acc=5444,,,5444.0,PON1,9606,Homo sapiens (human),[iron co-treated with ascorbic acid] results in decreased expression of PON1 protein|[iron co-treated with ascorbic acid] results in decreased activity of PON1 protein|butylated hydroxytoluene inhibits the reaction [[iron co-treated with ascorbic acid] results in decreased expression of PON1 protein],,,PMID:16052486,https://www.ncbi.nlm.nih.gov/pubmed/16052486,16052486,,
1019,2010156,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5444,PON1,https://ctdbase.org/detail.go?type=gene&acc=5444,,,5444.0,PON1,9606,Homo sapiens (human),"PON1 protein results in increased metabolism of [acrolein binds to ascorbic acid]|[pon1 protein results in increased metabolism of [acrolein binds to ascorbic acid]] which results in increased chemical synthesis of 5,6,7,8-tetrahydroxy-4-oxooctanal",,,PMID:20353174,https://www.ncbi.nlm.nih.gov/pubmed/20353174,20353174,,
1020,2010157,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5721,PSME2,https://ctdbase.org/detail.go?type=gene&acc=5721,,,5721.0,PSME2,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of PSME2 protein|ascorbic acid results in increased expression of PSME2 mRNA,,,PMID:22139585,https://www.ncbi.nlm.nih.gov/pubmed/22139585,22139585,,
1021,2010158,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5742,PTGS1,https://ctdbase.org/detail.go?type=gene&acc=5742,,,5742.0,PTGS1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [formaldehyde results in increased expression of PTGS1 mrna],,,PMID:27020608,https://www.ncbi.nlm.nih.gov/pubmed/27020608,27020608,,
1022,2010159,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [aspirin results in increased expression of PTGS2 mrna],,,PMID:17218764,https://www.ncbi.nlm.nih.gov/pubmed/17218764,17218764,,
1023,2010160,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [lead results in increased expression of PTGS2 protein],,,PMID:12761246,https://www.ncbi.nlm.nih.gov/pubmed/12761246,12761246,,
1024,2010161,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5444,PON1,https://ctdbase.org/detail.go?type=gene&acc=5444,,,5444.0,PON1,9606,Homo sapiens (human),"Oleic acid inhibits the reaction [[ascorbic acid co-treated with copper analog co-treated with calcium analog] results in decreased activity of pon1]|linoleic acid inhibits the reaction [9,11-linoleic acid inhibits the reaction [[ascorbic acid co-treated with copper analog co-treated with calcium analog] results in decreased activity of pon1]]|trans-10,cis-12-conjugated linoleic acid inhibits the reaction [[ascorbic acid co-treated with copper analog co-treated with calcium analog] results in decreased activity of PON1]|9,11-linoleic acid inhibits the reaction [[ascorbic acid co-treated with copper analog co-treated with calcium analog] results in decreased activity of pon1]|linoleic acid inhibits the reaction [trans-10,cis-12-conjugated linoleic acid inhibits the reaction [[ascorbic acid co-treated with copper analog co-treated with calcium analog] results in decreased activity of pon1]]|[ascorbic acid co-treated with copper analog co-treated with calcium analog] results in decreased activity of PON1",,,PMID:12934671,https://www.ncbi.nlm.nih.gov/pubmed/12934671,12934671,,
1025,2010162,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5445,PON2,https://ctdbase.org/detail.go?type=gene&acc=5445,,,5445.0,PON2,9606,Homo sapiens (human),"PON2 protein results in increased metabolism of [acrolein binds to ascorbic acid]|[pon2 protein results in increased metabolism of [acrolein binds to ascorbic acid]] which results in increased chemical synthesis of 5,6,7,8-tetrahydroxy-4-oxooctanal",,,PMID:20353174,https://www.ncbi.nlm.nih.gov/pubmed/20353174,20353174,,
1026,2010163,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5460,POU5F1,https://ctdbase.org/detail.go?type=gene&acc=5460,,,5460.0,POU5F1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of POU5F1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1027,2010164,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5460,POU5F1,https://ctdbase.org/detail.go?type=gene&acc=5460,,,5460.0,POU5F1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [cobalt results in increased expression of POU5F1 protein],,,PMID:24497960,https://www.ncbi.nlm.nih.gov/pubmed/24497960,24497960,,
1028,2010165,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5460,POU5F1,https://ctdbase.org/detail.go?type=gene&acc=5460,,,5460.0,POU5F1,9606,Homo sapiens (human),Ascorbic acid results in increased expression of POU5F1 mRNA,,,PMID:21166886,https://www.ncbi.nlm.nih.gov/pubmed/21166886,21166886,,
1029,2010166,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5460,POU5F1,https://ctdbase.org/detail.go?type=gene&acc=5460,,,5460.0,POU5F1,10090,Mus musculus (house mouse),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in decreased expression of POU5F1 mRNA,,,PMID:28189605,https://www.ncbi.nlm.nih.gov/pubmed/28189605,28189605,,
1030,2010167,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,13489,Dicentrarchus labrax (European seabass),Ascorbic acid affects the expression of PPARG mRNA,,,PMID:21281732,https://www.ncbi.nlm.nih.gov/pubmed/21281732,21281732,,
1031,2010168,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA,,,PMID:25932594,https://www.ncbi.nlm.nih.gov/pubmed/25932594,25932594,,
1032,2010169,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10090,Mus musculus (house mouse),Rosiglitazone promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PPARG mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PPARG mrna|tretinoin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PPARG mrna],,,PMID:32473317,https://www.ncbi.nlm.nih.gov/pubmed/32473317,32473317,,
1033,2010170,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10090,Mus musculus (house mouse),Tetrachlorodibenzodioxin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of PPARG mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of PPARG mrna|src protein promotes the reaction [tetrachlorodibenzodioxin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of PPARG mrna]],,,PMID:14505802,https://www.ncbi.nlm.nih.gov/pubmed/14505802,14505802,,
1034,2010171,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9823,Sus scrofa (pig),"[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of PPARG mrna|troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of PPARG mrna]|2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of PPARG mrna]",,,PMID:30481989,https://www.ncbi.nlm.nih.gov/pubmed/30481989,30481989,,
1035,2010172,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10891,PPARGC1A,https://ctdbase.org/detail.go?type=gene&acc=10891,,,10891.0,PPARGC1A,9606,Homo sapiens (human),Ascorbic acid results in increased expression of PPARGC1A mRNA,,,PMID:23056435,https://www.ncbi.nlm.nih.gov/pubmed/23056435,23056435,,
1036,2010173,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,23082,PPRC1,https://ctdbase.org/detail.go?type=gene&acc=23082,,,23082.0,PPRC1,9606,Homo sapiens (human),[arsenic trioxide co-treated with ascorbic acid] results in increased expression of PPRC1 mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
1037,2010174,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,400736,PRAMEF13,https://ctdbase.org/detail.go?type=gene&acc=400736,,,400736.0,PRAMEF13,9606,Homo sapiens (human),Ascorbic acid results in increased expression of PRAMEF13 mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
1038,2010175,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5052,PRDX1,https://ctdbase.org/detail.go?type=gene&acc=5052,,,5052.0,PRDX1,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with kojic acid co-treated with diethylnitrosamine] results in decreased expression of PRDX1 mRNA,,,PMID:18544905,https://www.ncbi.nlm.nih.gov/pubmed/18544905,18544905,,
1039,2010176,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10935,PRDX3,https://ctdbase.org/detail.go?type=gene&acc=10935,,,10935.0,PRDX3,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in decreased expression of PRDX3 mrna],,,PMID:23470461,https://www.ncbi.nlm.nih.gov/pubmed/23470461,23470461,,
1040,2010177,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5551,PRF1,https://ctdbase.org/detail.go?type=gene&acc=5551,,,5551.0,PRF1,10090,Mus musculus (house mouse),Ascorbic acid deficiency results in decreased expression of PRF1 mRNA,,,PMID:22306178,https://www.ncbi.nlm.nih.gov/pubmed/22306178,22306178,,
1041,2010178,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5579,PRKCB,https://ctdbase.org/detail.go?type=gene&acc=5579,,,5579.0,PRKCB,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of PRKCB mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
1042,2010179,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5588,PRKCQ,https://ctdbase.org/detail.go?type=gene&acc=5588,,,5588.0,PRKCQ,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in increased expression of PRKCQ mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
1043,2010180,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5617,PRL,https://ctdbase.org/detail.go?type=gene&acc=5617,,,5617.0,PRL,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chlorodiphenyl (54% chlorine) results in decreased expression of PRL protein],,,PMID:16298753,https://www.ncbi.nlm.nih.gov/pubmed/16298753,16298753,,
1044,2010181,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5617,PRL,https://ctdbase.org/detail.go?type=gene&acc=5617,,,5617.0,PRL,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of PRL protein],,,PMID:18602937,https://www.ncbi.nlm.nih.gov/pubmed/18602937,18602937,,
1045,2010182,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5627,PROS1,https://ctdbase.org/detail.go?type=gene&acc=5627,,,5627.0,PROS1,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of PROS1 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1046,2010183,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,38175,PSA,https://ctdbase.org/detail.go?type=gene&acc=38175,,,38175.0,Psa,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of PSA mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
1047,2010184,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5694,PSMB6,https://ctdbase.org/detail.go?type=gene&acc=5694,,,5694.0,PSMB6,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [epoxomicin results in increased expression of PSMB6 mrna]|ascorbic acid inhibits the reaction [rotenone results in increased expression of PSMB6 mrna],,,PMID:27345029,https://www.ncbi.nlm.nih.gov/pubmed/27345029,27345029,,
1048,2010185,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5702,PSMC3,https://ctdbase.org/detail.go?type=gene&acc=5702,,,5702.0,PSMC3,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in increased expression of PSMC3 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
1049,2010186,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [[vehicle emissions results in increased abundance of particulate matter] which results in increased expression of PTGS2 mrna],,,PMID:32525552,https://www.ncbi.nlm.nih.gov/pubmed/32525552,32525552,,
1050,2010187,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606,Homo sapiens (human),[juglone co-treated with ascorbic acid] results in decreased expression of PTGS2 mRNA,,,PMID:29992683,https://www.ncbi.nlm.nih.gov/pubmed/29992683,29992683,,
1051,2010188,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [JP8 aviation fuel results in increased expression of PTGS2 mrna],,,PMID:19095747,https://www.ncbi.nlm.nih.gov/pubmed/19095747,19095747,,
1052,2010189,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10090,Mus musculus (house mouse),[quartz co-treated with ascorbic acid] results in increased expression of PTGS2 protein|[quartz co-treated with ascorbic acid] results in increased expression of PTGS2 mRNA,,,PMID:17222177,https://www.ncbi.nlm.nih.gov/pubmed/17222177,17222177,,
1053,2010190,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10116,Rattus norvegicus (Norway rat),"Ascorbic acid inhibits the reaction [lipopolysaccharides results in increased expression of PTGS2 protein]|ascorbic acid inhibits the reaction [endotoxin, escherichia coli results in increased expression of PTGS2 protein]",,,PMID:17637181,https://www.ncbi.nlm.nih.gov/pubmed/17637181,17637181,,
1054,2010191,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [formaldehyde results in increased expression of PTGS2 mrna],,,PMID:27020608,https://www.ncbi.nlm.nih.gov/pubmed/27020608,27020608,,
1055,2010192,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [lead acetate results in increased expression of PTGS2 protein],,,PMID:22728154,https://www.ncbi.nlm.nih.gov/pubmed/22728154,22728154,,
1056,2010193,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGS2 protein],,,PMID:21873648,https://www.ncbi.nlm.nih.gov/pubmed/21873648,21873648,,
1057,2010194,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5745,PTH1R,https://ctdbase.org/detail.go?type=gene&acc=5745,,,5745.0,PTH1R,10090,Mus musculus (house mouse),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of PTH1R mrna|cadmium sulfate inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of PTH1R mrna],,,PMID:28189605,https://www.ncbi.nlm.nih.gov/pubmed/28189605,28189605,,
1058,2010195,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5744,PTHLH,https://ctdbase.org/detail.go?type=gene&acc=5744,,,5744.0,PTHLH,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of PTHLH mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1059,2010196,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5747,PTK2,https://ctdbase.org/detail.go?type=gene&acc=5747,,,5747.0,PTK2,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of PTK2 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1060,2010197,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5764,PTN,https://ctdbase.org/detail.go?type=gene&acc=5764,,,5764.0,PTN,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of PTN mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
1061,2010198,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5816,PVALB,https://ctdbase.org/detail.go?type=gene&acc=5816,,,5816.0,PVALB,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [[lead acetate results in increased abundance of lead] which results in decreased expression of PVALB protein],,,PMID:31708536,https://www.ncbi.nlm.nih.gov/pubmed/31708536,31708536,,
1062,2010199,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5865,RAB3B,https://ctdbase.org/detail.go?type=gene&acc=5865,,,5865.0,RAB3B,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of RAB3B mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1063,2010200,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5865,RAB3B,https://ctdbase.org/detail.go?type=gene&acc=5865,,,5865.0,RAB3B,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of RAB3B mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1064,2010201,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5870,RAB6A,https://ctdbase.org/detail.go?type=gene&acc=5870,,,5870.0,RAB6A,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in decreased expression of RAB6A mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
1065,2010202,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5879,RAC1,https://ctdbase.org/detail.go?type=gene&acc=5879,,,5879.0,RAC1,9606,Homo sapiens (human),Ascorbic acid promotes the reaction [arsenic trioxide results in increased activity of RAC1 protein],,,PMID:12239215,https://www.ncbi.nlm.nih.gov/pubmed/12239215,12239215,,
1066,2010203,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10111,RAD50,https://ctdbase.org/detail.go?type=gene&acc=10111,,,10111.0,RAD50,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of RAD50 mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
1067,2010204,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5889,RAD51C,https://ctdbase.org/detail.go?type=gene&acc=5889,,,5889.0,RAD51C,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in increased expression of RAD51C mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
1068,2010205,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,25788,RAD54B,https://ctdbase.org/detail.go?type=gene&acc=25788,,,25788.0,RAD54B,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of RAD54B mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1069,2010206,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5901,RAN,https://ctdbase.org/detail.go?type=gene&acc=5901,,,5901.0,RAN,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of RAN protein|ascorbic acid results in increased expression of RAN mRNA,,,PMID:22139585,https://www.ncbi.nlm.nih.gov/pubmed/22139585,22139585,,
1070,2010207,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5916,RARG,https://ctdbase.org/detail.go?type=gene&acc=5916,,,5916.0,RARG,13489,Dicentrarchus labrax (European seabass),Ascorbic acid results in decreased expression of RARG mRNA,,,PMID:21281732,https://www.ncbi.nlm.nih.gov/pubmed/21281732,21281732,,
1071,2010208,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,146713,RBFOX3,https://ctdbase.org/detail.go?type=gene&acc=146713,,,146713.0,RBFOX3,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of RBFOX3 protein|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of RBFOX3 mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
1072,2010209,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,282996,RBM20,https://ctdbase.org/detail.go?type=gene&acc=282996,,,282996.0,RBM20,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of RBM20 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1073,2010210,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1827,RCAN1,https://ctdbase.org/detail.go?type=gene&acc=1827,,,1827.0,RCAN1,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in increased expression of RCAN1 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
1074,2010211,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5966,REL,https://ctdbase.org/detail.go?type=gene&acc=5966,,,5966.0,REL,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [norepinephrine affects the localization of REL protein],,,PMID:23114885,https://www.ncbi.nlm.nih.gov/pubmed/23114885,23114885,,
1075,2010212,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10141,Cavia porcellus (domestic guinea pig),Ascorbic acid inhibits the reaction [ethanol results in decreased expression of RELA protein],,,PMID:24239723,https://www.ncbi.nlm.nih.gov/pubmed/24239723,24239723,,
1076,2010213,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,9606,Homo sapiens (human),[ascorbic acid co-treated with alpha-tocopherol co-treated with ferulic acid] inhibits the reaction [[ozone co-treated with oxygen] results in increased localization of RELA protein],,,PMID:26270818,https://www.ncbi.nlm.nih.gov/pubmed/26270818,26270818,,
1077,2010214,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,9606,Homo sapiens (human),[ascorbic acid co-treated with ferrous sulfate] results in increased activity of RELA protein|[hyaluronic acid co-treated with chondroitin sulfates] inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased activity of RELA protein],,,PMID:17879260,https://www.ncbi.nlm.nih.gov/pubmed/17879260,17879260,,
1078,2010215,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,9606,Homo sapiens (human),"Ascorbic acid inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased phosphorylation of RELA protein]",,,PMID:35349355,https://www.ncbi.nlm.nih.gov/pubmed/35349355,35349355,,
1079,2010216,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [hydrogen peroxide results in increased phosphorylation of and affects the localization of RELA protein],,,PMID:25305479,https://www.ncbi.nlm.nih.gov/pubmed/25305479,25305479,,
1080,2010217,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [norepinephrine affects the localization of RELA protein],,,PMID:23114885,https://www.ncbi.nlm.nih.gov/pubmed/23114885,23114885,,
1081,2010218,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10090,Mus musculus (house mouse),"[ascorbic acid co-treated with ferrous sulfate] results in increased activity of [NFKB1 protein binds to RELA protein]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased activity of [NFKB1 protein binds to RELA protein]]|mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased activity of [NFKB1 protein binds to RELA protein]]",,,PMID:23692848,https://www.ncbi.nlm.nih.gov/pubmed/23692848,23692848,,
1082,2010219,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [cyclosporine results in increased expression of RELA protein],,,PMID:19391111,https://www.ncbi.nlm.nih.gov/pubmed/19391111,19391111,,
1083,2010220,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [lead acetate affects the localization of RELA protein],,,PMID:22728154,https://www.ncbi.nlm.nih.gov/pubmed/22728154,22728154,,
1084,2010221,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,85397,RGS8,https://ctdbase.org/detail.go?type=gene&acc=85397,,,85397.0,RGS8,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of RGS8 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1085,2010222,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,22895,RPH3A,https://ctdbase.org/detail.go?type=gene&acc=22895,,,22895.0,RPH3A,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of RPH3A mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
1086,2010223,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6235,RPS29,https://ctdbase.org/detail.go?type=gene&acc=6235,,,6235.0,RPS29,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of RPS29 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1087,2010224,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3921,RPSA,https://ctdbase.org/detail.go?type=gene&acc=3921,,,3921.0,RPSA,10090,Mus musculus (house mouse),Ascorbic acid affects the expression of RPSA protein,,,PMID:19224539,https://www.ncbi.nlm.nih.gov/pubmed/19224539,19224539,,
1088,2010225,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6236,RRAD,https://ctdbase.org/detail.go?type=gene&acc=6236,,,6236.0,RRAD,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of RRAD mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1089,2010226,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860.0,RUNX2,9606,Homo sapiens (human),EZH2 protein inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of RUNX2 mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of RUNX2 mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
1090,2010227,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860.0,RUNX2,9606,Homo sapiens (human),Ascorbic acid results in increased expression of RUNX2 mRNA,,,PMID:28105418,https://www.ncbi.nlm.nih.gov/pubmed/28105418,28105418,,
1091,2010228,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860.0,RUNX2,9606,Homo sapiens (human),[cholecalciferol co-treated with beta-glycerophosphoric acid co-treated with ascorbic acid] results in increased expression of RUNX2 mRNA,,,PMID:17692823,https://www.ncbi.nlm.nih.gov/pubmed/17692823,17692823,,
1092,2010229,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860.0,RUNX2,9606,Homo sapiens (human),"[SAG compound co-treated with 2,4-di-tert-butylphenol co-treated with fibroblast growth factor 2 co-treated with ascorbic acid co-treated with alpha-glycerophosphoric acid co-treated with dexamethasone] results in decreased expression of RUNX2 mRNA",,,PMID:36682590,https://www.ncbi.nlm.nih.gov/pubmed/36682590,36682590,,
1093,2010230,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860.0,RUNX2,10090,Mus musculus (house mouse),[[dexamethasone co-treated with beta-glycerophosphoric acid co-treated with ascorbic acid] co-treated with fasudil] results in increased expression of RUNX2 protein|4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [[[dexamethasone co-treated with beta-glycerophosphoric acid co-treated with ascorbic acid] co-treated with fasudil] results in increased expression of RUNX2 protein]|4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [[[dexamethasone co-treated with beta-glycerophosphoric acid co-treated with ascorbic acid] co-treated with fasudil] results in increased expression of RUNX2 mrna]|[[dexamethasone co-treated with beta-glycerophosphoric acid co-treated with ascorbic acid] co-treated with fasudil] results in increased expression of RUNX2 mRNA,,,PMID:31935364,https://www.ncbi.nlm.nih.gov/pubmed/31935364,31935364,,
1094,2010231,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860.0,RUNX2,10090,Mus musculus (house mouse),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of RUNX2 mrna|rosiglitazone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of RUNX2 mrna],,,PMID:32473317,https://www.ncbi.nlm.nih.gov/pubmed/32473317,32473317,,
1095,2010232,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860.0,RUNX2,10090,Mus musculus (house mouse),"[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of RUNX2 mrna|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of RUNX2 mrna]",,,PMID:26492236,https://www.ncbi.nlm.nih.gov/pubmed/26492236,26492236,,
1096,2010233,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860.0,RUNX2,10090,Mus musculus (house mouse),U 0126 inhibits the reaction [ascorbic acid results in increased expression of RUNX2 mrna]|ascorbic acid results in increased expression of RUNX2 mRNA,,,PMID:20530736,https://www.ncbi.nlm.nih.gov/pubmed/20530736,20530736,,
1097,2010234,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860.0,RUNX2,10090,Mus musculus (house mouse),[folic acid co-treated with ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of RUNX2 protein,,,PMID:32324263,https://www.ncbi.nlm.nih.gov/pubmed/32324263,32324263,,
1098,2010235,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860.0,RUNX2,10116,Rattus norvegicus (Norway rat),NOG protein inhibits the reaction [ginsenoside rg3 inhibits the reaction [dexamethasone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of RUNX2 protein]]]|[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of RUNX2 protein|dexamethasone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of RUNX2 protein]|ginsenoside rg3 inhibits the reaction [dexamethasone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of RUNX2 protein]],,,PMID:27387537,https://www.ncbi.nlm.nih.gov/pubmed/27387537,27387537,,
1099,2010236,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860.0,RUNX2,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with phosphates] results in increased expression of RUNX2 mRNA,,,PMID:21613385,https://www.ncbi.nlm.nih.gov/pubmed/21613385,21613385,,
1100,2010237,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860.0,RUNX2,10116,Rattus norvegicus (Norway rat),[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] affects the expression of RUNX2 mrna|quercetin affects the reaction [hydrogen peroxide affects the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] affects the expression of RUNX2 mrna]]|hydrogen peroxide affects the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] affects the expression of RUNX2 mrna],,,PMID:27028516,https://www.ncbi.nlm.nih.gov/pubmed/27028516,27028516,,
1101,2010238,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860.0,RUNX2,9823,Sus scrofa (pig),"2,2-bis(4-glycidyloxyphenyl)propane promotes the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of RUNX2 mrna]|[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of RUNX2 mRNA",,,PMID:30481989,https://www.ncbi.nlm.nih.gov/pubmed/30481989,30481989,,
1102,2010239,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860.0,RUNX2,9606,Homo sapiens (human),[ascorbic acid co-treated with IL11 protein] results in increased expression of RUNX2 mRNA,,,PMID:17956465,https://www.ncbi.nlm.nih.gov/pubmed/17956465,17956465,,
1103,2010240,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860.0,RUNX2,9606,Homo sapiens (human),Ascorbic acid results in increased expression of RUNX2 mRNA,,,PMID:17274723,https://www.ncbi.nlm.nih.gov/pubmed/17274723,17274723,,
1104,2010241,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6281,S100A10,https://ctdbase.org/detail.go?type=gene&acc=6281,,,6281.0,S100A10,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of S100A10 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1105,2010242,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6273,S100A2,https://ctdbase.org/detail.go?type=gene&acc=6273,,,6273.0,S100A2,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [copper promotes the reaction [S100A2 protein binds to S100A2 protein]],,,PMID:21924240,https://www.ncbi.nlm.nih.gov/pubmed/21924240,21924240,,
1106,2010243,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6275,S100A4,https://ctdbase.org/detail.go?type=gene&acc=6275,,,6275.0,S100A4,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [copper promotes the reaction [S100A4 protein binds to S100A4 protein]],,,PMID:21924240,https://www.ncbi.nlm.nih.gov/pubmed/21924240,21924240,,
1107,2010244,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6277,S100A6,https://ctdbase.org/detail.go?type=gene&acc=6277,,,6277.0,S100A6,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of S100A6 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1108,2010245,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6285,S100B,https://ctdbase.org/detail.go?type=gene&acc=6285,,,6285.0,S100B,9913,Bos taurus (cattle),Ascorbic acid inhibits the reaction [cupric chloride promotes the reaction [S100B protein binds to S100B protein]],,,PMID:10666291,https://www.ncbi.nlm.nih.gov/pubmed/10666291,10666291,,
1109,2010246,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6285,S100B,https://ctdbase.org/detail.go?type=gene&acc=6285,,,6285.0,S100B,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of S100B mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of S100B protein,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
1110,2010247,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6285,S100B,https://ctdbase.org/detail.go?type=gene&acc=6285,,,6285.0,S100B,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of S100B mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1111,2010248,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,795,S100G,https://ctdbase.org/detail.go?type=gene&acc=795,,,795.0,S100G,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of S100G mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1112,2010249,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,23314,SATB2,https://ctdbase.org/detail.go?type=gene&acc=23314,,,23314.0,SATB2,9606,Homo sapiens (human),EZH2 protein inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of SATB2 mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of SATB2 mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
1113,2010250,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,949,SCARB1,https://ctdbase.org/detail.go?type=gene&acc=949,,,949.0,SCARB1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of SCARB1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1114,2010251,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,20249,SCD1,https://ctdbase.org/detail.go?type=gene&acc=20249,,,20249.0,Scd1,10090,Mus musculus (house mouse),Tetrachlorodibenzodioxin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of SCD1 mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of SCD1 mrna|src protein promotes the reaction [tetrachlorodibenzodioxin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of SCD1 mrna]],,,PMID:14505802,https://www.ncbi.nlm.nih.gov/pubmed/14505802,14505802,,
1115,2010252,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6326,SCN2A,https://ctdbase.org/detail.go?type=gene&acc=6326,,,6326.0,SCN2A,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of SCN2A mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1116,2010253,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6326,SCN2A,https://ctdbase.org/detail.go?type=gene&acc=6326,,,6326.0,SCN2A,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of SCN2A mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
1117,2010254,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6383,SDC2,https://ctdbase.org/detail.go?type=gene&acc=6383,,,6383.0,SDC2,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of SDC2 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1118,2010255,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6389,SDHA,https://ctdbase.org/detail.go?type=gene&acc=6389,,,6389.0,SDHA,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [arsenic trioxide results in decreased expression of SDHA protein],,,PMID:19422848,https://www.ncbi.nlm.nih.gov/pubmed/19422848,19422848,,
1119,2010256,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,174482,SDHB-1,https://ctdbase.org/detail.go?type=gene&acc=174482,,,174482.0,sdhb-1,6239,Caenorhabditis elegans,Ascorbic acid inhibits the reaction [SDHB-1 gene mutant form results in increased susceptibility to oxygen],,,PMID:19233206,https://www.ncbi.nlm.nih.gov/pubmed/19233206,19233206,,
1120,2010257,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,23480,SEC61G,https://ctdbase.org/detail.go?type=gene&acc=23480,,,23480.0,SEC61G,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of SEC61G mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1121,2010258,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10864,SLC22A7,https://ctdbase.org/detail.go?type=gene&acc=10864,,,10864.0,SLC22A7,9606,Homo sapiens (human),SLC22A7 protein results in increased transport of ascorbic acid,,,PMID:15901346,https://www.ncbi.nlm.nih.gov/pubmed/15901346,15901346,,
1122,2010259,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6401,SELE,https://ctdbase.org/detail.go?type=gene&acc=6401,,,6401.0,SELE,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [TNF protein results in increased expression of SELE mrna]|[ascorbic acid co-treated with lycopene co-treated with alpha-tocopherol] inhibits the reaction [TNF protein results in increased expression of SELE mrna],,,PMID:25551565,https://www.ncbi.nlm.nih.gov/pubmed/25551565,25551565,,
1123,2010260,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10512,SEMA3C,https://ctdbase.org/detail.go?type=gene&acc=10512,,,10512.0,SEMA3C,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of SEMA3C mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1124,2010261,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5265,SERPINA1,https://ctdbase.org/detail.go?type=gene&acc=5265,,,5265.0,SERPINA1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of SERPINA1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1125,2010262,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5055,SERPINB2,https://ctdbase.org/detail.go?type=gene&acc=5055,,,5055.0,SERPINB2,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of SERPINB2 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
1126,2010263,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5054,SERPINE1,https://ctdbase.org/detail.go?type=gene&acc=5054,,,5054.0,SERPINE1,10116,Rattus norvegicus (Norway rat),Ascorbic acid promotes the reaction [vitamin E inhibits the reaction [endosulfan results in increased activity of SERPINE1 protein]],,,PMID:21804306,https://www.ncbi.nlm.nih.gov/pubmed/21804306,21804306,,
1127,2010264,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,83667,SESN2,https://ctdbase.org/detail.go?type=gene&acc=83667,,,83667.0,SESN2,9606,Homo sapiens (human),[ascorbic acid co-treated with zinc acetate co-treated with motexafin gadolinium] results in decreased expression of SESN2 mrna|nutlin 3 inhibits the reaction [[ascorbic acid co-treated with zinc acetate co-treated with motexafin gadolinium] results in decreased expression of SESN2 mrna],,,PMID:20530418,https://www.ncbi.nlm.nih.gov/pubmed/20530418,20530418,,
1128,2010265,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6423,SFRP2,https://ctdbase.org/detail.go?type=gene&acc=6423,,,6423.0,SFRP2,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SFRP2 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1129,2010266,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6439,SFTPB,https://ctdbase.org/detail.go?type=gene&acc=6439,,,6439.0,SFTPB,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [nitrofen results in decreased expression of SFTPB mrna],,,PMID:16490937,https://www.ncbi.nlm.nih.gov/pubmed/16490937,16490937,,
1130,2010267,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6439,SFTPB,https://ctdbase.org/detail.go?type=gene&acc=6439,,,6439.0,SFTPB,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [nitrofen results in decreased expression of SFTPB protein],,,PMID:15083329,https://www.ncbi.nlm.nih.gov/pubmed/15083329,15083329,,
1131,2010268,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6439,SFTPB,https://ctdbase.org/detail.go?type=gene&acc=6439,,,6439.0,SFTPB,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [nitrofen results in decreased expression of SFTPB protein],,,PMID:16863852,https://www.ncbi.nlm.nih.gov/pubmed/16863852,16863852,,
1132,2010269,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6440,SFTPC,https://ctdbase.org/detail.go?type=gene&acc=6440,,,6440.0,SFTPC,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of SFTPC mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1133,2010270,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9467,SH3BP5,https://ctdbase.org/detail.go?type=gene&acc=9467,,,9467.0,SH3BP5,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SH3BP5 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1134,2010271,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6472,SHMT2,https://ctdbase.org/detail.go?type=gene&acc=6472,,,6472.0,SHMT2,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of SHMT2 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
1135,2010272,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6476,SI,https://ctdbase.org/detail.go?type=gene&acc=6476,,,6476.0,SI,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of SI mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1136,2010273,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4891,SLC11A2,https://ctdbase.org/detail.go?type=gene&acc=4891,,,4891.0,SLC11A2,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of SLC11A2 protein|ascorbic acid results in increased expression of SLC11A2 protein,,,PMID:18815723,https://www.ncbi.nlm.nih.gov/pubmed/18815723,18815723,,
1137,2010274,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,57084,SLC17A6,https://ctdbase.org/detail.go?type=gene&acc=57084,,,57084.0,SLC17A6,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of SLC17A6 mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
1138,2010275,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,57030,SLC17A7,https://ctdbase.org/detail.go?type=gene&acc=57030,,,57030.0,SLC17A7,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of SLC17A7 protein,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
1139,2010276,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9963,SLC23A1,https://ctdbase.org/detail.go?type=gene&acc=9963,,,9963.0,SLC23A1,13489,Dicentrarchus labrax (European seabass),Ascorbic acid results in increased expression of SLC23A1 mRNA,,,PMID:21281732,https://www.ncbi.nlm.nih.gov/pubmed/21281732,21281732,,
1140,2010277,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9963,SLC23A1,https://ctdbase.org/detail.go?type=gene&acc=9963,,,9963.0,SLC23A1,9031,Gallus gallus (chicken),SLC23A1 protein results in increased transport of ascorbic acid,,,PMID:17258485,https://www.ncbi.nlm.nih.gov/pubmed/17258485,17258485,,
1141,2010278,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9963,SLC23A1,https://ctdbase.org/detail.go?type=gene&acc=9963,,,9963.0,SLC23A1,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of SLC23A1 mrna|ascorbic acid deficiency results in increased expression of SLC23A1 mrna|ascorbic acid deficiency results in increased expression of SLC23A1 protein|ascorbic acid results in decreased expression of SLC23A1 protein,,,PMID:20471816,https://www.ncbi.nlm.nih.gov/pubmed/20471816,20471816,,
1142,2010279,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9963,SLC23A1,https://ctdbase.org/detail.go?type=gene&acc=9963,,,9963.0,SLC23A1,9606,Homo sapiens (human),Quercetin inhibits the reaction [SLC23A1 protein results in increased transport of ascorbic acid]|slc23a1 protein results in increased transport of ascorbic acid,,,PMID:11834736,https://www.ncbi.nlm.nih.gov/pubmed/11834736,11834736,,
1143,2010280,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9963,SLC23A1,https://ctdbase.org/detail.go?type=gene&acc=9963,,,9963.0,SLC23A1,9606,Homo sapiens (human),SLC23A1 gene polymorphism affects the abundance of ascorbic acid,,,PMID:20519558,https://www.ncbi.nlm.nih.gov/pubmed/20519558,20519558,,
1144,2010281,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9963,SLC23A1,https://ctdbase.org/detail.go?type=gene&acc=9963,,,9963.0,SLC23A1,9606,Homo sapiens (human),SLC23A1 protein affects the transport of ascorbic acid,,,PMID:12381735,https://www.ncbi.nlm.nih.gov/pubmed/12381735,12381735,,
1145,2010282,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9963,SLC23A1,https://ctdbase.org/detail.go?type=gene&acc=9963,,,9963.0,SLC23A1,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of SLC23A1 mRNA,,,PMID:20122894,https://www.ncbi.nlm.nih.gov/pubmed/20122894,20122894,,
1146,2010283,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9963,SLC23A1,https://ctdbase.org/detail.go?type=gene&acc=9963,,,9963.0,SLC23A1,10090,Mus musculus (house mouse),SLC23A1 protein affects the uptake of ascorbic acid,,,PMID:11984597,https://www.ncbi.nlm.nih.gov/pubmed/11984597,11984597,,
1147,2010284,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9962,SLC23A2,https://ctdbase.org/detail.go?type=gene&acc=9962,,,9962.0,SLC23A2,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [nickel sulfate results in decreased expression of SLC23A2 mrna],,,PMID:16288478,https://www.ncbi.nlm.nih.gov/pubmed/16288478,16288478,,
1148,2010285,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9962,SLC23A2,https://ctdbase.org/detail.go?type=gene&acc=9962,,,9962.0,SLC23A2,9606,Homo sapiens (human),Indomethacin inhibits the reaction [SLC23A2 protein results in increased uptake of ascorbic acid]|progesterone inhibits the reaction [SLC23A2 protein results in increased uptake of ascorbic acid]|genistein inhibits the reaction [SLC23A2 protein results in increased uptake of ascorbic acid]|quercetin inhibits the reaction [SLC23A2 protein results in increased uptake of ascorbic acid]|diclofenac inhibits the reaction [SLC23A2 protein results in increased uptake of ascorbic acid]|estradiol inhibits the reaction [SLC23A2 protein results in increased uptake of ascorbic acid]|hydrocortisone inhibits the reaction [SLC23A2 protein results in increased uptake of ascorbic acid],,,PMID:17092984,https://www.ncbi.nlm.nih.gov/pubmed/17092984,17092984,,
1149,2010286,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9962,SLC23A2,https://ctdbase.org/detail.go?type=gene&acc=9962,,,9962.0,SLC23A2,10090,Mus musculus (house mouse),Ascorbic acid deficiency results in increased expression of SLC23A2 protein,,,PMID:22001929,https://www.ncbi.nlm.nih.gov/pubmed/22001929,22001929,,
1150,2010287,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9962,SLC23A2,https://ctdbase.org/detail.go?type=gene&acc=9962,,,9962.0,SLC23A2,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of SLC23A2 mRNA,,,PMID:20122894,https://www.ncbi.nlm.nih.gov/pubmed/20122894,20122894,,
1151,2010288,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9962,SLC23A2,https://ctdbase.org/detail.go?type=gene&acc=9962,,,9962.0,SLC23A2,10090,Mus musculus (house mouse),SLC23A2 mRNA results in increased abundance of ascorbic acid,,,PMID:22558179,https://www.ncbi.nlm.nih.gov/pubmed/22558179,22558179,,
1152,2010289,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9962,SLC23A2,https://ctdbase.org/detail.go?type=gene&acc=9962,,,9962.0,SLC23A2,10116,Rattus norvegicus (Norway rat),SLC23A2 protein results in increased transport of ascorbic acid|ascorbic acid results in decreased expression of SLC23A2 mRNA,,,PMID:19418264,https://www.ncbi.nlm.nih.gov/pubmed/19418264,19418264,,
1153,2010290,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6513,SLC2A1,https://ctdbase.org/detail.go?type=gene&acc=6513,,,6513.0,SLC2A1,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of SLC2A1 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1154,2010291,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6517,SLC2A4,https://ctdbase.org/detail.go?type=gene&acc=6517,,,6517.0,SLC2A4,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of SLC2A4 mRNA,,,PMID:20122894,https://www.ncbi.nlm.nih.gov/pubmed/20122894,20122894,,
1155,2010292,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6517,SLC2A4,https://ctdbase.org/detail.go?type=gene&acc=6517,,,6517.0,SLC2A4,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with vitamin E] inhibits the reaction [diethylhexyl phthalate affects the localization of SLC2A4 protein],,,PMID:21911000,https://www.ncbi.nlm.nih.gov/pubmed/21911000,21911000,,
1156,2010293,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6529,SLC6A1,https://ctdbase.org/detail.go?type=gene&acc=6529,,,6529.0,SLC6A1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [[lead acetate results in increased abundance of lead] which results in decreased expression of SLC6A1 protein],,,PMID:31708536,https://www.ncbi.nlm.nih.gov/pubmed/31708536,31708536,,
1157,2010294,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,23657,SLC7A11,https://ctdbase.org/detail.go?type=gene&acc=23657,,,23657.0,SLC7A11,9606,Homo sapiens (human),Ascorbic acid results in increased expression of SLC7A11 mRNA,,,PMID:26198647,https://www.ncbi.nlm.nih.gov/pubmed/26198647,26198647,,
1158,2010295,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,11309,SLCO2B1,https://ctdbase.org/detail.go?type=gene&acc=11309,,,11309.0,SLCO2B1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of SLCO2B1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1159,2010296,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4086,SMAD1,https://ctdbase.org/detail.go?type=gene&acc=4086,,,4086.0,SMAD1,10090,Mus musculus (house mouse),"[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of SMAD1 mrna|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of SMAD1 mrna]",,,PMID:26492236,https://www.ncbi.nlm.nih.gov/pubmed/26492236,26492236,,
1160,2010297,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4089,SMAD4,https://ctdbase.org/detail.go?type=gene&acc=4089,,,4089.0,SMAD4,10090,Mus musculus (house mouse),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of SMAD4 mrna]|[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of SMAD4 mRNA",,,PMID:26492236,https://www.ncbi.nlm.nih.gov/pubmed/26492236,26492236,,
1161,2010298,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4090,SMAD5,https://ctdbase.org/detail.go?type=gene&acc=4090,,,4090.0,SMAD5,10090,Mus musculus (house mouse),"[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of SMAD5 mrna|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of SMAD5 mrna]",,,PMID:26492236,https://www.ncbi.nlm.nih.gov/pubmed/26492236,26492236,,
1162,2010299,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4093,SMAD9,https://ctdbase.org/detail.go?type=gene&acc=4093,,,4093.0,SMAD9,10090,Mus musculus (house mouse),"[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of SMAD9 mrna|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of SMAD9 mrna]",,,PMID:26492236,https://www.ncbi.nlm.nih.gov/pubmed/26492236,26492236,,
1163,2010300,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,79677,SMC6,https://ctdbase.org/detail.go?type=gene&acc=79677,,,79677.0,SMC6,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of SMC6 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
1164,2010301,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6622,SNCA,https://ctdbase.org/detail.go?type=gene&acc=6622,,,6622.0,SNCA,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of SNCA mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
1165,2010302,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,9606,Homo sapiens (human),[ascorbic acid co-treated with vitamin E] results in increased expression of SOD1 mRNA,,,PMID:22207723,https://www.ncbi.nlm.nih.gov/pubmed/22207723,22207723,,
1166,2010303,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [hydrogen peroxide results in decreased activity of SOD1 protein],,,PMID:28285367,https://www.ncbi.nlm.nih.gov/pubmed/28285367,28285367,,
1167,2010304,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [[lead acetate results in increased abundance of lead] which results in decreased expression of SOD1 mrna],,,PMID:31610155,https://www.ncbi.nlm.nih.gov/pubmed/31610155,31610155,,
1168,2010305,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,9606,Homo sapiens (human),Ascorbic acid results in increased expression of SOD1 mRNA,,,PMID:31576639|PMID:32913121,https://www.ncbi.nlm.nih.gov/pubmed/31576639|https://www.ncbi.nlm.nih.gov/pubmed/32913121,31576639|32913121,,
1169,2010306,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in increased expression of SOD1 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
1170,2010307,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of SOD1 mRNA,,,PMID:32913121,https://www.ncbi.nlm.nih.gov/pubmed/32913121,32913121,,
1171,2010308,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10090,Mus musculus (house mouse),SOD1 protein affects the abundance of ascorbic acid,,,PMID:16377630,https://www.ncbi.nlm.nih.gov/pubmed/16377630,16377630,,
1172,2010309,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10116,Rattus norvegicus (Norway rat),[alpha-tocopherol co-treated with ascorbic acid] inhibits the reaction [arsenite results in increased expression of SOD1 protein],,,PMID:21344382,https://www.ncbi.nlm.nih.gov/pubmed/21344382,21344382,,
1173,2010310,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with vitamin E] inhibits the reaction [diethylhexyl phthalate results in increased expression of SOD1 protein],,,PMID:29663635,https://www.ncbi.nlm.nih.gov/pubmed/29663635,29663635,,
1174,2010311,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [carbon tetrachloride results in decreased activity of SOD1 protein],,,PMID:30676168,https://www.ncbi.nlm.nih.gov/pubmed/30676168,30676168,,
1175,2010312,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased activity of SOD1 protein]|ascorbic acid inhibits the reaction [potassium dichromate results in decreased activity of SOD1 protein],,,PMID:17822687,https://www.ncbi.nlm.nih.gov/pubmed/17822687,17822687,,
1176,2010313,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [lead results in decreased expression of SOD1 protein],,,PMID:22056337,https://www.ncbi.nlm.nih.gov/pubmed/22056337,22056337,,
1177,2010314,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in decreased expression of SOD1 mrna],,,PMID:23470461,https://www.ncbi.nlm.nih.gov/pubmed/23470461,23470461,,
1178,2010315,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,9606,Homo sapiens (human),Ascorbic acid results in increased expression of SOD2 mrna|ascorbic acid deficiency results in increased expression of SOD2 mRNA,,,PMID:19932582,https://www.ncbi.nlm.nih.gov/pubmed/19932582,19932582,,
1179,2010316,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [HMOX1 protein results in increased expression of SOD2 mrna],,,PMID:10942521,https://www.ncbi.nlm.nih.gov/pubmed/10942521,10942521,,
1180,2010317,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [[lead acetate results in increased abundance of lead] which results in decreased expression of SOD2 mrna],,,PMID:31610155,https://www.ncbi.nlm.nih.gov/pubmed/31610155,31610155,,
1181,2010318,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [norepinephrine results in increased expression of SOD2 mrna],,,PMID:23114885,https://www.ncbi.nlm.nih.gov/pubmed/23114885,23114885,,
1182,2010319,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,9606,Homo sapiens (human),SOD2 protein results in increased susceptibility to ascorbic acid,,,PMID:15130278,https://www.ncbi.nlm.nih.gov/pubmed/15130278,15130278,,
1183,2010320,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,10116,Rattus norvegicus (Norway rat),[alpha-tocopherol co-treated with beta carotene co-treated with ascorbic acid co-treated with zinc co-treated with sodium selenite] results in decreased expression of SOD2 mRNA,,,PMID:23859036,https://www.ncbi.nlm.nih.gov/pubmed/23859036,23859036,,
1184,2010321,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with vitamin E co-treated with beta carotene co-treated with copper] inhibits the reaction [streptozocin results in decreased expression of SOD2 mrna]|[ascorbic acid co-treated with vitamin E co-treated with beta carotene co-treated with copper] inhibits the reaction [streptozocin results in decreased expression of SOD2 protein],,,PMID:18779489,https://www.ncbi.nlm.nih.gov/pubmed/18779489,18779489,,
1185,2010322,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [formaldehyde results in decreased expression of SOD2 mrna],,,PMID:27020608,https://www.ncbi.nlm.nih.gov/pubmed/27020608,27020608,,
1186,2010323,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [lead results in decreased expression of SOD2 protein],,,PMID:22056337,https://www.ncbi.nlm.nih.gov/pubmed/22056337,22056337,,
1187,2010324,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [lipopolysaccharides results in increased expression of SOD2 mrna],,,PMID:15612528,https://www.ncbi.nlm.nih.gov/pubmed/15612528,15612528,,
1188,2010325,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in decreased expression of SOD2 mrna],,,PMID:23470461,https://www.ncbi.nlm.nih.gov/pubmed/23470461,23470461,,
1189,2010326,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [sodium arsenite results in decreased expression of SOD2 mrna],,,PMID:20122981|PMID:20876158|PMID:21554548,https://www.ncbi.nlm.nih.gov/pubmed/20122981|https://www.ncbi.nlm.nih.gov/pubmed/20876158|https://www.ncbi.nlm.nih.gov/pubmed/21554548,20122981|20876158|21554548,,
1190,2010327,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6649,SOD3,https://ctdbase.org/detail.go?type=gene&acc=6649,,,6649.0,SOD3,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [estradiol results in decreased expression of SOD3 protein]|ascorbic acid inhibits the reaction [estradiol results in decreased expression of SOD3 mrna],,,PMID:25130429,https://www.ncbi.nlm.nih.gov/pubmed/25130429,25130429,,
1191,2010328,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,10141,Cavia porcellus (domestic guinea pig),Ascorbic acid inhibits the reaction [ethanol results in increased expression of TGFB1 protein],,,PMID:24239723,https://www.ncbi.nlm.nih.gov/pubmed/24239723,24239723,,
1192,2010329,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6649,SOD3,https://ctdbase.org/detail.go?type=gene&acc=6649,,,6649.0,SOD3,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [estradiol inhibits the reaction [NFE2L2 protein binds to SOD3 promoter]]|ascorbic acid affects the localization of SOD3 protein|ascorbic acid inhibits the reaction [estradiol results in decreased activity of SOD3 protein]|ascorbic acid results in increased activity of SOD3 protein|ascorbic acid inhibits the reaction [estradiol results in decreased expression of SOD3 protein]|ascorbic acid results in increased expression of SOD3 protein|ascorbic acid inhibits the reaction [estradiol results in decreased expression of SOD3 mrna],,,PMID:23027624,https://www.ncbi.nlm.nih.gov/pubmed/23027624,23027624,,
1193,2010330,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6272,SORT1,https://ctdbase.org/detail.go?type=gene&acc=6272,,,6272.0,SORT1,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of SORT1 mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
1194,2010331,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6656,SOX1,https://ctdbase.org/detail.go?type=gene&acc=6656,,,6656.0,SOX1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SOX1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1195,2010332,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6663,SOX10,https://ctdbase.org/detail.go?type=gene&acc=6663,,,6663.0,SOX10,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of SOX10 mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
1196,2010333,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6664,SOX11,https://ctdbase.org/detail.go?type=gene&acc=6664,,,6664.0,SOX11,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of SOX11 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1197,2010334,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9580,SOX13,https://ctdbase.org/detail.go?type=gene&acc=9580,,,9580.0,SOX13,9606,Homo sapiens (human),[arsenic trioxide co-treated with ascorbic acid] results in increased expression of SOX13 mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
1198,2010335,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6657,SOX2,https://ctdbase.org/detail.go?type=gene&acc=6657,,,6657.0,SOX2,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SOX2 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1199,2010336,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6657,SOX2,https://ctdbase.org/detail.go?type=gene&acc=6657,,,6657.0,SOX2,9606,Homo sapiens (human),Ascorbic acid results in increased expression of SOX2 mRNA,,,PMID:21166886,https://www.ncbi.nlm.nih.gov/pubmed/21166886,21166886,,
1200,2010337,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6657,SOX2,https://ctdbase.org/detail.go?type=gene&acc=6657,,,6657.0,SOX2,10090,Mus musculus (house mouse),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in decreased expression of SOX2 mRNA,,,PMID:28189605,https://www.ncbi.nlm.nih.gov/pubmed/28189605,28189605,,
1201,2010338,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6662,SOX9,https://ctdbase.org/detail.go?type=gene&acc=6662,,,6662.0,SOX9,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in decreased expression of SOX9 mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
1202,2010339,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6662,SOX9,https://ctdbase.org/detail.go?type=gene&acc=6662,,,6662.0,SOX9,9606,Homo sapiens (human),[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of SOX9 mrna|resveratrol inhibits the reaction [IL1B protein inhibits the reaction [[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of SOX9 mrna]]|il1b protein inhibits the reaction [[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of SOX9 mrna],,,PMID:26526931,https://www.ncbi.nlm.nih.gov/pubmed/26526931,26526931,,
1203,2010340,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6667,SP1,https://ctdbase.org/detail.go?type=gene&acc=6667,,,6667.0,SP1,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of SP1 protein,,,PMID:21919647,https://www.ncbi.nlm.nih.gov/pubmed/21919647,21919647,,
1204,2010341,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6670,SP3,https://ctdbase.org/detail.go?type=gene&acc=6670,,,6670.0,SP3,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of SP3 protein,,,PMID:21919647,https://www.ncbi.nlm.nih.gov/pubmed/21919647,21919647,,
1205,2010342,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6671,SP4,https://ctdbase.org/detail.go?type=gene&acc=6671,,,6671.0,SP4,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of SP4 protein,,,PMID:21919647,https://www.ncbi.nlm.nih.gov/pubmed/21919647,21919647,,
1206,2010343,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,121340,SP7,https://ctdbase.org/detail.go?type=gene&acc=121340,,,121340.0,SP7,9606,Homo sapiens (human),Rosiglitazone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]|tributyltin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]|bexarotene inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mRNA,,,PMID:25932594,https://www.ncbi.nlm.nih.gov/pubmed/25932594,25932594,,
1207,2010344,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4071,TM4SF1,https://ctdbase.org/detail.go?type=gene&acc=4071,,,4071.0,TM4SF1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of TM4SF1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1208,2010345,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,121340,SP7,https://ctdbase.org/detail.go?type=gene&acc=121340,,,121340.0,SP7,9606,Homo sapiens (human),"[SAG compound co-treated with 2,4-di-tert-butylphenol co-treated with fibroblast growth factor 2 co-treated with ascorbic acid co-treated with alpha-glycerophosphoric acid co-treated with dexamethasone] results in decreased expression of SP7 mRNA",,,PMID:36682590,https://www.ncbi.nlm.nih.gov/pubmed/36682590,36682590,,
1209,2010346,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7076,TIMP1,https://ctdbase.org/detail.go?type=gene&acc=7076,,,7076.0,TIMP1,9606,Homo sapiens (human),Ascorbic acid results in increased expression of TIMP1 protein,,,PMID:12510807,https://www.ncbi.nlm.nih.gov/pubmed/12510807,12510807,,
1210,2010347,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7076,TIMP1,https://ctdbase.org/detail.go?type=gene&acc=7076,,,7076.0,TIMP1,9606,Homo sapiens (human),[juglone co-treated with ascorbic acid] affects the expression of TIMP1 mRNA,,,PMID:29992683,https://www.ncbi.nlm.nih.gov/pubmed/29992683,29992683,,
1211,2010348,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7076,TIMP1,https://ctdbase.org/detail.go?type=gene&acc=7076,,,7076.0,TIMP1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [hydrogen peroxide results in increased expression of TIMP1 protein]|ascorbic acid inhibits the reaction [AGT protein modified form results in increased expression of TIMP1 protein],,,PMID:20881940,https://www.ncbi.nlm.nih.gov/pubmed/20881940,20881940,,
1212,2010349,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,121340,SP7,https://ctdbase.org/detail.go?type=gene&acc=121340,,,121340.0,SP7,10090,Mus musculus (house mouse),"Tretinoin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]|pioglitazone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]|d,d-T80-prallethrin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]|tetrabromobisphenol A inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]|triphenyltin hydroxide inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]|quinoxyfen inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna|rosiglitazone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]|allethrins inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]",,,PMID:32473317,https://www.ncbi.nlm.nih.gov/pubmed/32473317,32473317,,
1213,2010350,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,121340,SP7,https://ctdbase.org/detail.go?type=gene&acc=121340,,,121340.0,SP7,10090,Mus musculus (house mouse),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS1 protein co-treated with triphenyl phosphate] results in decreased expression of SP7 mrna|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS1 protein co-treated with firemaster 550] results in decreased expression of SP7 mRNA,,,PMID:25062436,https://www.ncbi.nlm.nih.gov/pubmed/25062436,25062436,,
1214,2010351,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,121340,SP7,https://ctdbase.org/detail.go?type=gene&acc=121340,,,121340.0,SP7,10090,Mus musculus (house mouse),"[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of SP7 protein|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of SP7 mrna]|[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of SP7 mrna|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of SP7 protein]",,,PMID:26492236,https://www.ncbi.nlm.nih.gov/pubmed/26492236,26492236,,
1215,2010352,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,121340,SP7,https://ctdbase.org/detail.go?type=gene&acc=121340,,,121340.0,SP7,10090,Mus musculus (house mouse),Deferoxamine inhibits the reaction [ascorbic acid results in increased expression of SP7 mrna]|ethyl protocatechuate inhibits the reaction [ascorbic acid results in increased expression of SP7 mrna]|ethyl protocatechuate inhibits the reaction [ascorbic acid results in increased expression of SP7 protein]|egln1 mRNA affects the reaction [ascorbic acid results in increased expression of SP7 protein]|ascorbic acid results in increased expression of SP7 protein|ascorbic acid results in increased expression of SP7 mrna|carbobenzoxy-leucyl-leucyl-norvalinal inhibits the reaction [ascorbic acid results in increased expression of SP7 mrna],,,PMID:21467157,https://www.ncbi.nlm.nih.gov/pubmed/21467157,21467157,,
1216,2010353,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,121340,SP7,https://ctdbase.org/detail.go?type=gene&acc=121340,,,121340.0,SP7,10090,Mus musculus (house mouse),[folic acid co-treated with ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of SP7 mrna|[folic acid co-treated with ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of SP7 protein,,,PMID:32324263,https://www.ncbi.nlm.nih.gov/pubmed/32324263,32324263,,
1217,2010354,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6678,SPARC,https://ctdbase.org/detail.go?type=gene&acc=6678,,,6678.0,SPARC,9606,Homo sapiens (human),[cholecalciferol co-treated with beta-glycerophosphoric acid co-treated with ascorbic acid] results in increased expression of SPARC protein,,,PMID:17692823,https://www.ncbi.nlm.nih.gov/pubmed/17692823,17692823,,
1218,2010355,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8404,SPARCL1,https://ctdbase.org/detail.go?type=gene&acc=8404,,,8404.0,SPARCL1,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of SPARCL1 mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
1219,2010356,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6696,SPP1,https://ctdbase.org/detail.go?type=gene&acc=6696,,,6696.0,SPP1,9606,Homo sapiens (human),[cholecalciferol co-treated with beta-glycerophosphoric acid co-treated with ascorbic acid] results in increased expression of SPP1 protein,,,PMID:17692823,https://www.ncbi.nlm.nih.gov/pubmed/17692823,17692823,,
1220,2010357,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6696,SPP1,https://ctdbase.org/detail.go?type=gene&acc=6696,,,6696.0,SPP1,9606,Homo sapiens (human),"[SAG compound co-treated with 2,4-di-tert-butylphenol co-treated with fibroblast growth factor 2 co-treated with ascorbic acid co-treated with alpha-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of SPP1 mRNA",,,PMID:36682590,https://www.ncbi.nlm.nih.gov/pubmed/36682590,36682590,,
1221,2010358,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6696,SPP1,https://ctdbase.org/detail.go?type=gene&acc=6696,,,6696.0,SPP1,10090,Mus musculus (house mouse),"[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of SPP1 mrna|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of SPP1 mrna]",,,PMID:26492236,https://www.ncbi.nlm.nih.gov/pubmed/26492236,26492236,,
1222,2010359,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6696,SPP1,https://ctdbase.org/detail.go?type=gene&acc=6696,,,6696.0,SPP1,9823,Sus scrofa (pig),"2,2-bis(4-glycidyloxyphenyl)propane promotes the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of SPP1 mrna]|troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of SPP1 mrna]|[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of SPP1 mRNA",,,PMID:30481989,https://www.ncbi.nlm.nih.gov/pubmed/30481989,30481989,,
1223,2010360,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,165679,SPTSSB,https://ctdbase.org/detail.go?type=gene&acc=165679,,,165679.0,SPTSSB,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SPTSSB mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1224,2010361,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8878,SQSTM1,https://ctdbase.org/detail.go?type=gene&acc=8878,,,8878.0,SQSTM1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of SQSTM1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1225,2010362,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8878,SQSTM1,https://ctdbase.org/detail.go?type=gene&acc=8878,,,8878.0,SQSTM1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [[vehicle emissions results in increased abundance of particulate matter] which results in increased expression of SQSTM1 mrna],,,PMID:32525552,https://www.ncbi.nlm.nih.gov/pubmed/32525552,32525552,,
1226,2010363,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6714,SRC,https://ctdbase.org/detail.go?type=gene&acc=6714,,,6714.0,SRC,10090,Mus musculus (house mouse),SRC protein promotes the reaction [tetrachlorodibenzodioxin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of SCD1 mrna]]|src protein promotes the reaction [tetrachlorodibenzodioxin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of PPARG mrna]],,,PMID:14505802,https://www.ncbi.nlm.nih.gov/pubmed/14505802,14505802,,
1227,2010364,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6720,SREBF1,https://ctdbase.org/detail.go?type=gene&acc=6720,,,6720.0,SREBF1,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SREBF1 mrna|tributyltin promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SREBF1 mrna]|bexarotene promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SREBF1 mrna]|rosiglitazone promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SREBF1 mrna],,,PMID:25932594,https://www.ncbi.nlm.nih.gov/pubmed/25932594,25932594,,
1228,2010365,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6721,SREBF2,https://ctdbase.org/detail.go?type=gene&acc=6721,,,6721.0,SREBF2,9606,Homo sapiens (human),SREBF2 protein affects the reaction [ascorbic acid results in increased expression of LDLR mrna]|ascorbic acid results in increased expression of SREBF2 mrna|ascorbic acid results in decreased metabolism of SREBF2 protein|srebf2 protein affects the reaction [ascorbic acid results in increased expression of LDLR protein],,,PMID:32913121,https://www.ncbi.nlm.nih.gov/pubmed/32913121,32913121,,
1229,2010366,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,140809,SRXN1,https://ctdbase.org/detail.go?type=gene&acc=140809,,,140809.0,SRXN1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SRXN1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1230,2010367,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6750,SST,https://ctdbase.org/detail.go?type=gene&acc=6750,,,6750.0,SST,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of SST mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1231,2010368,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6770,STAR,https://ctdbase.org/detail.go?type=gene&acc=6770,,,6770.0,STAR,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [cadmium results in decreased expression of STAR mrna],,,PMID:15055539,https://www.ncbi.nlm.nih.gov/pubmed/15055539,15055539,,
1232,2010369,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6770,STAR,https://ctdbase.org/detail.go?type=gene&acc=6770,,,6770.0,STAR,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of STAR mrna],,,PMID:18602937,https://www.ncbi.nlm.nih.gov/pubmed/18602937,18602937,,
1233,2010370,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6772,STAT1,https://ctdbase.org/detail.go?type=gene&acc=6772,,,6772.0,STAT1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [mercuric chloride inhibits the reaction [CNTF protein results in increased phosphorylation of STAT1 protein]],,,PMID:16896058,https://www.ncbi.nlm.nih.gov/pubmed/16896058,16896058,,
1234,2010371,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6772,STAT1,https://ctdbase.org/detail.go?type=gene&acc=6772,,,6772.0,STAT1,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of STAT1 mRNA,,,PMID:30597948,https://www.ncbi.nlm.nih.gov/pubmed/30597948,30597948,,
1235,2010372,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6774,STAT3,https://ctdbase.org/detail.go?type=gene&acc=6774,,,6774.0,STAT3,9606,Homo sapiens (human),Ascorbic acid affects the expression of STAT3 mRNA,,,PMID:30597948,https://www.ncbi.nlm.nih.gov/pubmed/30597948,30597948,,
1236,2010373,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6774,STAT3,https://ctdbase.org/detail.go?type=gene&acc=6774,,,6774.0,STAT3,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [mercuric chloride inhibits the reaction [CNTF protein results in increased phosphorylation of STAT3 protein]],,,PMID:16896058,https://www.ncbi.nlm.nih.gov/pubmed/16896058,16896058,,
1237,2010374,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6778,STAT6,https://ctdbase.org/detail.go?type=gene&acc=6778,,,6778.0,STAT6,9606,Homo sapiens (human),Ascorbic acid affects the expression of STAT6 mRNA,,,PMID:30597948,https://www.ncbi.nlm.nih.gov/pubmed/30597948,30597948,,
1238,2010375,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9262,STK17B,https://ctdbase.org/detail.go?type=gene&acc=9262,,,9262.0,STK17B,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of STK17B mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1239,2010376,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,11075,STMN2,https://ctdbase.org/detail.go?type=gene&acc=11075,,,11075.0,STMN2,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of STMN2 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1240,2010377,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8801,SUCLG2,https://ctdbase.org/detail.go?type=gene&acc=8801,,,8801.0,SUCLG2,10090,Mus musculus (house mouse),Ascorbic acid affects the expression of SUCLG2 protein,,,PMID:19224539,https://www.ncbi.nlm.nih.gov/pubmed/19224539,19224539,,
1241,2010378,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6817,SULT1A1,https://ctdbase.org/detail.go?type=gene&acc=6817,,,6817.0,SULT1A1,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of SULT1A1 mRNA,,,PMID:21144891,https://www.ncbi.nlm.nih.gov/pubmed/21144891,21144891,,
1242,2010379,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6818,SULT1A3,https://ctdbase.org/detail.go?type=gene&acc=6818,,,6818.0,SULT1A3,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of SULT1A3 mRNA,,,PMID:21144891,https://www.ncbi.nlm.nih.gov/pubmed/21144891,21144891,,
1243,2010380,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,20888,SULT1C1,https://ctdbase.org/detail.go?type=gene&acc=20888,,,20888.0,Sult1c1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of SULT1C1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1244,2010381,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6822,SULT2A1,https://ctdbase.org/detail.go?type=gene&acc=6822,,,6822.0,SULT2A1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of SULT2A1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1245,2010382,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6839,SUV39H1,https://ctdbase.org/detail.go?type=gene&acc=6839,,,6839.0,SUV39H1,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in decreased expression of SUV39H1 mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
1246,2010383,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,79723,SUV39H2,https://ctdbase.org/detail.go?type=gene&acc=79723,,,79723.0,SUV39H2,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in decreased expression of SUV39H2 mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
1247,2010384,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,41247,SYN,https://ctdbase.org/detail.go?type=gene&acc=41247,,,41247.0,Syn,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of SYN mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of SYN protein,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
1248,2010385,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6853,SYN1,https://ctdbase.org/detail.go?type=gene&acc=6853,,,6853.0,SYN1,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [corticosterone results in decreased expression of SYN1 protein],,,PMID:33872575,https://www.ncbi.nlm.nih.gov/pubmed/33872575,33872575,,
1249,2010386,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9066,SYT7,https://ctdbase.org/detail.go?type=gene&acc=9066,,,9066.0,SYT7,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of SYT7 mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
1250,2010387,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6901,TAFAZZIN,https://ctdbase.org/detail.go?type=gene&acc=6901,,,6901.0,TAFAZZIN,9606,Homo sapiens (human),[cholecalciferol co-treated with beta-glycerophosphoric acid co-treated with ascorbic acid] results in increased expression of TAFAZZIN mRNA,,,PMID:17692823,https://www.ncbi.nlm.nih.gov/pubmed/17692823,17692823,,
1251,2010388,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6876,TAGLN,https://ctdbase.org/detail.go?type=gene&acc=6876,,,6876.0,TAGLN,9606,Homo sapiens (human),[ascorbic acid co-treated with TGFB1 protein] results in increased expression of TAGLN mrna|ascorbic acid results in increased expression of TAGLN mRNA,,,PMID:18607632,https://www.ncbi.nlm.nih.gov/pubmed/18607632,18607632,,
1252,2010389,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6897,TARS1,https://ctdbase.org/detail.go?type=gene&acc=6897,,,6897.0,TARS1,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of TARS1 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
1253,2010390,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9882,TBC1D4,https://ctdbase.org/detail.go?type=gene&acc=9882,,,9882.0,TBC1D4,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with vitamin E] inhibits the reaction [diethylhexyl phthalate results in increased expression of TBC1D4 protein],,,PMID:21911000,https://www.ncbi.nlm.nih.gov/pubmed/21911000,21911000,,
1254,2010391,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6909,TBX2,https://ctdbase.org/detail.go?type=gene&acc=6909,,,6909.0,TBX2,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of TBX2 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1255,2010392,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6941,TCF19,https://ctdbase.org/detail.go?type=gene&acc=6941,,,6941.0,TCF19,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in decreased expression of TCF19 mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
1256,2010393,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6942,TCF20,https://ctdbase.org/detail.go?type=gene&acc=6942,,,6942.0,TCF20,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of TCF20 mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
1257,2010394,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6996,TDG,https://ctdbase.org/detail.go?type=gene&acc=6996,,,6996.0,TDG,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [sodium arsenite results in decreased expression of TDG protein],,,PMID:33388378,https://www.ncbi.nlm.nih.gov/pubmed/33388378,33388378,,
1258,2010395,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7015,TERT,https://ctdbase.org/detail.go?type=gene&acc=7015,,,7015.0,TERT,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of TERT mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
1259,2010396,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,80312,TET1,https://ctdbase.org/detail.go?type=gene&acc=80312,,,80312.0,TET1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [sodium arsenite results in decreased expression of TET1 protein],,,PMID:33388378,https://www.ncbi.nlm.nih.gov/pubmed/33388378,33388378,,
1260,2010397,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,80312,TET1,https://ctdbase.org/detail.go?type=gene&acc=80312,,,80312.0,TET1,9606,Homo sapiens (human),Ascorbic acid affects the activity of TET1 protein,,,PMID:24162740,https://www.ncbi.nlm.nih.gov/pubmed/24162740,24162740,,
1261,2010398,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,54790,TET2,https://ctdbase.org/detail.go?type=gene&acc=54790,,,54790.0,TET2,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [sodium arsenite results in decreased expression of TET2 protein],,,PMID:33388378,https://www.ncbi.nlm.nih.gov/pubmed/33388378,33388378,,
1262,2010399,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7018,TF,https://ctdbase.org/detail.go?type=gene&acc=7018,,,7018.0,TF,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of TF mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1263,2010400,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7018,TF,https://ctdbase.org/detail.go?type=gene&acc=7018,,,7018.0,TF,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of TF mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1264,2010401,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7018,TF,https://ctdbase.org/detail.go?type=gene&acc=7018,,,7018.0,TF,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of TF mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1265,2010402,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7020,TFAP2A,https://ctdbase.org/detail.go?type=gene&acc=7020,,,7020.0,TFAP2A,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of TFAP2A mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1266,2010403,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7032,TFF2,https://ctdbase.org/detail.go?type=gene&acc=7032,,,7032.0,TFF2,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of TFF2 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1267,2010404,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7037,TFRC,https://ctdbase.org/detail.go?type=gene&acc=7037,,,7037.0,TFRC,10090,Mus musculus (house mouse),[ascorbic acid co-treated with CAT protein] inhibits the reaction [zinc deficiency results in increased expression of TFRC protein],,,PMID:18073202,https://www.ncbi.nlm.nih.gov/pubmed/18073202,18073202,,
1268,2010405,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,10140,Cavia (guinea pigs),[ascorbic acid co-treated with ethanol] results in decreased expression of TGFB1 mRNA,,,PMID:22149461,https://www.ncbi.nlm.nih.gov/pubmed/22149461,22149461,,
1269,2010406,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,9606,Homo sapiens (human),[ascorbic acid co-treated with TGFB1 protein] results in increased expression of TAGLN mrna|[ascorbic acid co-treated with TGFB1 protein] results in increased expression of CNN1 protein|[ascorbic acid co-treated with TGFB1 protein] results in increased expression of CNN1 mrna|[ascorbic acid co-treated with TGFB1 protein] results in increased expression of ACTA2 mrna|[ascorbic acid co-treated with TGFB1 protein] results in increased expression of ACTA2 protein,,,PMID:18607632,https://www.ncbi.nlm.nih.gov/pubmed/18607632,18607632,,
1270,2010407,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of TGFB1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1271,2010408,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of TGFB1 mRNA,,,PMID:14566779,https://www.ncbi.nlm.nih.gov/pubmed/14566779,14566779,,
1272,2010409,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with kojic acid co-treated with diethylnitrosamine] results in decreased expression of TGFB1 mRNA,,,PMID:18544905,https://www.ncbi.nlm.nih.gov/pubmed/18544905,18544905,,
1273,2010410,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7042,TGFB2,https://ctdbase.org/detail.go?type=gene&acc=7042,,,7042.0,TGFB2,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of TGFB2 mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
1274,2010411,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7076,TIMP1,https://ctdbase.org/detail.go?type=gene&acc=7076,,,7076.0,TIMP1,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of TIMP1 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1275,2010412,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7082,TJP1,https://ctdbase.org/detail.go?type=gene&acc=7082,,,7082.0,TJP1,10141,Cavia porcellus (domestic guinea pig),Ascorbic acid inhibits the reaction [ethanol results in decreased expression of TJP1 mrna],,,PMID:24239723,https://www.ncbi.nlm.nih.gov/pubmed/24239723,24239723,,
1276,2010413,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7082,TJP1,https://ctdbase.org/detail.go?type=gene&acc=7082,,,7082.0,TJP1,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of TJP1 protein],,,PMID:29940330,https://www.ncbi.nlm.nih.gov/pubmed/29940330,29940330,,
1277,2010414,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7097,TLR2,https://ctdbase.org/detail.go?type=gene&acc=7097,,,7097.0,TLR2,10090,Mus musculus (house mouse),"CAT protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TLR2 protein]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TLR2 mrna]|mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TLR2 mrna]|[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TLR2 protein|[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TLR2 mrna|mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TLR2 protein]",,,PMID:23692848,https://www.ncbi.nlm.nih.gov/pubmed/23692848,23692848,,
1278,2010415,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7099,TLR4,https://ctdbase.org/detail.go?type=gene&acc=7099,,,7099.0,TLR4,10141,Cavia porcellus (domestic guinea pig),Ascorbic acid inhibits the reaction [ethanol results in increased expression of TLR4 mrna],,,PMID:24239723,https://www.ncbi.nlm.nih.gov/pubmed/24239723,24239723,,
1279,2010416,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with sesame oil] inhibits the reaction [abamectin results in increased expression of TNF protein]|ascorbic acid inhibits the reaction [abamectin results in increased expression of TNF protein],,,PMID:31739238,https://www.ncbi.nlm.nih.gov/pubmed/31739238,31739238,,
1280,2010417,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7054,TH,https://ctdbase.org/detail.go?type=gene&acc=7054,,,7054.0,TH,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of TH protein|[ascorbic acid co-treated with alpha-tocopherol co-treated with acetylcysteine] results in decreased expression of TH protein,,,PMID:25891525,https://www.ncbi.nlm.nih.gov/pubmed/25891525,25891525,,
1281,2010418,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7054,TH,https://ctdbase.org/detail.go?type=gene&acc=7054,,,7054.0,TH,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of TH mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1282,2010419,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7076,TIMP1,https://ctdbase.org/detail.go?type=gene&acc=7076,,,7076.0,TIMP1,9606,Homo sapiens (human),[ascorbic acid co-treated with quartz] results in increased expression of TIMP1 mRNA,,,PMID:27381660,https://www.ncbi.nlm.nih.gov/pubmed/27381660,27381660,,
1283,2010420,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7099,TLR4,https://ctdbase.org/detail.go?type=gene&acc=7099,,,7099.0,TLR4,10090,Mus musculus (house mouse),"[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TLR4 mrna|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TLR4 mrna]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TLR4 protein]|[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TLR4 protein|mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TLR4 mrna]|mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TLR4 protein]",,,PMID:23692848,https://www.ncbi.nlm.nih.gov/pubmed/23692848,23692848,,
1284,2010421,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7043,TGFB3,https://ctdbase.org/detail.go?type=gene&acc=7043,,,7043.0,TGFB3,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of TUBB3 protein|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of S100B mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of FOXM1 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GRIA2 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of LEF1 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of E2F2 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of RBFOX3 protein|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of HOXB1 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of SYN protein|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of RBFOX3 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of HES3 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of SYN mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of FZD10 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of SLC17A6 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GFAP mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of SLC17A7 protein|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GRIN1 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of TERT mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of S100B protein|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of MAP2 protein|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of DLG4 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GABRA2 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of INHBE mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GRIN2A mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of SCN2A mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of CNTN1 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of GLI1 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GRIN2B mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
1285,2010422,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7043,TGFB3,https://ctdbase.org/detail.go?type=gene&acc=7043,,,7043.0,TGFB3,9606,Homo sapiens (human),[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of ACAN mrna|[tgfb3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of SOX9 mrna|resveratrol inhibits the reaction [IL1B protein inhibits the reaction [[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of ACAN mrna]]|il1b protein inhibits the reaction [[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of COL2A1 mrna]|il1b protein inhibits the reaction [[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of ACAN mrna]|resveratrol inhibits the reaction [IL1B protein inhibits the reaction [[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of SOX9 mrna]]|il1b protein inhibits the reaction [[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of SOX9 mrna]|[tgfb3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in decreased expression of MMP13 mrna|[tgfb3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of COL2A1 mrna|il1b protein results in decreased susceptibility to [TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone]|il1b protein inhibits the reaction [[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in decreased expression of MMP13 mrna]|resveratrol inhibits the reaction [IL1B protein inhibits the reaction [[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of COL2A1 mrna]],,,PMID:26526931,https://www.ncbi.nlm.nih.gov/pubmed/26526931,26526931,,
1286,2010423,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7054,TH,https://ctdbase.org/detail.go?type=gene&acc=7054,,,7054.0,TH,10090,Mus musculus (house mouse),Ascorbic acid results in decreased expression of TH protein,,,PMID:22285708,https://www.ncbi.nlm.nih.gov/pubmed/22285708,22285708,,
1287,2010424,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7104,TM4SF4,https://ctdbase.org/detail.go?type=gene&acc=7104,,,7104.0,TM4SF4,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of TM4SF4 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1288,2010425,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,28959,TMEM176B,https://ctdbase.org/detail.go?type=gene&acc=28959,,,28959.0,TMEM176B,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of TMEM176B mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1289,2010426,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,164656,TMPRSS6,https://ctdbase.org/detail.go?type=gene&acc=164656,,,164656.0,TMPRSS6,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of TMPRSS6 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1290,2010427,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10140,Cavia (guinea pigs),[ascorbic acid co-treated with ethanol] results in decreased expression of TNF mRNA,,,PMID:22149461,https://www.ncbi.nlm.nih.gov/pubmed/22149461,22149461,,
1291,2010428,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10141,Cavia porcellus (domestic guinea pig),Ascorbic acid inhibits the reaction [ethanol results in increased expression of TNF protein],,,PMID:24239723,https://www.ncbi.nlm.nih.gov/pubmed/24239723,24239723,,
1292,2010429,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606,Homo sapiens (human),[ascorbic acid co-treated with lycopene co-treated with alpha-tocopherol] inhibits the reaction [TNF protein results in increased expression of CXCL8 mrna]|[ascorbic acid co-treated with lycopene co-treated with alpha-tocopherol] promotes the reaction [TNF protein results in increased expression of and results in increased secretion of IL10 protein]|[ascorbic acid co-treated with lycopene co-treated with alpha-tocopherol] inhibits the reaction [TNF protein results in increased expression of NFKBIA mrna]|[ascorbic acid co-treated with lycopene co-treated with alpha-tocopherol] inhibits the reaction [TNF protein results in increased expression of ICAM1 mrna]|[ascorbic acid co-treated with lycopene co-treated with alpha-tocopherol] inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of TNF protein]|[ascorbic acid co-treated with lycopene co-treated with alpha-tocopherol] inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of CXCL8 protein]|ascorbic acid inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of CXCL8 protein]|ascorbic acid inhibits the reaction [TNF protein results in increased expression of SELE mrna]|ascorbic acid inhibits the reaction [TNF protein results in increased expression of NFKBIA mrna]|ascorbic acid inhibits the reaction [TNF protein results in increased expression of CXCL8 mrna]|ascorbic acid inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of TNF protein]|[ascorbic acid co-treated with lycopene co-treated with alpha-tocopherol] inhibits the reaction [TNF protein results in increased expression of SELE mrna]|ascorbic acid promotes the reaction [TNF protein results in increased expression of and results in increased secretion of IL10 protein],,,PMID:25551565,https://www.ncbi.nlm.nih.gov/pubmed/25551565,25551565,,
1293,2010430,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [TNF protein results in increased expression of TNF mrna]|[ascorbic acid co-treated with lycopene co-treated with alpha-tocopherol] inhibits the reaction [TNF protein results in increased expression of TNF mrna],,,PMID:25551565,https://www.ncbi.nlm.nih.gov/pubmed/25551565,25551565|25551565,,
1294,2010431,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606,Homo sapiens (human),"Ascorbic acid inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of TNF protein]",,,PMID:35349355,https://www.ncbi.nlm.nih.gov/pubmed/35349355,35349355,,
1295,2010432,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [hydrogen peroxide results in increased expression of TNF protein],,,PMID:28285367,https://www.ncbi.nlm.nih.gov/pubmed/28285367,28285367,,
1296,2010433,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]|ascorbic acid inhibits the reaction [TNF protein results in increased abundance of hydrogen peroxide]|ascorbic acid inhibits the reaction [TNF protein results in increased abundance of nitric oxide],,,PMID:12723939,https://www.ncbi.nlm.nih.gov/pubmed/12723939,12723939,,
1297,2010434,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090,Mus musculus (house mouse),"[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TNF protein|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TNF protein]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TNF mrna]|mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TNF mrna]|mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TNF protein]|[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TNF mRNA",,,PMID:23692848,https://www.ncbi.nlm.nih.gov/pubmed/23692848,23692848,,
1298,2010435,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [streptozocin results in increased expression of TNF protein],,,PMID:28259689,https://www.ncbi.nlm.nih.gov/pubmed/28259689,28259689,,
1299,2010436,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090,Mus musculus (house mouse),Butylated hydroxytoluene inhibits the reaction [dextran sulfate promotes the reaction [ascorbic acid promotes the reaction [quartz results in increased secretion of TNF protein]]]|ascorbic acid promotes the reaction [quartz results in increased expression of TNF mrna]|dextran sulfate promotes the reaction [ascorbic acid promotes the reaction [quartz results in increased secretion of TNF protein]]|ascorbic acid promotes the reaction [quartz results in increased secretion of TNF protein]|cat protein inhibits the reaction [ascorbic acid promotes the reaction [quartz results in increased secretion of TNF protein]]|mannitol inhibits the reaction [ascorbic acid promotes the reaction [quartz results in increased secretion of TNF protein]]|ifng protein promotes the reaction [ascorbic acid promotes the reaction [quartz results in increased secretion of TNF protein]],,,PMID:19298665,https://www.ncbi.nlm.nih.gov/pubmed/19298665,19298665,,
1300,2010437,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116,Rattus norvegicus (Norway rat),"Ascorbic acid inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of TNF protein]|ascorbic acid inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of TNF mrna]|ascorbic acid deficiency promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of TNF protein]",,,PMID:30606963,https://www.ncbi.nlm.nih.gov/pubmed/30606963,30606963,,
1301,2010438,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [lead acetate results in increased expression of TNF protein],,,PMID:22728154,https://www.ncbi.nlm.nih.gov/pubmed/22728154,22728154,,
1302,2010439,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [norepinephrine results in increased secretion of TNF protein],,,PMID:15158148,https://www.ncbi.nlm.nih.gov/pubmed/15158148,15158148,,
1303,2010440,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [sodium arsenite results in increased expression of TNF protein],,,PMID:19429265,https://www.ncbi.nlm.nih.gov/pubmed/19429265,19429265,,
1304,2010441,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [sodium benzoate results in increased expression of TNF protein],,,PMID:35187746,https://www.ncbi.nlm.nih.gov/pubmed/35187746,35187746,,
1305,2010442,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [sodium fluoride results in increased expression of TNF protein],,,PMID:34089294,https://www.ncbi.nlm.nih.gov/pubmed/34089294,34089294,,
1306,2010443,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8792,TNFRSF11A,https://ctdbase.org/detail.go?type=gene&acc=8792,,,8792.0,TNFRSF11A,9606,Homo sapiens (human),[ascorbic acid co-treated with TNFSF11 protein] results in decreased expression of TNFRSF11A mRNA,,,PMID:15730627,https://www.ncbi.nlm.nih.gov/pubmed/15730627,15730627,,
1307,2010444,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4982,TNFRSF11B,https://ctdbase.org/detail.go?type=gene&acc=4982,,,4982.0,TNFRSF11B,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of TNFRSF11B mrna|ezh2 protein inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of TNFRSF11B mrna],,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
1308,2010445,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4982,TNFRSF11B,https://ctdbase.org/detail.go?type=gene&acc=4982,,,4982.0,TNFRSF11B,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of TNFRSF11B mRNA,,,PMID:17664058,https://www.ncbi.nlm.nih.gov/pubmed/17664058,17664058,,
1309,2010446,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8743,TNFSF10,https://ctdbase.org/detail.go?type=gene&acc=8743,,,8743.0,TNFSF10,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [TNFSF10 protein results in increased activity of CASP3 protein]|ascorbic acid inhibits the reaction [TNFSF10 protein results in increased activity of CASP9 protein]|ascorbic acid inhibits the reaction [TNFSF10 protein results in increased activity of CASP8 protein]|ascorbic acid results in decreased susceptibility to TNFSF10 protein|ascorbic acid inhibits the reaction [TNFSF10 protein results in increased chemical synthesis of reactive oxygen species]|ascorbic acid inhibits the reaction [TNFSF10 protein affects the localization of CYCS protein],,,PMID:23711929,https://www.ncbi.nlm.nih.gov/pubmed/23711929,23711929,,
1310,2010447,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8743,TNFSF10,https://ctdbase.org/detail.go?type=gene&acc=8743,,,8743.0,TNFSF10,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of TNFSF10 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1311,2010448,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8600,TNFSF11,https://ctdbase.org/detail.go?type=gene&acc=8600,,,8600.0,TNFSF11,10090,Mus musculus (house mouse),[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of and results in increased secretion of TNFSF11 protein,,,PMID:32156525,https://www.ncbi.nlm.nih.gov/pubmed/32156525,32156525,,
1312,2010449,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8600,TNFSF11,https://ctdbase.org/detail.go?type=gene&acc=8600,,,8600.0,TNFSF11,9606,Homo sapiens (human),[ascorbic acid co-treated with TNFSF11 protein] results in decreased expression of TNFRSF11A mrna|[ascorbic acid co-treated with TNFSF11 protein] results in decreased expression of CAR2 mRNA,,,PMID:15730627,https://www.ncbi.nlm.nih.gov/pubmed/15730627,15730627,,
1313,2010450,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8600,TNFSF11,https://ctdbase.org/detail.go?type=gene&acc=8600,,,8600.0,TNFSF11,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [TNFSF11 protein results in increased expression of CAR2 mrna]|ascorbic acid inhibits the reaction [TNFSF11 protein results in increased expression of CAR2 protein],,,PMID:15952411,https://www.ncbi.nlm.nih.gov/pubmed/15952411,15952411,,
1314,2010451,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,54543,TOMM7,https://ctdbase.org/detail.go?type=gene&acc=54543,,,54543.0,TOMM7,9606,Homo sapiens (human),[arsenic trioxide co-treated with ascorbic acid] results in decreased expression of TOMM7 mrna|ascorbic acid results in decreased expression of TOMM7 mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
1315,2010452,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7153,TOP2A,https://ctdbase.org/detail.go?type=gene&acc=7153,,,7153.0,TOP2A,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [wedelolactone results in decreased activity of TOP2A protein],,,PMID:22733624,https://www.ncbi.nlm.nih.gov/pubmed/22733624,22733624,,
1316,2010453,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [[ascorbic acid co-treated with zinc acetate co-treated with motexafin gadolinium] results in decreased expression of TP53 protein]|[ascorbic acid co-treated with zinc acetate co-treated with motexafin gadolinium] results in decreased expression of TP53 protein|nutlin 3 inhibits the reaction [[ascorbic acid co-treated with zinc acetate co-treated with motexafin gadolinium] results in decreased expression of TP53 protein]|benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[ascorbic acid co-treated with zinc acetate co-treated with motexafin gadolinium] results in decreased expression of TP53 protein],,,PMID:20530418,https://www.ncbi.nlm.nih.gov/pubmed/20530418,20530418,,
1317,2010454,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in increased phosphorylation of TP53 protein],,,PMID:31388677,https://www.ncbi.nlm.nih.gov/pubmed/31388677,31388677,,
1318,2010455,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [potassium bromate results in increased phosphorylation of TP53 protein],,,PMID:20067818,https://www.ncbi.nlm.nih.gov/pubmed/20067818,20067818,,
1319,2010456,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [potassium chromate(vi) results in increased expression of TP53 protein]|ascorbic acid inhibits the reaction [potassium chromate(vi) results in increased expression of TP53 protein modified form],,,PMID:25977998,https://www.ncbi.nlm.nih.gov/pubmed/25977998,25977998,,
1320,2010457,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [silicon dioxide results in increased expression of TP53 mrna]|ascorbic acid inhibits the reaction [silicon dioxide results in increased expression of TP53 protein],,,PMID:22245848,https://www.ncbi.nlm.nih.gov/pubmed/22245848,22245848,,
1321,2010458,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606,Homo sapiens (human),Ascorbic acid promotes the reaction [cisplatin results in increased expression of TP53 protein],,,PMID:21429301,https://www.ncbi.nlm.nih.gov/pubmed/21429301,21429301,,
1322,2010459,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606,Homo sapiens (human),[juglone co-treated with ascorbic acid] results in increased phosphorylation of TP53 protein,,,PMID:29992683,https://www.ncbi.nlm.nih.gov/pubmed/29992683,29992683,,
1323,2010460,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9669,Mustela putorius furo (domestic ferret),[beta carotene co-treated with alpha-tocopherol co-treated with ascorbic acid] inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of TP53 protein]|[beta carotene co-treated with alpha-tocopherol co-treated with ascorbic acid] inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of TP53 protein],,,PMID:16401635,https://www.ncbi.nlm.nih.gov/pubmed/16401635,16401635,,
1324,2010461,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,8022,Oncorhynchus mykiss (rainbow trout),[vitamin A co-treated with cholecalciferol co-treated with vitamin E co-treated with ascorbic acid] inhibits the reaction [[cyhalothrin co-treated with chlorantranilipole] results in increased expression of TP53 protein],,,PMID:36813254,https://www.ncbi.nlm.nih.gov/pubmed/36813254,36813254,,
1325,2010462,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in increased expression of and results in increased phosphorylation of TP53 protein]|ascorbic acid inhibits the reaction [potassium dichromate results in increased expression of TP53 mrna]|ascorbic acid inhibits the reaction [potassium dichromate results in increased localization of TP53 protein modified form],,,PMID:21262251,https://www.ncbi.nlm.nih.gov/pubmed/21262251,21262251,,
1326,2010463,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,11257,TP53TG1,https://ctdbase.org/detail.go?type=gene&acc=11257,,,11257.0,TP53TG1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of TP53TG1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1327,2010464,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7178,TPT1,https://ctdbase.org/detail.go?type=gene&acc=7178,,,7178.0,TPT1,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of TPT1 mRNA,,,PMID:22139585,https://www.ncbi.nlm.nih.gov/pubmed/22139585,22139585,,
1328,2010465,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7200,TRH,https://ctdbase.org/detail.go?type=gene&acc=7200,,,7200.0,TRH,10090,Mus musculus (house mouse),Ascorbic acid results in decreased expression of TRH mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
1329,2010466,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,57761,TRIB3,https://ctdbase.org/detail.go?type=gene&acc=57761,,,57761.0,TRIB3,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of TRIB3 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
1330,2010467,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,57761,TRIB3,https://ctdbase.org/detail.go?type=gene&acc=57761,,,57761.0,TRIB3,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of TRIB3 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1331,2010468,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10155,TRIM28,https://ctdbase.org/detail.go?type=gene&acc=10155,,,10155.0,TRIM28,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [hydrogen peroxide results in increased expression of TRIM28 protein],,,PMID:28285367,https://www.ncbi.nlm.nih.gov/pubmed/28285367,28285367,,
1332,2010469,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10155,TRIM28,https://ctdbase.org/detail.go?type=gene&acc=10155,,,10155.0,TRIM28,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [potassium chromate(vi) results in increased expression of TRIM28 protein modified form],,,PMID:25977998,https://www.ncbi.nlm.nih.gov/pubmed/25977998,25977998,,
1333,2010470,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9322,TRIP10,https://ctdbase.org/detail.go?type=gene&acc=9322,,,9322.0,TRIP10,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in decreased expression of TRIP10 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
1334,2010471,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,22059,TRP53,https://ctdbase.org/detail.go?type=gene&acc=22059,,,22059.0,Trp53,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [glycidamide results in increased expression of TRP53 mrna],,,PMID:32632975,https://www.ncbi.nlm.nih.gov/pubmed/32632975,32632975,,
1335,2010472,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,22059,TRP53,https://ctdbase.org/detail.go?type=gene&acc=22059,,,22059.0,Trp53,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of TRP53 mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
1336,2010473,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7224,TRPC5,https://ctdbase.org/detail.go?type=gene&acc=7224,,,7224.0,TRPC5,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [gadolinium promotes the reaction [TRPC5 protein results in increased transport of calcium]]|resveratrol promotes the reaction [ascorbic acid inhibits the reaction [gadolinium promotes the reaction [TRPC5 protein results in increased transport of calcium]]]|ascorbic acid inhibits the reaction [hydrogen peroxide promotes the reaction [TRPC5 protein results in increased transport of calcium]],,,PMID:21127073,https://www.ncbi.nlm.nih.gov/pubmed/21127073,21127073,,
1337,2010474,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7442,TRPV1,https://ctdbase.org/detail.go?type=gene&acc=7442,,,7442.0,TRPV1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [hydrogen peroxide results in increased expression of TRPV1 protein],,,PMID:28285367,https://www.ncbi.nlm.nih.gov/pubmed/28285367,28285367,,
1338,2010475,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,55503,TRPV6,https://ctdbase.org/detail.go?type=gene&acc=55503,,,55503.0,TRPV6,13489,Dicentrarchus labrax (European seabass),Ascorbic acid results in decreased expression of TRPV6 mRNA,,,PMID:21281732,https://www.ncbi.nlm.nih.gov/pubmed/21281732,21281732,,
1339,2010476,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7252,TSHB,https://ctdbase.org/detail.go?type=gene&acc=7252,,,7252.0,TSHB,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chlorodiphenyl (54% chlorine) results in decreased expression of TSHB protein],,,PMID:16298753,https://www.ncbi.nlm.nih.gov/pubmed/16298753,16298753,,
1340,2010477,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,706,TSPO,https://ctdbase.org/detail.go?type=gene&acc=706,,,706.0,TSPO,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of TSPO mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1341,2010478,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7276,TTR,https://ctdbase.org/detail.go?type=gene&acc=7276,,,7276.0,TTR,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of TTR mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1342,2010479,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10381,TUBB3,https://ctdbase.org/detail.go?type=gene&acc=10381,,,10381.0,TUBB3,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of TUBB3 protein,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
1343,2010480,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,22166,TXN1,https://ctdbase.org/detail.go?type=gene&acc=22166,,,22166.0,Txn1,10116,Rattus norvegicus (Norway rat),[alpha-tocopherol co-treated with ascorbic acid] inhibits the reaction [arsenite results in increased expression of TXN1 protein],,,PMID:21344382,https://www.ncbi.nlm.nih.gov/pubmed/21344382,21344382,,
1344,2010481,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,22166,TXN1,https://ctdbase.org/detail.go?type=gene&acc=22166,,,22166.0,Txn1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in decreased expression of TXN1 mrna],,,PMID:23470461,https://www.ncbi.nlm.nih.gov/pubmed/23470461,23470461,,
1345,2010482,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,25828,TXN2,https://ctdbase.org/detail.go?type=gene&acc=25828,,,25828.0,TXN2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in decreased expression of TXN2 mrna],,,PMID:23470461,https://www.ncbi.nlm.nih.gov/pubmed/23470461,23470461,,
1346,2010483,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10628,TXNIP,https://ctdbase.org/detail.go?type=gene&acc=10628,,,10628.0,TXNIP,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of TXNIP mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1347,2010484,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7296,TXNRD1,https://ctdbase.org/detail.go?type=gene&acc=7296,,,7296.0,TXNRD1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of TXNRD1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1348,2010485,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10587,TXNRD2,https://ctdbase.org/detail.go?type=gene&acc=10587,,,10587.0,TXNRD2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in decreased expression of TXNRD2 mrna],,,PMID:23470461,https://www.ncbi.nlm.nih.gov/pubmed/23470461,23470461,,
1349,2010486,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7297,TYK2,https://ctdbase.org/detail.go?type=gene&acc=7297,,,7297.0,TYK2,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of TYK2 mRNA,,,PMID:30597948,https://www.ncbi.nlm.nih.gov/pubmed/30597948,30597948,,
1350,2010487,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7299,TYR,https://ctdbase.org/detail.go?type=gene&acc=7299,,,7299.0,TYR,9606,Homo sapiens (human),Ethylenediamine inhibits the reaction [[TYR protein results in increased oxidation of caffeic acid phenethyl ester] which results in increased oxidation of ascorbic acid]|[tyr protein results in increased oxidation of caffeic acid phenethyl ester] which results in increased oxidation of ascorbic acid|glutathione inhibits the reaction [[TYR protein results in increased oxidation of caffeic acid phenethyl ester] which results in increased oxidation of ascorbic acid],,,PMID:20685355,https://www.ncbi.nlm.nih.gov/pubmed/20685355,20685355,,
1351,2010488,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7319,UBE2A,https://ctdbase.org/detail.go?type=gene&acc=7319,,,7319.0,UBE2A,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in decreased expression of UBE2A mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
1352,2010489,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,54575,UGT1A10,https://ctdbase.org/detail.go?type=gene&acc=54575,,,54575.0,UGT1A10,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of UGT1A10 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1353,2010490,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,22236,UGT1A2,https://ctdbase.org/detail.go?type=gene&acc=22236,,,22236.0,Ugt1a2,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of UGT1A2 mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
1354,2010491,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,54578,UGT1A6,https://ctdbase.org/detail.go?type=gene&acc=54578,,,54578.0,UGT1A6,10116,Rattus norvegicus (Norway rat),UGT1A6 protein affects the reaction [methylcholanthrene results in increased abundance of ascorbic acid],,,PMID:8263600,https://www.ncbi.nlm.nih.gov/pubmed/8263600,8263600,,
1355,2010492,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,54600,UGT1A9,https://ctdbase.org/detail.go?type=gene&acc=54600,,,54600.0,UGT1A9,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of UGT1A9 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1356,2010493,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,79799,UGT2A3,https://ctdbase.org/detail.go?type=gene&acc=79799,,,79799.0,UGT2A3,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of UGT2A3 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1357,2010494,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7366,UGT2B15,https://ctdbase.org/detail.go?type=gene&acc=7366,,,7366.0,UGT2B15,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of UGT2B15 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1358,2010495,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7367,UGT2B17,https://ctdbase.org/detail.go?type=gene&acc=7367,,,7367.0,UGT2B17,10116,Rattus norvegicus (Norway rat),UGT2B17 protein affects the reaction [phenobarbital results in increased abundance of ascorbic acid],,,PMID:8263600,https://www.ncbi.nlm.nih.gov/pubmed/8263600,8263600,,
1359,2010496,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,29128,UHRF1,https://ctdbase.org/detail.go?type=gene&acc=29128,,,29128.0,UHRF1,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in decreased expression of UHRF1 mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
1360,2010497,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,115426,UHRF2,https://ctdbase.org/detail.go?type=gene&acc=115426,,,115426.0,UHRF2,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of UHRF2 mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
1361,2010498,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7374,UNG,https://ctdbase.org/detail.go?type=gene&acc=7374,,,7374.0,UNG,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of UNG mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
1362,2010499,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7389,UROD,https://ctdbase.org/detail.go?type=gene&acc=7389,,,7389.0,UROD,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of UROD mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1363,2010500,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7412,VCAM1,https://ctdbase.org/detail.go?type=gene&acc=7412,,,7412.0,VCAM1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of VCAM1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1364,2010501,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7412,VCAM1,https://ctdbase.org/detail.go?type=gene&acc=7412,,,7412.0,VCAM1,9606,Homo sapiens (human),"Ascorbic acid inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of VCAM1 protein]",,,PMID:35349355,https://www.ncbi.nlm.nih.gov/pubmed/35349355,35349355,,
1365,2010502,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,89780,WNT3A,https://ctdbase.org/detail.go?type=gene&acc=89780,,,89780.0,WNT3A,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of TF mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of STMN2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HOXB3 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SOX1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of EGLN3 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of NR2F2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GCLM mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FABP1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HOXA2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FGB mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of EBF3 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of ZFAND2A mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of DCC mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of OTX2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of CDH10 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FLRT3 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of FOXD3 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of IL1R1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of SERPINA1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GPX2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FGF7 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GSTO1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ECSCR mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GRIA2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of TFAP2A mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of DCX mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ABCC1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of SLCO2B1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SRXN1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of CRYAB mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of AMHR2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ELAVL4 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of SCN2A mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of AFP mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of MYL4 mrna|[[ascorbic acid co-treated with ch,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1366,2010503,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7412,VCAM1,https://ctdbase.org/detail.go?type=gene&acc=7412,,,7412.0,VCAM1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [hydrogen peroxide results in increased expression of VCAM1 mrna]|ascorbic acid inhibits the reaction [hydrogen peroxide results in increased expression of VCAM1 protein],,,PMID:25305479,https://www.ncbi.nlm.nih.gov/pubmed/25305479,25305479,,
1367,2010504,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7412,VCAM1,https://ctdbase.org/detail.go?type=gene&acc=7412,,,7412.0,VCAM1,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in decreased expression of VCAM1 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
1368,2010505,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7416,VDAC1,https://ctdbase.org/detail.go?type=gene&acc=7416,,,7416.0,VDAC1,9606,Homo sapiens (human),VDAC1 protein results in increased susceptibility to [arsenic trioxide co-treated with ascorbic acid co-treated with disulfiram],,,PMID:24126434,https://www.ncbi.nlm.nih.gov/pubmed/24126434,24126434,,
1369,2010506,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,564511,VDRB,https://ctdbase.org/detail.go?type=gene&acc=564511,,,564511.0,vdrb,13489,Dicentrarchus labrax (European seabass),Ascorbic acid results in decreased expression of VDRB mRNA,,,PMID:21281732,https://www.ncbi.nlm.nih.gov/pubmed/21281732,21281732,,
1370,2010507,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,9606,Homo sapiens (human),[ascorbic acid co-treated with quartz] results in increased expression of VEGFA mRNA,,,PMID:27381660,https://www.ncbi.nlm.nih.gov/pubmed/27381660,27381660,,
1371,2010508,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,9606,Homo sapiens (human),[juglone co-treated with ascorbic acid] results in decreased expression of VEGFA mRNA,,,PMID:29992683,https://www.ncbi.nlm.nih.gov/pubmed/29992683,29992683,,
1372,2010509,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,51442,VGLL1,https://ctdbase.org/detail.go?type=gene&acc=51442,,,51442.0,VGLL1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of VGLL1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1373,2010510,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7428,VHL,https://ctdbase.org/detail.go?type=gene&acc=7428,,,7428.0,VHL,9606,Homo sapiens (human),[benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with ketoglutaric acids co-treated with ascorbic acid co-treated with ferrous chloride] promotes the reaction [VHL protein binds to HIF1A protein]|manganese chloride inhibits the reaction [[benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with ketoglutaric acids co-treated with ascorbic acid co-treated with ferrous chloride] promotes the reaction [VHL protein binds to HIF1A protein]],,,PMID:19263519,https://www.ncbi.nlm.nih.gov/pubmed/19263519,19263519,,
1374,2010511,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7431,VIM,https://ctdbase.org/detail.go?type=gene&acc=7431,,,7431.0,VIM,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of VIM mRNA,,,PMID:22139585,https://www.ncbi.nlm.nih.gov/pubmed/22139585,22139585,,
1375,2010512,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7432,VIP,https://ctdbase.org/detail.go?type=gene&acc=7432,,,7432.0,VIP,10116,Rattus norvegicus (Norway rat),Ascorbic acid affects the expression of VIP protein,,,PMID:22127604,https://www.ncbi.nlm.nih.gov/pubmed/22127604,22127604,,
1376,2010513,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,55350,VNN3P,https://ctdbase.org/detail.go?type=gene&acc=55350,,,55350.0,VNN3P,9606,Homo sapiens (human),Ascorbic acid affects the expression of VNN3P mrna|ascorbic acid deficiency results in increased expression of VNN3P mRNA,,,PMID:19932582,https://www.ncbi.nlm.nih.gov/pubmed/19932582,19932582,,
1377,2010514,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,27072,VPS41,https://ctdbase.org/detail.go?type=gene&acc=27072,,,27072.0,VPS41,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of VPS41 mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
1378,2010515,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7443,VRK1,https://ctdbase.org/detail.go?type=gene&acc=7443,,,7443.0,VRK1,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in decreased expression of VRK1 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
1379,2010516,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7448,VTN,https://ctdbase.org/detail.go?type=gene&acc=7448,,,7448.0,VTN,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of VTN mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1380,2010517,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7448,VTN,https://ctdbase.org/detail.go?type=gene&acc=7448,,,7448.0,VTN,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of VTN mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
1381,2010518,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7453,WARS1,https://ctdbase.org/detail.go?type=gene&acc=7453,,,7453.0,WARS1,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of WARS1 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
1382,2010519,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10352,WARS2,https://ctdbase.org/detail.go?type=gene&acc=10352,,,10352.0,WARS2,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of WARS2 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
1383,2010520,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7481,WNT11,https://ctdbase.org/detail.go?type=gene&acc=7481,,,7481.0,WNT11,10090,Mus musculus (house mouse),Cadmium sulfate inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of WNT11 mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of WNT11 mRNA,,,PMID:28189605,https://www.ncbi.nlm.nih.gov/pubmed/28189605,28189605,,
1384,2010521,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,25937,WWTR1,https://ctdbase.org/detail.go?type=gene&acc=25937,,,25937.0,WWTR1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of WWTR1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1385,2010522,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7498,XDH,https://ctdbase.org/detail.go?type=gene&acc=7498,,,7498.0,XDH,9913,Bos taurus (cattle),Ascorbic acid results in decreased activity of XDH protein,,,PMID:35395231,https://www.ncbi.nlm.nih.gov/pubmed/35395231,35395231,,
1386,2010523,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7498,XDH,https://ctdbase.org/detail.go?type=gene&acc=7498,,,7498.0,XDH,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [hydrogen peroxide results in increased activity of XDH protein],,,PMID:28285367,https://www.ncbi.nlm.nih.gov/pubmed/28285367,28285367,,
1387,2010524,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7512,XPNPEP2,https://ctdbase.org/detail.go?type=gene&acc=7512,,,7512.0,XPNPEP2,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of XPNPEP2 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1388,2010525,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7515,XRCC1,https://ctdbase.org/detail.go?type=gene&acc=7515,,,7515.0,XRCC1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [reactive oxygen species results in decreased expression of XRCC1 protein]|ascorbic acid inhibits the reaction [fenretinide results in decreased expression of XRCC1 protein],,,PMID:16124896,https://www.ncbi.nlm.nih.gov/pubmed/16124896,16124896,,
1389,2010526,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7515,XRCC1,https://ctdbase.org/detail.go?type=gene&acc=7515,,,7515.0,XRCC1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [XRCC1 mutant form results in increased susceptibility to chromium hexavalent ion],,,PMID:22241526,https://www.ncbi.nlm.nih.gov/pubmed/22241526,22241526,,
1390,2010527,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7531,YWHAE,https://ctdbase.org/detail.go?type=gene&acc=7531,,,7531.0,YWHAE,10090,Mus musculus (house mouse),Ascorbic acid affects the expression of YWHAE protein,,,PMID:19224539,https://www.ncbi.nlm.nih.gov/pubmed/19224539,19224539,,
1391,2010528,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,51201,ZDHHC2,https://ctdbase.org/detail.go?type=gene&acc=51201,,,51201.0,ZDHHC2,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of ZDHHC2 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1392,2010529,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,90637,ZFAND2A,https://ctdbase.org/detail.go?type=gene&acc=90637,,,90637.0,ZFAND2A,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of ZFAND2A mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1393,2010530,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7718,ZNF165,https://ctdbase.org/detail.go?type=gene&acc=7718,,,7718.0,ZNF165,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of ZNF165 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1394,2102665,54670067,IUPHAR/BPS Guide to PHARMACOLOGY,Ascorbic Acid,4532,[14C]ascorbic acid,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4532,1041,Sodium-dependent vitamin C transporter 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1041,Q9UHI7,Solute carrier family 23 member 1,9963.0,SLC23A1,9606,Homo sapiens (human),Binding,,4.19,PMID:11895172,https://www.ncbi.nlm.nih.gov/pubmed/11895172,11895172,,
1395,2102666,54670067,IUPHAR/BPS Guide to PHARMACOLOGY,Ascorbic Acid,4532,[14C]ascorbic acid,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4532,1042,Sodium-dependent vitamin C transporter 2,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1042,Q9UGH3,Solute carrier family 23 member 2,9962.0,SLC23A2,9606,Homo sapiens (human),,,4.19,,,,,
1396,2102667,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0002213,Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3,https://www.drugbank.ca/bio_entities/BE0002213,Q96Q83,Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3,,,9606,Homo sapiens (human),Activator,,,PMID:12486230,https://www.ncbi.nlm.nih.gov/pubmed/12486230,12486230,,"Duncan T, Trewick SC, Koivisto P, Bates PA, Lindahl T, Sedgwick B: Reversal of DNA alkylation damage by two human dioxygenases. Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16660-5. Epub 2002 Dec 16."
1397,2102668,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0001225,Xylose isomerase,https://www.drugbank.ca/bio_entities/BE0001225,P24300,Xylose isomerase,,,1929,Streptomyces rubiginosus,Substrate,,,PMID:11278838,https://www.ncbi.nlm.nih.gov/pubmed/11278838,11278838,,"Li S, Taylor KB, Kelly SJ, Jedrzejas MJ: Vitamin C inhibits the enzymatic activity of Streptococcus pneumoniae hyaluronate lyase. J Biol Chem. 2001 May 4;276(18):15125-30. Epub 2001 Jan 12."
1398,2102669,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0002192,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2",https://www.drugbank.ca/bio_entities/BE0002192,O00469,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2",5352.0,PLOD2,9606,Homo sapiens (human),Cofactor,,,PMID:9344473,https://www.ncbi.nlm.nih.gov/pubmed/9344473,9344473,,"Yeowell HN, Walker LC, Murad S, Pinnell SR: A common duplication in the lysyl hydroxylase gene of patients with Ehlers Danlos syndrome type VI results in preferential stimulation of lysyl hydroxylase activity and mRNA by hydralazine. Arch Biochem Biophys. 1997 Nov 1;347(1):126-31. doi: 10.1006/abbi.1997.0319."
1399,2102670,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0002117,"Phytanoyl-CoA dioxygenase, peroxisomal",https://www.drugbank.ca/bio_entities/BE0002117,O14832,"Phytanoyl-CoA dioxygenase, peroxisomal",5264.0,PHYH,9606,Homo sapiens (human),Cofactor,,,PMID:11555634,https://www.ncbi.nlm.nih.gov/pubmed/11555634,11555634,,"Mukherji M, Chien W, Kershaw NJ, Clifton IJ, Schofield CJ, Wierzbicki AS, Lloyd MD: Structure-function analysis of phytanoyl-CoA 2-hydroxylase mutations causing Refsum's disease. Hum Mol Genet. 2001 Sep 1;10(18):1971-82. doi: 10.1093/hmg/10.18.1971."
1400,2102671,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0002195,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3",https://www.drugbank.ca/bio_entities/BE0002195,O60568,Multifunctional procollagen lysine hydroxylase and glycosyltransferase LH3,8985.0,PLOD3,9606,Homo sapiens (human),Cofactor,,,PMID:9344473,https://www.ncbi.nlm.nih.gov/pubmed/9344473,9344473,,"Yeowell HN, Walker LC, Murad S, Pinnell SR: A common duplication in the lysyl hydroxylase gene of patients with Ehlers Danlos syndrome type VI results in preferential stimulation of lysyl hydroxylase activity and mRNA by hydralazine. Arch Biochem Biophys. 1997 Nov 1;347(1):126-31. doi: 10.1006/abbi.1997.0319."
1401,2102672,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0002197,Gamma-butyrobetaine dioxygenase,https://www.drugbank.ca/bio_entities/BE0002197,O75936,Gamma-butyrobetaine dioxygenase,8424.0,BBOX1,9606,Homo sapiens (human),Cofactor,,,PMID:6432788|PMID:10709635|PMID:1962562,https://www.ncbi.nlm.nih.gov/pubmed/6432788|https://www.ncbi.nlm.nih.gov/pubmed/10709635|https://www.ncbi.nlm.nih.gov/pubmed/1962562,6432788|10709635|1962562,,"Dunn WA, Rettura G, Seifter E, Englard S: Carnitine biosynthesis from gamma-butyrobetaine and from exogenous protein-bound 6-N-trimethyl-L-lysine by the perfused guinea pig liver. Effect of ascorbate deficiency on the in situ activity of gamma-butyrobetaine hydroxylase. J Biol Chem. 1984 Sep 10;259(17):10764-70.|Vaz FM, van Gool S, Ofman R, IJlst L, Wanders RJ: Carnitine biosynthesis. Purification of gamma-butyrobetaine hydroxylase from rat liver. Adv Exp Med Biol. 1999;466:117-24.|Rebouche CJ: Ascorbic acid and carnitine biosynthesis. Am J Clin Nutr. 1991 Dec;54(6 Suppl):1147S-1152S."
1402,2102673,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0000138,Dopamine beta-hydroxylase,https://www.drugbank.ca/bio_entities/BE0000138,P09172,Dopamine beta-hydroxylase,1621.0,DBH,9606,Homo sapiens (human),Cofactor,,,PMID:9505234|PMID:1894598|PMID:10947967|PMID:3097015,https://www.ncbi.nlm.nih.gov/pubmed/9505234|https://www.ncbi.nlm.nih.gov/pubmed/1894598|https://www.ncbi.nlm.nih.gov/pubmed/10947967|https://www.ncbi.nlm.nih.gov/pubmed/3097015,9505234|1894598|10947967|3097015,,"Suzuki E, Kurata T, Shibata M, Mori M, Arakawa N: Activities of D- and L-xyloascorbic acid and D- and L-araboascorbic acid as a cofactor for dopamine beta-hydroxylase reaction. J Nutr Sci Vitaminol (Tokyo). 1997 Oct;43(5):491-6.|Pettingill TM, Strange RW, Blackburn NJ: Carbonmonoxy dopamine beta-hydroxylase. Structural characterization by Fourier transform infrared, fluorescence, and x-ray absorption spectroscopy. J Biol Chem. 1991 Sep 15;266(26):16996-7003.|Feng J, Shi J, Sirimanne SR, Mounier-Lee CE, May SW: Kinetic and stereochemical studies on novel inactivators of C-terminal amidation. Biochem J. 2000 Sep 1;350 Pt 2:521-30.|Menniti FS, Knoth J, Diliberto EJ Jr: Role of ascorbic acid in dopamine beta-hydroxylation. The endogenous enzyme cofactor and putative electron donor for cofactor regeneration. J Biol Chem. 1986 Dec 25;261(36):16901-8."
1403,2102674,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0001361,Hyaluronate lyase,https://www.drugbank.ca/bio_entities/BE0001361,Q54873,Hyaluronate lyase,,,170187,Streptococcus pneumoniae TIGR4,Inhibitor,,,PMID:11278838|PMID:14567553|PMID:15322107,https://www.ncbi.nlm.nih.gov/pubmed/11278838|https://www.ncbi.nlm.nih.gov/pubmed/14567553|https://www.ncbi.nlm.nih.gov/pubmed/15322107,11278838|14567553|15322107,,"Li S, Taylor KB, Kelly SJ, Jedrzejas MJ: Vitamin C inhibits the enzymatic activity of Streptococcus pneumoniae hyaluronate lyase. J Biol Chem. 2001 May 4;276(18):15125-30. Epub 2001 Jan 12.|Okorukwu ON, Vercruysse KP: Effects of ascorbic acid and analogs on the activity of testicular hyaluronidase and hyaluronan lyase on hyaluronan. J Enzyme Inhib Med Chem. 2003 Aug;18(4):377-82.|Botzki A, Rigden DJ, Braun S, Nukui M, Salmen S, Hoechstetter J, Bernhardt G, Dove S, Jedrzejas MJ, Buschauer A: L-Ascorbic acid 6-hexadecanoate, a potent hyaluronidase inhibitor. X-ray structure and molecular modeling of enzyme-inhibitor complexes. J Biol Chem. 2004 Oct 29;279(44):45990-7. Epub 2004 Aug 18."
1404,2102675,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0002200,Peptidyl-glycine alpha-amidating monooxygenase,https://www.drugbank.ca/bio_entities/BE0002200,P19021,Peptidyl-glycine alpha-amidating monooxygenase,5066.0,PAM,9606,Homo sapiens (human),Cofactor,,,PMID:17570561|PMID:16773376|PMID:17002377|PMID:9211255,https://www.ncbi.nlm.nih.gov/pubmed/17570561|https://www.ncbi.nlm.nih.gov/pubmed/16773376|https://www.ncbi.nlm.nih.gov/pubmed/17002377|https://www.ncbi.nlm.nih.gov/pubmed/9211255,17570561|16773376|17002377|9211255,,"Romero I, Teresa Sanchez-Ballesta M, Maldonado R, Isabel Escribano M, Merodio C: Anthocyanin, antioxidant activity and stress-induced gene expression in high CO2-treated table grapes stored at low temperature. J Plant Physiol. 2008;165(5):522-30. Epub 2007 Jun 13.|Floryszak-Wieczorek J, Milczarek G, Arasimowicz M, Ciszewski A: Do nitric oxide donors mimic endogenous NO-related response in plants? Planta. 2006 Nov;224(6):1363-72. Epub 2006 Jun 14.|Crespo A, Marti MA, Roitberg AE, Amzel LM, Estrin DA: The catalytic mechanism of peptidylglycine alpha-hydroxylating monooxygenase investigated by computer simulation. J Am Chem Soc. 2006 Oct 4;128(39):12817-28.|Kolhekar AS, Mains RE, Eipper BA: Peptidylglycine alpha-amidating monooxygenase: an ascorbate-requiring enzyme. Methods Enzymol. 1997;279:35-43. doi: 10.1016/s0076-6879(97)79007-4."
1405,2102676,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0002208,Prolyl 3-hydroxylase 3,https://www.drugbank.ca/bio_entities/BE0002208,Q8IVL6,Prolyl 3-hydroxylase 3,10536.0,P3H3,9606,Homo sapiens (human),Cofactor,,,PMID:29289682,https://www.ncbi.nlm.nih.gov/pubmed/29289682,29289682,,"Osipyants AI, Poloznikov AA, Smirnova NA, Hushpulian DM, Khristichenko AY, Chubar TA, Zakhariants AA, Ahuja M, Gaisina IN, Thomas B, Brown AM, Gazaryan IG, Tishkov VI: L-ascorbic acid: A true substrate for HIF prolyl hydroxylase? Biochimie. 2018 Apr;147:46-54. doi: 10.1016/j.biochi.2017.12.011. Epub 2017 Dec 28."
1406,2102677,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0002206,Prolyl 3-hydroxylase 2,https://www.drugbank.ca/bio_entities/BE0002206,Q8IVL5,Prolyl 3-hydroxylase 2,55214.0,P3H2,9606,Homo sapiens (human),Cofactor,,,PMID:29289682,https://www.ncbi.nlm.nih.gov/pubmed/29289682,29289682,,"Osipyants AI, Poloznikov AA, Smirnova NA, Hushpulian DM, Khristichenko AY, Chubar TA, Zakhariants AA, Ahuja M, Gaisina IN, Thomas B, Brown AM, Gazaryan IG, Tishkov VI: L-ascorbic acid: A true substrate for HIF prolyl hydroxylase? Biochimie. 2018 Apr;147:46-54. doi: 10.1016/j.biochi.2017.12.011. Epub 2017 Dec 28."
1407,2102678,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0000060,Prolyl 4-hydroxylase subunit alpha-1,https://www.drugbank.ca/bio_entities/BE0000060,P13674,Prolyl 4-hydroxylase subunit alpha-1,5033.0,P4HA1,9606,Homo sapiens (human),Cofactor,,,PMID:29289682,https://www.ncbi.nlm.nih.gov/pubmed/29289682,29289682,,"Osipyants AI, Poloznikov AA, Smirnova NA, Hushpulian DM, Khristichenko AY, Chubar TA, Zakhariants AA, Ahuja M, Gaisina IN, Thomas B, Brown AM, Gazaryan IG, Tishkov VI: L-ascorbic acid: A true substrate for HIF prolyl hydroxylase? Biochimie. 2018 Apr;147:46-54. doi: 10.1016/j.biochi.2017.12.011. Epub 2017 Dec 28."
1408,2102679,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0002203,2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2,https://www.drugbank.ca/bio_entities/BE0002203,Q6N063,2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2,79676.0,OGFOD2,9606,Homo sapiens (human),Cofactor,,,PMID:25540771,https://www.ncbi.nlm.nih.gov/pubmed/25540771,25540771,,"Kuiper C, Vissers MC: Ascorbate as a co-factor for fe- and 2-oxoglutarate dependent dioxygenases: physiological activity in tumor growth and progression. Front Oncol. 2014 Dec 10;4:359. doi: 10.3389/fonc.2014.00359. eCollection 2014."
1409,2102680,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0002215,Lysine-specific demethylase 5D,https://www.drugbank.ca/bio_entities/BE0002215,Q9BY66,Lysine-specific demethylase 5D,8284.0,KDM5D,9606,Homo sapiens (human),Cofactor,,,PMID:17320162,https://www.ncbi.nlm.nih.gov/pubmed/17320162,17320162,,"Lee MG, Norman J, Shilatifard A, Shiekhattar R: Physical and functional association of a trimethyl H3K4 demethylase and Ring6a/MBLR, a polycomb-like protein. Cell. 2007 Mar 9;128(5):877-87. Epub 2007 Feb 22."
1410,2102681,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0002205,DNA oxidative demethylase ALKBH2,https://www.drugbank.ca/bio_entities/BE0002205,Q6NS38,DNA oxidative demethylase ALKBH2,121642.0,ALKBH2,9606,Homo sapiens (human),Activator,,,PMID:12486230,https://www.ncbi.nlm.nih.gov/pubmed/12486230,12486230,,"Duncan T, Trewick SC, Koivisto P, Bates PA, Lindahl T, Sedgwick B: Reversal of DNA alkylation damage by two human dioxygenases. Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16660-5. Epub 2002 Dec 16."
1411,2102682,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0002210,Prolyl 3-hydroxylase OGFOD1,https://www.drugbank.ca/bio_entities/BE0002210,Q8N543,Prolyl 3-hydroxylase OGFOD1,55239.0,OGFOD1,9606,Homo sapiens (human),Cofactor,,,PMID:25540771,https://www.ncbi.nlm.nih.gov/pubmed/25540771,25540771,,"Kuiper C, Vissers MC: Ascorbate as a co-factor for fe- and 2-oxoglutarate dependent dioxygenases: physiological activity in tumor growth and progression. Front Oncol. 2014 Dec 10;4:359. doi: 10.3389/fonc.2014.00359. eCollection 2014."
1412,2102683,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0002223,Transmembrane prolyl 4-hydroxylase,https://www.drugbank.ca/bio_entities/BE0002223,Q9NXG6,Transmembrane prolyl 4-hydroxylase,54681.0,P4HTM,9606,Homo sapiens (human),Cofactor,,,PMID:27183028,https://www.ncbi.nlm.nih.gov/pubmed/27183028,27183028,,"Vasta JD, Raines RT: Human Collagen Prolyl 4-Hydroxylase Is Activated by Ligands for Its Iron Center. Biochemistry. 2016 Jun 14;55(23):3224-33. doi: 10.1021/acs.biochem.6b00251. Epub 2016 May 31."
1413,2102684,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0002217,Egl nine homolog 1,https://www.drugbank.ca/bio_entities/BE0002217,Q9GZT9,Egl nine homolog 1,54583.0,EGLN1,9606,Homo sapiens (human),Cofactor,,,PMID:29567393,https://www.ncbi.nlm.nih.gov/pubmed/29567393,29567393,,Smirnoff N: Ascorbic acid metabolism and functions: A comparison of plants and mammals. Free Radic Biol Med. 2018 Jul;122:116-129. doi: 10.1016/j.freeradbiomed.2018.03.033. Epub 2018 Mar 20.
1414,2102685,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0002211,Egl nine homolog 2,https://www.drugbank.ca/bio_entities/BE0002211,Q96KS0,Prolyl hydroxylase EGLN2,112398.0,EGLN2,9606,Homo sapiens (human),Cofactor,,,PMID:17627474|PMID:17627521|PMID:29567393,https://www.ncbi.nlm.nih.gov/pubmed/17627474|https://www.ncbi.nlm.nih.gov/pubmed/17627521|https://www.ncbi.nlm.nih.gov/pubmed/29567393,17627474|17627521|29567393,,"Nytko KJ, Spielmann P, Camenisch G, Wenger RH, Stiehl DP: Regulated function of the prolyl-4-hydroxylase domain (PHD) oxygen sensor proteins. Antioxid Redox Signal. 2007 Sep;9(9):1329-38.|Bruegge K, Jelkmann W, Metzen E: Hydroxylation of hypoxia-inducible transcription factors and chemical compounds targeting the HIF-alpha hydroxylases. Curr Med Chem. 2007;14(17):1853-62.|Smirnoff N: Ascorbic acid metabolism and functions: A comparison of plants and mammals. Free Radic Biol Med. 2018 Jul;122:116-129. doi: 10.1016/j.freeradbiomed.2018.03.033. Epub 2018 Mar 20."
1415,2102686,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0002219,Egl nine homolog 3,https://www.drugbank.ca/bio_entities/BE0002219,Q9H6Z9,Prolyl hydroxylase EGLN3,112399.0,EGLN3,9606,Homo sapiens (human),Cofactor,,,PMID:29567393,https://www.ncbi.nlm.nih.gov/pubmed/29567393,29567393,,Smirnoff N: Ascorbic acid metabolism and functions: A comparison of plants and mammals. Free Radic Biol Med. 2018 Jul;122:116-129. doi: 10.1016/j.freeradbiomed.2018.03.033. Epub 2018 Mar 20.
1416,2102687,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0001979,"Thioredoxin reductase 1, cytoplasmic",https://www.drugbank.ca/bio_entities/BE0001979,Q16881,"Thioredoxin reductase 1, cytoplasmic",7296.0,TXNRD1,9606,Homo sapiens (human),Substrate,,,PMID:26779027,https://www.ncbi.nlm.nih.gov/pubmed/26779027,26779027,,"Figueroa-Mendez R, Rivas-Arancibia S: Vitamin C in Health and Disease: Its Role in the Metabolism of Cells and Redox State in the Brain. Front Physiol. 2015 Dec 23;6:397. doi: 10.3389/fphys.2015.00397. eCollection 2015."
1417,2102688,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0002202,Prolyl 3-hydroxylase 1,https://www.drugbank.ca/bio_entities/BE0002202,Q32P28,Prolyl 3-hydroxylase 1,64175.0,P3H1,9606,Homo sapiens (human),Cofactor,,,PMID:29289682,https://www.ncbi.nlm.nih.gov/pubmed/29289682,29289682,,"Osipyants AI, Poloznikov AA, Smirnova NA, Hushpulian DM, Khristichenko AY, Chubar TA, Zakhariants AA, Ahuja M, Gaisina IN, Thomas B, Brown AM, Gazaryan IG, Tishkov VI: L-ascorbic acid: A true substrate for HIF prolyl hydroxylase? Biochimie. 2018 Apr;147:46-54. doi: 10.1016/j.biochi.2017.12.011. Epub 2017 Dec 28."
1418,2102689,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0000168,Solute carrier family 23 member 1,https://www.drugbank.ca/bio_entities/BE0000168,Q9UHI7,Solute carrier family 23 member 1,9963.0,SLC23A1,9606,Homo sapiens (human),Substrate,,,PMID:10331392|PMID:16011461|PMID:17008880|PMID:17258485|PMID:17541511|PMID:17645691|PMID:17664139,https://www.ncbi.nlm.nih.gov/pubmed/10331392|https://www.ncbi.nlm.nih.gov/pubmed/16011461|https://www.ncbi.nlm.nih.gov/pubmed/17008880|https://www.ncbi.nlm.nih.gov/pubmed/17258485|https://www.ncbi.nlm.nih.gov/pubmed/17541511|https://www.ncbi.nlm.nih.gov/pubmed/17645691|https://www.ncbi.nlm.nih.gov/pubmed/17664139,10331392|16011461|17008880|17258485|17541511|17645691|17664139,,"Tsukaguchi H, Tokui T, Mackenzie B, Berger UV, Chen XZ, Wang Y, Brubaker RF, Hediger MA: A family of mammalian Na+-dependent L-ascorbic acid transporters. Nature. 1999 May 6;399(6731):70-5.|Wilson JX: Regulation of vitamin C transport. Annu Rev Nutr. 2005;25:105-25. doi: 10.1146/annurev.nutr.25.050304.092647.|Kang JS, Kim HN, Jung da J, Kim JE, Mun GH, Kim YS, Cho D, Shin DH, Hwang YI, Lee WJ: Regulation of UVB-induced IL-8 and MCP-1 production in skin keratinocytes by increasing vitamin C uptake via the redistribution of SVCT-1 from the cytosol to the membrane. J Invest Dermatol. 2007 Mar;127(3):698-706. Epub 2006 Sep 28.|Johnston L, Laverty G: Vitamin C transport and SVCT1 transporter expression in chick renal proximal tubule cells in culture. Comp Biochem Physiol A Mol Integr Physiol. 2007 Mar;146(3):327-34. Epub 2006 Dec  5.|Savini I, Rossi A, Pierro C, Avigliano L, Catani MV: SVCT1 and SVCT2: key proteins for vitamin C uptake. Amino Acids. 2008 Apr;34(3):347-55. Epub 2007 Jun 1.|Perez MJ, Castano B, Gonzalez-Buitrago JM, Marin JJ: Multiple protective effects of melatonin against maternal cholestasis-induced oxidative stress and apoptosis in the rat fetal liver-placenta-maternal liver trio. J Pineal Res. 2007 Sep;43(2):130-9.|Steiling H, Longet K, Moodycliffe A, Mansourian R, Bertschy E, Smola H, Mauch C, Williamson G: Sodium-dependent vitamin C transporter isoforms in skin: Distribution, kinetics, and effect of UVB-induced oxidative stress. Free Radic Biol Med. 2007 Sep 1;43(5):752-62. Epub 2007 May 10."
1419,2102690,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0000087,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1",https://www.drugbank.ca/bio_entities/BE0000087,Q02809,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1",5351.0,PLOD1,9606,Homo sapiens (human),Cofactor,,,PMID:17100196|PMID:11752352|PMID:9344473,https://www.ncbi.nlm.nih.gov/pubmed/17100196|https://www.ncbi.nlm.nih.gov/pubmed/11752352|https://www.ncbi.nlm.nih.gov/pubmed/9344473,17100196|11752352|9344473,,"Salavoura K, Valari M, Kolialexi A, Mavrou A, Kitsiou S: A case of Ehlers Danlos syndrome type VI. Genet Couns. 2006;17(3):291-4.|Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.|Yeowell HN, Walker LC, Murad S, Pinnell SR: A common duplication in the lysyl hydroxylase gene of patients with Ehlers Danlos syndrome type VI results in preferential stimulation of lysyl hydroxylase activity and mRNA by hydralazine. Arch Biochem Biophys. 1997 Nov 1;347(1):126-31. doi: 10.1006/abbi.1997.0319."
1420,2102717,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0009869,Solute carrier family 23 member 2,https://www.drugbank.ca/bio_entities/BE0009869,Q9UGH3,Solute carrier family 23 member 2,9962.0,SLC23A2,9606,Homo sapiens (human),Substrate,,,PMID:16011461,https://www.ncbi.nlm.nih.gov/pubmed/16011461,16011461,,Wilson JX: Regulation of vitamin C transport. Annu Rev Nutr. 2005;25:105-25. doi: 10.1146/annurev.nutr.25.050304.092647.
1421,2102718,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0001057,"Solute carrier family 2, facilitated glucose transporter member 1",https://www.drugbank.ca/bio_entities/BE0001057,P11166,"Solute carrier family 2, facilitated glucose transporter member 1",6513.0,SLC2A1,9606,Homo sapiens (human),Substrate,,,PMID:16011461,https://www.ncbi.nlm.nih.gov/pubmed/16011461,16011461,,Wilson JX: Regulation of vitamin C transport. Annu Rev Nutr. 2005;25:105-25. doi: 10.1146/annurev.nutr.25.050304.092647.
1422,2102719,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0004707,"Solute carrier family 2, facilitated glucose transporter member 3",https://www.drugbank.ca/bio_entities/BE0004707,P11169,"Solute carrier family 2, facilitated glucose transporter member 3",6515.0,SLC2A3,9606,Homo sapiens (human),Substrate,,,PMID:16011461,https://www.ncbi.nlm.nih.gov/pubmed/16011461,16011461,,Wilson JX: Regulation of vitamin C transport. Annu Rev Nutr. 2005;25:105-25. doi: 10.1146/annurev.nutr.25.050304.092647.
1423,2102720,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0000893,"Solute carrier family 2, facilitated glucose transporter member 4",https://www.drugbank.ca/bio_entities/BE0000893,P14672,"Solute carrier family 2, facilitated glucose transporter member 4",6517.0,SLC2A4,9606,Homo sapiens (human),Substrate,,,PMID:16011461,https://www.ncbi.nlm.nih.gov/pubmed/16011461,16011461,,Wilson JX: Regulation of vitamin C transport. Annu Rev Nutr. 2005;25:105-25. doi: 10.1146/annurev.nutr.25.050304.092647.
1424,2102721,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0000530,Serum albumin,https://www.drugbank.ca/bio_entities/BE0000530,P02768,Albumin,213.0,ALB,9606,Homo sapiens (human),Binder,,,PMID:12090938|PMID:6735617,https://www.ncbi.nlm.nih.gov/pubmed/12090938|https://www.ncbi.nlm.nih.gov/pubmed/6735617,12090938|6735617,,"Lozinsky E, Novoselsky A, Glaser R, Shames AI, Likhtenshtein GI, Meyerstein D: Effect of ionic strength on the binding of ascorbate to albumin. Biochim Biophys Acta. 2002 Jul 3;1571(3):239-44. doi: 10.1016/s0304-4165(02)00257-x.|Oelrichs BA, Kratzing CC, Kelly JD, Winzor DJ: The binding of ascorbate to bovine serum albumin. Int J Vitam Nutr Res. 1984;54(1):61-4."
1425,2102722,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0002221,"Trimethyllysine dioxygenase, mitochondrial",https://www.drugbank.ca/bio_entities/BE0002221,Q9NVH6,"Trimethyllysine dioxygenase, mitochondrial",55217.0,TMLHE,9606,Homo sapiens (human),Cofactor,,,PMID:17944936,https://www.ncbi.nlm.nih.gov/pubmed/17944936,17944936,,"van Vlies N, Ofman R, Wanders RJ, Vaz FM: Submitochondrial localization of 6-N-trimethyllysine dioxygenase - implications for carnitine biosynthesis. FEBS J. 2007 Nov;274(22):5845-51. doi: 10.1111/j.1742-4658.2007.06108.x. Epub 2007 Oct 18."
